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The research conducted for this thesis has led to the development of an intramolecular gold-
catalysed direct arylation protocol whereby tethered arenes and aryltrimethylsilanes are 
coupled (Scheme 1). In Chapter 1, the key synthetic and mechanistic studies that have 
ultimately led to the conception of this project are introduced. In Chapter 2, the substrate scope 
of intramolecular direct arylation is assessed. The reaction tolerates a wide range of substrates 
with tether lengths between one and five units (containing C, N and O) generating 5- to 9-
membered rings. Substrates that lead to 5-membered rings (1  2) can tolerate a broad 
electronic range of substituents and proceed under the mildest reaction conditions (≤ 1 mol% 
catalyst, room temperature) and with excellent yields. A smaller collection of examples is 
demonstrated for the cyclisation to 6- and 7- membered rings (3  4, 5  6), but no heating is 
required and good yields are maintained throughout the series. The synthetically challenging 
synthesis of 8- and 9- membered rings (7  8, 9  10) is successful, albeit with slightly more 
forcing conditions (4 mol%, up to 50 °C). The methodology was subsequently applied in the 
successful 10-step synthesis of natural product allocolchicine 11. 
 
Scheme 1. Intramolecular gold-catalysed direct arylation. 
In Chapter 3, the operative reaction mechanism is elucidated. Reaction monitoring techniques 
allowed for the detailed study of linear free energy relationships (LFERs) and kinetic isotope 
effects (KIEs), which in turn allowed for deduction of the reaction turnover-limiting step 
(TLS) and thus the first quantitative experimental data on the effects of aryl electron demand 
and conformational freedom on the rate of reductive elimination from diarylgold(III) species. 
The mechanistic investigation led to the observation of complex kinetic profiles for specific 
substrates. The origin of these unusual effects is the focus of Chapter 4. By combining 
iii 
 
experiment with kinetic simulation, an off-cycle catalyst inhibition pathway was identified and 
the understanding of this process allowed for a re-optimisation of reaction conditions. 
In Chapter 5, the general kinetic parameters that could govern any domino reaction combining 
inter- and intramolecular direct arylation are deduced through kinetic analysis and simulation 
of hypothetical systems. The results of the kinetic analysis were proved experimentally 
through the successful combination of intra- and intermolecular gold-catalysed direct 
arylation. The products of intramolecular cyclisation 2, generated in-situ, are demonstrated to 
couple with intermolecular aryltrimethylsilanes 12, resulting in a rapid increase in molecular 
complexity from simple substrates in one pot. 
Lay Summary 
Despite the long-held belief that gold is unreactive, gold complexes which arise from the 
oxidation of elemental gold possess unique and potent reactivity. Indeed, over the past 2 
decades, synthetic chemists across the globe have demonstrated numerous applications of gold 
as a catalyst to construct complex and useful molecules. Catalysts are molecules added to a 
reaction, to either speed it up, or to allow the reaction to occur in the first place, and remain 
unchanged at the end of the reaction. Catalysis is of enormous industrial significance, 
particularly in a day and age where consideration of environmental impact is of fundamental 
importance. One of the most significant classes of catalytic reactions used in chemistry is 
cross-coupling, which allows for the facile and rapid construction of very important molecular 
scaffolds. However, traditional cross-coupling reactions have a fundamental flaw, and that is 
significant waste is generated.  
Previous research in the Lloyd-Jones research group has described a gold-catalysed approach 
to cross-coupling, rivalling traditional approaches through a reduced environmental impact 
resulting from minimised waste, as well as milder operative reaction conditions. This research 
was primarily on the intermolecular reaction, which is the formation of a single molecule from 
two components. This thesis primarily describes the development of the intramolecular 
variant, which is the transformation of one molecule to another. Rendering the reaction 
intramolecular has led to fundamental new insights, not only with respect to novel reactivity 
which was exploited in the synthesis of a biologically active natural product, but also through 
a greater understanding of the reaction mechanism. The mechanistic investigation was of 
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1.1 Biaryl Synthesis via Transition-Metal Catalysed Cross-
Coupling 
Organic chemistry revolves around the synthesis of carbon based compounds, the building 
blocks of all known life. Often inspired by nature, the role of the synthetic organic chemist is 
to construct molecules through the breaking and forming of new chemical bonds. Synthetic 
chemistry has undoubtedly shaped modern society, leading to a thriving pharmaceutical 
industry tackling the challenges of modern medicine, and through to advances in 
agrochemicals in the fight to ensure food security.[1] The bioactive molecules upon which these 
industries rely can vary significantly in structure, they can be simple or complex, derived from 
nature or entirely synthetic, but one common feature that many of these molecules possess is 
the presence of an aromatic moiety. In drug development and medicinal chemistry, aromatic 
groups are “by far the most essential pharmacophores”, and greater than 75% of recent phase 
III or marketed pharmaceuticals contain at least one aromatic group.[2] It is therefore 
unsurprising that significant efforts have gone into the development of strategies to 
functionalise aromatic molecules, and, in particular, to form new carbon-carbon bonds. A 
landmark development in the synthesis of C-C bonds in aromatic molecules was the advent of 
transition-metal catalysed coupling reactions. In a relatively short time-frame, methodologies 
developed from simple homocoupling protocols under forcing conditions, to cross-coupling 
procedures with near perfect selectivity and minimal catalyst loadings.[3] Although other 
metals such as Cu,[4] Ni[5–10] and Fe[11–14] are competent catalysts in certain cross-coupling 
reactions, it is palladium that transcends the field.[15] The pioneering scientists who led the 
advance of palladium-catalysed cross couplings in organic synthesis, Negishi, Heck and 
Suzuki, were rewarded for their efforts in the award of the 2010 Nobel prize for chemistry.[3]  
One of the key structural motifs constructed through transition-metal-catalysed cross-coupling 
is the biaryl, which is ubiquitous in nature and industry. It is found in many bioactive 
molecules suitable for agrochemical and medicinal purposes, as well as being the key 







Figure 1.1. Industrially important biaryl containing molecules. 
The basic strategy to synthesise biaryls using palladium catalysis involves the coupling of an 
aryl (pseudo)halide with an aryl organometallic reagent, with the identity of the organometallic 
reagent distinguishing between the myriad available protocols.[5,9,10,17,18] The general 
mechanism involves the oxidative addition of the aryl (pseudo)halide to the Pd(0) species, 
followed by transmetalation of the organometallic coupling partner yielding a (diaryl)Pd(II) 
complex which can reductively eliminate to give the desired biaryl and regenerate the Pd(0) 
species completing the cycle (Scheme 1.1). 
                  
Scheme 1.1. General palladium-catalysed cross-coupling catalytic cycle. 
1.1.1 Direct Arylation 
Whilst traditional cross-coupling methods are widely employed and continuously studied, a 
new phase of development has begun, where there is equal emphasis on efficiency, particularly 
with regards to step economy and streamlined synthesis. Traditional cross-coupling methods 
are inherently wasteful as both coupling partners require pre-functionalisation, which may 
require multiple tedious steps, only for these activated functional groups to ultimately form 





functionalisation and instead considering the aryl C-H bond as a functional group (Scheme 
1.2).[19–21] The ultimate strategy would be the ability to cross-couple two unactivated arenes in 
a formal dehydrogenative coupling reaction. This is a formidable challenge, however, as 
discrimination between multiple C-H bonds is non-trivial and the possibility for poor 
regioselectivity is high. Although some notable approaches have been developed, they 
currently lack generality.[22] An alternative approach which has gained much traction in recent 
years is that of direct arylation, where one of the pre-functionalised coupling partners is 
replaced with a simple arene, thus significantly improving the likelihood for acceptable 
regioselectivity. There are two approaches, one were the organometallic is replaced and a 
catalytic cycle resembling Scheme 1.1 will occur with Ar-M replaced with Ar-H, or the other 
where the halide can be replaced, and in this case an external oxidant will be required to 
complete the catalytic cycle. 
 
Scheme 1.2. Comparison between traditional cross-coupling and C-H functionalisation 
methods.  
 
1.1.2 Mechanism of C-H Metalation 
A major driving force in the development and optimisation of novel methodologies is 
mechanistic understanding. This is certainly true in the field of direct arylation where seminal 





impossible.[23] One of the key questions in a direct arylation reaction is the mechanism by 
which the C-H bond is replaced with a carbon-metal bond , which is commonly referred to as 
the C-H activation step. The most common modes of C-H activation postulated in direct 
arylation reactions are, oxidative addition, sigma-bond metathesis (σBM), electrophilic 
metalation (electrophilic aromatic substitution- SEAr), and concerted metalation-
deprotonation (CMD), Scheme 1.3.[24]   
 
Scheme 1.3. Mechanisms for C-H bond metalation.[25] 
Oxidative Addition 
Oxidative addition is typical for electron-rich, low-valent complexes of the late transition 
metals.[26] For example, rhodium complexes were one of the first shown to be capable of 
oxidative addition across both arene and alkane C-H bonds. A thorough mechanistic 
investigation across several research groups unveiled the mechanism of C-H bond metalation 
of benzene from 13 (Scheme 1.4). Irradiation of 13 results in the elimination of dihydrogen 
and formation of an unstable, coordinatively unsaturated 16-electron complex 14. Rapid π-







Scheme 1.4. Mechanism of oxidative for low-valent ruthenium complex.   
Despite a thorough understanding of oxidative addition across C-H bonds, aside from limited 
examples, it is not normally the mechanism of C-H bond activation in catalytic direct arylation 
reactions.  
Sigma-Bond Metathesis 
In contrast, σBM is typically restricted to low valent early transition metals and is characterised 
by a 4-membered transition state. In particular, it is a mechanistic pathway for metals that 
cannot undergo oxidative addition.[26] Whilst σBM has been invoked in certain catalytic direct 
arylation reactions of late transition metals, evidence is low and other processes (such as CMD, 
vide infra) are proposed preferentially. 
Electrophilic Metalation 
Electrophilic metalation is one of the most commonly invoked mechanisms for arene 
metalation and is typically the proposed mechanism in the reaction of electron-rich arenes with 
late transition- and main-group metals in high oxidation states. The reaction pathway consists 
of a π-complexation of the arene to the metal, followed by formation of a Wheland 
intermediate (WI), which upon rearomatisation forms the aryl-metal species. Depending on 
the kinetically significant step during metalation, Hammett linear free energy relationships 
(LFER) correlate against σ or σ+ and typically the reaction constants (ρ/ρ+) are large and 
negative. Additionally, regioselectivity is predictable with ortho/para selectivity for arenes 
bearing EDGs or halogens and meta selectivity for those bearing EWGs. The presence of a 
1H/2H kinetic isotope effect is entirely dependent on the rate-limiting event in stoichiometric 
studies of metalation. If it is the π-complexation, a significant KIE is not expected as there is 
no change in hybridisation nor is a C-H bond broken during this step. If Wheland intermediate 
formation is rate-limiting, then an inverse secondary KIE may be expected due to the change 
in hybridisation from sp2 to sp3 at the reacting carbon. If rearomatisation is found to be rate-
limiting, a primary KIE can be expected. 
An example of electrophilic metalation is the reaction of arenes with cationic, highly 
electrophilic Rh(III) species. Cationic octaethylporphyrinatorhodium(III) complex 18, which 





1.5). A reaction constant of ρ = −5.43 was obtained, alongside no measurable kinetic isotope 
effect. Regioselectivity was high for the para isomer for the reaction of anisole, toluene and 
chlorobenzene, whereas methyl benzoate was meta selective. The authors concluded that these 
results were consistent with an electrophilic metalation, with a rate limiting π-complexation.[34]   
 
Scheme 1.5. Electrophilic metalation by a Rh(III) complex. 
Concerted Metalation Deprotonation 
For many years, catalysed direct arylation reactions were primarily proposed to proceed via 
SEAr type mechanisms, particularly with palladium, which has a significant history of 
catalysing direct arylation reactions. Indeed, pioneering examples of direct arylation involved 
the coupling of electron-rich heteroarenes and aryl halides using palladium.[35] It was intuitive 
to assume that the nucleophilicity of the arene was of importance as it was replacing the 
organometallic coupling partner required in more conventional cross-coupling, and therefore 
that electrophilic metalation was occurring.  
However, in the mid-2000s, mechanistic work in several research groups began to uncover an 
alternative mode of metalation where a Wheland intermediate is not formed, and the C-H bond 
cleavage occurs by simultaneous metalation and intramolecular deprotonation.  Initially 
referred to as internal electrophilic substitution (IES) or ambiphilic metal-ligand activation 
(AMLA), the mechanism is most commonly known as concerted metalation deprotonation 
(CMD).[36]  
Crucial to the development of this new theory was the use of intramolecular reactions to probe 
the reaction mechanism. The first compelling evidence of an alternative mechanism to SEAr  
in catalytic direct arylation was through intramolecular competition experiments advanced in 
separate studies by the research groups of Fagnou[37,38] and Echavarren.[39] In a study of 
intramolecular direct arylation by Fagnou, the regioselectivity of several substrates was 
measured when the coupling arene was unsymmetrical. Although ortho coupling was possible, 





grounds, with the ortho-site being sterically inaccessible. However, when the substituent was 
fluorine, the major observed isomer was the ortho product (Entry 7, Table 1.1).  
Table 1.1. Regioselectivity in Pd-catalysed intramolecular direct arylation 
 
This is inconsistent with an SEAr mechanism as the ortho position is significantly less 
nucleophilic than the para site due to inductive effects. Additionally, cyclisation of naphthyl 
substrate 22, led to both regioisomeric products, 23 and 24, in near equal proportions (Scheme 
1.6). However, electrophilic additions to naphthalenes are well known to favour the 1-
position.[40] This lack of selectivity was another indication that the reaction may not be 
occurring via an SEAr mechanism.[37,38] 
 
Scheme 1.6. Regioselectivity in Pd-catalysed intramolecular direct arylation. 
A more systematic investigation into the effect of aryl electronics on palladium-catalysed 
intramolecular direct arylation was performed in the research group of Echavarren.[39] A series 
of substituted bromobenzyldiarylmethanes were subjected to direct arylation reaction 
conditions, followed by DDQ oxidation to aid product analysis (Scheme 1.7). The 
regioselectivity pattern of arylation was analysed in combination with computational studies. 
In each example, arylation took place preferentially on the less electron-rich aromatic, with 






Scheme 1.7. Intramolecular competition reaction of electronically biased arenes.  
Once again, the results were incompatible with an SEAr mechanism which would result in 
arylation of the more electron-rich ring. Three mechanisms were theorised, and subjected to 
computational analysis. The potential mechanisms envisioned were; 1) an unassisted, σBM 
type process, 2) an intramolecular base-assisted and 3) and intermolecular base-assisted 
mechanism (Scheme 1.8). The energy barrier to the unassisted process was at least 20 kcal 
mol-1 higher than both assisted processes. Discrimination between the intra- and intermolecular 
mechanism was difficult as similar energy barriers were obtained with a small bias toward the 
intermolecular process.  
 
Scheme 1.8. Proposed Mechanisms of C-H bond activation. 
Therefore, in reactions that proceed via a CMD mechanism, the acidity of the C-H bonds, 
rather than the nucleophilicity of the aromatic is of importance. CMD mechanisms are 
commonly invoked in the arylation of electron-neutral or electron-deficient arenes, however 





values are obtained in CMD mechanisms, however to uncover the mechanism of C-H 
activation a comprehensive mechanistic investigation is required. 
1.1.3 Directing Group-Assisted Direct Arylation 
As previously stated, control of regioselectivity is one of the biggest challenges of direct 
arylation chemistry. A common strategy used to control regioselectivity is through directed C-
H bond activation (Scheme 1.9). A directing-group can be employed to hold the catalyst in a 
specific position so that it can react with the desired C-H bond. Not only does this strategy 
lead to the control of regiochemistry, but fundamentally, the direct arylation becomes 
intramolecular and ultimately a more facile process. Significant advances have been gained in 
the field of ortho-functionalisation and numerous strategies are available across several 
metals.[19–21] Directing groups bear an available lone pair of electrons that can coordinate to 
the transition-metal, and the direct arylation can typically proceed via a 5- or 6-membered 
metallacycle. 
 
Scheme 1.9. Directing group strategy for regiocontrol in direct arylation. 
Once again, numerous examples are available using palladium catalysis, with several oxidative 
examples involving organometallic coupling partners, as well as numerous examples 
involving aryl halides too. The list of available functional groups implemented as directing 
groups is ever increasing and has been comprehensively reviewed.[19–21] For example, Sanford 
and co-workers have demonstrated the versatility of directing groups in the direct arylation 







Scheme 1.10. Representative examples of directing groups used in Pd catalysed direct 
arylation. 
A notable example of ortho-functionalisation by Kakiuchi et al.[43,44] using ruthenium catalysis 
is a direct arylation of arylboronates with aromatic ketone 25, employing a carbonyl as the 
directing group (Scheme 1.11). 
 
Scheme 1.11. Ruthenium catalysed direct arylation employing a ketone directing group. 
However, the substrate scope was rather limited with respect to the ketone, as the tert-butyl 
group was key in preventing diarylation, which is a common problem when directing groups 
are employed. When replacing the tert-butyl group with methyl or iso-propyl groups, 
diarylation products were obtained in 60% and 76% respectively, with only minor amounts of 
monoarylation product isolated. The proposed origin of the improved selectivity when the tert-
butyl group is employed is through steric repulsion of the newly introduced phenyl group and 
the tert-butyl group, thus blocking access to the second position for metalation. Through a 
combination of inter- and intramolecular competition experiments, a plausible mechanism was 
proposed which involved: 1) an irreversible pre-coordination of the ruthenium to the ketone; 
2) a regioselective oxidative addition yielding a ruthenium hydride species; 3) a second 
equivalent of 25 inserts into the [Ru]-H bond; 4) transmetalation of the boronate; and 5) 






Scheme 1.12. Proposed mechanism of Ru-catalysed direct arylation. [43,44] 
Whilst ortho-functionalisation is well established, the use of directing groups to facilitate 
meta-functionalisation is significantly underdeveloped. This is due to the difficulty in 
accessing these remote positions, and ingenious methods have been required to advance the 
field. 
Since the seminal work by the research group of Yu demonstrating the meta-olefination of 
aromatic molecules using a “template-assisted meta-selective C-H activation” strategy in 
2012,[45] there has been increased interest in developing the strategy.[46–49] Further 
developments by Yu et al. extended their methodology to a direct arylation strategy with an 
extended nitrile directing group, which made the meta-position accessible (Scheme 1.13).[50] 
 





The nitrile template could be removed post arylation by hydrolysis under mild conditions 
yielding the desired carboxylic acid, with the template also being recovered. 
1.1.4 Direct Arylation in the Absence of a Directing Group 
Although significant traction has been gained with the use of directing groups, the general 
applicability is somewhat limited as the directing group may be undesired in the final product, 
and therefore this strategy could be considered as another form of “pre-functionalisation”. In 
the absence of directing-groups, the control of regiochemistry becomes significantly more 
difficult and relies on an understanding of the inherent reactivity of the catalyst employed 
towards specific C-H bonds. Whilst direct arylation of heteroarenes with aryl halides has 
shown to be relatively facile, as the inherent electron bias of the heteroarene can be sufficient 
to control the selectivity arylation, electron-neutral and poor arenes provide a significantly 
greater challenge.[19] It is therefore the mechanism of C-H activation that will dictate the 
regiochemistry, with different products expected depending on an SEAr or CMD type 
mechanism.[24] 
Ye and co-workers recently reported a palladium-catalysed direct arylation of arylboronic 
acids with monosubstituted arenes (Scheme 1.14).[51] The regioselectivity was highly para-
selective, consistent with an SEAr mechanism. However, the reaction conditions were forcing 
as 10 mol% of catalyst is required with solvent quantities of arene (≈ 100 equiv.). This clearly 
demonstrates the difficulty of direct arylation of simple aromatics in the absence of directing 
groups. 
 
Scheme 1.14. Palladium-catalysed direct arylation (SEAr mechanism). 
An unprecedented arylation procedure was reported by Fagnou in 2006[23] where electron-
deficient arenes are coupled with aryl halides. Prior to this study, the most commonly invoked 
mechanism for direct arylation was via an SEAr type pathway. The authors recognised that this 
pathway was ultimately limiting to substrate scope as many aromatic compounds would not 
be nucleophilic enough. However, through the mechanistic rationalisation that the recently 





arylation of perfluorobenzenes and aryl halides. For example, pentafluorobenzene 26 reacts 
with 4-bromotoluene 27 to furnish biaryl 28 in near quantitative yields (Scheme 1.15). 
Fundamentally, a large excess of either coupling partner was not required and almost equal 
stoichiometries of both coupling partners were used.  
 
Scheme 1.15. Representative example of palladium-catalysed direct arylation (CMD 
mechanism).  
Competition experiments between different perfluoroarenes demonstrated that the relative 
reactivity of the arenes are predicted by their relative acidities. Therefore, in general the more 
electron-deficient arene react preferentially, which is the opposite reactivity trend to that 
predicted by an SEAr mechanism, and wholly consistent with a CMD mechanism. 
Whilst notable examples of direct arylation with other transition metals have been shown, 
palladium is by far the most widely used catalyst. This versatile metal has been so widely 
studied and this has led to a multitude of ligands to ensure effective optimisation of several 
processes. However, there are still some flaws in palladium-catalysed direct arylation 
protocols. Significantly, high temperatures are consistently used to ensure efficient 
transformation of starting materials to product. Therefore, the search for new, milder 
conditions, with different catalyst species is of the upmost importance. 
1.2. Gold-Catalysed Aryl Cross-Coupling  
Gold, regarded to be the noblest of all the metals,[52] is probably the most widely known 
element across the globe.[53] This rare metal - which is resistant to corrosion and oxidation, 
whilst remaining easy to mould - has accompanied mankind throughout history as a measure 
of currency and, to this day, remains a symbol of wealth.[53] In addition the aesthetic properties 
of gold and corresponding use in jewellery, the inertness of elemental gold has resulted in 
applications in dentistry, electronic connectors, space technology, and even as a food 
additive.[54] However, the resistance of elemental gold to react has resulted in gold being one 
of the most overlooked metals in the periodic table with regard to chemical reactivity. Indeed, 
gold in its zero-oxidation state is generally unreactive, but when exposed to strongly oxidising 





past 20 years, the growth in interest into gold as a catalyst for a plethora of chemical 
transformations has been substantial.  
By far the most common use for gold as a catalyst has been to facilitate the nucleophilic attack 
upon C-C π-bonds through Lewis acid activation in its gold(I) oxidation state.[53,55–60] The 
ability of gold to act as a mild, carbophilic Lewis acid has been exploited in numerous 
applications. For example, the use of gold in cycloisomerisations of enynes has been 
demonstrated to be one of the most important and versatile methods to rapidly construct 
complex cyclic structures from simple acyclic substrates. An early demonstration of the 
synthetic utility of gold(I) catalysed cycloisomerisations by Toste and co-workers was the 
reaction of 1,5-enynes to bicyclo[3.1.0]hexenes (Scheme 1.16). The reactions were conducted 
at room temperature with 1-3 mol% of catalyst and were high yielding (> 82%). A notable 
demonstration of this reaction was the conversion of enantio-enriched 29 to 30 with excellent 
transfer of chirality as well as a high diastereomeric ratio.[61] 
 
Scheme 1.16. Catalytic cycle (Top), and example (bottom) of gold(I) catalysed 
cycloisomerisation of 1,5-enynes.[61] 
Gold(I) complexes are often found to show greater reactivity than other electrophilic salts such 
as Pt(II) and are unique in that they are highly reactive and selective for π-bonds.[56] The high 
π-acidity is attributed to relativistic effects, which are at a maximum with gold.[62] Of particular 





often require a simple experimental set up due to air and moisture tolerance, low catalyst 
loadings are prevalent, and regularly reactions require no additional heating.[56]  
Whilst significant transformations are available with the use of gold(I) as a catalyst, the use of 
gold as a catalyst for synthesis of the highly prized biaryl motif is a formidable challenge. The 
use of gold as a catalyst in cross-coupling to generate biaryls is highly sought after due to the 
unique properties of gold outlined; it has good functional group tolerance, reactions are often 
mild and tolerate air, moisture and often operate at room temperature. However, for such a 
reaction to operate, a gold(I/III) redox cycle must operate. A hypothetical catalytic cycle of a 
traditional cross-coupling reaction with a gold-catalyst can serve to illustrate some of the 
potential issues of designing a gold-catalysed cross-coupling procedure (Scheme 1.17).  
 
Scheme 1.17. Hypothetical gold-catalysed cross-coupling reaction. 
Whilst the fundamental steps of oxidative addition, transmetalation, and reductive elimination 
have been well studied in many other transition metals, the overall mechanistic understanding 
of homogeneous gold catalysis remains less well developed. However, in recent years, 
stoichiometric studies have shed new light on the mechanistic pathways of these processes. 
1.2.1 Oxidative Addition 
The major hurdle in the replacement of palladium with gold in a traditional cross-coupling 
reaction is the oxidative addition. Indeed, the high redox potential of gold(I) to gold(III) have 
previously led researchers to believe that the oxidative addition of, for example, an aryl halide 
to gold(I) was impossible.[63] This consensus has been reversed as recent key stoichiometric 
studies have demonstrated that oxidative addition of CAr-X bonds to gold(I) is indeed possible. 
The first direct evidence of oxidative addition of C(sp2)-X bonds to a mononuclear gold(I) 
centre was demonstrated by Amgoune, Bourissou et al.[64] To facilitate the oxidative addition, 





the phosphine placed the metal in close proximity to the CAr-X bond to allow for an 
intramolecular oxidative addition (Scheme 1.18). Indeed, for compound 31, coordination of 
the phosphine to gold(I) occurred rapidly forming 32, which decayed in a first-order fashion 
to the Au(III) complex 33, consistent with an intramolecular unimolecular oxidative addition.  
 
Scheme 1.18. Intramolecular oxidative addition to gold(I). 
Whilst oxidative addition into the analogous CAr-Br bond was demonstrated, significantly 
higher temperatures were required (130 °C). No oxidative addition into the CAr-Cl bond, even 
at elevated temperatures for several hours, was observed. The barrier to oxidative addition of 
CAr-Br bonds to gold(I) could be reduced, and therefore milder conditions employed, when 
diphosphine ligands were used. Au(III) pincer complex 35 was formed from aryl bromide 34 
at a reduced temperature of 60 °C, demonstrating the importance of a second phosphine arm 
(Scheme 1.19). DFT calculations suggested that bidentate coordination of the phosphine 
ligands to gold facilitates a more facile oxidative addition than the 8-bromo naphthyl 
counterpart.[64] 
 
Scheme 1.19. Synthesis of pincer gold(III) complex through oxidative addition. 
Although oxidative addition into CAr-X bonds has been shown to be experimentally possible, 
its use in general cross-coupling has yet to be demonstrated as the high redox potential 
necessitates specific ligand environments which limits the general applicability in catalytic 
reactions. 
1.2.2 Transmetalation 
Unlike many oxidative addition processes, transmetalation of aryl groups to gold is a 
significantly more facile process. There are numerous examples of transmetalation to both 
Au(I)/(III) from reagents such as boron (including, aryl borates,[65] boronic acids[66] and 





Historical studies into the transmetalation at gold focused on the use of lithium and Grignard 
reagents, however due to the limit this placed on functional group tolerance, recent studies 
have focused on more mild transmetalating agents. Arylboronic acids have been shown to 
transmetalate to both gold(I) and gold(III) under mildly basic conditions. For example, Nolan 
et al. studied the reaction of ArB(OH)2 with AuCl(IPr) in detail and demonstrated that the 
identity of the base was crucial. Indeed, replacing Cs2CO3 with KOH allowed for significantly 
milder reaction conditions, from 70 °C over 24 h with Cs2CO3, to room temperature for 1 h 
using KOH. A gold(I) hydroxide was proposed to be the key intermediate to which 
transmetalation occurs (Scheme 1.20).[72] 
 
Scheme 1.20. KOH promoted transmetalation of boron-to-gold(I) 
Bochmann was subsequently able to demonstrate direct transmetalation of arylboronic acids 
with a gold(III) hydroxide pincer complex 36 (Scheme 1.21). Both electron-rich and electron 
deficient boronic acids were successful in transmetalating.[73] 
 
Scheme 1.21. Transmetalation of boron-to-gold(III) hydroxide species. 
Although the presence of base favours transmetalation of arylboronic acids, it is not a 
requirement. Nevado et al. were able to demonstrate a gold(III)-boron transmetalation in the 
absence of base, albeit under forcing conditions. However, only very electron-deficient 
boronic acids could transmetalate, with electron-rich examples completely unreactive. The 
mechanism of transmetalation proposed to explain this reactivity trend was a rate-determining 
chloride abstraction from 37 by the highly electrophilic boron species 38, followed by 
coordination of the hydroxy group to form intermediate 39, which upon migration of the aryl 
group yields 40 (Scheme 1.22). The proposed chloride abstraction would be disfavoured for 






Scheme 1.22. Direct transmetalation of electron-deficient boronic acids to Au(III) in the 
absence of base. 
1.2.3 Reductive Elimination 
Despite advances in the understanding of oxidative addition and transmetalation, the 
parameters that govern reductive elimination from diarylgold(III) complexes remains 
understudied. Seminal studies into reductive elimination from trialkyl and dialkylgold(III) 
phosphine complexes were performed by Kochi. It was proposed that dissociation of the 
phosphine was required for reductive elimination, this occurring via a high-energy T-shaped 
species. Indeed, added phosphine retarded the rate of reaction which implied a dissociative 
pre-equilibrium prior to reductive elimination (Scheme 1.23).[75]  
 
Scheme 1.23. Proposed mechanism of reductive elimination from di/trialkyl gold(III) 
complexes. 
In one of the few studies into reductive elimination of biaryls from diarylgold(III) complexes, 
Vicente et al. first demonstrated that the dissociative pre-equilibrium with the phosphine 
ligand seen in dialkylgold(III) complexes may not be required. In fact, for reductive 







Scheme 1.24. Proposed mechanism of reductive elimination from diarylgold(III) complexes. 
These results were corroborated by Toste et al. who studied the mechanism of reductive 
elimination from non-chelating diarylgold(III) complex 41 by measuring the rate of reductive 
elimination to biaryl 43. It was concluded that reductive elimination could indeed occur via a 
four-coordinate species, and that two pathways were possible (Scheme 1.25), one where 
reductive elimination occurred from neutral complex 41, and the other where added phosphine 
increased the rate of reductive elimination through the formation of cationic intermediate 42 
(where k2 > 1000k1). In fact, reductive elimination from 42 was determined to be “among the 
fastest C–C bond-forming reductive eliminations (between −50 and −10 °C) reported for any 
transition metal complex.”[77]  
 
Scheme 1.25. Neutral and ionic mechanisms for reductive elimination from diarylgold(III) 
complexes. 
In contrast, when Nevado et al. prepared similar diarylgold(III) phosphine complex 40,[74]  
reductive elimination was slow, and forcing conditions were required, thus suggesting that aryl 
electronics have a large effect on the rates of reductive elimination from diarylgold(III) 






Scheme 1.26. Slow reductive elimination of electron-deficient biaryl. 
1.2.4 Gold-Catalysed Direct Arylation 
Transmetalation and reductive elimination, two of the three major transformations in a general 
gold-catalysed cross-coupling reaction to generate a biaryl, have been demonstrated to be 
relatively facile processes. The major obstacle is therefore the oxidative addition which has 
only been demonstrated in highly designed systems. A strategy which has been implemented 
in recent years, and has been demonstrated in three distinct studies, is the replacement of the 
aryl halide with an arene and the concomitant use of an external oxidant for an oxidative gold-
catalysed direct arylation reaction (Scheme 1.27).  
 
Scheme 1.27. General gold-catalysed direct arylation mechanism. N.B. Exact order of steps 
may vary depending on conditions. 
The ability of gold(III) to selectively react with arenes under mild conditions to generate 
arylgold(III) complexes is well-established, and is widely understood to proceed via an SEAr 
type mechanism.[78] The first example of direct auration of aromatic molecules and gold(III) 
complexes was demonstrated over 80 years ago by Kharasch and Isbell in the auration of 
benzene using anhydrous AuCl3.[79] However, it was not until 2008 when the first example of 
a gold-catalysed C-C coupling reaction to generate biaryls was demonstrated by Tse et al.[80] 
The protocol, which generated a series of homocoupled arenes, was studied at 2 mol% 







Scheme 1.28. Oxidative gold-catalysed biaryl homocoupling. 
The first account of the use of oxidative gold-catalysis in a cross-coupling reaction to generate 
biaryls was jointly demonstrated in 2012 by the research groups of Lloyd-Jones and Russell.[81] 
Inspired by the oxidative coupling of arenes reported by Tse, and the recent observation of 
homocoupling of aryltrimethylsilanes in their recently reported oxidative gold-catalysed 
oxyarylation of alkenes,[69] the direct arylation of arenes by aryltrimethyl silanes was reported 
(Scheme 1.29). 
 
Scheme 1.29. Representative scope of gold-catalysed direct arylation with 
aryltrimethylsilanes. * = 87% Site selectivity 
In contrast to many previous direct arylation procedures, the reaction conditions are 
remarkably mild; the reaction does not require a large excess of either coupling partner, it 
operates at room temperature, under air, and with low catalyst loadings (1-2 mol%), and was 
demonstrated to tolerate moisture. Fundamentally, the reaction required no directing groups 
and regioselectivity was high and based on SEAr reactivity. The substrate scope incorporated 
a number of mildly electron-rich arenes, electron-rich and electron-deficient silanes, and also 





intact despite the oxidative nature of the reaction. In addition, recent developments have shown 
a number of heterocycles to be efficient arene coupling partners.[82] 
The reaction was subsequently subjected to a substantial mechanistic study which outlined the 
steps in the catalytic cycle (Scheme 1.30) and resulted in identification of an improved 
precatalyst, thtAuBr3, with a significantly reduced induction period.[83] The turnover-limiting 
step in the cycle was found to be π-complexation of the arene to the arylgold(III) complex.  
 
Scheme 1.30. Simplified catalytic cycle for gold-catalysed direct arylation. 
Once again, the use of intramolecular direct arylation was key in elucidating the reaction 
mechanism. The ordering of catalytic events (i.e. transmetalation vs arene auration as the first 
step) was identified through the successful cyclisation of 1a, with 2a as the sole product 
(Scheme 1.31, Top). Excellent selectivity for the C-3 position would be required for C-H 
auration if this was the first step, however this was dismissed as the C-5 position was 
independently shown to be the most reactive to SEAr through the iodination of 45 to 46 
(Scheme 1.31, bottom). Reversible C-H auration could explain the observed selectivity, 
however this was discounted as no isotopic incorporation was observed when conducting the 






Scheme 1.31. Intramolecular direct arylation as a mechanistic tool. 
In 2016, Nevado and co-workers developed a similar approach with boronic esters (either 
pinacol (Bpin) or 2,3-pentanediol (Bpen) esters) as transmetalating agents instead of 
arylsilanes. The scope was found to be complimentary to the reaction developed by Ball, 
Lloyd-Jones and Russell, as only extremely electron-deficient boronic acids were competent 
in the reaction (Scheme 1.32). Whilst this restricts the substrate scope, it allows for the 
synthesis of arenes that have not been shown to be possible with the use of arylsilanes.[84]  
 
Scheme 1.32. Representative scope of gold-catalysed direct arylation with boronic esters. [a] 





Whilst for many decades gold(III) has been known to react with arenes via an SEAr type 
mechanism, and that electron-rich substrates are more reactive, it has been recently shown that 
gold(I) has the opposite reactivity and that electron-deficient arenes react preferentially, 
consistent with a CMD type mechanism (Scheme 1.33).[85] 
 
Scheme 1.33. Dependence of the mechanism of C-H bond metalation on gold oxidation 
state.  
The marked difference between gold(III) and gold(I) towards C-H bond activation was 
recently discovered by the research group of Larrosa.[85] In their study, solely electron-
deficient arenes were shown to react with the Au(I) complex at the most electron-deficient C-
H bond (Scheme 1.34). The reactions were performed with a mild base and at 50 °C; however, 
a silver additive was crucial for reactivity. The exact role of the silver is yet to be determined 
but C-H activation by silver followed by transmetalation to gold was ruled out through control 
experiments.  
 
Scheme 1.34. C-H bond metalation of electron-deficient arenes by Au(I). 
The reactivity difference between Au(I) and Au(III) was exploited by the same research group 
in a catalytic cross-dehydrogenative protocol coupling electron-rich with electron-deficient 






Scheme 1.35. Gold-catalysed double C-H activation of arenes (Top) and proposed catalytic 
cycle (bottom). 
1.3 Summary and Project Aims  
Biaryl molecules are fundamentally important across the chemical industry. Whilst the cross-
coupling of aryl halides and organometallic reagents is the most popular route to these 
structures, direct arylation procedures where aromatic C-H bonds are functionalised is an 
increasingly popular alternative. Direct arylation catalysed by palladium has received the most 
attention, but recently, gold-catalysed approaches have been developed. The direct arylation 
of arenes by aryltrimethylsilanes developed in this research group[81,83] was a significant 
breakthrough, and compared with typical palladium-catalysed conditions, the reaction 
proceeds under remarkably mild conditions.  
Whilst intermolecular gold-catalysed direct arylations have been advanced, at the time this 
project was started,[87] there were no such methodologies available to synthesise cyclic biaryls 
through intramolecular direct arylation. Whilst 1a (Scheme 1.31) was demonstrated to cyclise 
successfully, the reaction was not optimised, nor was the scope of the reaction assessed. 





established. The aim of this project was to develop the intramolecular gold-catalysed direct 
arylation, from both a synthetic and mechanistic aspect. Not only are the products of 
intramolecular direct arylation of high synthetic value, but as seen in several instances in this 










2. Intramolecular Direct Arylation: Substrate Scope 

























ABSTRACT: Chapter 2 
The use of aryltrimethylsilanes in intramolecular gold-catalysed direct arylation is 
demonstrated. Utilising the conditions developed for intermolecular coupling, 31 examples are 
shown, spanning 5- to 9- membered rings. In the most electron-rich examples, significant 
diaryliodonium salt is formed from the reaction of the cyclised product with the hypervalent 
iodine oxidant, resulting in moderate to poor yields. The use of 
[bis(trifluoroacetoxy)iodo]benzene (PIFA), which is not competent in intermolecular 
coupling, largely eliminates this deleterious process and allows for the implementation of 
previously unexplored molecular architectures. This is demonstrated through the formal 
synthesis of natural product allocolchicine, which bears a highly electron-rich trimethoxy-
arene moiety.     
Substrates 2a, c-e, i, q-s, u, w, 3a, e, and 5b-d were prepared and characterised by Dr. Liam 
Ball. The results presented in this Chapter have been communicated: T. J. A. Corrie, L. T. 
Ball, G. C. Lloyd-Jones, C. A. Russell, J. Am. Chem. Soc. 2017, 139, 245 and T. J. A. Corrie, 
G. C. Lloyd-Jones, Topics in Catalysis, 2017, 60, 570. 
2.1   Introduction 
Tricyclic biaryls (Scheme 2.1) are an extremely broad class of compound with innumerable 
applications across organic chemistry, materials science and pharmaceutical chemistry, as well 
as being a common motif in several natural products, including the antibiotic vancomycin 
which is on the World Health Organisation’s List of Essential Medicines.[88]   
 




Due to the importance of the cyclic biaryl, countless strategies are available to synthesise this 
moiety, with many methodologies dedicated to the synthesis of just a single class of this 
diverse structure. For example, synthesis of one of the simplest tricyclic biaryls, fluorene, is 
still subject to intense research despite numerous strategies available for its synthesis.[89] 
Modern methods tend to utilise C-H activation as a strategy, with functionalisation of both 
C(sp2)-H and C(sp3)-H bonds employed in recent syntheses of fluorene (Scheme 2.2). 
 
Scheme 2.2. Select C-H activation methods for synthesis of fluorene.[90–96] 
In recent years, intramolecular direct arylation has become a successful strategy in the 
synthesis of tricyclic biaryls.[19–21] Unlike intermolecular direct arylation, where poor 
regioselectivity can be obtained in the absence of directing groups, regioselectivity in 
intramolecular direct arylation is restricted through the conformational bias the tether enforces 





Scheme 2.3. Regioselectivity in inter- and intramolecular direct arylation. 
2.1.1 Direct Arylation Strategies to construct 5- and 6-Membered Rings 
The synthesis of 5- and 6-membered rings is easily accessible through direct arylation, with 
higher ring sizes providing a more significant challenge. Over the past 40 years, research into 
intramolecular direct arylation has gained much attention. Palladium has been at the heart of 
the research, and many classes of 5- and 6- membered rings can be synthesised via direct 




A seminal study into palladium-catalysed intramolecular direct arylation was by Ames and 
Opalko in 1983.[97] In their report, a series of functionalised dibenzofurans were synthesised 
from the corresponding 2-bromophenyl phenyl ethers. A large electronic range was tolerated, 
but harsh conditions were required with catalyst loadings up to 10 mol% and temperatures of 
at least 150 °C (scheme 2.4).  
 
Scheme 2.4. Early example of palladium-catalysed direct arylation of ethers 
Some of the most important studies into palladium-catalysed intramolecular direct arylation 
from both a mechanistic and preparative aspect were from the research group of Fagnou. 
Whilst previous studies were only successful for specific substrate classes, and relied upon 
high catalyst loadings, the reaction conditions developed by Fagnou led to an extensive 
substrate scope, with a myriad of 5- and 6- membered rings synthesised from aryl bromides, 
chlorides and iodides. A selection of the broad substrate scope is shown in scheme 2.5.[37,38]  
 
Scheme 2.5. Representative scope of modern Pd-catalysed direct arylation. 
Whilst impressively low catalyst loadings were demonstrated, high temperatures were 




understanding of the CMD mechanism, led to a reduction in temperature to 50 °C when pivalic 
acid was used as an additive (Scheme 2.6). The pivalic acid formed potassium pivalate in-situ, 
which was found to be a superior base, in part due to increased solubility compared to K2CO3. 
 
Scheme 2.6. PivOH as an additive in mild direct arylation. 
2.1.2 Synthesis of 7+ Membered Rings 
Whilst the synthesis of 5- and 6-membered rings via intramolecular direct arylation is 
relatively facile, the opposite is found with larger ring systems. Examples of the synthesis of 
7+ membered rings are rare, and often relatively electron-rich arene coupling partners are 
required to react with the electrophilic metal centre. The difficulty in synthesising such 
structures arises from a large entropic cost in forming the metallocycle as well as transannular 
strain.[98,99] Once again, the research of Fagnou reported an early example of the synthesis of 
7-membered ring 27 under palladium-catalysed conditions (Scheme 2.7). Successful ligand 
design facilitated the reaction, as modification of PhDave-Phos, which was employed in the 
synthesis of smaller rings, to the more electron-deficient 28, resulted in a more electrophilic 
catalyst and increased reactivity.[100] This example is noteworthy for the low catalyst loading 
required, however high temperatures are still needed. 
 
Scheme 2.7. Synthesis of 7-membered ring by Pd-catalysed direct arylation. 
A notable example of 7-membered ring synthesis via a palladium-catalysed direct arylation 
was reported by Saget and Cramer in their enantioselective syntheses of chiral 
dibenzazepinones with quaternary stereogenic centres (Scheme 2.8).[101] The reactions 
proceeded under relatively mild conditions of 80 °C with 5 mol% Pd compared to the harsh 
conditions typically required (up to 130 °C, 10 mol% Pd) and represented the first example of  




of the synthesis of a larger ring system when the reactive arene can be a simple phenyl group 
(R4 = H), and therefore not significantly activated for either SEAr or CMD-type mechanisms. 
 
Scheme 2.8. Representative example of enantioselective direct arylation.  
The research group of Greaney demonstrated the synthesis of 7- and 8- membered rings 
containing biaryls through palladium-catalysed dehydrogenative coupling (Scheme 2.9).[102] 
The substrate scope of the 7- membered rings was wide as both electron-donating and 
withdrawing phenyl substituents were tolerated, as were tethers both with and without 
heteroatoms (N, O). Intriguingly, the success of the 8-membered ring reaction relied on the 
inclusion of a nitrogen in the tether as in its absence, no reaction occurred. This was attributed 
to coordination of the nitrogen to palladium, reducing transannular strain and stabilising the 
catalyst (Scheme 2.9, bottom). 
 




An additional insight into the mechanism of the reaction was through the regioselectivity of 
cyclisation of 49 where ortho-arylation generates 50, consistent with a CMD-type mechanism 
(Scheme 2.10). 
 
Scheme 2.10.  Mechanistic insight into arylation mechanism. 
One of the few examples of the synthesis of 9-membered rings via direct arylation was reported 
by the research group of Beccalli in 2006 (Scheme 2.11).[103] Seven-, eight- and nine-
membered indole-based biaryls were synthesised under palladium-catalysed conditions, 
however significantly reduced yields were reported for the 9-membered examples.  
 
Scheme 2.11. Synthesis of 8- and 9- membered rings via direct arylation. * = microwave 
heating at 160 °C. 
2.1.3 Synthesis of Natural Products 
Despite the rich library of cyclic biaryl natural products,[104] applications of intramolecular 
direct arylation in natural product synthesis are relatively rare. Whilst the application of a 
methodology to model substrates (vide supra) can give an indication of synthetic value, 
implementation of a strategy in complex molecule synthesis can be a true test of robustness. 
Natural product synthesis can highlight the deficiencies of certain processes and expose 
problems in catalyst chemo-, regio- (and perhaps stereo-) selectivity, as well as other critical 
aspects relating to catalyst stability, efficiency, activity and functional group compatibility. It 
is therefore unsurprising that despite the enormous advances in the field of direct arylation, 
applications to complex molecules are uncommon.  
Pioneering studies by Bringmann et al.[105,106] led to the advancement of 2-haloaryl esters in 




   
Scheme 2.12. Examples of natural products synthesised where the biaryl is formed through 
direct arylation.[107–109] 
The strategy was only successful for 6-membered cyclic lactones however, and efforts to 
synthesise larger ring sizes have failed. For example, in the formal synthesis of (−)-steganone 
51 by Abe and Harayama, attempts to form a 7-membered biaryl lactone 53 from aryl iodide 
52 via direct arylation were unsuccessful and only protodehalogenation was observed (Scheme 
2.13).[110] 
 
Scheme 2.13. Failure of direct arylation of 2-haloaryl ester in synthesis of 7-membered ring 
The authors had to alter their synthetic strategy such that the direct arylation of  54 yielded 6-
membered cyclic lactone 55 which could be ring opened atropselectively to yield 56, which 





Scheme 2.14. Total synthesis of (−)-steganone via direct arylation 
The atropselective ring opening strategy was pioneered in the research group of Bringmann. 
This dynamic kinetic resolution relies on the two atropisomers rapidly equilibrating, and one 
being selectively reduced by the chiral reducing agent whilst the other restores the equilibrium 
with the consumed atropisomer.[106]  
Although many natural products synthesised via direct arylation are derived from ester 
linkages, several other linkages have also been employed including, ketones, amides and 
amines.[104] As previously mentioned, the synthesis of larger rings via direct arylation is 
synthetically challenging and there are only a limited number of examples in general. It is 
therefore unsurprising that despite numerous available targets, only a handful of examples 
exist. Two notable examples are the synthesis of allocolchicine 11, a 7-membered cyclic 
biaryl, by Fagnou and Leblanc,[113] and the synthesis of (±)-rhazinilam 61 by Trauner et al.,[114] 
employing an unprecedented nine-membered ring synthesis (Scheme 2.15). The reaction 
conditions developed by Fagnou were found to be optimal for the synthesis of rhazinilam after 
an extensive ligand screen. The high temperature and catalyst loading required for these 





Scheme 2.15. Intramolecular direct arylation in natural product synthesis.  
2.1.4 Chapter Aims 
 
Scheme 2.16. Gold-catalysed inter- and intramolecular direct arylation. 
Significant developments into intramolecular direct arylation have led to a myriad of synthetic 
applications. Typically, palladium is the catalyst of choice to facilitate this transformation, 
however, high temperatures are invariably required, and strategies to synthesise ring sizes 
greater than 6-membered are limited. Therefore, a gold-catalysed approach is highly desired 
as the characteristic qualities of gold-catalysis (e.g. low temperatures, excellent functional 
group tolerance, air and moisture sensitivity, short reaction times) are lacking in current state-




halides are tolerated, thus the use of gold in intramolecular direct arylation could increase the 
scope of post-cyclisation derivatisation. The aim of this project was to develop the synthetic 
methodology of a gold-catalysed intramolecular direct arylation, based on the previous 
intermolecular direct arylation of arenes by aryltrimethylsilanes (Scheme 2.16). Preliminary 
studies demonstrated the success of a single, electronically activated substrate leading to a 5-
membered ring (Chapter 1, Scheme 1.31). The full electronic range of substituents was to be 
explored, followed by an investigation into the limits of ring size. The final aim was to utilise 
the methodology in the synthesis of a natural product to demonstrate the full synthetic value 
of the reaction.  
2.2 Substrate Scope 
2.2.1 Synthesis of 5-membered rings 
The previously reported reaction conditions for the coupling of aryltrimethylsilanes and arenes 
were optimised for intermolecular reactions, where 1-2 mol% of catalyst was successful for a 
range of coupling reactions (Scheme 2.17).  
 
Scheme 2.17. Standard reaction conditions for intermolecular coupling. 
It was therefore necessary to assess whether these were ideal conditions for intramolecular 
coupling, or if further optimisation was necessary. Each component of the reaction has at least 
one key role in the intermolecular coupling which were determined in prior mechanistic 
studies,[83] and these roles were assessed in the context of an intramolecular reaction when 
considering additional optimisation. The methanol has several roles, it solubilises all the 
reaction components resulting in a visibly homogenous mixture, key for in-situ NMR 
monitoring of the reaction, as well as likely being responsible for cleavage of the TMS group 
(Scheme 2.18).  
 




However, methanol also acts as an inhibitor preventing effective π-complexation, which is the 
turnover-limiting step in intermolecular coupling, and the CSA is necessary to displace the 
methanol, resulting in a more active catalyst (Scheme 2.19).  
 
Scheme 2.19. Role of CSA in the π-complexation of the arene. 
The CSA also reacts with iodobenzene diacetate (IBDA/PhI(OAc)2) to form the in-situ 
oxidant, which is presumably a mixture of HCIB 62 (R = H) and MCIB 63 (R = Me) depending 
on the presence of water (Scheme 2.20). From this point forward, the term “IBDA/CSA” will 
be used to refer to the mixture of IBDA and CSA as a method of preparing the presumed in-
situ oxidants 62/63, and the term “HCIB, 62” will be used when this compound is 
independently synthesised and used instead of the IBDA/CSA mixture. Due to the necessity 
of CSA in the pre-equilibrium to π-complexation, it is a requirement in intermolecular 
coupling that: [CSA] ≥ [IBDA], and if this is not the case, all CSA is sequestered as the 
oxidant. 
 
Scheme 2.20. Identity of the in-situ oxidants. 
The oxidant is also responsible for the rapid activation of the precatalyst thtAuBr3. During 
precatalyst activation, five equivalents of oxidant relative to the catalyst are consumed, and 
two of the three bromide ligands are taken up by either the arene or silane coupling partner 
following oxidation. The tetrahydrothiophene (tht) ligand is oxidised to the sulfoxide, and an 






Scheme 2.21. Proposed catalyst activation mechanism.  
The use of hypervalent iodine oxidants is a strict requirement for the coupling to operate, and 
the use of other oxidants does not lead to any turnover of catalyst. The origin of this is currently 
unclear; although rapid redox of the Au(I) to Au(III) is required to inhibit disproportionation. 
By rendering the reaction intramolecular, the effective molarity of the arene moiety will be 
raised significantly. As the TLS in the intermolecular coupling is π-complexation, it was 
expected that this increase in molarity could lead to an increase in rate such that substantial 
changes in reaction conditions with regard to catalyst loading, and possibly the need for CSA 
if direct displacement of methanol could be tolerated (Scheme 2.19). Initial optimisation was 
performed with substrate 1b. Employing the reaction conditions developed for the 
intermolecular coupling to the cyclisation of 1b to fluorene, 2b, led to a successful reaction, 
and a short (40 min.) reaction time, significantly shorter than all intermolecular examples (> 5 
hours). This is informative as it gives a measure of the impact the short tether has on reactivity, 
especially as the most electronically-similar intermolecular example, 4-fluorophenylsilane 12a 
with toluene 64, required 45 hours to go to completion (Scheme 2.22).  
 
Scheme 2.22. Comparison of inter- and intramolecular direct arylation of electronically 
similar arenes  
Whilst the ratio of IBDA:CSA used in the intermolecular coupling (1.3:1.5) was successful 
for 1b, at the end of the reaction 0.2 equivalents of oxidant remained. This excess oxidant 




mechanism.[115] Hypervalent iodine oxidants are very electrophilic at iodine and therefore 
prone to react with electron-rich arenes, such as fluorene (Scheme 2.23).[115]  
 
Scheme 2.23. Diaryliodonium salt formation. 
To reduce the impact of this, the ratio of IBDA:CSA was reduced to the minimum necessary, 
1.1:1.3. With these conditions in hand, the effect of catalyst concentration was analysed (Table 
2.1). Pleasingly, high yields were maintained for loadings as low as 0.1 mol%.  
Table 2.1 Effect on catalyst loading on yield of cyclisation of 1b. 
 
Entry Catalyst Loading (mol%) Yield (%)* Time (min) 
1 2 92% 15 
2 1 98% 25 
3 0.5 97% 60 
4 0.1 99% 540 
Substrate (0.05 mmol), thtAuBr3 (1 mol%), PhI(OAc)2 (0.055 mmol), CSA (0.065 mmol) in 
CDCl3/CD3OD (50:1, 0.1 M). *Yield by NMR spectroscopy. 
Due to the presence of bromodesilylation during the activation of the catalyst (Scheme 2.21), 
higher yields were obtained with lower catalyst loadings as less of the substrate was consumed 
during the activation of the catalyst 
Whilst the success of the reaction at 0.1 mol% was impressive, the duration of the reaction 
was much less convenient than at 0.5 mol%. Therefore, the optimum conditions for substrate 
1b were 0.5 mol% catalyst, 1.1 equivalents of IBDA and 1.3 equivalents of CSA. The next 
step was to assess the generality of these conditions against other substrates. 1c and 1d were 
chosen due to the large electronic range in which they span. Unfortunately, 0.5 mol% was not 
a suitable catalyst loading for either substrate but for different reasons. Cyclisation of 1d 
proved impractically slow, with only 5% of product formed after 5 hours, whereas with 1c, 
total consumption of the oxidant occurred within a few hours, but with only a 17% yield of 




92% yield was obtained after 16 hours. However, only minor improvements were gained with 
1c, where a 33% NMR yield was obtained (Scheme 2.24).  
 
Scheme 2.24. Effect of catalyst loading on electronically-biased substrates 
The origin of the reduced yield for the reaction of 1c was rapid decomposition of the product 
to its diaryliodonium salt, which outcompeted cyclisation. Recognising that this could be 
severely detrimental to the methodology and substrate scope; alternative oxidants were sought.  





* meta-chloroperbenzoic acid **tert-Butyl hydroperoxide. 
Unfortunately, as seen in the intermolecular reaction, no product was observed for oxidants 
other than those based on hypervalent iodine (See Chapter 6 for further discussion). However, 
trace amounts of product was observed by 1H NMR spectroscopy when IBDA was used in the 
absence of CSA. Heating this reaction to 55 °C led to full conversion of starting material. This 
is a clear difference with the intermolecular reaction where successful turnover depended on 
having CSA in excess ([CSA] ≥ [IBDA]) (scheme 2.19, vide supra). This disconnection 
Entry Oxidant Additive Yield 
1 IBDA CSA (1.3 equiv.) 98% 
2 IBDA  Trace 
3   IBDA  95% (55 °C) 
4 PIFA, 66  80% 
5  Oxone CSA (1.3 equiv.) 0% 
6 mCPBA* CSA (1.3 equiv.) 0% 




between the intra- and intermolecular reaction suggests that for π-complexation to occur, 
camphorsulfonic acid may not be necessary and that the acetic acid generated from IBDA 
forms an active enough catalyst when the arene is closely tethered (Scheme 2.25).  
 
Scheme 2.25. Proposed mechanism of π-complexation in inter- and intramolecular direct 
arylation. 
With this result in hand, the use of bis(trifluoroacetoxy)iodobenzene (PIFA, 66), a 
commercially available hypervalent iodine oxidant, which introduces a stronger acid than 
IBDA (trifluoracetic acid-TFA- vs acetic acid) was attempted. Pleasingly PIFA was competent 
as an oxidant at room temperature, with similar reaction times and a comparable yield to the 
IBDA/CSA system.  
Importantly, the use of PIFA led to a significant improvement in yield of substrate 1c which 
suffers from significant diaryliodonium salt formation with IBDA/CSA (Table 2.3).  
Table 2.3. Effect of oxidant on the cyclisation of 23c. 
 
thtAuBr3 (mol%)  
Yield of 1c to 2c (%) 









[a] IBDA (1.1 equiv), CSA (1.3 equiv). [b] 1.1 equiv. Yield by 1H 





When PIFA is used, catalyst loadings could be reduced without an adverse effect on yield. 
This is in stark contrast to IBDA/CSA, where lowering of catalyst loading led to extremely 
poor yields due to competitive diaryliodonium formation. This result demonstrates the relative 
resistance of PIFA toward diaryliodonium salt formation compared to IBDA/CSA. 
Unfortunately, PIFA was not suitable for the cyclisation of 1d, suggesting that trifluoroacetate 
is insufficiently labile to be used in combination with deactivated arenes. With standard 
conditions in-hand, and either IBDA/CSA or PIFA as the oxidant species, the substrate scope 
was assessed. Table 2.4 shows the full substrate scope of 5-membered rings, using either PIFA 
or IBDA/CSA. 
Although the use of 1 mol% of catalyst was a convenient standard condition, significantly 
lower loadings could be used. For example, cyclisation of 1a (Table 2.4, entry 3) was complete 
in under 2 min using 1 mol% Au (95% yield), and with 0.06 mol% Au, the reaction proceeded 
to 80% conversion, with a formal turnover number of 1330. The range of reaction times was 
dependent on the electronics of the arene moiety, with electron-deficient examples requiring 
the longest reaction times. However, the reaction timescales were still convenient, with the 
most sluggish examples (1d, h, m, n) going to completion overnight. 
Of particular note is the large electronic range tolerated on the arene moiety in the synthesis 
of substituted fluorenes, with high yields maintained throughout the series. Whilst the arene 
substrate in the intermolecular reaction is required to be relatively electron-rich, the 
intramolecular reaction can even tolerate CF3 substituents (1h, 1m).   
In the cases where substituents are meta- to the methylene linker, and therefore two 
regioisomeric products are possible, high regioselectivity is observed in favour of the product 
resulting from arylation para to the substituent (Scheme 2.26). 
 
Scheme 2.26. Regioselectivity in intramolecular direct arylation 
This ratio improved with electron-withdrawing ability as the inductive effects reduce the 






Table 2.4. Substrate scope of intramolecular direct arylation for 5-membered rings. 
 
2.2.2 Synthesis of 6+ Membered Rings 
To demonstrate the general applicability of the reaction conditions across a wide range of 
examples, the methodology was applied to larger ring systems (Table 2.5). In the synthesis of 
the 6-membered ring systems, once again using the minimum excess of oxidant possible (1.1 
equivalents) was necessary to avoid over oxidation of product, which in the case of 9,10-
dihydrophenanthrene 4a, included oxidation to phenanthrene when excess oxidant was used. 
Under the standard conditions, benzo[c]chromene examples 4d-f (Table 2.5, entry 2 and 3) 
suffered from the formation of several unidentified minor side products, derived from 
oxidation, which complicated purification. Unfortunately, the implementation of PIFA as an 




gold-TFA complex 67 is not reactive enough to facilitate rapid π-complexation of the arene 
moiety in longer tethers.  
 
Scheme 2.27. Effect of increase in tether length on π-complexation with a TFA ligand. 
Diluting the reaction with respect to the substrate and oxidant, whilst maintaining the same 
catalyst concentration as the standard conditions significantly reduced side product formation, 
and facilitated purification. 
Table 2.5. Substrate scope of intramolecular direct arylation for 6- and 7-membered rings. 
 
As mentioned previously, methodologies to prepare greater than 6-membered rings through 




formation of the desired metallocycle is often proposed as the difficult step, and the increase 
in tether length reduces the effective molarity of the incoming arene, making the formation of 
the metallocycle less entropically favoured. In addition, transannular and torsional strain make 
this process even more difficult. Somewhat surprisingly, the synthesis of 7-membered rings 
did not require significantly modified or harsher conditions. (Table 2.5, entries 4 – 7). 
Although longer reaction times were required, the reaction conditions were still mild, with 
reactions proceeding at room temperature at catalyst loadings of 2 mol%. Additionally, the 
linker could be entirely methylene based, or contain both N or O as the central atom.  
Given the ease in which 7-membered rings could be synthesised, the next goal was to attempt 
to construct even larger ring sizes and discover the limit of the ring size that could be formed. 
It was anticipated that at some point, as with many macrocyclisations, intermolecular coupling 
would begin to outcompete intramolecular cyclisation. The synthesis of 8-, 9- and 10-
membered rings was attempted by subjecting 7, 9 and 69 to the arylation conditions (Scheme 
2.28). The cyclisation of 7 proceeded smoothly with an excellent yield of 75% after 16 h at 
room temperature, albeit with a slightly higher catalyst loading of 4 mol% compared to other 
ring sizes. Pleasingly, 9-membered ring 10 could be isolated with a good yield of 52%. 
However, more forcing conditions were needed as in addition to the 4 mol% catalyst required, 
2 equivalents of CSA and a temperature of 50 °C were necessary. Unfortunately, the synthesis 
of 10-membered 70 was not successful and subjecting 69 to the same reaction conditions as 9 
led to a complex mixture. This was indicative of an oligomerisation reaction due to competing 
intermolecular reactions. Nevertheless, the synthesis of 8- and 9-membered rings was a 
significant achievement, and although the conditions were more forceful than those used in 
the other substrates, they are remarkably mild compared with literature syntheses of these ring 
sizes. Both 8 and 10 were solids at room temperature and single crystals suitable for X-ray 





Scheme 2.28. Synthesis of 8- and 9- membered rings, with X-ray crystal structures of 8 and 
10 (8- and 9- membered rings). 
The reaction conditions developed herein for intramolecular direct arylation represent a 
breakthrough with regards to the breadth of substrate scope, operational simplicity and mild 
reaction conditions. A single set of conditions is suitable for the synthesis of ring sizes varying 
from 5- to 9-membered, with a large range of substituents, and with most reactions occurring 
at room temperature. Additionally, external ligands are not required, eliminating the 
requirement for laborious screening. However, there were limitations to the scope as substrates 
containing a basic nitrogen were not tolerated, and therefore substrate classes such as 
carbazoles were not accessed. This is potentially due to binding to and deactivation of the 
catalyst, or through reaction with the CSA. However, employing protecting groups such as the 
mesyl functional group allows access to nitrogen containing heterocycles. Given the ease in 
which 7-membered rings are synthesised, the final goal was to apply this methodology toward 
the formal synthesis of allocolchicine 11, which had previously been synthesised by Fagnou 
and Leblanc who employed a palladium-catalysed direct arylation. It was anticipated that a 
gold-catalysed approach could lead to significant improvements, particularly with respect to 
reaction temperature. Additionally, whilst the substrate scope demonstrated thus far 
encompasses a wide variety of functional groups, the application of the methodology toward 
a natural product would demonstrate the applicability of the chemistry, as well as potentially 





2.3 Formal Synthesis of (±)-Allocolchicine 
2.3.1 Background 
Isolated from Colchicum autumnale, allocolchicine 11 is the first discovered natural 
allocolchinoid. For over a millennium, plant extracts from C. autumnale have been used in 
medicine, initially for rheumatism and swelling, and subsequently gout.[116] The major alkaloid 
produced by C. autumnale, and the source of the biological effects, is colchicine 71, which 
was first isolated in 1820 by Pelletier and Caventou. As well as having anti-inflammatory 
effects, colchicine also has antimitotic effects.  
 
Scheme 2.29. Structures of natural products colchicine and allocolchicine. 
The mechanism of action of colchicine that leads to antimitotic effects is to bind to the protein 
tubulin and by doing so inhibit microtubule polymerisation. Since tubulin availability is 
fundamental to cell division, colchicine can act to disrupt mitosis and behave as “mitotic 
poison.” Mitotic poisons, also known as spindle poisons, can help to stop the spread of 
tumours, however the toxicity of colchicine means it is not applicable as an anti-cancer agent. 
Allocolchicine and its analogues, however, are also known to bind tubulin but have 
significantly lower toxicity thresholds and are therefore promising drug targets.[117]   
The first stereoselective total synthesis of (−)-allocolchicine was performed by Wulff et al. in 
2003 and is a 14 step synthesis with a 7% overall yield (Scheme 2.30) starting from 
commercially available ketone 72.[118] The key bond forming step was a regioselective Diels-
Alder reaction of 73 with methyl propiolate 74, which after aromatisation yielded the 
allocolchinoid skeleton 75. Deprotection of the TBDMS ether and oxidation of the resultant 
alcohol gave 76, which could be reduced enantioselectively using LiBH4 and TarB-NO2,[119] a 
chiral Lewis acid to 77. Mitsunobu conditions were subsequently used to invert the 
stereochemistry using Zn(N3)-2Py, forming azide 78. Reduction of the azide, followed by 





Scheme 2.30. Total synthesis of allocolchicine. (i) Methyl propiolate, toluene, 110 °C; (ii) 
DDQ, CH2Cl2, rt; (iii) TBAF-3H2O, THF, rt; (iv) NMO-H2O, 5% TPAP, 4 Å MS, CH2Cl2, rt; 
(v) TarB-NO2, LiBH4, (vi) Ph3P, DIAD, Zn(N3)2-2Py, toluene, rt; (vii) H2, 5% 
Pd/CaCO3/3.5% Pb, EtOH, rt; (vii) Ac2O, pyridine, CH2Cl2, rt. 
Two years after the synthesis of (−)-allocolchicine by Wulff et al., Fagnou and Leblanc 
reported their enantioselective formal synthesis of allocolchicine (Scheme 2.31). This route 
cut 4 steps off the synthetic route of Wulff and had an impressive overall yield of 26%. The 








Scheme 2.31. Formal synthesis of allocolchicine. (i) PdCl2(PPh3)2 (1 mol%), CuI (3 mol %), 
Et3N, THF, rt; (ii) 1. (S)-pinene, 9-BBN, THF, reflux 2. 81 3. NaOH, H2O2; (iii) NaH, 
CH3OCH2Br, THF, 0 °C to rt. (iv) NH2NHSO2C6H4CH3, AcONa, DME/H2O, reflux. (v) 
PdCl2(PPh3)2 (5 mol%), K2CO3 (3 equiv), MeOH (15 equiv), DMF, CO (5 atm), 95 °C; (vi) 
Pd(OAc)2 (10 mol%), DavePhos (10 mol%), K2CO3 (2 equiv.) DMA, 145 °C; (vii) MeOH, 
HCl, reflux. 
Although a direct arylation approach to the total synthesis of allocolchicine has been shown, 
the reaction conditions for the cyclisation are notably harsh with high temperatures and 
catalyst loadings. Despite the harsh conditions, this is the state-of-the-art approach, as 
Fagnou’s conditions continue to be used successfully to this day. An alternative, gold-
catalysed approach, is therefore desirable as milder reactions conditions as well as different 
functional group tolerance to palladium is possible. In addition, the possibility to directly 
compare the methodologies could serve to highlight both the advantages and deficiencies of 
the gold-catalysed direct arylation chemistry. 
2.3.2 Retrosynthesis of Allocolchicine  
Retrosynthetic analysis (Scheme 2.32) was initiated from 76, which is an intermediate along 
the reaction pathway of Wulff and co-workers. The first disconnection was at the methyl ester 
back to aryl chloride 6e. A key point in the synthetic strategy was to demonstrate the 
orthogonality of the gold-catalysed direct arylation methodology to palladium(0) cross-
coupling. This goal could be realised with a palladium-catalysed carbonylation of the aryl 
chloride to the ester. This strategy would be of high synthetic value as rapid access to 




coupling, and in fact it has been shown that some of the largest biological differences between 
allocolchinoids has been due to alteration of this ring.  The next disconnection was at the biaryl 
linker, leading to compound 5e. The silane could theoretically be placed on either side of the 
molecule, but it was desirable for the arene to be the trimethoxy moiety as it is significantly 
more activated for electrophilic metalation than the aryl chloride. The final disconnection was 
between the two methylene groups in the linker between the aromatics. This disconnection 
went back to silyl enol ether 87, which could be prepared from ketone 86, and benzyl bromide 
88. 
 
Scheme 2.32. Retrosynthesis of allocolchicine. 
2.3.3 Model Studies: Formal Synthesis of Allocolchicine Analogue 
Prior to any synthetic studies, the tolerance of the trimethoxy-arene moiety to the reaction 
conditions had to be assessed. As previously demonstrated, electron-rich arenes are prone to 
diaryliodonium salt formation, and this was to be the most electron-rich example attempted. 
Trimethoxytoluene 89 was used as a proxy to measure the effect of oxidant on the starting 
material (Scheme 2.33). Subjecting trimethoxytoluene to the standard reaction conditions 
(without the gold catalyst) led its rapid degradation, with all of the arene converted, within 
seconds, to the diaryliodonium salt 90.  
 
Scheme 2.33. Effect of IBDA/CSA on trimethyl toluene. 
This immediately removed the possibility of employing the IBDA/CSA conditions in the 




the reaction. Subjecting trimethoxytoluene to PIFA under the reaction solvent conditions 
demonstrated a good stability toward the oxidant, with only minimal degradation to the 
diaryliodonium salt after several hours. Although PIFA was shown to be ineffective in the Au-
catalysed synthesis of ring sizes greater than five membered, it was of interest to understand 
if the increase in tether length could be offset by the very activated arene.  
Due to the relative expense of ketone 86 and the availability of 2’-bromoacetophenone 91, the 
synthetic route was first optimised for allocolchicine analogue 92. This analogue had also been 
prepared by the research group of Fagnou. 
 
Scheme 2.34. Allocolchicine analogue for model studies. 
The synthesis of key intermediate 5f was achieved in just two steps (Scheme 2.35). The first 
step was conversion of the ketone to silyl enol ether 93, which after lithium-halogen exchange 
using nBuLi, resulted in a retro-Brook rearrangement forming lithium enolate 94. This was 
then alkylated by trimethoxy benzylbromide 87 to afford ortho-silyl arylketone 5f. 
Unfortunately, only moderate yields of 5f were obtained due to competing double alkylation 
by the lithium enolate of 5f, to generate 95. Despite the moderate yield, in just two steps all of 
the carbons required to complete the formal synthesis of the allocolchicine analogue were in 
place. 
 




With 5f synthesised, the gold-catalysed direct arylation protocol could be attempted (Scheme 
2.36). Unfortunately, no product was observed over the course of several hours. Despite this, 
it was promising that no significant degradation of the starting material was observed, 
confirming the stability of 6f toward PIFA as the oxidant.   
 
Scheme 2.36. Attempted cyclisation of 5f. 
It was proposed that that the presence of the benzylic ketone may be the cause of the lack of 
reactivity. Indeed, in palladium-catalysed direct arylation, 2-haloaryl esters (vide supra) only 
cyclised when the products formed were 6-membered, and not larger (Scheme 2.13). The 
rigidity that the ketone might install on the carbon skeleton could restrict the configuration of 
the incoming arene, and therefore prevent successful π-complexation. Thus, it was anticipated 
that the ketone could be modified to a functional group that the cyclisation could tolerate. To 
explore the impact of the identity of the benzylic substituent on the reactivity towards 
arylation, a number of analogues were prepared from ketone 5f, via alcohol 5g (Scheme 2.37). 
 
Scheme 2.37. Synthesis of analogues to test cyclisation. (i) NaBH4, MeOH, 0 °C - rt; (ii) 
Me3OBF4, Proton-Sponge®, 0 °C - rt; (iii) Ac2O, DMAP, pyridine, 0 °C - rt; (iv) 
(PhO)2P(O)N3, DBU, toluene, 0 °C - rt. 
The impact of the benzylic substituent on the success of the reaction is clearly demonstrated 





Scheme 2.38. Effect of benzylic substituents on synthesis of the allocolchinoid skeleton. 
Whilst alcohol 5g and ester 5i did not form any cyclised product, both methyl ether 5h and 
azide 5j did lead to productive catalysis. Pleasingly, the cyclisation of methyl ether 5h was an 
efficient process, yielding 85% of the desired product in under 2 h at room temperature. 
Control experiments demonstrated the reaction is indeed gold-catalysed, and not PIFA 
mediated, as previous studies have demonstrated PIFA can facilitate oxidative biaryl coupling 
of the allocolchinoid skeleton in the presence of BF3.OEt2.[120] The cyclisation of azide 5j to 
6j is a step economic route as it directly intercepts the synthetic pathway of Fagnou, however 
the poor yield and difficulty preparing the starting material excluded its use. Although methyl 
ether 5h was successful in cyclising, the inability to selectively deprotect the methyl group to 
form alcohol 6g and enter the desired synthetic pathway precluded the use of 5h in the formal 
synthesis, and therefore other, more readily deprotected ethers were considered.  
In the synthetic pathway of Fagnou and Leblanc, a MOM protecting group was employed, and 
therefore the use of a MOM protecting group in this study would lead to a direct comparison 
of  methodologies. Additionally, it was of interest to discover if MOM protecting groups would 
withstand the acidic nature of the reaction. The MOM protection was achieved with MOMBr 
in the presence of DIPEA. The cyclisation of MOM protected 5k was successful, with the 
MOM protecting group remaining intact during the reaction timescale. The reaction compared 
favourably to the palladium-catalysed conditions developed by Fagnou, with higher isolated 
yields, lower temperature and shorter reaction times (Scheme 2.39).   
 




2.3.4 Formal Synthesis of Allocolchicine 
With an effective synthetic route established, the formal synthesis of allocolchicine was 
attempted. Comparable yields to the model study were obtained for the steps leading up to the 
direct arylation, however, crucially, the cyclisation itself took significantly longer, with a 
poorer yield, than the model study (5 h vs 2.5 h and 56 vs 75%).  Efforts to improve the yield 
through change in temperature, reaction concentration and solvent ratio were unsuccessful (see 
Chapter 4 for analysis of kinetics). Nevertheless, the formal synthesis of allocolchicine was 
completed by subjecting 5m to the palladium-catalysed methoxycarbonylation conditions 
developed by Buchwald,[121] to afford 85, which intercepts the synthetic pathway of Fagnou. 
 
Scheme 2.40. Formal synthesis of allocolchicine. (i) TMSCl, Et3N, NaI, CH3CN, rt; (ii) 1. 
nBuLi, THF, −78 °C; 2. 88, −78 °C – rt; (iii) NaBH4, MeOH/THF, 0 °C – rt; (iv) MOMBr, 
DIPEA, DMAP, CH2Cl2, 0 °C – 70 °C; (v) thtAuBr3 (5 mol%), PhI(OCOCF3)2, CHCl3/MeOH 
(50:1); (vi) Pd(OAc)2 (4 mol%), dcpp.2HBF4 (8 mol%), K2CO3, 4 Å MS, CO, dmso, 120 °C. 
Whilst the brevity of the route rivals that of Fagnou (10 steps to allocolchicine), the overall 
yield is particularly hampered by the poor isolated yield of 5e from the retro-Brook alkylation 
reaction. Further developments to synthesise this scaffold via other higher yielding routes may 
make this synthesis more attractive. The completion of the formal synthesis of allocolchicine 
demonstrates both strengths and weaknesses in the gold-catalysed methodology. The tolerance 
of the highly rich trimethoxy-arene moiety represents a new benchmark in what can be 
achieved in terms of electronics in gold-catalysed direct arylation. It is made possible by 




intermolecular reactions, is key. The orthogonality of the methodology to palladium(0) cross-
coupling is also demonstrated by the late stage methoxycarbonylation reaction, thus raising 
the possibility for facile diversification of this scaffold. The cyclisation step is also particularly 
mild, with half the catalyst loading required relative to the palladium needed, and significantly 
lower temperatures (room temperature vs 145 °C). However, the functional group tolerance is 
low and only methyl ethers were demonstrated to cyclise efficiently. In addition, the yield of 
the key cyclisation was lower than in the model study. The origin of these detrimental features 
is discussed in detail in Chapter 4.  
2.4 Summary and Conclusions  
The intramolecular gold-catalysed direct arylation of arenes by aryltrimethylsilanes has been 
developed. The reaction generates 5- to 9- membered rings in good to excellent yields, with 
the majority of examples requiring 1-2 mol% of catalyst and proceeding at room temperature. 
Of the 35 preparative examples, 10 form heterocycles. Deleterious diaryliodonium salt 
formation in the most electron-rich examples was circumvented with the use of PIFA as 
oxidant. With a reduced tendency for diaryliodonium salt formation, PIFA was implemented 
in the formal synthesis of allocolchicine, a natural product with a highly electron-rich 
trimethoxy-arene moiety. The broad substrate scope, as well as the mild reaction conditions, 
result in the gold-catalysed approach being a desirable alternative to state-of-the-art palladium-
catalysed routes in the synthesis of a variety of cyclic biaryls. Although the scope presented 
herein encompasses a wide range of substrates, it is not exhaustive, and further investigations 
into the full substrate scope, in particular of larger ring sizes is still necessary. Whilst the 
investigation into the scope demonstrated the methodology to be synthetically useful, the 
major goal was to understand the mechanism of cyclisation, and use the intramolecular 
reaction as a vehicle to understand mechanistic processes which could not otherwise be 
investigated in the intermolecular system. A comprehensive investigation into the mechanism 


































ABSTRACT: Chapter 3 
The mechanism of intramolecular gold-catalysed direct arylation is elucidated. Rendering the 
reaction intramolecular results in predominantly simple pseudo-zero order reaction profiles, 
perfect for kinetic study, and thus allows for a detailed investigation into linear free energy 
relationships and kinetic isotope effects. The resting state, and therefore the turnover-limiting 
step (TLS), of the reaction is highly dependent on tether length and the electronic properties 
of the aryl moiety, and shifts from reductive elimination when the tether is a single methylene 
unit, to π-complexation for longer tethers or when the arene bears strongly electron-
withdrawing substituents (σ > 0.43). For the first time, the effect of aryl electronics on the rate 
of reductive elimination is demonstrated and is shown to be accelerated by electron-donating 
substituents (ρ = −2.0). Additionally, in contrast to previous reports into reductive elimination 
from diarylgold(III) complexes, reductive elimination is proposed to proceed via a rapidly 
reacting 3-coordinate species, and, a slower, methanol bound, 4-coordinate complex. 
The results presented in this Chapter have been communicated: T. J. A. Corrie, L. T. Ball, G. 
C. Lloyd-Jones, C. A. Russell, J. Am. Chem. Soc. 2017, 139, 245. 
3.1 Introduction 
3.1.1 Mechanistic Background 
In 2014, this research group reported the results of a mechanistic study into the intermolecular 
gold-catalysed direct arylation reaction.[83] The catalytic cycle (Scheme 3.1, bottom) was 
determined based on the examination of rate data, KIE experiments, linear free-energy 
relationships and competition studies. Most the studies were based on the coupling of 39a with 
96, a well-behaved model system (Scheme 3.1, Top). 
Transmetalation: The first step of the catalytic cycle is transmetalation of the 
aryltrimethylsilane. This is proposed to proceed via a reversible π-complexation, followed by 
irreversible Wheland intermediate (WI) formation. The origin of the selectivity for the silane 
over the arene at this step is the proposed stabilisation of the WI by silicon, due to silicon 
hyperconjugation.[122] In order for this selectivity to be achieved, π-complexation of the more 
electron-rich arene must be fully reversible, and therefore under Curtin-Hammett conditions, 
such that silane transmetalation outcompetes arene metalation (kTMS >> kH). After formation 









Scheme 3.1. Catalytic cycle (bottom) primarily based on kinetic data obtained from reaction 
of 39a and 96 (Top).[83] 
Competition experiments between different substituted silanes showed that transmetalation is 
accelerated by electron-donating groups (ρ = −1.6). In absolute rate terms, the electronic 
identity of the silane has little effect on the overall rate of the reaction (ρ = −0.2). 
π-Complexation: The π-complexation of the incoming arene to the Au(III) centre was 
assigned as the TLS of the reaction, and therefore all rate data corresponded to this step in the 
cycle. For π-complexation to occur, CSA must displace methanol in a pre-equilibrium. This 
led to a first-order dependence on the concentration of CSA, and an inverse order in methanol. 
As methanol is known to exist as a dimer in chloroform, this was an inverse half 





complexation would lead to predominant silane homocoupling due to the stabilisation of the 
resultant WI by Si. However, an irreversible π-complexation results in the more electron-rich 
arene outcompeting an electronically neutral silane (kH2
 > kTMS2). When less activated arenes 
are coupled with electron-rich silanes, then competing silane homocoupling is observed.  
Deprotonation: No KIEs were detected in independent rate measurements or intermolecular 
competition experiments, consistent with π-complexation as the TLS. An electrophilic 
metalation was proposed due to the observation of increasing rate with increasing arene 
electron-density. 
Reductive Elimination: As π-complexation was found to be the TLS in this reaction, no 
information on reductive elimination was gained. However, Toste and co-workers propose that 
reductive elimination proceeds via a 4-coordinate complex (See Chapter 1, section 1.2.3). 
Oxidation: The final step is the re-oxidation of Au(I) to Au(III). Only hypervalent iodine 
oxidants are competent, and the origin of this, and the mechanism of oxidation are unclear. 
3.1.2 Chapter Aims 
It was postulated that a mechanistic investigation into the intramolecular direct arylation 
reaction could lead to new mechanistic insights into the chemistry of gold(III) complexes. 
Although a thorough kinetic analysis into the intermolecular reaction had been performed, the 
conclusions were based on detailed study of a single, well-behaved, model system (Scheme 
3.1, Top). Information on the other steps in the cycle were derived from competition 
experiments, literature precedent, or from model stoichiometric reactions rather than catalytic 
processes. In the intermolecular reaction, π-complexation of the arene to gold was found to be 
the turnover-limiting step, leading to pseudo first-order kinetic profiles. It was anticipated that 
the tethering of the arene to the aryl-silane, and thus in turn to the aryl-gold, would raise the 
effective molarity of the arene, and therefore potentially change the turnover limiting step to 
another point in the cycle. 
As demonstrated in Chapter 2, the intramolecular process tolerates a large range of arene 
substituents. This is particularly notable in examples generating substituted fluorene products 
bearing highly electron withdrawing groups, such as CF3. This is in contrast to intermolecular 
coupling where electron-rich arenes are required. The diverse electronic range, and minimal 
side product generation suggests that this could be a perfect system to study mechanistically. 
Indeed, the breadth of examples available alleviates the need for the use of a single model 
system, and afforded the opportunity to assess the effect of electronics, and tether length, on 





3.2 Mechanistic Investigation 
3.2.1 Analysis of Reaction Kinetics 
The mechanistic investigation began by monitoring the kinetics of cyclisation of 1b by 1H 
NMR spectroscopy under the standard reaction conditions (Figure 3.1, left). Doing so 
unveiled, after a short induction period, clean pseudo-zero order kinetics. The kinetic profile 
alone gave a wealth of information about the TLS of the reaction. Firstly, it must be a 
unimolecular process, as an intermolecular TLS, or an intermolecular pre-equilibrium would 
give pseudo-first order kinetics. This eliminated both the transmetalation of the silane and the 
Au(I)-Au(III) redox by the oxidant as the TLS. Also, no curvature toward the end of the 
reaction, which can be observed in pseudo-zero profiles, suggests that no change in the TLS 
to an intermolecular process occurs at the end of the reaction. This can happen as the rate of 
bimolecular reactions become very slow toward the end of the reaction due to the reduced 
probability of collision. This observation indicates that the bimolecular reactions in the 
catalytic cycle (transmetalation and oxidation) must be fast processes. Based on the catalytic 
cycle determined from the mechanistic study into the intermolecular reaction (Scheme 3.1), 
the TLS could be π-complexation of the arene, Wheland-intermediate formation, 
deprotonation, ligand loss or reductive elimination. To probe the mechanism further, the effect 
of temperature on the rate reaction of 1b was measured. Eyring analysis over a temperature 
range of 10-35 °C gave activation parameters of ∆H‡ = +26 kcal mol ̶ 1and ∆S‡ = +21 e.u. 
(Figure 3.1, right). 
 
 
Figure 3.1. Left: Pseudo-zero-order kinetics for consumption of 1b at 27 °C. Right: Eyring 































Although interpretation of these activation parameters must be taken with care, the results are 
markedly different from what would be expected if π-complexation of the arene to the gold 
were turnover-limiting (for intermolecular arylation, the activation entropy, ∆S‡, is strongly 
negative).[83] The results suggest a turnover limiting step that occurs after π-complexation, and 
further experiments were performed to deduce whether it involves Wheland intermediate 
formation, deprotonation, reductive elimination from the resulting diarylgold species, or 
another process, prior to Au(I)-Au(III) redox. 
3.2.2 Kinetic Isotope Effects 
One of the simplest and widely-used strategies to investigate reaction mechanisms in C-H 
activation chemistry is the substitution of the reactive C-H bond with a C-D bond to measure 
the kinetic isotope effect (KIE). Despite the wide-spread use of this strategy, misinterpretations 
are rife in the literature, particularly when using competition experiments to comment on 
whether the deprotonation is turnover-limiting or not. In an attempt to clarify what insights 
can be drawn from KIE experiments, an essay by Hartwig outlines the three most common 
types of KIE experiments and the merits of each.[124]  
The gold-standard approach to investigate whether C-H cleavage is involved in the TLS is 
through independent rate measurements of the protonated and deuterated substrates. The ratio 
of the rate constants obtained from these independent rate measurements gives the KIE for the 
reaction. Although the observation of a large and positive KIE is excellent evidence that C-H 
cleavage occurs at the TLS, the measurement of small KIEs resulting from equilibria or change 
in hybridisation relies on high accuracy measurements and may be undetectable. In the context 
of the intramolecular gold-catalysed direct arylation, the absolute rates of turnover of 1b versus 
d5-1b in (Scheme 3.2, Top) were experimentally indistinguishable. Thus, the perdeuterated 
phenyl ring induces no significant kinetic isotope effect (KIE) on the overall rate of catalytic 
turnover. This eliminates C-H cleavage as the turnover-limiting step of the reaction. The 
second strategy to investigate the C-H cleavage event is through intramolecular competition 
experiments. Although the identity of the TLS cannot be assigned with such an experiment, 
the selectivity determining event leading to deprotonation can be explored. In such 
experiments the accuracy of measuring the KIE is typically very high as only the product 
ratios, and not rates, need to be measured at the end of the reaction.  To probe the deprotonation 
further, substrate d1-1b was prepared and a significant KIE (kH/kD = 2.5) was measured by 1H 






Scheme 3.2. KIE experiments. Top: Independent rate measurements; bottom: Intramolecular 
competition experiment. 
This observation was important as, although deprotonation is not turnover-limiting, the 
deprotonation is clearly kinetically significant and selectivity determining in this competition 
experiment. The lack of an inverse secondary KIE also demonstrates that Wheland 
intermediate formation is not kinetically significant. For this KIE to be expressed, the 
isotopomeric precursor η2 -complexes -II(1b) and II’(1b), Scheme 3.3- must be able to 
equilibrate prior to selectivity-determining C ̶ H / C  ̶D cleavage. Equilibration could occur in 
a non-dissociative manner, i.e. within discrete π-complexes (pathway A) or by reversible π-
complexation (via I(1b), pathway B).  
 
Scheme 3.3. Proposed η2-Arene π-complexes. 
To assess whether pathway B was operating and a reversible π-complexation was possible, a 
KIE experiment for bis-arene substrate d5-1x was undertaken (Scheme 3.4). If π-complexation 
was irreversible, then no significant KIE would be expected as the product would be 
determined upon π-complexation, and therefore an approximate1 1:1 ratio would be obtained 
regardless of isotope incorporation. However, the same primary KIE (kH/kD = 2.5) was 
                                                     





measured with bis-arene substrate d5-1x as d5-1b confirming that π-complexation is indeed 
reversible under these conditions, with C ̶ H / C  ̶D cleavage being selectivity-determining, but 
not turnover-limiting. This is yet another mechanistic difference to the intermolecular protocol 
where π-complexation is irreversible and turnover-limiting. 
 
Scheme 3.4. Intramolecular KIE experiment. 
3.2.3 Deprotonation Mechanism: SEAr vs CMD 
The observation of primary KIEs in direct arylation often leads to the conclusion that a 
concerted metalation deprotonation (CMD) type pathway is operative and not SEAr. However, 
from a kinetic perspective, this is not necessarily correct, as an SEAr pathway under Curtin-
Hammett control whereby π-complexation, and subsequent Wheland intermediate formation, 
is fast and reversible but deprotonation is irreversible, the product distribution will reflect the 
relative rates of the irreversible deprotonation and therefore lead to a primary KIE. To explore 
the mechanism of deprotonation in more detail, a series of intramolecular competition 
experiments were designed so that the electronic demand of arylation could be measured 
(Figure 3.2). The aim of this experiment was to determine whether the acidity of the proton 
would be of importance, as expected in a CMD type process, or if the nucleophilicity of the 
arene would dominate, which is likely for an SEAr type reaction.  The results clearly show that 
reaction at the more electron-rich arene occurs, which is consistent with an SEAr type process. 
All but one of the examples are meta substituted and hence electronic effects are primarily 
inductive and fit against σ, however the one para example 1y fits the data significantly better 
when σ+ is used instead of σ. While clearly more examples are required to verify this trend, 
this result could signify a selectivity determining Wheland intermediate formation, as the 









Figure 3.2. Substituent partitioning due to different arene electronics. 
Therefore, the selectivity determining step may change from deprotonation when the 
electronic bias on the aromatic rings is negligible (d5-1x) to WI formation upon electronic 
perturbation of the rings. 
Although negative ρ values have been obtained in certain studies where a CMD type 
mechanism is proposed, the ranges observed (−0.4 - −1.6)[36] are significantly lower than what 
is obtained in this study. The reaction constant obtained from these competition experiments 
(ρ/ρ+ = − 4.8/4.9) is much more consistent with electrophilic metalation.  
Further support for an SEAr type pathway was obtained through the observed regioselectivity 
of substrates 1k and 1ad (Scheme 3.5, Top) and comparing these values to similar experiments 
under Pd-catalysis where CMD is the operative mechanism (Scheme 3.5, bottom). Firstly, 
preferential arylation ortho- to a fluorine substituent is characteristic of a CMD mechanism, 
as seen in the cyclisation of 19 where the ortho:para ratio of products is 19:81. This is not 
observed under gold-catalysis as the reaction is almost completely para selective with a ratio 
of isomers of >98:2 for the cyclisation of 1k, and thus inconsistent with a CMD mechanism 
and entirely consistent with an electrophilic metalation. The naphthyl substrate 1ad also reacts 
as expected for an SEAr type reaction with the major isomer forming through reaction at the 
more nucleophilic 1-position. Whereas under Pd-catalysed direct arylation, the reaction of 
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Scheme 3.5. Regioselectivity pattern arising from SEAr (Top) and CMD (bottom) 
mechanisms. 
Additional evidence supportive of Wheland intermediate formation along the reaction pathway 
is the attenuation of the KIE when the methylene bridge in d1-1b is replaced with an O-linker 
d1-1v (scheme 3.6). The presence of the oxygen linker next to the resulting carbocation could 
lead to its stabilisation relative to the methylene bridged example. This stabilisation may 
reduce reversibility to the π-complex and therefore Wheland intermediate would effectively 
become selectivity determining and a roughly equal proportion of H and D would react. At the 
limit of a fully irreversible Wheland intermediate formation, an inverse secondary KIE could 
be expected. As this is not the case and a small KIE is still measured, it is possible that the 







Scheme 3.6. Proposed origin of diminished KIE in presence of oxygen linker. 
3.2.4 Hammett Linear Free Energy Relationships 
The evidence obtained so far pointed towards reductive elimination as the TLS for substrate 
1b. Indeed, the pseudo-zero order kinetic profile ruled out transmetalation of the silane and 
oxidation of the metal, the large entropy of activation eliminated π-complexation and the 
results of the kinetic isotope effect experiments meant deprotonation or Wheland intermediate 
formation were not turnover-limiting. By process of elimination, it was therefore likely that 
reductive elimination, or a yet to be uncovered step in the catalytic cycle, was the TLS. To 
enforce this hypothesis the effect of aryl electronics on the rate of the reaction was measured. 
It was expected if reductive elimination was the TLS that, regardless of whether the substituent 
was initially on the arene (1i-n) or silane (iso-1i-n) ring, identical rates would be obtained. 
This is because each substrate would converge at common intermediate, IV(1i-n), prior to the 
TLS and therefore should react at equal rates (Scheme 3.7). 
 
Scheme 3.7. Regioisomeric starting materials converging on common intermediate prior to 
reductive elimination. 
The temporal kinetic profiles were obtained for a series of substituted arenes and silanes 
(Figure 3.3). When the arene is substituted (Figure 3.3, Top), pseudo-zero order profiles are 
maintained throughout the series, albeit with increased curvature with the most electron-





significantly longer reaction times and complex kinetic profiles when electron-withdrawing 









































By combining kinetic simulation with experimental observation, an off-cycle catalyst 
deactivation pathway was proposed and the exact nature of this deactivation is the focus of the 
next chapter. However, it was found that addition of electron-rich arenes to the reaction 
mixture could prevent the deactivation pathway and the on-cycle mechanism could be 
explored. The additive of choice was 2-bromothiophene, 98, and its addition to examples 
bearing electron-withdrawing substituents on the aryltrimethylsilane led to pseudo-zero order 
profiles being observed once again (Figure 3.4). 
 
 
Figure 3.4. Temporal kinetic profiles of substituted silanes in the presence of 2-
bromothiophene to eliminate catalyst deactivation. 
Combining the data from arene and silane substitution into a single Hammett LFER plot 
(Figure 3.5) demonstrates that regardless of which ring the substituent is positioned on, 
identical rates are obtained up to σ = 0.43 with a reaction constant of ρ= −2.0. A break in the 
Hammett plot is observed for the most electron-withdrawing groups, where reduced rates and 
increased curvature is observed when the arene is substituted (vide infra). The effect of 
electronics on the TLS is therefore substantially different to what was earlier measured in 
competition between electronically biased pairs of arenes (Figure 3.2), therefore affirming the 






















To further explore the effect of aryl electronics on rate, the rate of cyclisation of disubstituted 
examples 1ae and 1t, were measured. The rates were predicted by the sum of their sigma 
values as shown on Figure 3.5, indicating that once again, regardless of provenance, the impact 
of a substituent on the rate of turnover is identical. 
 
 
Figure 3.5. LFER analysis of rates of catalytic turnover during cyclisation of (di)substituted 
silanes and arenes; log10(kX/kH) = −2.0σ − 0.06; σ-values are additive for 1ae/1t. Conditions: 
substrate (0.05 mmol), thtAuBr3 (2 mol%), 2-bromothiophene (0.5 mmol), PhI(OAc)2 (0.055 
mmol), CSA (0.065 mmol), CDCl3/CD3OD (50:1, 0.1 M). Note: Dashed line for illustrative 
purposes only.  
These results suggest convergence at a common intermediate at, or prior, to the TLS. This 
condition can be satisfied at any point after C−H cleavage to generate a diarylgold 
intermediate. Further evidence for convergence at a common intermediate arises from the 
identical rates of turnover of bis-TMS substrate 1af and 1b (R = H), both of which generate 
2b, via the same intermediate IV(1b) (Scheme 3.8). Reaction of bis-silane 1af thus involves a 










































monoaryl-gold intermediate. This selective intramolecular C-Si versus C-H auration is 
consistent with the conclusions drawn previously from intermolecular examples: when π-
complexation is reversible, generation of a TMS-stabilised Wheland intermediate is favoured. 
To ensure that the 2b generated was not as a result of rapid protodesilylation of 2af, the 
reaction was performed in deuterated solvent. As no deuterium incorporation was observed, 
2b must be formed exclusively via pathway A. 
 
Scheme 3.8. Further evidence for reductive elimination as the TLS. 
These results strongly indicate that reductive elimination is the TLS for the vast majority of 
examples measured. 
3.2.5 Reductive Elimination  
In Chapter 1, reductive elimination from gold(III) complexes was introduced, however the 
parameters that govern this process are not well understood. Two major studies have given 
some insights into the process. Kochi demonstrated that reductive elimination from 
dialkylgold(III) complexes requires the dissociation of a ligand to afford a three-coordinate 
gold species prior to reductive elimination, and that addition of phosphine retarded the 
reaction. Toste and co-workers came to the opposite conclusion for diarylgold(III) 
complexes,[77] and determined that reductive elimination can occur from the 4-coordinate 
species, and that addition of phosphine increases the rate of reaction by providing an ionic 
pathway. Despite determining the rate of reductive elimination from a particular gold complex 





substituents on the rate of reductive elimination.   However, comparing Toste’s results with 
Nevado’s study on [Ar2Au(PPh3)Cl] complex 40, where Ar = C6F5, demonstrates that electron-
withdrawing groups likely reduce the rate of reductive elimination as forcing conditions were 
required for reductive elimination to occur in this case (150 °C, 20 h).[74] The results presented 
herein confirm this, and quantify the electronic effect of aryl substituents through the Hammett 
LFER (Figure 3.5); reaction constant of ρ = −2.0. It was only by investigating the 
intramolecular reaction, and therefore changing the TLS from π-complexation to reductive 
elimination, that allowed for this elementary step to be studied without the reliance on 
stoichiometric studies, as is so often needed.[125–128] Indeed, it is relatively uncommon to find 
that reductive elimination as the turnover limiting step in any C(sp2)-C(sp2) cross-coupling 
reaction.[129,130] In most examples, oxidative addition or transmetalation is turnover-limiting. 
Despite determining that reductive elimination from these gold(III) complexes involves a large 
and positive ∆S‡, indicating significant decrease in order at the transition state, and that the 
process is accelerated by electron-donating substituents (ρ=  ̶ 2.0), there were still several key 
questions: 1) How does reductive elimination from diarylgold(III) complexes compare with 
other transition metals? 2) What is the ligand speciation, i.e. does reductive elimination occur 
from a 3- or 4-coordinate species? 3) Can the gold(III) intermediates be observed or 
characterised? 
1) Comparison with Literature: The acceleration of reductive-elimination by electron-
donating substituents (ρ = –2.0; Figure 3.5) is partially consistent with literature precedent for 
other Ar2[M] complexes (M = Pt, Pd), where electron-withdrawing substituents are found to 
strengthen the ground-state metal-carbon bonds, and therefore reduce the rate of reductive 
elimination (ρ = –1.0 - –1.5).[131,132] However, Hartwig showed from LFER analyses, that 
reductive elimination from Ar2[Pt] complexes “is faster from complexes with a larger 
difference between the electron-donating properties of the two aryl groups.”[131,132] In other 
words, the electronic effects of substituent on reductive elimination rates are not simply 
additive. This is clearly not the case in the system measured herein, as disubstituted examples 
1ae and 1t react at a rate predicted by the sum of their σ values, thus showing that within the 
electronic range analysed, electronic effects on reductive elimination from gold are indeed 
additive. This is in agreement with computational studies on reductive elimination from cis-
[AuPPh3(Ar1)(Ar2)] complexes which calculated that the electronic effect of aryl substitution 
should be additive.[133]  
2) Ligand speciation: A much-discussed issue in the literature is whether reductive 





assess whether there was a pre-equilibrium prior to reductive elimination, and if any of the 
reaction components affected the rate, the order in each component was assessed. In the rate 
analysis of 1b, it was found that the reaction had a zero-order dependence on all reaction 
components (oxidant, CSA, substrate) other than the catalyst itself and methanol. An inverse 
order was observed in methanol (Figure 3.6, Left). The inverse order suggests that methanol 
is behaving as an inhibitor, which was also found in the intermolecular study. However, in 
contrast to the intermolecular study, increasing the concentration of methanol does not lead to 
the rate of reaction becoming zero, instead, at high methanol concentrations the rate saturates. 
These results are consistent with two species being in equilibrium that can reductively 
eliminate. This can be interpreted as a fast reacting 3-coordinate species V(1b), and a slower 
reacting, methanol-bound 4-coordinate species IV(1b) (Figure 3.6, Left). Therefore, as the 
concentration of methanol increases, the equilibrium shifts to IV(1b), and the reaction slows 




Figure 3.6. Left: Rate-dependence on [CD3OD]. Right: Proposed pre-equilibrium to explain 
observed rate dependence.   
Based on this hypothesis, the maximum rate of reductive elimination should occur when there 
is no methanol.   Unfortunately, methanol is required in the reaction to solubilise the CSA, and 
therefore methanol was replaced with TFE to estimate the rate in its absence. As a significantly 
more acidic alcohol (pka 12.4 vs 15.5),[134] one would expect the equilibrium to shift 
significantly toward V(1b). Indeed, significantly greater rates were observed when methanol 
























when monitoring the reaction using TFE gives an approximation of k1, and that the kobs 
obtained when the reaction is saturated with methanol gives k2, simulation software can be 
used to extract the equilibrium constant Keq using the derived rate expression (equation 1). The 
aim of the simulation was to confirm that the observed rate dependence on methanol can be 
predicted by this hypothesis and the associated rate equation.   However, a complication to the 
simulation is the fact that methanol is known to occur as a dimer in solution with chloroform, 
and the equilibrium constant Keq2 is not reported.[123] Whilst the presence of this dimerisation 
excludes the extraction of meaningful values of Keq and Keq2 as various combinations can be 
used, good fits to the data can be obtained. This confirms that the observed kinetics can be 
explained by reductive elimination occurring via a fast reacting 3-coordindate species and a 
slower reacting, methanol-bound 4-coordinate species. Whilst this is at odds with the results 
from Toste and co-workers, the system demonstrated herein differs in that i) the two aryl 
groups are tethered and ii) there are no phosphine ligands present.  
Alternatively, these results could be attributed to medium effects as Komiya and Kochi[135] 
demonstrated significant rate differences in reductive elimination from dialkylgold(III) 
complexes using different solvents. In their report, it was shown that increasing solvent 
polarity favoured reductive elimination. Whilst significant efforts would be required to 
eliminate the possibility of medium effects causing the changes in rate presented herein, the 
observation that increasing solvent polarity reduces the overall rates is at odds with Komiya 
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Figure 3.7.  Overlay of simulated and experimental data (Top left) using the rate equation 
(Top right) derived from mechanistic hypothesis (Bottom). 
3. Observation of Resting State. Although the purported resting states could not be 
independently isolated, a species consistent with being a catalytic intermediate, tentatively 
assigned as IV(1b), was observed by 1H NMR spectroscopy. In the methylene region (ca. 4 
ppm) of the 1H NMR spectrum a peak was observed with an integral equating to approximately 
1 mol% of the starting material, identical to the catalyst loading used in the experiment. The 
species is absent before initiation, grows to a steady state, and then disappears upon total 
consumption of the starting material. Additionally, repeating the reaction at increased catalyst 
loadings gave the expected increase in intermediate concentration, confirming the relationship 
between catalyst loading and intermediate concentration. A final confirmation of the 




































Figure 3.8. Top: Pseudo-zero-order kinetics (after induction period, ∼300 s) for cyclisation of 
1b using 1.0, 1.5, and 2.0 mol% Au. Middle: temporal concentration of catalyst resting state, 
tentatively assigned as IV(1b). Bottom: temporal turnover rate of 1b/M s−1. 
3.2.6 Change in TLS and Shifting Resting States 
Reductive elimination is the TLS for the majority of cyclisations that lead to fluorenes. Strong 
evidence for this conclusion was the measurement of identical rates, regardless of whether 
substituents were located on the arene, or silane moiety. However, when substantially electron-









































Scheme 3.9. Effect of aryl substituent on observed rate constant for cyclisation.  
Whilst pseudo-zero order profiles are maintained when the substituent on the silane-bearing 
aromatic ring is varied, substitution of the arene with electron-withdrawing groups leads to 
slower cyclisation, with increased curvature in the kinetic profiles. This is particularly 
significant in the cyclisation of 1m, where substantially different rates and kinetic profiles are 
observed when compared to its constitutional isomer iso-1m (Figure 3.9).   
 
 
Figure 3.9. Comparison of rates of isomers 1m and iso-1m. Conditions: substrate (0.05 
mmol), thtAuBr3 (2 mol%), 2-bromothiophene (0.5 mmol), PhI(OAc)2 (0.055 mmol), CSA 
(0.065 mmol), CDCl3/CD3OD (50:1, 0.1 M). 
These observations suggest a change in the TLS, and the curvature observed is the result of a 
rate dependence on CSA, which is not found in examples where reductive elimination is 
turnover-limiting. During the reaction, CSA is liberated as the oxidant is consumed, and 
















confirmed by deliberate addition of CSA to the reaction, and an observed increase in rate. 
These results are consistent with π-complexation as the TLS for 1m as the dependence on CSA 
was also found in the intermolecular coupling where π-complexation is turnover limiting. This 
hypothesis was reinforced by interception of the proposed monoaryl resting state I(1m) with 
2-bromothiophene 98, resulting in co-generation of biaryl 99. This interception is not observed 
with iso-1m due to the rapid rate of intramolecular C-H auration (Scheme 3.10).  
  
Scheme 3.10. Intermolecular interception of monoaryl resting state. 
Intriguingly, the maximum rate observed in the cyclisation of 1m approaches the rate observed 
for the cyclisation of iso-1m, where reductive elimination is the TLS (Figure 3.9). This 
suggests that the TLS may change during the reaction from π-complexation, when the 
concentration of CSA is low, to reductive elimination at high CSA concentrations. Analysis 
and kinetic simulation of the partitioning between 1m and 99 as a function of conversion 












Figure 3.10. Interception of intramolecular cyclisation of 1m by 98 with simulated data from 
model in Scheme 3.11. 
It is clear from Figure 3.10 that the partition between 2m and 99 is changing as the reaction 
progresses. Assuming π-complexation is the selectivity determining step, the observation 
suggests that the rate of π-complexation in the intramolecular coupling is affected by the free 
[CSA], which is increasing through the course of the reaction, whereas under the reaction 
conditions, the intermolecular coupling is not significantly affected and therefore k1 ≈ k2 < k3 
(Scheme 3.11). The slight downward curve observed for the formation of 99 suggests a shift 
in TLS for the intramolecular cyclisation from π-complexation to reductive elimination and 






























Scheme 3.11. Model to explain partition observed in Figure 3.10. X denotes anionic or neutral 
ligands 
Kinetic modelling of the reaction based on Scheme 3.11 was performed based on the following 
rate and equilibrium constants: k1 = 0.0027 dm3mol ̶ 1s ̶ 1, k2 = 0.0040 dm3mol ̶ 1s ̶ 1, k3 = 0.034 
s ̶ 1, k4 = 0.0077 s ̶ 1 and Keq = 1.85 (the values reported are for purely illustrative purposes only 
and no rate or equilibrium constant should be used in isolation). To investigate this further, the 
intermolecular coupling of 98 with 100 was monitored (Figure 3.12). As expected, the initial 
rate of formation of 99 and 101 are similar, however the rate of 101 is increasing slightly (as 
expected if k2 is slightly greater than k1) whereas the rate of 99 is decreasing with time, which 
is consistent with a shifting of resting state from I(1m) to IV/V(1m) in the competition 
experiment. In the absence of a shift in resting state, one would expect rate of formation of 99 








Figure 3.12. Combined concentration/time plots for the formation of 99 and 101 
3.2.7 Effect of Tether Length on Rate 
Calculations on reductive elimination from unconstrained [(Ar1)(Ar2)Au(PPh3)Cl] complexes 
show that the lowest energy transition state involves Au−Ar conformations in which the two 
aryl rings are oriented face-to-face.[133]  The short tethers employed herein will likely make 
this conformation less accessible, and therefore reducing the rate of reductive elimination 
versus unconstrained examples. Longer, non-rigid tethers are therefore expected to allow 
greater Au−Ar conformational mobility and thus a lower energetic barrier to the attainment of 
the requisite face-to-face orientation of the two aryl rings. However, longer tethers will also 
reduce the effective molarity of the arene in the precursor C−H auration. The kinetics of 
cyclisation of 1b (−CH2− tether) are distinct from those of 3a (−CH2CH2− tether), Figure 3.13. 
In the latter case, increase of the tether length by one methylene unit results in a curved kinetic 
profile, similar to that found for substrate 1m (Figure 3.9) and therefore indicative of a 





















Figure 3.13. Turnover to generate 5- versus 6-membered rings. As the reaction proceeds, the 
turnover rate of 3a accelerates, becoming faster than that of 1b. 
A key observation is that, as the reaction evolves, the rate of turnover of 3a becomes faster 
than that of 1b, for which reductive elimination is the TLS. In other words, the intrinsic rate 
of reductive elimination from the longer −CH2CH2− tethered intermediate IV/V(3a) must be 
faster than that from the more constrained, −CH2− tethered intermediate IV/V(1b) (Scheme 
3.12). However, the extent to which reductive elimination is accelerated cannot currently be 
quantified as the rate data obtained for 3a does not result from reductive elimination as the 
TLS. 
 
Scheme 3.12. Effect of tether length (n) and flexibility on rate of reductive elimination. 
Whilst the relative rates of reductive elimination cannot be quantified in these examples, 




















Although in absolute rate comparisons, 3a cyclises faster than 1b, in competition this is not 
the case. Using 102 to perform an intramolecular competition experiment, the 5-membered 
ring cyclisation outcompetes the 6-membered ring forming process by a factor of 13 (Scheme 
3.13). This selectivity may arise from the differential developing strain in 6-membered versus 
7-membered aurocycles generated from rings A / B respectively.  
 
Scheme 3.13. Intramolecular competition (A versus B) to generate 5-membered (103) versus 
6-membered (104) rings. 
Further investigation into the formation of 6-membered ring systems revealed an 
intramolecular primary KIE of 1.9 for d1-3a, indicative of partially reversible Wheland 
intermediate generation (Scheme 3.14). Once again, stabilisation of the Wheland intermediate 
by replacing the CH2 linker with oxygen in d1-3d eliminates the KIE. 
 
Scheme 3.14. KIEs for 6-membered ring cyclisation of d1-3a and d1-3d. 
The final demonstration of the effect of tether length on the rate of cyclisation was through the 
monitoring of the cyclisation of 5a to form 7-membered ring 6a (Figure 3.14). The curvature 
that is seen in the cyclisation of 3a is maintained, however a significantly slower rate is 
observed, approximately 30-fold slower than the 6-membered analogue 3a. Despite the 
increased reaction times, this is still a significantly faster reaction than the coupling of toluene 
in the intermolecular reaction which took approximately 45 h. This demonstrates that even 







Figure 3.14. Turnover to generate 7-membered ring 6a. 
3.3 Summary  
 

















In 2014, a mechanistic investigation into intermolecular gold-catalysed direct arylation 
resulted in the elucidation of the catalytic cycle. However, several features were unexplored 
due to the kinetic restrictions from π-complexation being the turnover-limiting step. This has 
led to the re-examination of the mechanistic features of the reaction through investigation of 
the intramolecular variant presented herein. The results of this study are in total agreement 
with the previous report, and through the exploitation of features not accessible to the 
intermolecular reaction, key new insights have been uncovered.  
Rendering the arylation process intramolecular induces several changes that facilitate 
mechanistic investigation. First, unlike the intermolecular system, the vast majority of the 
intramolecular substrates undergo turnover with simple and reproducible kinetics, without 
complications from side reactions such as arene oxidation or arylsilane homocoupling. 
Second, only electron-rich arenes can be arylated intermolecularly, limiting the range of arene 
substituents that can be explored in linear free-energy relationships. In contrast, the 
intramolecular system tolerates a wide range of arene substituents, both electron-donating and 
electron-withdrawing, and the kinetics have been determined for substituents with σ- values 
ranging from −0.3 to +0.6. Third, relative to all of the other steps in the intermolecular catalytic 
cycle, reductive elimination from diarylgold(III) is fast. Consequently, it has not previously 
been possible to acquire kinetic data for this key C−C bonding-forming process. This is the 
case in many catalysed processes, and therefore kinetic data for reductive elimination under 
catalytically relevant conditions is sparse. The ability to monitor the reductive elimination 
from diarylgold(III) complexes IV/V in this study relies on the reaction being intramolecular. 
Not only does the short tether induce a high effective molarity which leads to rapid π-
complexation, it also restricts the conformational freedom of the aromatic rings to attain the 
required face-to-face arrangement and thus reduces the rate of reductive elimination relative 
to the other steps in the cycle. The combination of these two processes is sufficient to cause 
reductive elimination to be the TLS in many cases. Therefore, for the first time, the effect of 
aryl electronics on the rate of reductive elimination has been demonstrated through Hammett 
LFER studies, with a reaction constant of ρ = −2.0.  
Competition experiments exclusive to intramolecular coupling allowed for investigation into 
other steps in the catalytic cycle that are not turnover limiting. In particular, new insights into 
the mechanism of C-H auration were attained through KIE experiments and arene competition 
reactions. Strong evidence of an SEAr metalation mechanism was attained through the 
measurement of the reaction constant for metalation (ρ = −4.8) and the attenuation of the 





However, the elucidation of this mechanism relied on the understanding of complex off-cycle 
processes. Indeed, electron-deficient silanes suffer from low reactivity under the standard 
conditions and examples of the unusual kinetic profiles obtained are shown in Figure 3.3. 
These effects were bypassed through the addition of a π-rich arene, 2-bromothiophene, and 
allowed for the on-cycle mechanism to be explored. The following chapter provides a detailed 
investigation into the cause of this reactivity, and through the combination of experimental 































ABSTRACT: Chapter 4 
A novel catalyst inhibition pathway is uncovered whereby initial catalyst deactivation is 
reversed by the product of the reaction. This auto-reactivation pathway results in unique 
kinetic profiles, and reactions with extreme sensitivity to both substrate and catalyst 
concentrations. Several mechanistic hypotheses are proposed to explain the observed data, and 
simulation software is employed to distinguish between models that cannot kinetically explain 
the results from those that can. Water is identified as the source of catalyst inhibition, and 
elimination of this results in significantly improved rates of reaction. Catalyst deactivation is 
also identified in the cyclisations of allocolchicine precursors. An entirely different catalyst 
deactivation pathway is proposed and results from the formation of a highly active inhibitor 
from the reaction of the starting material with the oxidant.  
The results presented in section 4.5 of this Chapter have been communicated: T. J. A. Corrie, 
G. C. Lloyd-Jones, Topics in Catalysis, 2017, 60, 570. 
4.1 Introduction  
The aim of kinetic analysis is to uncover and detail the mechanism of a reaction, and by doing 
so, further optimisations, or inspirations for novel developments, may be possible. In catalysis, 
the turnover-limiting step is the key to understanding which components affect the rate of a 
reaction, and therefore the factors that govern this elementary step. The classical approach to 
uncovering the TLS is either through initial rate studies, or through pseudo first-order 
conditions, where the concentrations of other components are held artificially high whilst the 
rate dependence of a single component is measured. Whilst such methods do provide a route 
to determining the rate law and the TLS of a reaction, they do not provide a full picture of the 
whole reaction under synthetically relevant conditions.[136,137] The modernisation of analytical 
techniques has resulted in such approaches becoming redundant, as analysis of global kinetic 
profiles, through in-situ analysis or by sampling, is an attractive and viable alternative. 
Depending on the approach, the data obtained can be from differential methods, such as 
calorimetry, where rate is measured directly, or integral methods, such as NMR spectroscopy, 
where the change in concentration of a species can be monitored against time. If simple 
kinetics are observed, such as the pseudo-zero order profiles measured in this study, or clean 
pseudo-first order profiles, then trivial mathematical operations can be performed to extract 
rate constants. However, catalytic reactions can be complicated, indeed the dynamic nature of 
the solution resulting from changing concentrations of substrates can lead to varying 
importance of catalytic intermediates, and therefore the factors that govern the rate at the start 




monitoring of the entire reaction can such processes be identified. The presence of catalyst 
deactivation pathways and off-cycle processes can lead to significantly complex kinetic 
profiles, for which the cause can be difficult to untangle. Whilst hypotheses can be easily 
proposed, proving the exact mechanism of off-cycle processes is non-trivial. However, 
confidence in a mechanistic model can be attained through kinetic simulations, whereby 
agreement between computational and experimental results can serve to validate a model and 
indicate that a particular hypothesis is kinetically plausible.[136–138] 
Catalyst deactivation is a deleterious and ultimately inevitable[139] process in any catalytic 
reaction whereby a catalyst loses its activity and productive turnover eventually ceases. The 
understanding of catalyst deactivation processes is vital, particularly in industrial cases where 
the efficiency of a process is key and even small amounts of catalyst deactivation can render 
a process inoperable. Catalyst deactivation can be caused by a number of different factors in 
both heterogeneous,[140–142] and homogeneous[139] catalysis, however the modes of catalyst 
deactivation in homogeneous catalysis are relatively under-studied. Factors that can cause 
catalyst deactivation in homogeneous catalysis include, amongst others, catalyst inhibition by 
a poison, ligand degradation and metal deposition.[139] The lack of research into modes of 
catalyst deactivation is likely due to such processes being overlooked. Indeed, in typical 
reaction screening techniques, several different catalysts or ligands at similar loadings will be 
left for an arbitrary amount of time and then product yields will subsequently be compared. 
Catalyst or ligands with poor conversions will often be discarded and those with good 
conversions further optimised. It is entirely possible, however, that the catalysts that lead to 
poor yields have a high activity and turnover frequency, but a low turnover-number due to 
deactivation. Only through analysis of temporal kinetic profiles can the cause of deactivation 
be identified, and the outcome of understanding deactivation can be a more active and stable 
catalyst. 
4.2 Chapter Aims 
In Chapter 3, the kinetic profiles associated with electron-deficient silanes were introduced. 
The kinetic profiles were highly complex, with three distinct regions, and significantly 
different to the pseudo-zero order profiles obtained when the silane was unsubstituted, 
indicating that catalyst inhibition was occurring. The aim of this chapter is to understand the 
cause of these unexpected profiles, and through kinetic simulation construct mechanisms that 




4.3 Initial studies 
A common cause for catalyst deactivation is the presence of a poison or inhibitor, often 
introduced into the reaction due to impure starting materials, or generated during the reaction, 
that can react with the catalyst and prevent turnover. Depending on whether this reaction is 
reversible or irreversible, or where in the catalytic cycle the inhibition occurs, different kinetic 
profiles can be expected. This can be demonstrated with a basic simulation of a simple two 
step catalytic cycle where the first step is catalyst-substrate binding, and the second is product 
release (Figure 4.1). To reflect the conditions of intramolecular direct arylation, product 
release was assigned as the TLS. Two cycles were envisioned, with catalyst inhibition 
occurring at different stages in the cycle. Two simulations were run for each reaction, with 







Figure 4.1. Hypothetical catalytic cycles A and B and expected kinetic profiles depending 
on presence and mode of catalyst inhibition. 
The simulation was set with a constant concentration of inhibitor. In the absence of inhibition, 
pseudo-zero order profiles are obtained with rates dependent on k2. When there is inhibition, 
and if it is reversible, curvature can be observed if cycle A is operating, with the extent of 
curvature dependent on the equilibrium constant (k3/ k−3) and the relative rate constants of 
inhibition and catalyst substrate binding (k1 vs k3). The origin of this curvature is due to the 
substrate concentration dependence in the inhibition pathway. As the reaction progresses, and 




catalyst-inhibitor species. In cycle B, this is not the case and instead pseudo-zero order profiles 
are maintained but the absolute rate of reaction is reduced. The rate is dependent on the 
equilibrium constant, and not the absolute values of k3 and k-3 provided k2 is not an order of 
magnitude greater than k3. When deactivation is irreversible, both reactions will eventually 
stall. The conversion at which the reaction stalls will depend on the catalyst concentration, 
and, depending on inhibition location, the k1:k3 or k2:k3 partition respectively. 
Whilst these kinetic profiles can give an appreciation of the impact that different modes of 
inhibition can have, real systems are often significantly more complex. Indeed, in this study, 
the kinetic profiles obtained when EWGs are positioned on the silane vs the simple pseudo-
zero order profiles when the arene is substituted must be due to significantly more complicated 
processes (e.g. Figure 4.2).  
 
 
Figure 4.2. Comparison of kinetic profiles obtained when Cl is placed on: A) the arene and 
B) the silane. Conditions:  Substrate (0.1 M), thtAuBr3 (2 mol%), IBDA (0.11 M), CSA (0.13 
M), CDCl3/ CD3OD (50:1). 
It was of great interest to understand the cause of these unexpected profiles, and through 
kinetic simulation construct a mechanism to explain the unusual behavior. Prior to any 
simulation, an attempt to empirically rationalise the kinetic profiles was undertaken. In the 
first region of the kinetic profile, the initial rate is fast but rapidly decreases, consistent with 
catalyst deactivation. However, the reaction does not stall completely and, in the second 
distinct region of the curve, enters a pseudo-zero order regime for an extended time period. In 
































the reaction profile it was proposed that there is an initial, possibly irreversible, deactivation 
and that every catalyst turnover consumes a small percentage of the active species. If, however, 
the product that is generated is able to liberate the active catalyst from inhibition, this would 
allow for productive turnover to be restored once again. Based on this hypothesis, the addition 
of product at the beginning of the reaction should have a profound effect on the rate and kinetic 
profile and indeed that is what was found. The rate increased with increasing concentration of 
product with saturation at approximately 5 equivalents (Figure 4.3).  
 
 
Figure 4.3. Effect of added product 2l on the rate of turnover of iso-1l 
At high product concentrations, pseudo-zero order kinetics were observed, with identical rates 
to the substituted arene example, consistent with reductive elimination as the TLS.  
4.3.1 Source of Inhibition 
Uncovering the source of the inhibition was vital for the construction of a successful model, 
because accurate concentrations for the inhibitor needed to be built into the simulation. Despite 
significant efforts, no impurity or side product could be identified to explain the observed 
kinetics. Trace impurities in the starting material silane were discounted as rigorous 
purification was undertaken, and the distinct kinetics were still observed across a range of 
substrates, and not one isolated case. In addition, careful analysis of the reaction mixture at the 
end of the reaction gave no indication of a side product that could explain the inhibition. It was 
eventually found that upon changing the batch of CSA, the extent of inhibition reduced 
significantly. The prior batch of CSA was found to be saturated with water, and placing this 























attempts to prevent the inhibition by running the reaction under anhydrous conditions were 
unsuccessful, and this was found to be a result of water being generated as a co-product during 
the reaction. Under the standard reaction conditions IBDA and CSA are mixed to form the in-
situ oxidants 62/63, where presumably R=Me (63) under anhydrous conditions. However, it 
was found that the acetic acid that is generated from this reaction and the methanol co-solvent 
react to form methyl acetate and water in an acid-catalysed esterification (Scheme 4.1). 
  
Scheme 4.1. Acid catalysed esterification leading to formation of water.  
It was undesirable to include this equilibrium in subsequent simulations as it would be an 
additional source of error. Therefore, to simplify the system, IBDA and CSA were replaced 
with preformed oxidant, HCIB (R = H, 62), to avoid the formation of acetic acid. Upon 
activation of the gold pre-catalyst, the oxidant will liberate an equivalent of water relative to 
the catalyst, and this could easily be built into any model. Deliberate addition of water at the 
start of the reaction led to a profound effect on the extent of deactivation, with more 












Figure 4.4. Effect of increasing H2O concentration on inhibition of iso-1l to 2l. 
The deactivation was demonstrated to be reversible through the addition of 3 Å molecular 
sieves (MS) to the reaction. This is demonstrated in Figure 4.5 which displays the full kinetic 
profile when 2 equivalents of water are added to the reaction, and the effect of 3 Å MS, added 
after 15 h, to a repeat of this reaction. 
 
Figure 4.5. Full kinetic profile of addition of 2 equiv. of H2O, and effect of addition of 3 Å 
MS to a repeat of this reaction. 
In addition to water being an inhibitor, the oxidant was also found to be equally competent in 






































concentration of HCIB and water is kept constant, but their mole fractions are varied, showed 
near identical kinetic profiles (Figure 4.6). 
 
 
Figure 4.6. Effect of [H2O] and [HCIB] on catalyst inhibition. Conditions: Substrate (0.1 
M), thtAuBr3 (2 mol%), CDCl3/ CD3OD (50:1). 
Two plausible explanations for this observation are; 1) the oxidant behaves as an inhibitor with 
an identical ability to deactivate gold as water or; 2) The oxidant is in equilibrium with 
methanol, generating water, and therefore addition of HCIB leads to indirect addition of water. 
For the second hypothesis to be valid, the equilibrium must be biased towards the generation 
of water (Scheme 4.2).  
 
Scheme 4.2. Possible equilibrium to explain behaviour of 62 as an inhibitor. 
4.4 Kinetic Simulations 
With a reasonable hypothesis in hand, kinetic simulations2 were then used to explore 
mechanisms for the proposed catalyst deactivation and off-cycle pathways. The catalytic cycle 
was simplified into a three-step process (Scheme 4.3). First, the gold(III) catalyst can react 
with the substrate (S), in the transmetalation step. This step must be set arbitrarily high, so as 
                                                     






















not to become fully or partially turnover-limiting. As reductive elimination is turnover-
limiting, from a kinetic perspective it is unnecessary to include the steps in between 
transmetalation and reductive elimination. The second step, product release (reductive 
elimination), is the step that governs the rate of catalytic turnover in the absence of 
deactivation. The final step is re-oxidation of gold(I) to gold(III) to complete the cycle. Whilst 
the rate of this step is not kinetically significant, it is included in some cases (vide infra), the 
oxidant is the limiting reagent.   
 
Scheme 4.3. Basic catalytic cycle to be simulated. 
4.4.1 Model A 
Model A was the first system tested to explain the observed kinetics (Scheme 4.4). The 
hypothesis was that at the beginning of the catalytic cycle the catalyst ([Au]III) can partition 
between the substrate (S) (leading to productive catalysis) and an inhibitor (I), where I = H2O, 
Oxidant (62). The catalyst-inhibitor complex ([Au]III-I) is inactive but upon reaction with 
product (P) the active catalyst can be released. As no side product was isolated, a ligand 
displacement, rather than a chemical reaction, was preferred. The inhibition was placed at this 
point in the catalytic cycle to allow a competition between inhibition and transmetalation. The 
transmetalation rate of aryltrimethylsilanes is reduced when EWGs are in place,[83] and thus 
inhibition will be maximised when the silane is electron-deficient, consistent with the 
observation that only electron-deficient silanes exhibit these unusual processes.  
 




The reaction used to test the model was the cyclisation of iso-1l to 2l. In this reaction, one 
equivalent of water was deliberately added at the start of the reaction, with HCIB as the 
oxidant. However, the kinetic simulation was in poor agreement with experiment (Figure 4.7). 
Whilst the simulation was able to correlate with the experimental data initially, the end of the 
reaction gave a very poor fit and this is as a result of the expected dependence of the partition 
on substrate concentration. With decreasing concentration of substrate, partitioning to the 
catalyst-inhibitor complex would be maximized. 
 
 
Figure 4.7. Simulated fit (dashed lines) to experimental data of conversion of iso-1l to 2l 
using Model A. 
4.4.2 Model B 
To eliminate the dependence of the deactivation mechanism on the substrate concentration, 
Model B was generated. In Model B, the deactivation is moved to another point in the catalytic 
cycle, and by doing so removes dependence on the starting material in the deactivation 
mechanism. Although the fit was not perfect, it was a significant improvement to that obtained 























                                                             
Figure 4.8. Simulated fit (dashed lines) to experimental data of conversion of iso-1l to 2l 
using Model B. 
To validate the model, further experiments were necessary. Indeed, a requirement of Model B 
is that a change in substrate concentration should not impact on the rate, or the overall 
appearance of the reaction profile. To test this hypothesis, the reaction was repeated under 
identical conditions apart from a 3-fold increase in substrate concentration. Model B predicts 
no change in the overall profile, however this was not observed and a significant rate increase 
was measured when higher substrate concentrations were employed (Figure 4.9). This 
observation cannot be explained using Model B, and is in fact more consistent with Model A, 
where an increase in starting material concentration will increase the rate of the partition 
favouring productive catalysis. In Model A, the deactivation is clearly in the correct part of 
the cycle, but the simulation demonstrates that there must be additional processes present. 
 
Figure 4.9. Simulated fit (dashed lines) to experimental data of conversion of iso-1l to 2l at 


































4.4.3 Model C 
Model A was augmented to provide the more complex Model C (Scheme 4.5). The hypothesis 
was that the product of the reaction had a dual role. Firstly, to displace the inhibitor from the 
catalyst and secondly to behave as a ligand to prevent further inhibition from occurring. 
Therefore, toward the end of the reaction when the substrate concentration is low, but product 
concentration is high, the inhibition pathway is effectively bypassed due to the stabilisation 
effect of the product on the catalyst. The simulation (Figure 4.10) gave an excellent fit to the 
experimental data based on the rate constants shown in Table 4.1, indicating that this model 
might be a better representation of the off-cycle pathways. 
 
Scheme 4.5. Model C. 
 
Figure 4.10. Simulated fit (dashed lines) to experimental data of conversion of iso-1l to 2l 





















Table 4.1. Rate constants for which the optimum fit to experimental data is obtained using 
Model C for conversion of iso-1l to 2l. 
Entry Rate constant Value 
Standard 
Error 
1 k1 160 dm3 mol-1 s-1 30 
2 k2 0.0069 s-1 7×10-4 
3 k3 10000 dm3 mol-1 s-1 - 
4 k4 19 dm3 mol-1 s-1 1 
5 k5 4.7×10-4 dm3 mol-1 s-1 7×10-5 
6 k6 
8000 dm3 mol-1 s-1 
1500 
7 k7 1000 dm3 mol-1 s-1 10000 
 
4.4.4 Chemical Justification of Model 
Whilst model C gives a plausible mechanistic pathway that explains the observed kinetics, it 
does not explain why such a deactivation process occurs. The inhibition kinetics observed in 
this study are unique, and there has been no other example of reactivation of a catalyst species 
by the product of said reaction reported in the literature to date. These kinetics are solely 
observed in the intramolecular reaction, and not detected in the intermolecular variant. A 
plausible explanation for this observation is the instability of the catalyst species in the absence 
of π-rich arenes. Due to the absence of strongly defined ligands, the ligand environment is 
possibly dynamic and changes depending on the electronic demand on each step of the cycle. 
π-Rich arenes possibly behave as L-type ligands in the form of π-complexes, and in their 
absence, it is likely that σ-donors such as water bind. If water bound as a ligand deactivates 
the catalyst, then the absence of π-rich arenes would be detrimental. In the intermolecular 
direct arylation, π-rich arenes are employed as substrates anyway, and therefore would prevent 
deactivation. However, by rendering the process intramolecular, due to the short tether length, 
and thus increased effective molarity of the arene moiety, substrates that otherwise would not 
react (i.e. non-π-rich arenes) are able to. Therefore, at the start of the reaction, there are no π-
rich species and the gold species may be prone to deactivation. Fundamentally, the product of 




generated during the reaction, and able to recover any deactivated catalyst in an auto-
reactivation process. 
4.4.5 Validation of the Mechanistic Model 
Although the simulation gave an excellent fit to the data for iso-1l, the model is quite complex, 
with several rate constants. Indeed, with enough freedom, any elaborate model will be able to 
fit a single set of data. This is emphasised in the large standard errors obtained from the 
simulation of data from the cyclisation of iso-1l. To validate the model, not only must it be 
chemically plausible, it must also fit over multiple data sets. The results from the simulation 
indicated that the reaction would have a large sensitivity to both catalyst and substrate 
concentration. Due to the length in which the reactions took with substrate iso-1l it was not 
convenient to systematically measure the effect of concentration with this substrate. Therefore, 
the reaction of substrate iso-1k, where turnover is faster, but similar kinetic profiles are 
obtained, was monitored. Using Model C, an excellent fit to across 6 different conditions using 
a single set of rate constants was obtained. This fit is excellent support that a mechanism 
resembling Model C is operating.  
 
 
Figure 4.11. Simulated fit (dashed lines) to experimental data of conversion of iso-1k to 2k 
using Model C. Conditions: HCIB (0.13 M), CDCl3:CD3OD (50:1) and; A: iso-1k (0.1 M), 
thtAuBr3 (0.00025 M, 0.25 mol%); B: iso-1k (0.1 M), thtAuBr3 (0.0005 M, 0.5 mol%); C: iso-
1k (0.05 M), thtAuBr3 (0.0005 M, 1 mol%); D: iso-1k (0.1 M), thtAuBr3 (0.001 M, 1 mol%); 
E: iso-1k (0.1 M), thtAuBr3 (0.002 M, 2 mol%); F: iso-1k (0.1 M), thtAuBr3 (0.002 M, 2 






















Table 4.2. Rate constants for which the optimum fit to experimental data is obtained using 
Model C for conversion of iso-1k to 2k. 
 
Entry Rate constant Value 
Standard 
Error 
1 k1 0.032 dm3 mol-1 s-1 5×10-4 
2 k2 0.024 s-1 0.01 
3 k3 1000 dm3 mol-1 s-1 - 
4 k4 0.0031 dm3 mol-1 s-1 7×10-4 
5 k5 4.7×10-4 dm3 mol-1 s-1 2×10-5 
6 k6 
3.22 dm3 mol-1 s-1 
0.3 
7 k7 1000 dm3 mol-1 s-1 - 
*Includes unimolecular precatalyst activation rate constant kprecat = 0.0042 s-1 
The most extreme effects are observed for the cyclisation of 1p to 2p, where the effect of 
changing both catalyst and substrate concentration is profound (Figure 4.12). Indeed, reaction 
times were increased by a factor of 40 when quartering the catalyst loading from 2 mol% to 
0.5 mol%, 10 times more than what would be expected in the absence of deactivation. Perhaps 
more striking, and counterintuitive, is the effect of substrate concentration. Performing the 
reaction over 4 substrate concentrations, keeping the catalyst concentration constant, 
demonstrated that the reaction which had to do the most turnovers (0.2 M substrate, 0.001M 




fewest (0.01M substrate, 0.001 M catalyst = 10 mol%, 10 turnovers) had completed just a 




Figure 4.12. Top: Effect of varying catalyst concentration at a fixed [1p] (0.1 M). Bottom: 
Effect of [1p] at a fixed [catalyst] (0.001 M). 
These results emphasise the need for careful consideration of both catalyst and substrate 
concentration in screening of reaction conditions. If catalyst a deactivation mechanism similar 
to the process demonstrated herein occurs in other reactions, the difference between success 
and failure could be determined by a choice of catalyst loading, or initial substrate 
concentration, or both.  
4.4.6 Re-optimisation of Reaction Conditions 
With the knowledge that water was the source of inhibition, efforts were made to alter the 
system so that no catalyst deactivation occurred and maximum rates were achieved. Whilst the 



































sustainable solution. It was envisioned that replacing the methanol co-solvent with TFE could 
be a potential solution. As previously mentioned, the addition of IBDA and CSA in the 
presence of methanol leads to the production of water through an acid catalysed esterification 
of the resultant acetic acid. TFE is significantly more acidic than methanol, and therefore this 
esterification is unlikely to occur (Scheme 4.6).  
 
Scheme 4.6. Replacement of methanol with TFE should avoid production of water. 
That is indeed the case, as the replacement of methanol with TFE eliminates the catalyst 
deactivation and restores rapid rates. This is emphasised in the synthesis of 2l which takes 
approximately over 11 hours to go to completion under standard conditions due to catalyst 
deactivation, but when TFE is employed takes just 25 minutes (Figure 4.13). 
 
 
























4.5 Catalyst Deactivation in Natural Product Synthesis 
In Chapter 2, the formal synthesis of allocolchicine was presented. Despite good yields and 
short reaction times in the arylation step of model substrate 5k, the inclusion of a chlorine para 
to the silane in the formal synthesis led to reduced yields and increased reaction times (Scheme 
4.7).  
 
Scheme 4.7. Effect of electron-deficient silane on yield and reaction time in synthesis of 
allocolchicine skeleton. 
As demonstrated in the first part of this chapter, electron-deficient silanes can cause catalyst 
inhibition. However, the strategies that eliminated the inhibition (i.e. addition of 2-
bromothiophene or replacement of methanol with TFE) did not lead to improved yields in the 
synthesis of this scaffold. Therefore, another process must be causing the reduced efficiency. 
Indeed, a catalyst auto-reactivation mechanism would not be expected as electron-rich arenes 
were shown to prevent inhibition, and these substrates bear a highly electron-rich moiety.  To 
probe the cause of the difference between 5k and 5m, and to gain an understanding of the 
implications of using these complex molecules in the direct arylation reaction, the kinetics of 
cyclisation were monitored (Figure 4.14). The observed kinetics are indicative of severe 
catalyst deactivation as both reactions stall with significant amounts of starting material 













Figure 4.14. Comparison of kinetic profiles of the cyclisation of 3 and 11. 
In order to assess whether the deactivation is innate to the PIFA system, or as a result of the 
substrate, the kinetics of cyclisation of ‘defunctionalised’ 5a were monitored (Figure 4.15). 
Although PIFA was used successfully in other substrates, reaction times were short and a full 
kinetic examination was not undertaken. Therefore, there could be a deactivation process 
unique to PIFA. The rate of cyclisation of 5a is very slow compared to the initial rate of 5k 
and 5m, emphasising the impact of the highly reactive arene in 5k, 5m. However, the kinetic 






































The difference in substrate structure between 5k / 5m and 5a, is the absence of both the MOM 
ether and a highly electron-rich arene in 5a, suggesting that the cause of deactivation is due to 
the presence of one or both of these functional groups. A generic catalyst deactivation 
mechanism was considered (Scheme 4.8). Here, a side-reaction, involving the sidechain ('Z') 
functionality, converts substrate (5k or 5m) into an inhibitor (105), which then undergoes 
competitive transmetalation with the gold to generate an off-cycle complex 106. If this species 
is unable to cyclise to 107, or to reductively eliminate the biaryl product, and thus unable to 
release gold back on-cycle, then progressive catalyst inhibition will occur. The impact of the 
inhibition process will depend on the relative rate of reaction of substrate (5k / 5m) versus the 
inhibitor (105) with the Au(III). 
 
Scheme 4.8. General deactivation mechanism due to side product formation. 
Initial concerns related to the lability of the MOM protecting group. Due to the acidic nature 







Scheme 4.9. Possible in-situ deprotection of MOM protecting group under the reaction 
conditions 
As noted in Chapter 2, neither 5g nor 5l undergo cyclisation. Moreover, inclusion of a sub-
stoichiometric amount of alcohol 5l in the reaction of 5k resulted in an even earlier onset of 
catalyst inhibition (Figure 4.16). 
 
 
Figure 4.16. Cyclisation of 5k under: A) standard conditions; B) with 10 mol% 5g added at 
the start of the reaction. 
Whilst this confirms that alcohol 5g can act as a catalyst poison, possibly by competition with 
5k for the catalyst, and then strong off-cycle Au-chelation (108, Scheme 4.10), 5g could not 
be isolated from the reaction, or detected in-situ. Consequently, the kinetics of cyclisation of 
the acid stable methyl ether 5h were monitored, with the expectation that no catalyst 
deactivation would occur if MOM deprotection is required for inhibition. However, 5h was 
found to undergo the same potent inhibition; indeed the initial rate and overall conversion 




















Scheme 4.10. Possible mechanism for deactivation by alcohol 5g. 
 
 
Figure 4.17.  Kinetic profile for cyclisation of 5h showing deactivation is still present 
without MOM protecting group. 
Product inhibition of the catalyst was excluded by addition of the product to the reaction, 
which resulted in no detrimental effect to the rate. Therefore, efforts were made to identify 
side products in the reaction mixture that might behave as inhibitors. Whilst the reactions 
afforded satisfactory material balance, small quantities of side-products (109a-c) were 
identified by NMR spectroscopy. The rate of formation of these side products was largely 

















and 5m by 1H NMR indicated that 109a-c are diaryliodonium salts; this was subsequently 
confirmed by mass spectrometry. 
 
 
Figure 4.18.  Formation of side products 109a-c under the reaction conditions. 
To assess whether the formation of these side products are connected to the deactivation, 
substrate 5k was exposed to PIFA prior to addition of catalyst to allow for a build-up of 109a. 
Significantly greater catalyst deactivation was observed when 109a is present from the outset, 
thus strongly linking the reaction of the starting material with PIFA to the catalyst deactivation 









































Figure 4.19. Cyclisation of 5k under: A) standard conditions; B) with premixing of substrate 
5k and PIFA before initiating reaction. 
On the basis of steric hindrance and reduced electron density on the arene ring, diaryliodonium 
generation would be expected to deactivate the trimethoxy-arene ring in aurated intermediates 
to aromatic electrophilic substitution (110a-c to 111a-c), and thus prevent release of gold 
(Scheme 4.11). Therefore, it would not be the diaryliodonium salt generation per se that is 
poisoning the catalyst, but the result of tethering this salt to an arylsilane that can still undergo 
reaction with the gold catalyst (109a-c  110a-c). 
 
Scheme 4.11.  Tentative assignment of catalyst inhibitor, and associated deactivation pathway. 
To verify that the tethering of the silane to the diaryliodonium salt was instrumental to the 
deactivation and not an effect of diaryliodonium salts in general, trimethoxytoluene, 89, was 
allowed to react with PIFA to form the diaryliodonium, 90 (Scheme 4.12). Addition of this to 



















that the tethering of the silane is crucial in the proposed deactivation mechanism (Scheme 
4.13). 
 
Scheme 4.12.  Control experiment for diaryliodonium salts as general catalyst poisons. 
 
Scheme 4.13.  Proposed deactivation mechanism. 
This deactivation mechanism is consistent with the experimental observation that absolute rate 
of cyclisation is an important factor in dictating the final conversion (Figure 4.18); a feature 
that is not general in catalyst deactivation. As shown in Figure 4.18, the initial rate of inhibitor 
formation is independent of the identity of the substrate, as would be expected if there is no 
significant influence of the aryl silane at the end of the tether on the rate of reaction of the 
trimethoxybenzene ring with the oxidant. The impact of this is that the cyclisations that 
proceed with the fastest absolute rate will have the lowest percentage of inhibitor at a given 
time, and therefore will suffer least inhibition and attain greatest conversion before stalling 





Scheme 4.14.  Reactivity and conversion trend. 
The difference in turnover rate between MOM-protected 5k, methyl ether 5m, and alcohol 5g, 
can be tentatively attributed to the coordinating ability of the oxygen ortho- to the silane. If 
the oxygen can coordinate to the catalyst after the transmetalation (Scheme 4.15), this could 
serve to slow π-complexation of the arene to the gold, and thus the rate of cyclisation. 
 
Scheme 4.15.  Possible origin of decreased cyclisation rate with more-coordinating oxygen 
functionality. 
Due to the ability to monitor the formation of the proposed inhibitor, kinetic modelling 
software can be used to calculate the partitioning between the productive cycle and the 
deactivation pathway (k1 and k2, Scheme 4.13). A good fit for the deactivation of 5k can be 
obtained at both 1 and 2 mol% catalyst (Figure 4.19) using the deactivation mechanism shown 
in Scheme 4.13. The model indicates that the in-situ generated diaryliodonium salt (106) is a 
powerful inhibitor, as k2 ≈ 5 × k1. It is surprising that a distal diaryliodonium salt would have 
the effect of accelerating the rate of transmetalation at the silane. Whilst efforts are ongoing to 
understand this process, an accelerated transmetalation of the catalyst-inhibiting silane-









Figure 4.20.  Kinetics of cyclisation of 5k at: A) 2 mol% and B) 1 mol%. Dashed lines are 
simulated data using the model outlined in Scheme 4.13, simulation agrees with experimental 
when: k1:k2 = 1:5 (where k1, k2 >> k3), k3 = 0.014 s-1 (TLS) and k5 = 1.63×10-4 dm3 mol-1 s-1. k4 
was set to an arbitrary value of > 100 dm3 mol-1 s-1.  
4.6 Summary 
Two mechanisms of catalyst deactivation have been unveiled. Whilst the mechanism of each 
deactivation process is different, the origin is the same. Both catalyst deactivation pathways 
occur as a result of the hypervalent iodine oxidant, and are unique to the intramolecular 
coupling. In the first case, the oxidant leads to production of water which was shown to be a 
potent, but reversible inhibitor when π-rich arenes are present. This is only arises in the 
intramolecular examples due to the significant differences in arene electronics in the starting 
material and product. In the second case, the oxidant can react with the tethered arene to form 
a diaryliodonium salt. This reaction serves to deactivate the arene to SEAr, and therefore 
prevent release of the catalyst once transmetalation to this species occurs. Thus, the tethering 
of arene and silane is crucial to this deactivation mechanism. These two studies demonstrate 























































ABSTRACT: Chapter 5 
Through theoretical kinetic analysis, the general principles which govern the rate and 
selectivity of catalytic domino arylations combining intramolecular and intermolecular 
couplings, are described. Kinetic simulations reveal that the order of events, and whether 
intramolecular cyclisation precedes intermolecular coupling, or vice versa, has a large impact 
on the expected kinetic profiles. The potential for catalyst inhibition is uncovered, and the 
cause and possible solutions are discussed.  The selectivity for one mechanistic pathway over 
the other is found to be key for high regioselectivity, as a combination of both routes leads to 
a mixture of products under the simulated conditions. The process is confirmed experimentally 
through the combination of intra- and intermolecular gold-catalysed direct arylation. The 
reaction proceeds predominantly via an intramolecular-intermolecular ordering of events, and 
gives good agreement to the theoretical data. Electronic perturbation of the system results in 
competing intermolecular-intramolecular coupling and the formation of a second regioisomer, 
as predicted in the theoretical kinetic analysis.  
This project was performed in collaboration with Dr. L. Ball and Dr A. Cresswell. Preliminary 
results were collected by Dr. L. Ball, and authentic samples were synthesised and characterised 
by Dr. A. Cresswell (compounds specifically referenced in the text). 
5.1 Introduction 
One of the key requisites in the design of synthetic routes to complex molecules is efficiency. 
Within the term efficiency come a number of factors, including, but not limited to, step-
economy, purification, waste and time. These factors are fundamental in reducing 
environmental impact as well as maximising profits. One strategy to improve efficiency which 
has gained significant attention is the performance of multiple transformations in ‘one-pot.’  
The use of a single reactor to transform simple reagents into complex targets, which would 
otherwise take multiple steps, is the ultimate efficiency strategy. By performing reactions in 
one-pot, only one optimisation is needed, wasteful workups and purification steps are avoided, 
and therefore, significant energy and time is saved. In catalysis, depending on the nature of the 
transformations, several one-pot reaction types exist, however two of the main categories are 
domino (cascade) and tandem catalysis.[143–146] 
5.1.1 Taxonomy 
Tietze originally defined ‘domino’ reactions as those involving “two or more bond-forming 
transformations which take place under the same reaction conditions, without adding 
additional reagents or catalysts, and in which the subsequent reactions result as a consequence 




stipulated that, in addition to Tietze’s earlier definition for domino reactions, “multiple 
transformations are effected via a single catalytic mechanism”. Conversely, ‘tandem’ catalysis 
denotes “coupled catalyses in which sequential transformation of the substrate occurs via two 
(or more) mechanistically distinct processes”.[148] These definitions distinguish domino and 
tandem catalysis from other one-pot procedures where a second catalyst is added after the first 
catalytic transformation is complete, which are known as one-pot (multicatalytic) 
reactions.[148] Tandem catalysis can be subcategorised into orthogonal catalysis,[143] assisted-
tandem catalysis and auto-tandem catalysis[149] depending on the number of catalyst species 
present and if the user intervenes in the reaction or not (Figure 5.1).  
 
Figure 5.1. Flowchart guide to nomenclature of one-pot catalytic processes. 
In orthogonal catalysis, two or more catalyst species are present in the reaction from the outset, 
each with a different mechanistic role. Each catalyst is, in theory, independent of one another, 
and the product of one catalytic cycle becomes the substrate for the other. Auto-tandem 
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catalysis is similar to orthogonal tandem catalysis as two (or more) mechanistically different 
catalytic cycles are operating, however in auto-tandem catalysis there is only a single catalyst 
species which can perform two or more functions. In assisted-tandem catalysis, there is a single 
multifunctional catalyst, but a chemical trigger is required to access new functionality. 
5.1.2 Domino and Tandem Catalysis 
Domino catalysis can either be intermolecular, where release of intermediates from the 
catalytic cycle occurs, or, more commonly, intramolecular where several elaborations occur 
within a single cycle. The term “cascade” catalysis is often used as an alternative to domino, 
particularly when there are ≥ 3 elaborations.[148] In 2009, Lautens and Candito reported an 
intramolecular palladium-catalysed domino direct arylation/N-Arylation procedure for the 
synthesis of phenanthridine 114 (Scheme 5.1, Top).[150] The proposed catalytic cycle is based 
on the Catellani reaction,[151–153] and the independent mechanistic studies by Hartwig et al.[154] 
and Barluenga et al.[155] into Pd-catalysed C-N bond forming reactions (Scheme 5.1, bottom).  
 





The proposed mechanism involves; A, oxidative addition of aryl iodide 112; B, 
carbopalladation with norbornene; C, C-H activation; D, biaryl formation through a proposed 
oxidative addition to 113 (PdII – PdIV), reductive elimination, decarbopalladation sequence; E, 
N-Si bond cleavage and; F, product releasing reductive elimination. 
A recent development of orthogonal tandem catalysis was demonstrated by, Lautens et al once 
again,[156,157] where rhodium-catalysed alkyne arylation of 115 precedes palladium-catalysed 
C-N coupling of intermediate 116. Despite the potential for multiple reaction pathways, a 
single product was isolated (Scheme 5.2).    
 
Scheme 5.2. Orthogonal catalysis employing Rh and Pd catalysts. 
The reaction conditions were compatible for both metals and no interference between the 
catalysts on the individual steps were found. However, the choice of ligand was vital to the 
success of the reaction. In control experiments swapping the ligands on the metals, i.e. Rh/X-
Phos and Pd/BINAP shut down each respective reaction in isolation. Whilst with rhodium this 
was because no binding to X-Phos was observed, and the phosphine-free rhodium led to 
decomposition of the starting material, with palladium the presence of BINAP reduced the 
reactivity of the metal altogether. Therefore, the presence of excess BINAP in the tandem 
reaction led to competitive binding with palladium versus X-Phos and reduced reactivity. To 
achieve optimum conditions the precatalysts and ligands were mixed in the desired ratio prior 
to addition to the reaction. An overall 69% yield was obtained for the domino reaction, 
compared with the 71% obtained for the two-step combined yield. The key issue here, which 
is a general problem with many one-pot procedures, is that one set of reaction conditions may 
not be the optimal reaction conditions for both catalytic processes. Although each step can be 





Palladium displays a rich array of reactivity which has been exploited in catalysis for several 
coupling reactions including C-C, C-N and C-O bond forming processes.[3] It is therefore 
unsurprising that palladium is a popular choice for the development of auto-tandem reactions. 
A seminal contribution for the use of direct arylation in auto-tandem catalysis originated from 
the Bedford research group in the synthesis of carbazoles from 2-chloro-N-alkylated anilines 
and aryl bromides (Scheme 5.3).[158] The reaction combines a Buchwald-Hartwig coupling of 
an aryl halide 118 with an aniline 119, yielding intermediate 120 which can undergo a direct 
arylation reaction.  
 
Scheme 5.3. Auto-tandem catalysis. 
Utilising different halides allowed for discrimination between the two starting materials for 
the initial oxidative addition. The presence of the more reactive bromine on 119 allowed for 
the desired Buchwald-Hartwig reaction to occur before any oxidative addition into the 118 
occurs. In auto-tandem reactions in general, excellent selectivity is often required as the 
substrates used are often activated for multiple transformations, but the order in which they 
occur can be vital for the success of the tandem protocol. 
The necessity to control the order of reactions through excellent selectivity is emphasised in a 
palladium-catalysed auto-tandem Heck, direct arylation protocol advanced by Fagnou et al. to 
form functionalised cyclic biaryls (Scheme 5.4).[159]  
 




In theory, the order of events and whether the intramolecular direct arylation occurs first, 
followed by the intermolecular Heck in an intramolecular-intermolecular ‘intra-inter’ pathway 
or vice-versa in an ‘inter-intra’ pathway should lead to the same product (Scheme 5.5).  
 
Scheme 5.5. “Intra-inter” vs “inter-intra” pathway. 
However, the order in which the reaction events occurred proved to be vital. Once again, the 
utilisation of aryl chlorides and bromides to direct the order of oxidative addition led to the 
success or failure of the reaction depending on where they are situated. If the aryl bromide is 
placed on the substrate geared toward direct arylation 122a, then the desired product is not 
isolated, instead the Heck product 125 forms competitively. The origin of this is intermolecular 
trapping of the palladium intermediate I(122) that would otherwise undergo the direct 
arylation (Scheme 5.6). In palladium catalysis, the direct arylation, or ‘C-H activation’ step 
can be turnover-limiting,[160] or at least kinetically significant enough to be sufficiently long 
lived that an intermolecular coupling can outcompete the intramolecular process. This 
observation led to the authors swapping the position of the halides such that the desired 
intermolecular reaction occurs first, followed by direct arylation. By doing so, good yields 
were obtained for the desired product (Scheme 5.7). 
 





Scheme 5.7. Tandem “inter-intra” Heck, direct arylation reaction. 
An assisted tandem step was also demonstrated through a final hydrogenation of the auto-
tandem product 124. In assisted tandem catalysis, a chemical trigger can transform the catalyst 
so that is has an additional function. The addition of hydrogen gas to the reaction after the 
auto-tandem reaction was complete allowed for a palladium-catalysed hydrogenation of 124 
to occur (Scheme 5.8). This demonstrates the potential multifunctional catalysts like palladium 
have in generating molecular complexity in a single pot.   
 
Scheme 5.8. Auto-tandem Heck, direct arylation and assisted-tandem hydrogenation. 
5.1.3 Chapter Aims 
Despite significant developments in domino and tandem catalysis, there are no examples of 
domino or tandem arylations combining intra- and intermolecular coupling. With the new 
mechanistic insights into the intramolecular cyclisation in-hand, and the prior knowledge into 
the kinetics of the intermolecular direct arylation, it was anticipated that these reactions could 
be combined into a one-pot arylation protocol. As inter- and intramolecular arylations with 
gold proceed via the same mechanism, this would be, by definition, a domino reaction.  It was 
proposed that an a priori rationalisation of such a procedure with the aid of kinetic simulation 
would lead to insights that would guide the design of such a procedure. The aim of this was to 




general, and then use the gold-catalysed direct arylation as a case-study. Therefore, a general 
reaction sequence was envisioned where ‘intra’ and ‘inter’ substrates 128 and 129 could 
couple via intermediates 130/131b (vide infra) to form domino arylation product 132 (Scheme 
5.9). This is the general reaction for which a theoretical kinetic analysis would be performed 
on. This general reaction could apply to a variety of catalysts, and kinetic analysis would be 
performed under the important assumption that C-X functionalisation (transmetalation, 
oxidative addition) is the first selectivity determining step, followed by C-H metalation.  
 




5.2 Kinetic Analysis of Domino Arylation 
When considering a domino reaction combining an intramolecular and intermolecular direct 
arylation, two competing pathways can be envisioned.  One pathway could involve the 
cyclisation preceding intermolecular coupling, in an intramolecular-intermolecular pathway 
“intra-inter,” and vice-versa where intermolecular coupling occurs first, followed by 
intramolecular direct arylation, in an “inter-intra” pathway (Scheme 5.10). Whilst both routes 
can lead to a product of domino arylation, there is significant potential for each route to form 
a different isomer 130a/b. Whilst the regioselectivity of intramolecular cyclisation is pre-
defined due to the conformational bias enforced by the tether, the regioselectivity of the 
intermolecular coupling is dictated by the innate reactivity of the C-H bonds. The mechanism 
of metalation will control which C-H bond will react, with acidity being a factor in a CMD 
mechanism and nucleophilicity with SEAr. As the reacting arenes 128 and 130 in the 
intermolecular coupling in the “inter-intra” and “intra-inter” routes are not identical, with 
differing steric and electronic properties, it is likely that that (at least) two regioisomeric 
products will form. 
 
Scheme 5.10. “Inter-intra”- and “intra-inter” pathways to domino arylation products. 
Therefore, it was envisioned that for a regioselective domino arylation procedure, one of these 
routes must be dominant, as a mixture could lead to poor selectivity. Using kinetic simulation 
software and constructing a mechanistic model based on the catalytic sequence depicted in 
Scheme 5.11, the kinetic parameters that impact on the success or failure of a “inter-intra” or 





Scheme 5.11. General catalytic cycle for “intra-inter” and “inter-intra” domino arylation. 
5.2.1 “Inter-Intra” Domino Reaction 
First, the kinetic parameters that would allow for an “inter-intra” sequence were assessed using 
kinetic modelling. There are two key partitions in the catalytic cycle that were identified to 
influence product distribution: 1) The competition between substrate 128 and 129 for the 
catalyst, dictated by the k1:k2 ratio and, 2) The relative rates of intermolecular arylation (130 
 132a, and 128  131b), which is determined by the k4:k5 ratio. To reflect the conditions 
found in the gold-catalysed direct arylation, the rate of the intramolecular reaction is controlled 
by k3/k7 and the rate of the intermolecular reaction controlled by k4/k5. The absolute values of 
k1 and k2 were set arbitrarily high so that they do not become turnover, or partially turnover-
limiting. Due to the similarity of 128 and 131b, it was assumed that k1 = k6, and k3 = k7. The 
effect of the partitioning between 128 and 129 (k1:k2) was initially assessed independently by 
enforcing the condition k4 = 0 in the kinetic simulation (Table 5.1, entries 1-8), and then the 
effect of the k4:k5 ratio was analysed (Table 5.1, entries 9-11). Table 5.1 shows the effect these 
kinetic parameters have on product distribution, and Figures 5.1 and 5.2 (numbered according 
to entry number of Table 5.1) show the associated expected kinetic profiles for select 
examples. The absolute values of k1, k2 and k6 do not affect the overall appearance of the kinetic 
profiles, providing they are much greater than the other rate constants. The absolute values of 




one order of magnitude, the overall shape of the profile and expected conversion will not 
change significantly.  
Table 5.1. Simulated product distribution of “inter-intra” domino arylation. 
 
Entry k2:k1 k4:k5 Cat/ mol% 





1 1:1 0:1 2 37 - 38 25 
2 5:1 0:1 2 14 - 65 21 
3 10:1 0:1 2 8 - 76 16 
4 50:1 0:1 2 2 - 85 13 
5 60:1 0:1 2 <2 - 0 >98 
6 10:1 0:1 5 9 - 72 19 
7 10:1 0:1 10 11 - 59 30 
8 10:1 0:1 12 12 - 0 88 
9 10:1 0.1:1 2 0 8 0 92 
10 10:1 0.5:1 2 1 9 0 90 
11 10:1 10:1 2 0 13 0 87 
12* 10:1 0:1 2 <2 -  >98 
Fixed simulated conditions: 128 (0.05 M), 129 (0.05 M), k1 and k6 = 100 dm3 mol-1 s-1                         
k3 and k7 = 0.027 s-1, k5 = 0.1 dm3 mol-1 s-1. * 128 (0.055 M), 129 (0.05 M). 
The simulation gave vital insights into the kinetic parameters that govern an “inter-intra” direct 
arylation procedure. The effect of varying the k2:k1 ratio is striking, as low yields of the domino 




employed (50:1), but at a critical ratio (60:1, Table 5.1, entry 5) the yield is predicted to 
become nearly quantitative. Counterintuitively, at ratios below 60:1, the yields are predicted 
to improve as this partition becomes less selective. For example, a 13% yield of 132b is 
predicted with a ratio of 50:1 (Table 5.1, entry 4), whereas when the reaction is completely 
unselective (Table 5.1, entry 1), a 25% yield is predicted. However, significantly more of the 
pre-cyclised intermediate 131b is predicted at higher ratios. These unusual observations, and 
the associated kinetic profiles (Figure 5.1), are a result of the k2:k6 ratio, and the presence of 
“intra cycle 1”. The simulation was programmed with a 1:1 stoichiometry of 128 and 129, 
however due to the competing “intra cycle 1,” the total amount of 128 consumed per turnover 
is greater than the amount that is converted to 132b, even when the k2:k1 ratio is high, as some 
is lost as 130. The consequence of this is that the 1:1 stoichiometry is not maintained 
throughout the reaction, and at some point 128 is totally consumed when some 129 remains. 
With a high k2:k1 ratio, and therefore high k2:k6 ratio (as k1 ≈ k6 under the simulated conditions), 
the catalyst will quickly partition to catalyst intermediate VI(129), and with no 128 to react 
with the reaction will stall. As the k2/k6:k1 ratio is lowered, more catalyst can partition to 
I(131b) via “intra-cycle 2,” and consequently form a higher yield of 132b. At a critical ratio, 
which was observed to be ca. 60:1 under these conditions, the partition to “intra-cycle 1” is so 
insignificant that the loss of concentration of 128 by conversion to 130 is no longer important. 
However, achieving such selectivity under real conditions could be a significant challenge as 


















                
 
Figure 5.1. Simulated kinetic profiles of “inter-intra” domino arylation showing effect of 
k2:k1 ratio when k4 = 0.  
Three strategies were proposed to improve the yield of 132b without the need for extremely 
high k2:k1 ratios (strategies assessed at k2:k1 = 10:1). The first strategy was to increase the 
128:129 ratio so that there is always an excess of 128 to release the catalyst. This was indeed 
the case, and increasing the ratio to 1.1:1 was sufficient, and a 98% yield of 132b was predicted 
(Table 5.1, entry 12) compared with a 16% yield under identical conditions with a 1:1 
stoichiometry (Table 5.1, entry 3). The second strategy was to simply increase the catalyst 
loading. If the following conditions are satisfied [Cat]0 > [S2] when [S1] = 0, then although a 
significant proportion of the catalyst will rest at VI(129) once all 128 has been consumed, 
there will still be an excess concentration of catalyst that can continue to turnover. This is 
demonstrated in Table 5.1, entries 3,6-8 where an increase in loading from 2 mol% to 12 mol% 
catalyst is required for the reaction to go to completion, and a predicted 88% yield (See Figure 
























































cycle to operate by varying the value of k4. The cause of the reaction stalling is that 130 cannot 
react to release the catalyst once 128 has run out, and therefore by allowing 130 to react with 
VI(129), there is another route for the catalyst to be released. Using k2:k1 = 10:1 as the standard 
conditions to assess the effect of increasing k4 values demonstrated that allowing this 
“undesired” pathway to occur is in fact beneficial for the reaction. Whilst reduced 
regioisomeric ratios would be obtained, the predicted effect on yield and reaction profile is 
profound. At a ratio of k2:k1 = 10:1, the absolute value of k4 did not impact greatly on the 
overall regioselectivity. However, the overall rate of reaction was increased with increasing k4 
values as this rate constant controls the release of active catalyst from intermediate VI(129). 
The result of these simulations show that the factors which control a potential “inter-intra” 
domino arylation are complicated, particularly if complete regioselectivity is desired. Either 
extremely high selectivity (k2:k1) for one coupling partner is required, or careful consideration 
of stoichiometry and catalyst concentration is needed to prevent the reaction from stalling. In 
order for perfect selectivity, the product from the undesired, but unavoidable “intra cycle 1” 
must be unreactive to arylation (k4 = 0), however, this requirement leads to the detrimental 









































































































5.2.2 “Intra-Inter” Domino Reaction 
 
Scheme 5.12. General catalytic cycle for domino “intra-inter” direct arylation. 
The same kinetic analysis for the “inter-intra” sequence was performed on a proposed “intra-
inter” protocol, with the simulations performed under the initial assumption that k5 = 0, so that 
once again the effect of the k1:k2 partition could be monitored in isolation. Once again, the rate 
of the intramolecular reaction is controlled by k3 and the rate of the intermolecular reaction 
controlled by k4 and the absolute values of k1 and k2 were set arbitrarily high. The same 
absolute k values were employed for direct comparison with the “inter-intra” system. In 
contrast to the results from the “inter-intra” system, the factors which affected the potential 
success of this reaction were significantly more intuitive. Under the conditions k1 > k2, the 
reaction is predicted to go to completion, with the extent of the build-up of intermediate 130 
depending on how high the k1:k2 ratio is. Intriguingly, when k1 = k2 and therefore the 
partitioning is totally unselective, the reaction is still predicted to be successful. This is 
because, in theory, the 50% of catalyst that partitions to the intramolecular substrate will form 
cyclised product in perfect stoichiometry to react with the other 50% of catalyst that is resting 
as intermediate VI(129). However, this relies on an exact 1:1 stoichiometry of the two starting 
materials. Even a small discrepancy in favour of the intermolecular substrate 129, will shift 
the partition slightly in favour of intermediate VI(129) and ultimately lead to deactivation of 
the catalyst. In addition, the lack of selectivity results in the prediction of significantly longer 
reaction times due to a steady state concentration of 130. When k2 > k1, there is significant 
potential for deactivation to occur, as the catalyst will partition to VI(129) and will be unable 
to release. Even when the partition is only slightly biased (k1:k2 = 1:1.1), the reaction at the 




The conversion is highly dependent on catalyst concentration, as the higher the catalyst loading 




Figure 5.3. Effect of k1:k2 partition on “intra-inter” domino arylation.  
Once again, if the competing cycle is allowed to operate and k5 ≠ 0, then stalling will not occur, 
but a mixture of isomers will be obtained, with the regioselectivity dependent on both k1:k2 
and k4:k5. When k1:k2 significantly favours one pathway (e.g. k1:k2 = 10:1 or 1:10), then the 
effect of k4:k5 is not substantial, however when the k1:k2 partition is less selective, the ratio of 

































































Table 5.2. Simulated effect of k4:k5 ratio at different k1:k2 ratios on regioisomeric ratio. 
Entry k1:k2 k4:k5 132a (%) 132b (%) 
1 1:1 1:1 51 49 
2 1:1 10:1 72 28 
3 1:1 1:10 39 61 
4 10:1 1:1 91 9 
5 10:1 1:10 78 22 
6 10:1 1:100 77 23 
7 10:1 10:1 97 3 
8 1:10 1:1 10 90 
9 1:10 1:10 8 92 
10 1:10 1:100 8 92 
11 1:10 10:1 12 88 
 
5.2.3 Additional Considerations 
The results and kinetic profiles presented herein provide a guide to the requisite kinetic 
parameters that will guide a domino “intra-inter” or “inter-intra” reaction. The overriding 
message is that for good selectivity and yields, a high ratio for one “X” functional group over 
the other is required (k1 > k2 for “intra-inter” and k2 >>k1 for “inter-intra”). A perfectly 
regioselective “inter-intra” sequence provides a significantly greater challenge due to the 
potential for the reaction stalling if this selectivity if not extremely high, however strategies 
involving altering the stoichiometry of the starting materials or increasing catalyst loading are 
predicted to aid the process. Whilst this guide may provide a framework to which domino 
arylations could be designed, for simplicity some important assumptions were enforced upon 
the simulations. Firstly, the innate regioselectivity of intermolecular arylation was not 
discussed (Scheme 5.13). The simulation was set so that 130 formed a single regioisomer of 
132a in the “intra-inter” coupling and 128 formed 131b, and therefore 132b exclusively in the 
“inter-intra” coupling. However, considering the number of C-H bonds available, 4 possible 
isomers could form in either case, resulting from 7 possible intermediates in the “inter-intra” 
reaction. In addition to this, over-arylation of 132a might be possible due to the electronic 






Scheme 5.13. Possible regioselectivity issues in domino arylation. 
Another deleterious process could be the formation of side products from intermediate I(128).  
As seen in the auto-tandem Heck, direct arylation study by Fagnou et al.,[159] intermediates of 
type I can be prone to intermolecular trapping if they are sufficiently long lived (Scheme 5.14). 
If the rate of this is significant, then the overall tandem process could become inoperable. 
 
Scheme 5.14. Intermolecular interception of catalyst intermediate I(128). 
5.3 Gold-Catalysed “Intra-inter” Domino Arylation 
5.3.1 Identification of Model System 
With these kinetic principles in-hand, it was anticipated that a gold-catalysed “intra-inter” 
domino sequence could be developed (Scheme 5.15). This prediction was based on a thorough 
mechanistic understanding of both the intramolecular (Chapter 3) and intermolecular direct 






Scheme 5.15. General gold-catalysed “intra-inter” domino arylation. 
It is clear from the simulations that for a successful reaction, k1 must be greater than k2 
otherwise stalling of the reaction, or an ‘inter-intra’ pathway, will occur. This selectivity 
requirement is possibly the largest obstacle to a successful domino arylation protocol, as 
significant discrimination between identical functional groups may be difficult. Previous 
studies into the intermolecular direct arylation demonstrated that ortho-substituted 
aryltrimethylsilanes (e.g., 12b, Scheme 5.16) transmetalate to Au(III) ~20 times faster than 
their non-ortho- substituted counterparts (e.g., 12c), a phenomenon attributed to steric 
decompression upon Wheland intermediate formation. As all of the intramolecular substrates 
examined thus far are ortho-substituted, it was expected that a predominantly ‘intra-inter’ 
pathway should operate. 
 




It was clear that judicious choice of intramolecular substrate was going to be key to the success 
of the reaction. As shown in Chapter 2, the scope of the intramolecular direct arylation is large, 
spanning 5 – 9 membered rings. However, as the tether length increases, the lifetime of 
intermediate I increases substantially, to the point that varying the tether can alter the resting 
state of the catalyst (Scheme 5.17).  In the domino arylation, if I is long lived then there is 
potential for intermolecular trapping of this intermediate.  
 
Scheme 5.17. Effect of tether-length on likelihood for intermolecular trapping of catalyst 
intermediate I. 
Another consideration is the relative reactivity of the intramolecular substrate, and its cyclised 
product, toward SEAr, and therefore k4 vs k5. Although these parameters were found to be less 
important than the k1:k2 ratio, for perfect regioselectivity, ideally k5 would be close to zero. 
These factors led to the nomination of substrates leading to fluorenes to be the intramolecular 
coupling partners (Scheme 5.18). 
This system was chosen for investigation for the following reasons: 1) The kinetics are well 
understood and the rate constant for cyclisation can easily extracted from the pseudo-zero 
order reaction profiles (k3) ; 2) the turnover-limiting step is reductive elimination (k3) and 
therefore intermolecular interception of short lived I (Scheme 5.17) is unlikely; 3) the fluorene 
product 2a-u is sufficiently electron-rich to undergo effective intermolecular coupling but, 4) 
the starting material 1a-u should not be significantly activated for intermolecular SEAr and 
therefore k4 is expected to be much greater than k5. This will reduce the potential for an ‘inter-
intra’ arylation; 5) the R group can be used modulate the sterics and electronics to prevent 
over-arylation; 6) control of regiochemistry should be achieved as fluorenes react 





Scheme 5.18. Proposed “intra-inter” domino arylation cycle leading to arylated fluorenes. 
5.3.2 Initial Studies 
The domino arylation procedure was attempted with 1l and 12a. The reaction was monitored 
by both 19F and 1H NMR spectroscopy. The reaction conditions were modified from the 
standard conditions outlined in chapter 2 to minimise the effect of diaryliodonium salt 
formation, which is more significant due to the requirement of 2 equivalents of oxidant. 
Therefore, the concentration with respect to the substrates was reduced from 0.1 M to 0.05 M, 
but the overall concentration of oxidant was approximately the same (0.12 M) as previously 







Figure 5.4. Domino arylation of 1l and 12a. 
Pleasingly, the success of the “intra-inter” domino reaction was experimentally confirmed, 
with similar kinetic profiles to those predicted in the simulations for high k1:k2 ratios (Figure 
5.3). As expected, a significant build-up of 2l was observed, which then decayed to the desired 
product 133a. Two other products were observed in the coupling reaction, and careful analysis 
by 1D and 2D NMR methods unveiled the structures as regioisomer 133b, and over-arylation 
product 134. It was anticipated that these products were a result of imperfect post-cyclisation 
regioselectivity as the second most reactive position for SEAr is the 4-position in fluorenes.[161] 
However, to ensure this was not a result of a pre-cyclisation “inter-intra” pathway, the 






















Figure 5.5. Intermolecular arylation of 2l and 12a (dashed lines indicate simulated data). 
The same side products were observed when the intermolecular reaction was monitored in 
isolation (Figure 5.5), confirming the imperfect selectivity is inherent in the reaction, rather 
than being a result of a competing pathway. Through kinetic simulation of this reaction profile, 
the rate constant for intermolecular arylation (controlled by turnover-limiting π-
complexation[83]) and over-arylation could be extracted. The extracted rate constants were k4= 
0.033 dm3 mol–1 s–1 for the formation of major isomer 133a, k4’= 0.006 dm3 mol–1 s–1 for the 
formation of minor isomer 133b, and k8= 0.020 dm3 mol–1 s–1 for over-arylation to 134 from 
133b (Scheme 5.19).iii  Interestingly, the simulation predicted that the over-arylation is solely 
from minor isomer 133b. These results demonstrate that the 2-position of 2l is 5.5× more 
reactive than the 4-position (k4 vs k4’), this is in excellent agreement for the rate difference of 
molecular chlorination of fluorene (2b), where the 2-position is measured to be 7.7-fold more 
reactive than the 4-position.[162] 
 
 
                                                     


















Scheme 5.19. Origin of regioselectivity and double arylation. 
The next goal was to extract the k1:k2 ratio through simulation of the kinetic profile for the 
domino reaction. To do so, the individual rate constant for intramolecular coupling was also 
required. Monitoring the intramolecular reaction in isolation gave a rate constant of k3 = 0.027 
s–1 for the turnover-limiting reductive elimination. Employing the rate constants k3, k4 and k4’ 
extracted from the individual rate measurements, and allowing for flexibility in k1 and k2, an 
excellent fit to the experimental data was obtained when the ratio of the transmetalation 
partition (k1/k2) was 28:1. This k1/k2 ratio is pleasingly consistent with the previous 




Figure 5.6. Overlay of simulated (dashed) and experimental data for domino arylation of 1l 





















Although two regioisomers are obtained, the selective nature of the over-arylation means that 
after extended reaction times the only two products are isomer 133a and over-arylation product 
134. However, on a preparative scale, the two compounds were not separable by column 
chromatography. The compounds could be separated by recrystallisation, yielding 30% of 
133a. 
5.3.3 Substrate Scope and “Inter-Intra” pathways. 
The successful domino arylation of 1l and 12a proves the concept of an “intra-inter” reaction, 
meeting the requirements outlined in the kinetic simulation study. Whilst the reaction was 
entirely selective for an “intra-inter” pathway, with no product observed from a competing 
“inter-intra” reaction, imperfect post cyclisation regioselectivity led to minor isomer 133b and 
over-arylation product 134. These side products ultimately led to poor isolated yields, and 
therefore reduced the synthetic utility of process. Therefore, efforts to uncover a different class 
of substrate where post cyclisation regiochemistry is perfect and over-arylation does not occur.  
Fluorene 2o (derived from arylsilane 1o), where the 4-position is blocked, was found to 
undergo gold-catalysed arylation with 12a to give 135-F-F in 76% yield by NMR 
spectroscopy as a single regioisomer (>99:1 rr), and without any overarylation (Scheme 5.20). 
Therefore, this class of substrate was chosen to investigate the domino-arylation further. 
 
Scheme 5.20. Arylation of fluorene 2o cleanly affords 135-F-F as a single regioisomer (no 
136-F-F, or other isomer detected). 
Following on from this result, the effect of electronic perturbation through varying the para 
substituent on 12 was measured. First, 1o and 12b were subjected to the standard domino 








Figure 5.7. Regioselective Domino Arylation of 2o and 12b. 
Pleasingly, a similar kinetic profile to the reaction of 1l and 12a was obtained, with a large 
build-up of 2o and a subsequent decay to domino product 136a. The product was formed as a 
single regioisomer, with an 80% yield by NMR in under 2 hours. The high yield was 
maintained on a preparative scale, as 78% could be isolated. A small substrate scope for a 
series of differently substituted intermolecular silane substrates were then studied (Scheme 
5.21). 
 
Scheme 5.21. Effect of varying “inter” silane on domino arylation.iv 
                                                     
iv Authentic sample of 136-F-F prepared and characterised by Dr. A. Cresswell. Compounds 12a-d 


















Intriguingly, when less electron-deficient ‘inter’ silanes are employed, approximately 5% of a 
second regioisomer 136 is obtained. As perfect regioselectivity is obtained when the 
intermolecular arylation is performed in isolation, this result suggests that the intramolecular 
substrate 2o is now sufficiently activated, and that a competing “inter-intra” pathway is 
operating (Scheme 5.22). The reactivity of 2o toward arylation was confirmed through the 
control reaction of 138 and 12a, in which isomer 139 was obtained.v 
 
Scheme 5.22. Proposed mechanistic pathway for production of isomers 135 and 136. 
In the mechanistic study into intermolecular direct arylation, competition experiments 
confirmed that C−Si auration is accelerated by electron-releasing substituents (ρ = −1.6).[83] 
Therefore, more electron-rich ‘inter’ silanes will increase k2 and more electron-rich ‘intra’ 
silanes will increase k1. Therefore, more electron-deficient ‘inter’ silanes should lead to more 
product from the “intra-inter” pathway. This was observed as 135-F-CF3, which is formed 
from the most electron-deficient ‘inter’ silane 12b (and therefore the lowest k2), gave the 
highest regioselectivity, however a noticeable trend was not observed with the other examples. 
This is likely due to the transmetalation selectivity (k1/k2) being so high already that, within 
experimental error, a trend cannot be measured within this small electronic range (σ = 0 - 
0.23). 
                                                     




The effect of altering the electronics on the ‘intra’ silane on yield and product distribution was 
then studied (Scheme 5.23). Regioselectivity was mostly unaffected by the substituent on the 
‘intra’ silane, apart from 1ag which bears a strongly deactivating para CF3 group. The identity 
of the substituent did have a large effect on yield, however. When R = H, significant quantities 
of diarylated product are observed, stressing the importance of having a substituent to prevent 
additional arylation either through electronic or steric effects. Longer reaction times, or more 
forcing conditions are required when the silane is deactivated due to the catalyst inhibition 
processes outlined in Chapter 4. This results in a poorer yield for 135-Cl-F, and the necessity 
to heat the reaction of 1ag and 12a to form 135-CF3-F.  
 
Scheme 5.23. Effect of varying “intra” silane on domino arylation. a17% of the diarylated 
product was also isolated. bReaction was run at 50 °C. cCombined yield as measured by 19F 
NMR spectroscopy against an internal standard. 
The poor regioselectivity obtained in the coupling of 1ag and 12a (60:40 rr) indicated that a 
significant amount of product was being generated via an “inter-intra” pathway. To ensure this 
was the case, the intermolecular coupling was monitored in isolation (Scheme 5.24).  
 
Scheme 5.24. Innate regioselectivity of arylation of 2ah and 12a.vi 
                                                     




Unlike the coupling of 2o and 12a (Scheme 5.20), the regioselectivity was not perfect in this 
case (88:12 rr), suggesting that the remote CF3 substituent exerts a significant influence on 
innate regioselectivity. However, the regioselectivity obtained is significantly higher than that 
observed in the domino arylation, indicating a significant proportion of 135-F-CF3 is formed 
from “inter-intra” coupling. Monitoring of the reaction confirmed this as a significant build-
up of the products from both the “intra-inter” and “inter-intra” mechanistic pathways.  
 
 
Figure 5.8. Domino arylation with intermediates and products from both “intra-inter” and 
“inter-intra” pathways. 
The presence of two regioisomers which result from different mechanistic pathways raised the 




















a new class of coupling partner “T” would need to be designed as a replacement for the TMS 
group, which displays a greater selectivity for the gold catalyst, so that greater discrimination 
between the ‘inter’ and ‘intra’ substrates can be obtained. By doing so, depending on the 
position of “T”, the reaction could proceed via an ‘inter-intra’ pathway yielding one 
regioisomer, or an ‘inter-intra’ to give the other (Scheme 5.25). 
 
Scheme 5.25. Design of new transmetalating reagent could lead to increased regioselectivity. 
Recent developments in the group have shown that replacing the TMS group with 3-
hydroxypropyldimethylsilyl (HPDMS)[82] leads to increased transmetalation rates. Whilst the 
exact mechanism that leads to this rate acceleration is undetermined, a plausible explanation 
is through an intramolecular delivery of the gold after binding to the alcohol (Scheme 5.26).  
 




It was hoped that replacing 12a with 140vii in the domino arylation with 1ag could lead to a 
selectivity switch. Unfortunately, no change in selectivity was obtained when employing 
HPDMS (Scheme 5.27). Studies into quantifying the rate acceleration by HPDMS, and the 
exact mechanism of transmetalation are ongoing, however a possible explanation for this lack 
of improvement could be that at high temperatures the impact of intramolecular delivery by 
the alkoxy group is reduced. 
 
Scheme 5.27.  Use of HPDMS on ‘inter’ silane for domino arylation. 
5.4 Summary  
Through kinetic simulation, the guiding principles for the development of domino reactions 
combining intra- and intermolecular direct arylation are presented. Two distinct mechanistic 
pathways are shown, where the ordering of events, either “intra-inter” or “inter-intra”, can 
have a great impact on kinetic profile, yield and regioselectivity. The crucial kinetic parameter 
which largely determines these three factors is the partition between the “C-X” functional 
groups on the ‘inter’ and ‘intra’ substrate (k1 vs k2). For a successful reaction, one of these 
pathways must dominate (i.e. k1 > k2 or k2 > k1), as a mixture of both pathways could either 
lead to catalyst deactivation, or a mixture of isomers, depending on the innate reactivity of the 
substrates. 
This theoretical analysis, in combination with prior mechanistic understanding into intra- and 
intermolecular gold-catalysed direct arylation, led to the proposal that an “intra-inter” arylation 
protocol could be developed. This is confirmed experimentally, with excellent agreement to 
the simulated data. The success of this reaction underpins how mechanistic understanding, in 
combination with computational rationale, can be key in the development of novel 
methodologies. Under certain circumstances the reaction displays impressive levels of both 
chemo- and regioselectivity, however, deliberate electronic perturbation of the system can 
                                                     




trigger an alternative “inter-intra” pathway and lead to a mixture of isomers, as predicted by 
the kinetic simulation. Attempts to exploit this competing process using novel transmetalating 
reagents failed, however further exploration into reagents that transmetalate at vastly different 
rates that could lead to complete discrimination between two mechanistic pathways is an 
enticing prospect for the future. Whilst only a select number of substrates were attempted as a 
proof of concept, considering the breadth of substrates available through intramolecular direct 






























6.1 Conclusions  
The intramolecular direct arylation of aryltrimethylsilanes and arenes has been investigated 
from both preparative and mechanistic aspects. The reaction generates 5- to 9-membered rings, 
with the majority of reactions requiring only 1 – 2 mol% of catalyst at room temperature. The 
breadth of scope and mild reaction conditions employed establishes this methodology as a 
viable alternative to typical palladium-catalysed routes.  
Intramolecular arylation, particularly the examples generating substituted fluorene products 
proved ideal for mechanistic study. The large electronic range tolerated allowed for a holistic 
investigation of the reaction mechanism, as opposed to the reliance on a single well-behaved 
model system. Investigation across numerous substrates avoided erroneous extrapolation of 
conclusions, as small structural changes resulted in significant kinetic consequences. Indeed, 
depending on tether length and arene electronics, the catalyst resting state moved from a 
monoaryl gold(III) complex I, to a diarylgold(III) complex IV/V, with turnover-limiting π-
complexation or reductive elimination, respectively.   
Monitoring of the entire kinetic profile, as opposed to initial rate studies, unveiled a complex 
off-cycle pathway when electron-deficient silanes are used. In combination with kinetic 
modelling, a novel catalyst inhibition pathway was unveiled. The importance of identifying 
catalyst inhibition pathways was stressed, as understanding and avoiding these processes can 
lead to highly active catalyst species. 
Finally, the mechanistic understanding of both the intra- and intermolecular protocols led to 
the advance of a domino-arylation reaction. Kinetic simulation was key in outlining the general 
principles for such a reaction to be successful, with the conclusions applicable to any domino 
arylation protocol. 
6.2 Additional Experiments and Future Work 
6.2.1 Au(I)/Au(III) redox 
In combination with prior studies into intermolecular arylation, the catalytic cycle and the 
factors that govern each step are now well-understood. It is only the final step in the catalytic 
cycle, the Au(I)/Au(III) redox, for which minimal mechanistic information is known. 
However, understanding this process could lead to significant synthetic advances. As 
demonstrated throughout this project, the oxidant is the source of several deleterious 
processes; it forms diaryliodonium salts from electron-rich arenes, limiting substrate scope 
and causing catalyst deactivation in the synthesis of allocolchicine, it releases water, which 




it is necessary, as only hypervalent iodine oxidants have been shown to be competent. If it 
could be understood why hypervalent oxidants are needed, and if this information leads to the 
use of inorganic oxidants, the process would be transformed by the tolerance of new, highly 
electron-rich functionality, which could include a broader range of heterocycles, many of 
which are not currently tolerated.  
6.2.1.1 Speciation of Hypervalent Iodine Oxidants 
Studies into hypervalent iodine oxidant species by Koser et al demonstrated that that the 
speciation of hypervalent iodine oxidants in solution is complicated.[163] This is a significant 
hurdle to understanding the oxidation process as identifying the active species is non-trivial. 
When HCIB is employed under the reaction conditions, a single species is observed by 1H 
NMR, suggesting that all species present are in rapid equilibrium. However, when PIFA was 
used it was noted that the speciation was different depending on whether methanol was a co-
solvent or not.  
In dry chloroform, PIFA can be observed as a single species in solution by 1H NMR. However, 
upon addition of methanol, a new distinct species is observed immediately. The observation 
of two distinct by 1H NMR suggests a relatively slow equilibrium, however the time between 
mixing and running the experiment is sufficient for the equilibrium to be reached. The peak of 
the new species broadens and slowly shifts upfield with time, consistent with a fast equilibrium 
with another species in solution (Figure 6.1).  As PIFA was found to not be a competent 
oxidant in the absence of methanol, it was of interest to identify the different species as one of 
these is likely the active oxidant. In addition, PIFA is a commercially available oxidant, and 
has been used in combination with alcohols synthetically,[164–167] so identifying speciation 
would be of interest to the general chemical community. 
 
Figure 6.1. 1H NMR spectra of PIFA, before and after addition of methanol. 
t = 0 
t = 2 min 







X-ray crystallographic analysis on the final species, C, confirmed that the anhydride of PIFA 
had formed 141. With the final species identified, the mechanism of its formation, and the 
identity of the intermediate species, was investigated. 
 
 
Scheme 6.1. Top: Formation of 141 via unknown intermediates. Bottom X-ray crystal 
structure of 141. 
Alcock and Varvoglis[168] previously reported the synthesis of 141 by treating PIFA with a 
strong base, such as NaOMe. Alongside 141, trifluoromethyl acetate 142 was formed leading 
to the mechanistic conclusion that attack at the carbonyl occurred over attack at iodine to form 
143, which could then subsequently attack another molecule of PIFA, but at iodine. In the 
study presented herein, close inspection of the reaction mixture revealed trifluoromethyl 
acetate had formed, therefore it was of interest to assess whether the same type of mechanism 
was operating under non-basic conditions (Scheme 6.2). 
 
Scheme 6.2. Proposed mechanism of anhydride formation under basic conditions, and 




To assess whether a similar mechanism occurred in the non-basic system investigated herein, 
the temporal profile of the equilibration was measured (Figure 6.2). The formation of the 
anhydride was monitored by the change in chemical shift in the 1H NMR spectra observed on 
conversion of 66 to 141. The concentration of trifluoromethyl acetate was monitored by 19F 
NMR spectroscopy.   
 
 
Figure 6.2. Formation of 141 and trifluoromethyl acetate from 66 and MeOH. 
These results are inconsistent with the mechanism proposed by Alcock and Varvoglis for the 
base-mediated process.[168] PIFA reaches equilibrium with ‘A’ rapidly, but without associated 
production of 142, which would be expected if the identity of A was 144. In fact, the rate of 
formation of 142 mirrors that of the anhydride 141. Therefore, another mechanism must be 
controlling the conversion of PIFA to 141. An alternative mechanism was proposed (Scheme 
6.3), where methanol attacks PIFA at iodine first, liberating TFA and forming 145a. The 
methanol co-solvent then reacts with TFA, forming an equilibrium with trifluoromethyl 
acetate and water. The water then displaces methanol, forming the hydroxy species 144, which 
then rapidly reacts with another molecule of PIFA to form 141. Since the generation of 
anhydride 141 mirrors the formation of 142, the equilibrium from 144 to 141 must be fast. 
Control experiments confirmed that methanol and TFA do indeed form 142. If methanol is 
replaced with water, then 144 can form directly from PIFA, and thus form 141. Therefore, if 
dry solvents are not employed with PIFA, it is likely a significant proportion of the oxidant 


















Scheme 6.3. Proposed mechanism and speciation of PIFA in CHCl3/MeOH. 
To investigate this equilibration in more detail, the effect of other alcohols on the equilibrium 
was measured. A Hammett LFER plot was generated from a series of para substituted benzyl 
alcohols. These alcohols were significantly less reactive towards esterification, and therefore 




Figure 6.3. Hammett LFER for series of substituted benzyl alcohols. 
The equilibrium is favoured by electron-donating substituents (ρ = − 0.8), due to stabilisation 
of the electron-deficient iodine centre with a more electron-rich alcohol. The effect of different 































alcohols on this equilibrium constant was then measured (Table 6.1). Surprisingly, even with 
very acidic alcohols such as TFE (entry 4) and hexafluoroisopropanol (HFIP, entry 5), this 
equilibrium still occurs, albeit with low equilibrium constants.  
Table 6.1. Equilibrium constants for series of alcohols. 
 
Entry Alcohol Keq 
1 MeOH 0.92 
2 Isopropanol 1.03 
3 Tert-butanol 0.59 
4 Trifluoroethanol 0.005 
5 HFIP 0.001 
 
From a synthetic perspective, the presence of this equilibrium is important in the reduction of 
diaryliodonium salt formation. It was noted during the synthesis of allocolchicine that the 
absence of methanol, or the use of more acidic alcohols such as TFE, led to increased rates of 
diaryliodonium salt formation. This suggests that 145a is less susceptible to diaryliodonium 
salt formation than PIFA.  Additionally, the fact that the direct arylation procedure does not 
turnover in the absence of methanol suggests that the active oxidant is one of the species 
formed during this equilibration. A reasonable hypothesis is that the hydroxy species 144 is 
the active oxidant, as pre-coordination of this species to gold(I) may be required to facilitate 
oxidation. 
Finally, the effect of addition of methanol to IBDA, which is widely used in organic synthesis 
was determined. The initial displacement of acetic acid with methanol to 146 was observed, 
but there was no further equilibration to the anhydride. Crucially, in control experiments, 
acetic acid did not react with methanol to form methyl acetate. In the absence of this 
equilibrium, no water is liberated, and therefore no route to the anhydride is available as 147 
is not formed. A Job plot was constructed, and this confirmed the proposed 1:1 ratio between 








𝐾 =  
[𝟏𝟒𝟔][𝐴𝑐𝑂𝐻]
[𝐼𝐵𝐷𝐴][𝑀𝑒𝑂𝐻]
= 0.07 ± 0.01 
Figure 6.4. Job plot of equilibrium of IBDA and MeOH and equilibrium constant. 
The fact that IBDA is not a competent oxidant, even in the presence of methanol, gives further 
evidence of the importance of the hydroxy species 144/147. Further experiments are needed 
to assess this hypothesis, possibly through deliberate addition of water to IBDA in catalysis to 
observe whether this induces turnover through the formation of the hydroxy species 147. 
6.2.1.2 mCPBA as an Alternative Oxidant 
It was proposed that catalytically generating the active hypervalent iodine species through in-
situ oxidation of an aryl iodide by mCPBA would limit the negative impacts of the hypervalent 
iodine oxidant by maintaining a constant low concentration (Scheme 6.4). The use of sub-
stoichiometric levels of 4-fluoroiodobenzene 148 in the presence of a stoichiometric amounts 
of mCPBA was attempted in the cyclisation of 1a. The use of 4-fluorobenzene was to track 
the oxidation process to F-HCIB (149) by 19F NMR spectroscopy No turnover was observed 

























Scheme 6.4. Proposal for in-situ formation of active oxidant by mCPBA. 
 
Scheme 6.5. Attempted synthesis of 2a using aryl iodide 148 and mCPBA. 
It was anticipated that this redox process could be dependent on solvent, and therefore 
chloroform and methanol were replaced with MeCN. Turnover was observed when MeCN 
was used as a solvent, however upon inspection of the 19F NMR spectrum, there was no 
indication that 149 had formed. Control experiments revealed that the addition of 148 was not 
needed, and mCPBA was facilitating the Au(I)/Au(III) redox. 
 
Scheme 6.6. Synthesis of 2a using mCPBA as the oxidant. 
However, the reaction was slow, as 1a, which under the standard conditions forms 2a 




spectroscopy. Additionally, 1.5 equivalents of mCPBA was not sufficient due to an apparent 
background degradation of the by-product methoxytrimethylsilane by mCPBA (Figure 6.5). 
 
Figure 6.5. Fate of TMS group under A, the standard reaction conditions and B, with 
mCPBA. 
Nevertheless, this is mechanistically interesting as it is the first example of a non-hypervalent 
iodine oxidant facilitating turnover. Additionally, qualitatively the identity of the substrate 
does not seem to affect the rate of turnover, as both 1a and 1b, which have vastly different 
reaction times under standard conditions (See Table 2.4, Chapter 2), form roughly the same 
amount of their respective products in equal times. This could be due to a turnover-limiting 
oxidation. 
 
Scheme 6.7. Effect of substrate on conversion at identical time point using mCPBA as the 
oxidant. Yield by 1H NMR. 
If chloroform is used instead of MeCN, Au particulates form rapidly, and therefore the 
presence of MeCN may serve to stabilise Au(I) prior to slow oxidation. The overall structure 









bind, and an aromatic group, which could lead to stabilisation through π-complexation. These 
results warrant further investigation, and emphasise the point that solvent choice could be key 
in the identification of an alternative oxidant system. 
6.2.2 Ligand Development 
Preliminary results from Dr. L. Ball identified a rate increase in the coupling of 98 and 12a 
upon addition of catalytic quantities of a sulfoxide (e.g. DMSO). It was not conclusively 
determined whether this increase was due to a ligand or solvent effect. The realisation that 
intra- and intermolecular direct arylation proceed with different turnover-limiting steps raised 
the prospect of investigating the effect of sulfoxides on different steps in the catalytic cycle. 
Repetition of the studies confirmed the effect of the addition of DMSO. The rate increase 
continued with increasing concentrations of DMSO, however, evidence of catalyst 
deactivation occurred when 5 equivalents of DMSO are added.  
 
 
Figure 6.6. Effect of DMSO on rate of consumption of 12a.  



















Scheme 6.8. Intramolecular cyclisation of 1b proceeds at the same rate with and without 
DMSO. 
As two different TLSs are operative, this suggested that sulfoxides exclusively increase the 
rate of π-complexation.  To verify this hypothesis, the effect of DMSO on the rate of coupling 
of 12a and 151 was investigated. Once again, no rate increase was observed. In fact, reduced 
rates are observed with added DMSO (Figure 6.7). 
 
 
Figure 6.7. Effect of DMSO on rate of coupling of 12a and 151. 
This seemingly selective rate enhancement for coupling of 98 is further demonstrated through 
the addition of DMSO to the competition experiment introduced in Chapter 3, where 98 can 
compete with the intramolecular cyclisation of 2m. If π-complexation of the respective intra- 
and intermolecular arene moieties to the resulting monoaryl gold(III) resting state I(2m) is the 
selectivity determining step, then one would expect DMSO, if ligated to the gold, to accelerate 
each step equally. This should lead to no selectivity difference whether DMSO is present or 
not. However, this is not observed (Figure 6.8) and a complete selectivity switch occurs from 
2m as the major product in the absence of DMSO, to 99 when 20 mol% DMSO is added. 
Whilst these effects are not fully understood, it could suggest that the kinetically significant 
step of C-H metalation in substrates such as 2m and 151 is not π-complexation, with WI 






















Figure 6.8. Partition between intramolecular cyclisation, and intermolecular coupling under 
standard conditions (A) and with 20 mol% DMSO (B) 
Further investigation into the effect of DMSO is needed, as conclusive evidence of sulfoxide 
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8.1 General Information 
Procedures employing air or moisture-sensitive materials were performed with anhydrous 
solvents (vide infra) using standard Schlenk techniques, under an atmosphere of anhydrous 
nitrogen. Glassware necessary for these manipulations were previously oven dried (200 °C) 
or flame-dried and allowed to cool under vacuum (ca 0.5 Torr). 
Analytical thin-layer chromatography was performed on precoated aluminium-backed plates 
(Silica Gel 60 F254; Merck), and visualised using a combination of UV light (254 nm) and 
ethanolic phosphomolybdic acid, aqueous basic potassium permanganate, iodine or vanillin 
stains. Preparative thin-layer chromatography (for less than ca 15 mg of sample) was 
performed on precoated, analytical aluminium-backed plates (Silica Gel 60 F254; Merck). 
Column chromatography was performed using Davisil® 60A silica gel (35-70 μm; Fisher 
Scientific) or Geduran® Silica Gel 60 (40-63 µm; Merck). 
NMR spectra were recorded at 27 °C unless stated otherwise; 1H, 13C{1H}, and 19F NMR 
spectra were recorded at 600/500/400 MHz, 125/100 MHz and 470/376/282 MHz, 
respectively, using Bruker Avance I 600, Bruker Avance I 400, Bruker Avance III 500 and 
Bruker Avance III+ 400 spectrometers. 1H and 13C{1H} NMR spectra were referenced to 
residual solvent peaks (CHCl3, δH 7.26 ppm; CDCl3, δC 77.16 ppm); chemical shifts are 
reported in ppm relative to tetramethylsilane standard. 19F NMR spectra are reported in ppm 
relative to a BF3·OEt2 external standard. Coupling constants, J, were calculated using 
Mestrenova versions 6, 8 or 9, and are reported to the nearest 0.1 Hz. Coupling constants that 
did not match as a result of digitization are reported as rounded averages. The following 
abbreviations (and their combinations) are used to label the multiplicities: s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet) and br (broad).  
Dry solvents were obtained by passing solvent through a column of anhydrous alumina using 
an Anhydrous Engineering Grubbs-type system and stored under anhydrous nitrogen. 
Reaction solvents chloroform (CHCl3) (amylene stabilised, HPLC grade, Sigma-Aldrich) and 
chloroform-d3 (CDCl3) (99.8 atom % D, Sigma-Aldrich) were passed through a plug of 
activated basic Al2O3 (Brockmann I), distilled and held over 3 Å molecular sieves in a Strauss 
flask under nitrogen in the dark. Triethylamine and trimethylsilyl chloride were distilled from 
CaH2. Solvents employed for Pd-catalysed cross-couplings were degassed by repeated freeze-
pump-thaw cycles. Unless stated otherwise, reagents were purchased from commercial sources 






The precatalyst, thtAuBr3, was prepared via an improved procedure[1] to that originally 
reported.[2] 
Infrared spectra of neat compounds were recorded over the range 4000-600 cm–1 using a 
Bruker Platinum ATR Quicksnap™ attachment (diamond cell) on a Bruker Alpha FT-IR 
Spectrometer. Melting points were measured using a SMP10 melting point apparatus in open 
capillaries and are uncorrected. Mass spectra were recorded on Bruker microTOF II or 
Finnigan MAT 900 XLP spectrometers. 
X-ray measurements were made on crystals mounted on a MITIGEN holder in Paratone oil. 
Data were collected using a Rigaku Oxford Diffraction SuperNova diffractometer equipped 
with an Oxford Cryosystems Cryostream 700+ low-temperature apparatus operating at T = 
120.0 K. Data were measured using ω scans of 1.0° per frame for 1.0 s using CuKα radiation 
(sealed X-ray tube, 50 kV, 0.8 mA). The total number of runs and images was based on the 
strategy calculation from the program CrysAlisPro (Agilent, V1.171.37.35e, 2014). Cell 
parameters were retrieved, refined and data reduction was performed using the CrysAlisPro 
(Agilent, V1.171.37.35e, 2014) software which corrects for Lorentz polarisation. The 
structures were solved by Direct Methods using the ShelXS[3] structure solution program and 
refined by Least Squares using ShelXL.[3] All non-hydrogen atoms were refined 
















8.2 Experimental Procedures and Characterisation Data 
 
Scheme 8.1. General Procedures for Synthesis of (2-benzylphenyl)trimethylsilanes 
General Procedure 1: n-Butyllithium (0.98 – 1.00 eq.) was added dropwise to a stirred 
solution of the requisite aryl bromide (1.00 – 1.03 equiv) in THF (0.4 M) at –78 °C. The 
reaction was stirred at this temperature for 1 h, then the requisite 2-bromobenzaldehyde (1.00 
equiv) was added dropwise, and the mixture was allowed to warm to room temperature and 
was stirred for the time specified. The reaction was quenched with H2O, then the aqueous 
phase was separated and extracted with Et2O (3 ×), and the combined organic portions were 
dried (MgSO4), filtered and concentrated in vacuo to give the crude product.  
General Procedure 2A: A Schlenk flask containing the requisite diarylmethanol (1.00 equiv) 
was evacuated and back-filled with N2 three times, then CH2Cl2 (0.3 M) was added. The 
solution was cooled to 0 °C, then TFA (4.00 equiv) was added dropwise. After 2 min, Et3SiH 
(2.00 equiv) was added dropwise, and the reaction stirred at room temperature overnight. The 
volatiles were then evaporated under a stream of N2 to give the crude product. 
 General Procedure 2B: A Schlenk flask containing the requisite diarylmethanol (1.00 equiv) 
was evacuated and back-filled with N2 three times, then CH2Cl2 (1.6 M) was added. The 
solution was cooled to 0 °C, then TFA (8.00 equiv) was added dropwise. After 2 min, Et3SiH 
(2.00 equiv) was added dropwise, and the reaction stirred at room temperature overnight. The 
volatiles were then evaporated under a stream of N2 to give the crude product.  
General Procedure 3: n-Butyllithium (1.10 equiv) was added dropwise to a stirred solution 
of the requisite aryl bromide (1.00 equiv) in THF (0.4 M) at –78 °C. The reaction was stirred 
at this temperature for the time specified, then Me3SiCl (1.50 equiv) was added dropwise, and 
the mixture was allowed to warm to room temperature and was stirred overnight. The reaction 
was quenched with H2O, then the aqueous phase was separated and extracted three times with 
Et2O; the combined organic portions were dried (MgSO4), filtered and concentrated in vacuo 
to give the crude product. Purification was achieved with flash column chromatography on 








(2-Bromophenyl)phenylmethanol: Following General Procedure 1, nBuLi (1.6 M in hexanes, 
3.13 mL, 5.00 mmol) was added dropwise to a stirred solution of bromobenzene (0.56 mL, 
5.25 mmol) in THF (13 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, 
then 2-bromobenzaldehyde (0.60 mL, 5.10 mmol) was added dropwise, and the mixture was 
allowed to warm to room temperature and was stirred for 2 h. Flash column chromatography 
(20% Et2O in hexanes) afforded (2-bromophenyl)phenylmethanol as a viscous, colourless 
liquid (1.10 g, 4.18 mmol, 84%). 
Characterisation data were consistent with literature values: 1H and 13C{H} NMR.[4] 
1H NMR (300 MHz, CDCl3): δ 7.70 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.55 (dd, J = 8.0 Hz, 1.3 Hz, 
1H), 7.44-7.28 (m, 6H), 7.16 (ddd, J = 7.8 Hz, 7.4 Hz, 1.8 Hz, 1H), 6.21 (s, 1H), 2.39 (s, 1H).  
13C{1H} NMR (125 MHz, CDCl3): δ 142.5, 142.1, 132.8, 129.1, 128.5, 127.8, 127.7, 127.0, 
122.8, 74.8. 1 × CAr not observed. HRMS calcd. for C13H11BrO: 261.9993 [M]+; found (EI+): 
261.9986.  
1-Benzyl-2-bromobenzene: Following General Procedure 2A, (2-
bromophenyl)phenylmethanol (1.10 g, 4.18 mmol) in CH2Cl2 (14 mL) was reacted with TFA 
(1.23 mL, 16.0 mmol) and Et3SiH (1.28 mL, 8.00 mmol). Purification via flash column 
chromatography (pentane) afforded 1-benzyl-2-bromobenzene as a colourless liquid (0.84 g, 
3.38 mmol, 81%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[5] 
1H NMR (500 MHz, CDCl3): δ 7.59 (app. d, J = 8.0 Hz, 1H), 7.32 (app. t, J = 7.6 Hz, 2H), 
7.26-7.21 (m, 4H), 7.16 (dd, J = 7.7 Hz, 1.9 Hz, 1H), 7.10 (dd, J = 7.6 Hz, 2.1 Hz, 1H), 4.14 
(s, 2H).  13C{1H} NMR (125 MHz, CDCl3): δ 140.4, 139.5, 132.8, 131.1, 129.0, 128.5, 127.9, 
127.4, 126.2, 124.9, 41.7.  νmax(neat)/cm–1: 3061, 2914, 1566, 1495, 1438, 1023, 742, 716. 
HRMS calcd. for C13H11Br: 246.0044 [M]+; found (EI+): 246.0045. 
(2-Benzylphenyl)trimethylsilane: Following General Procedure 3, nBuLi (1.6 M in hexanes, 
2.20 mL, 3.51 mmol) was added to 1-benzyl-2-bromobenzene (0.83 g, 3.34 mmol) in THF 
(8.5 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then Me3SiCl (0.55 





overnight. Purification via flash column chromatography (hexanes) afforded the title 
compound as a colourless liquid (0.70 g, 2.90 mmol, 87%). 
1H NMR (500 MHz, CDCl3): δ 7.56 (dd, J = 7.3 Hz, 1.5 Hz, 1H), 7.32-7.27 (m, 3H), 7.24-
7.21 (m, 2H), 7.12 (app. d, J = 7.3 Hz, 2H), 7.02 (app. d, J = 7.6 Hz, 1H), 4.18 (s, 2H), 0.33 
(s, 9H). 13C{1H} NMR (125 MHz, CDCl3): δ 146.2, 141.4, 138.8, 134.5, 1298, 129.3, 129.1, 
128.3, 125.9, 125.4, 41.6, 0.3. νmax(neat)/cm–1: 3059, 3027, 2953, 1495, 1451, 1248, 1121, 
1074, 1030, 832, 723. HRMS calcd. for C16H20Si: 240.1334 [M]+; found (EI+): 240.1335. 
[2-(4-Chlorobenzyl)phenyl]trimethylsilane (1f) 
 
(2-Bromophenyl)(4-chlorophenyl)methanol: Following General Procedure 1, nBuLi (1.6 M 
in hexanes, 3.13 mL, 5.00 mmol) was added dropwise to a stirred solution of 1-bromo-4-
chlorobenzene (1.01 mL, 5.25 mmol) in THF (13 mL) at –78 °C. The reaction was stirred at 
this temperature for 1 h, then 2-bromobenzaldehyde (0.60 mL, 5.10 mmol) was added 
dropwise, and the mixture was allowed to warm to room temperature and was stirred for 2 h. 
Column chromatography (20% Et2O in hexanes) afforded (2-bromophenyl)(4-
chlorophenyl)methanol as a viscous, colourless liquid (1.22 g, 4.09 mmol, 82%). 
1H NMR (300 MHz, CDCl3): δ 7.57-7.53 (m, 2H), 7.39-7.30 (m, 5H), 7.17 (app. td, J = 7.9 
Hz, 1.8 Hz, 1H), 6.18 (s, 1H), 1.25 (s, 1H).  13C{1H} NMR (125 MHz, CDCl3): δ 142.2, 140.6, 
133.5, 132.9, 129.4, 128.6, 128.4, 127.9, 122.7, 74.1. 1 × CAr not observed.  
1-Bromo-2-(4-chlorobenzyl)benzene: Following General Procedure 2A, (2-
bromophenyl)(4-chlorophenyl)methanol (1.20 g, 4.03 mmol) in CH2Cl2 (13 mL) was reacted 
with TFA (1.23 mL, 16.0 mmol) and Et3SiH (1.28 mL, 8.0 mmol). Column chromatography 
(pentane) afforded 1-bromo-2-(4-chlorobenzyl)benzene as a colourless liquid (0.75 g, 2.65 
mmol, 66%). 
1H NMR (500 MHz, CDCl3): δ 7.59 (d, J = 7.9 Hz, 1H), 7.28-7.24 (m, 3H), 7.15-7.10 (m, 
4H), 4.10 (s, 2H). 13C{1H} NMR (125 MHz, CDCl3): δ 139.8, 137.9, 133.0, 132.1, 131.0, 
130.3, 128.9, 128.1, 127.6, 124.8, 41.1. HRMS calcd. for C13H10ClBr: 279.9654 [M]+; found 
(EI+): 279.9658.  
[2-(4-Chlorobenzyl)phenyl]trimethylsilane: Following General Procedure 3, nBuLi (1.6 M 





2.96 mmol) in THF (7 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 
Me3SiCl (0.49 mL, 3.85 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (pentane) afforded the 
title compound as a colourless liquid (0.64 g, 2.34 mmol, 79%). 
1H NMR (500 MHz, CDCl3): δ 7.55 (dd, J = 7.4 Hz, 1.5 Hz, 1H), 7.30 (app. td, J = 7.4 Hz, 
1.6 Hz, 1H), 7.26-7.22 (m, 3H), 7.02 (d, J = 8.6 Hz, 2H), 6.99 (app. d, J = 7.6 Hz, 1H), 4.13 
(s, 2H), 0.31 (s, 9H).13C{1H} NMR (125 MHz, CDCl3): δ 145.5, 139.9, 138.9, 134.6, 131.7, 
130.4, 129.8, 128.4, 125.6, 40.9, 0.31. 1 × CAr not observed. νmax(neat)/cm–1: 3056, 2953, 
2897, 1489, 1431, 1406, 1262, 1248, 1123, 1091, 1015, 832, 793, 750. HRMS calcd. for 
C16H19ClSi: 274.0939 [M]+; found (EI+): 274.0926. 
Trimethyl{2-[4-(trifluoromethyl)benzyl]phenyl}silane (1h) 
 
(2-Bromophenyl)[4-(trifluoromethyl)phenyl]methanol: Following General Procedure 1, 
nBuLi (2.38 M in hexanes, 3.81 mL, 9.06 mmol) was added dropwise to a stirred solution of 
4-bromobenzotrifluoride (1.24 mL, 8.89 mmol) in THF (20 mL) at –78 °C. The reaction was 
stirred at this temperature for 20 min, then 2-bromobenzaldehyde (1.03 mL, 8.89 mmol) was 
added dropwise, and the mixture was allowed to warm to room temperature and was stirred 
for 2 h. Purification via flash column chromatography (20% EtOAc in hexanes) afforded (2-
bromophenyl)[4-(trifluoromethyl)phenyl]methanol as a viscous, colourless liquid (2.40 g, 
7.59 mmol, 85%). 
Characterisation data were consistent with literature values: 1H,  13C{1H} NMR and IR.[4] 
1H NMR (400 MHz, CDCl3): δ 7.63 – 7.47 (m, 6H), 7.35 (app. t, J = 7.6 Hz, 1H), 7.18 (app. 
t, J = 7.6 Hz, 1H), 6.28 (s, 1H), 2.45 (br.s, 1H). 13C{1H} NMR (100 MHz, CDCl3): δ 146.1, 
142.1, 133.2, 130.0 (q, J = 32 Hz), 129.7, 128.7, 128.1, 127.3, 125.6 (q, J = 3.9 Hz), 124.2 (q, 
J = 270 Hz), 122.9, 74.3. 19F NMR (377 MHz, CDCl3): δ -62.5 (s). νmax(neat)/cm–1: 3330, 
3067, 1619, 1467, 1321, 1161, 1108, 1065, 1014, 858, 838, 750. 
1-Bromo-2-[4-(trifluoromethyl)benzyl]benzene: Following General Procedure 2B, (2-
bromophenyl)[4-(trifluoromethyl)phenyl]methanol (2.38 g, 7.54 mmol) in CH2Cl2 (4.5 mL) 





via flash column chromatography (hexanes) afforded 1-bromo-2-[4-
(trifluoromethyl)benzyl]benzene as a colourless liquid (1.90 g, 6.03 mmol, 80%).  
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.9, 1.3 Hz, 1H), 7.55 (d, J = 7.7 Hz, 2H), 7.35 
– 7.23 (m, 3H), 7.19 – 7.08 (m, 2H), 4.18 (s, 2H).13C{1H} NMR (100 MHz, CDCl3): δ 143.8, 
139.4, 133.2, 131.3, 129.3, 128.8 (q, J = 32 Hz), 128.5, 127.8, 125.5 (q, J = 3.8 Hz), 125.0, 
124.4 (q, J = 270 Hz), 41.7. 19F NMR (377 MHz, CDCl3): δ -62.4 (s). νmax(neat)/cm–1: 3063, 
2929, 1618, 1469, 1417, 1321, 1160, 1116, 1065, 1018, 917, 839, 805, 743, 660. HRMS calcd. 
for C14H10F3Br: 313.9913 [M] +; found (EI+): 313.9910. 
Trimethyl{2-[4-(trifluoromethyl)benzyl]phenyl}silane: Following General Procedure 3, 
nBuLi (2.38 M in hexanes, 2.57 mL, 6.12 mmol) was added to 1-bromo-2-[4-
(trifluoromethyl)benzyl]benzene (1.61 g, 5.10 mmol) in THF (15 mL) at –78 °C. The reaction 
was stirred at this temperature for 1 h, then Me3SiCl (0.97 mL, 7.65 mmol) was added 
dropwise, and the mixture was stirred at room temperature overnight. Purification via flash 
column chromatography (hexanes) afforded the title compound as a colourless liquid (1.26 g, 
4.07 mmol, 80%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.5, 1.7 Hz, 1H), 7.54 (d, J = 7.8 Hz, 2H), 7.30 
(app. td, J = 7.5, 1.7 Hz, 1H), 7.24 (app. td, J = 7.5, 1.4 Hz, 1H), 7.20 (d, J = 7.8 Hz, 2H), 6.99 
– 6.96 (m, 1H), 4.22 (s, 2H), 0.32 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 145.8, 145.1, 
139.2, 134.9, 130.1, 129.6, 129.5, 128.5 (q, J = 32 Hz), 126.0, 125.4 (q, J = 3.8 Hz), 124.5 (q, 
J = 270 Hz), 41.6, 0.48. νmax(neat)/cm–1: 2956, 1618, 1416, 1321, 1250, 1161, 1120, 1065, 
1018, 833, 738. HRMS calcd. for C17H19F3Si: 308.1203 [M]+; found (EI+):  308.1201 
[2-(3-Methoxybenzyl)phenyl]trimethylsilane (1j) 
 
(2-Bromophenyl)(3-methoxyphenyl)methanol: Following General Procedure 1, nBuLi (1.6 
M in hexanes, 3.13 mL, 5.00 mmol) was added dropwise to a stirred solution of 3-
bromoanisole (0.66 mL, 5.25 mmol) in THF (13 mL) at –78 °C. The reaction was stirred at 
this temperature for 1 h, then 2-bromobenzaldehyde (0.60 mL, 5.10 mmol) was added 
dropwise, and the mixture was allowed to warm to room temperature and was stirred for 2 h. 
Column chromatography (15% EtOAc in hexanes) afforded (2-bromophenyl)(3-
methoxyphenyl)methanol as a viscous, colourless liquid (1.23 g, 4.20 mmol, 84%).  





1H NMR (500 MHz, CDCl3): δ 7.58 (dd, J = 8.0 Hz, 1.7 Hz, 1H), 7.55 (dd, J = 8.0 Hz, 1.1 
Hz, 1H), 7.35 (app. td, J = 7.6 Hz, 1.2 Hz, 1H), 7.27 (app. t, J = 8.0 Hz, 1H), 7.16 (app. td, J 
= 7.6 Hz, 1.7 Hz, 1H), 7.00-6.19 (m, 2H), 6.84 (ddd, J = 8.3 Hz, 2.5 Hz, 1.2 Hz, 1H), 6.19 (s, 
1H), 3.80 (s, 3H), 2.39 (s, 1H). 13C{1H} NMR (125 MHz, CDCl3): δ 159.6, 143.7, 142.3, 
132.8, 129.5, 129.2, 128.5, 127.7, 122.8, 119.3, 113.0, 112.6, 74.6, 55.2. νmax(neat)/cm–1: 
3376, 3060, 3000, 2834, 1585, 1487, 1465, 1454, 1435, 1254, 1014, 743. 
1-Bromo-2-(3-methoxybenzyl)benzene: Following General Procedure 2A, (2-
bromophenyl)(3-methoxyphenyl)methanol (1.20 g, 4.10 mmol) in CH2Cl2 (14 mL) was 
reacted with TFA (1.23 mL, 16.0 mmol) and Et3SiH (1.28 mL, 8.0 mmol). Column 
chromatography (0% → 10% Et2O in hexanes) afforded 1-bromo-2-(3-
methoxybenzyl)benzene as a colourless liquid (0.64 g, 2.31 mmol, 56%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR.[6] 
1H NMR (400 MHz, CDCl3): δ 7.58 (dd, J = 8.0 Hz, 1.3 Hz, 1H), 7.24 (app. td, J = 7.3 Hz, 
1.3 Hz, 1H), 7.23 (ddd, J = 8.0 Hz, 7.6 Hz, 0.6 Hz, 1H), 7.15 (dd, J = 7.7 Hz, 1.9 Hz, 1H), 
7.09 (ddd, J = 8.0 Hz, 7.3 Hz, 1.8 Hz, 1H), 6.81-676 (m, 3H), 4.11 (s, 2H), 3.79 (s, 3H).  
13C{1H} NMR (100 MHz, CDCl3): δ 159.7, 141.1, 140.2, 132.8, 131.1, 129.4, 127.9, 127.5, 
124.9, 121.4, 114.9, 111.5, 55.1, 41.7. νmax(neat)/cm–1: 3054, 3000, 2833, 1598, 1567, 1488, 
1454, 1436, 1253, 1146, 1044, 1023, 928, 874, 778, 738, 690, 660.  
[2-(3-Methoxybenzyl)phenyl]trimethylsilane: Following General Procedure 3, nBuLi (1.6 M 
in hexanes, 1.59 mL, 2.54 mmol) was added to 1-bromo-2-(3-methoxybenzyl)benzene (0.64 
g, 2.31 mmol) in THF (6 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, 
then Me3SiCl (0.38 mL, 3.00 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (20% CH2Cl2 in 
hexanes) afforded the title compound as a colourless liquid (0.52 g, 1.91 mmol, 83%).  
1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 7.2 Hz, 1.7 Hz, 1H), 7.29 (dd, J = 7.4 Hz, 1.6 
Hz, 1H), 7.22 (app. td, J = 7.4 Hz, 1.3 Hz, 1H), 7.21 (app. t, J = 7.9 Hz, 1H), 7.03 (ddd, J = 
7.7 Hz, 1.9 Hz, 1.3 Hz, 1H), 6.76 (ddd, J = 8.2 Hz, 2.7 Hz, 0.8 Hz, 1H), 6.71 (dtd, J = 7.5 Hz, 
1.6 Hz, 0.8 Hz, 1H), 6.66 (dd, J = 2.3 Hz, 1.8 Hz, 1H), 4.15 (s, 2H), 3.77 (s, 3H), 0.33 (s, 9H). 
13C{1H} NMR (125 MHz, CDCl3): δ 159.7, 146.0, 143.1, 138.8, 134.5, 129.8, 129.30, 129.26, 
125.5, 121.7, 115.1, 111.2, 55.1, 41.6, 0.34. νmax(neat)/cm–1: 3054, 2952, 2833, 1600, 1584, 
1488, 1453, 1433, 1261, 1248, 1151, 1122, 1050, 832, 732. HRMS calcd. for C17H22OSi: 







(2-Bromophenyl)(3-fluorophenyl)methanol: Following General Procedure 1, nBuLi (1.6 M 
in hexanes, 3.13 mL, 5.00 mmol) was added dropwise to a stirred solution of 3-
bromofluorobenzene (0.59 mL, 5.25 mmol) in THF (10 mL) at –78 °C. The reaction was 
stirred at this temperature for 1 h, then 2-bromobenzaldehyde (0.60 mL, 5.10 mmol) was added 
dropwise, and the mixture was stirred at room temperature for 2 h. Purification via flash 
column chromatography (10% → 20% Et2O in hexanes) afforded (2-bromophenyl)(3-
fluorophenyl)methanol as a viscous, colourless liquid (1.31 g, 4.67 mmol, 93%). 
1H NMR (500 MHz, CDCl3): δ 7.55 (app. td, J = 8.0 Hz, 1.4 Hz, 2H), 7.36 (app. td, J = 7.4 
Hz, 1.4 Hz, 1H), 7.31 (app. td, J = 7.9 Hz, 5.9 Hz, 1H), 7.21-7.12 (m, 3H), 6.98 (m, 1H), 6.21 
(s, 1H). 13C{1H} NMR (125 MHz, CDCl3): δ 162.9 (d, J = 246 Hz), 144.7 (d, J = 6.7 Hz), 
142.1, 132.9, 129.9 (d, J = 7.6 Hz), 129.4, 128.5, 127.9, 122.7, 122.5 (d, J = 2.9 Hz), 114.6 (d, 
J = 21.0 Hz), 113.9 (d, J = 22.9 Hz), 74.1.19F NMR (470 MHz, CDCl3): δ –112.5 (ddd, J = 
9.7 Hz, 8.7 Hz, 5.4 Hz). νmax(neat)/cm–1: 3329, 3066, 2251, 1589, 1438, 1246, 1016, 905. 
HRMS calcd. for C13H10BrFO: 279.9899 [M]+; found (EI+): 279.9896. 
1-Bromo-2-(3-fluorobenzyl)benzene: Following General Procedure 2A, (2-bromophenyl)(3-
fluorophenyl)methanol (1.29 g, 4.59 mmol) in CH2Cl2 (14 mL) was reacted with TFA (1.38 
mL, 18.0 mmol) and Et3SiH (1.44 mL, 9.0 mmol). Purification via flash column 
chromatography (pentane) afforded 1-bromo-2-(3-fluorobenzyl)benzene as a colourless liquid 
(0.85 g, 3.22 mmol, 70%). 
1H NMR (300 MHz, CDCl3): δ 7.59 (dd, J = 7.9 Hz, 1.4 Hz, 1H), 7.30-7.23 (m, 2H), 7.18-
7.09 (m, 2H), 6.99 (app. d, J = 7.6 Hz, 1H), 6.95-6.86 (m, 2H), 4.12 (s, 2H). 13C{1H} NMR 
(125 MHz, CDCl3): δ 162.9 (d, J = 245.1 Hz), 142.0 (d, J = 7.6 Hz), 139.5, 133.0, 131.1, 
129.8 (d, J = 7.6 Hz), 128.2, 127.6, 124.8, 124.6 (d, J = 2.9 Hz), 115.8 (d, J = 21.0 Hz), 113.2 
(d, J = 21.9 Hz), 41.4. 19F NMR (282 MHz, CDCl3): δ –113.3 (ddd, J = 9.7 Hz, 8.7 Hz, 6.5 
Hz). νmax(neat)/cm–1: 3059, 2924, 1589, 1486, 1440, 1248, 1025, 741. HRMS calcd. for 
C13H10BrF: 263.9950 [M]+; found (EI+): 263.9949. 
3-(2-Trimethylsilylbenzyl)fluorobenzene: Following General Procedure 3, nBuLi (1.6 M in 
hexanes, 2.20 mL, 3.51 mmol) was added to 1-bromo-2-(3-fluorobenzyl)benzene (0.85 g, 3.19 





Me3SiCl (0.53 mL, 4.15 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (pentane) afforded the 
title compound as a colourless liquid (0.74 g, 2.87 mmol, 90%).  
1H NMR (500 MHz, CDCl3): δ 7.56 (dd, J = 7.4 Hz, 1.5 Hz, 1H), 7.32 (app. td, J = 7.4 Hz, 
1.5 Hz, 1H), 7.27-7.23 (m, 2H), 7.03 (app. d, J = 7.6 Hz, 1H), 6.93-6.89 (m, 2H), 6.78 (app. 
d, J = 10.1 Hz, 1H), 4.17 (s, 2H), 0.32 (s, 9H). 13C{1H} NMR (125 MHz, CDCl3): δ 162.9 (d, 
J = 245 Hz), 145.2, 144.1 (d, J = 7.6 Hz), 138.9, 134.7, 129.9, 129.7 (d, J = 8.6 Hz), 129.4, 
125.7, 124.7 (d, J = 1.9 Hz), 115.9 (d, J = 21.0 Hz), 112.9 (d, J = 21.0 Hz), 41.3, 0.3. 19F NMR 
(470 MHz, CDCl3): δ –113.6 (ddd, J = 9.3 Hz, 9.0 Hz, 6.2 Hz). νmax(neat)/cm–1: 2956, 2250, 




(2-Bromophenyl)(3-chlorophenyl)methanol: Following General Procedure 1, nBuLi (2.38 M 
in hexanes, 6.55 mL, 15.6 mmol) was added dropwise to a stirred solution of 3-
chlorobromobenzene (1.84 mL, 15.6 mmol) in THF (39 mL) at –78 °C. The reaction was 
stirred at this temperature for 1 h, then 2-bromobenzaldehyde (1.82 mL, 15.6 mmol) was added 
dropwise, and the mixture was stirred at room temperature for 2 h. Purification via flash 
column chromatography (10% EtOAc in hexanes) afforded (2-bromophenyl)(3-
chlorophenyl)methanol as a viscous, pale yellow liquid (3.89 g,  13.0 mmol, 84%).  
1H NMR (400 MHz, CDCl3): δ 7.55 (dd, J = 8.0, 1.3 Hz, 1H), 7.52 (dd, J = 7.8, 1.7 Hz, 1H), 
7.43 – 7.40 (m, 1H), 7.35 (app. td, J = 7.6, 1.3 Hz, 1H), 7.31 – 7.21 (m, 3H), 7.17 (app. td, J 
= 7.7, 1.7 Hz, 1H), 6.18 (s, 1H), 2.40 (br.s, 1H).13C{1H} NMR (100 MHz, CDCl3): δ 144.3, 
142.1, 134.5, 133.1, 129.9, 129.6, 128.7, 128.1, 128.0, 127.2, 125.3, 122.9, 74.3. 
νmax(neat)/cm–1: 3351, 3063, 1595, 1467, 1434, 1181,  1016, 887, 780, 755, 731, 701. HRMS 
calcd. for C13H10OBrCl: 295.9598 [M]+; found (EI+): 295.9590 
1-Bromo-2-(3-chlorobenzyl)benzene: Following General Procedure 2B, (2-
bromophenyl)(3-chlorophenyl)methanol (3.49 g, 11.7 mmol) in CH2Cl2 (7 mL) was reacted 
with TFA (10.0 mL, 93.6 mmol) and Et3SiH (3.74 mL, 23.4 mmol). Purification via flash 
column chromatography (hexanes) afforded 1-bromo-2-(3-chlorobenzyl)benzene as a 





1H NMR (400 MHz, CDCl3): δ 7.58 (dd, J = 7.9, 1.3 Hz, 1H), 7.31 – 7.05 (m, 7H), 4.10 (s, 
2H). 13C{1H} NMR (100 MHz, CDCl3): δ 141.7, 139.6, 134.4, 133.2, 131.3, 129.8, 129.2, 
128.4, 127.8, 127.3, 126.6, 125.0, 41.5. νmax(neat)/cm–1: 2953, 2874, 1473, 1440, 1237, 1070, 
1016, 869, 774, 739. HRMS calcd. for C13H10BrCl: 279.9649[M]+; found (EI+): 279.9645 
[2-(3-Chlorobenzyl)phenyl]trimethylsilane: Following General Procedure 3, nBuLi (2.38 M 
in hexanes, 5.0 mL, 12.0 mmol) was added to 1-bromo-2-(3-chlorobenzyl)benzene (3.03 g, 
10.8 mmol) in THF (25 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, 
then Me3SiCl (2.0 mL, 15.8 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (hexanes) afforded the 
title compound as a colourless liquid (2.03 g, 7.38 mmol, 69%). 
1H NMR (400 MHz, CDCl3): δ 7.62 (dd, J = 7.3, 1.4 Hz, 1H), 7.37 (app. td, J = 7.5, 1.6 Hz, 
1H), 7.33 – 7.23 (m, 3H), 7.19 – 7.12 (m, 1H), 7.10 – 7.01 (m, 2H), 4.21 (s, 2H), 0.38 (s, 9H). 
13C{1H} NMR (100 MHz, CDCl3): δ 145.3, 143.7, 139.1, 134.8, 134.4, 130.1, 129.7, 129.6, 
129.3, 127.4, 126.4, 125.9, 41.4, 0.49. νmax(neat)/cm–1: 3056, 2953, 1596, 1474, 1429, 1248, 




(2-Bromophenyl)[3-(trifluoromethyl)phenyl]methanol: Following General Procedure 1, 
nBuLi (2.38 M in hexanes, 3.55 mL, 8.46 mmol) was added dropwise to a stirred solution of 
3-bromobenzotrifluoride (1.23 mL, 8.89 mmol) in THF (20 mL) at –78 °C. The reaction was 
stirred at this temperature for 1 h, then 2-bromobenzaldehyde (1.08 mL, 9.30 mmol) was added 
dropwise, and the mixture was allowed to warm to room temperature and was stirred for 2 h. 
Purification via flash column chromatography (5% → 10% EtOAc in hexanes) afforded (2-
bromophenyl)[3-(trifluoromethyl)phenyl]methanol as a viscous, colourless liquid (2.34 g, 
7.06 mmol, 79%).  
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR.[4] 
1H NMR (400 MHz, CDCl3): δ 7.74 (s, 1H), 7.61 – 7.51 (m, 3H), 7.51 (dd, J = 7.8, 1.8 Hz, 
1H), 7.45 (app. t, J = 7.7 Hz, 1H), 7.35 (app. td, J = 7.4, 1.0 Hz, 1H), 7.18 (app. td, J = 7.9, 
1.8 Hz, 1H), 6.27 (s, 1H), 2.50 (br.s, 1H).13C{1H} NMR (100 MHz, CDCl3): δ 143.2, 142.1, 





J = 270 Hz), 123.8 (q, J = 3.8 Hz), 122.9, 74.3. 19F NMR (377 MHz, CDCl3): δ -62.5 (s). 
νmax(neat)/cm–1: 3375, 3068, 1592, 1569, 1468, 1439, 1376, 1161, 1119, 797, 748, 721, 701, 
662. 
1-Bromo-2-[3-(trifluoromethyl)benzyl]benzene: A Schlenk flask containing (2-
bromophenyl)[3-(trifluoromethyl)phenyl]methanol (2.27 g, 7.20 mmol) was evacuated and 
back-filled with N2 three times, then Et3SiH (2.41 mL, 15.0 mmol) was added and the mixture 
was stirred and cooled to 0 °C. Cold TFA (10 mL, 130 mmol) was added dropwise and the 
reaction was allowed to warm to room temperature and was stirred overnight. The volatiles 
were then evaporated under a stream of N2 to give the crude product which was purified via 
flash column chromatography (hexanes) to afford 1-bromo-2-[3-
(trifluoromethyl)benzyl]benzene as a colourless liquid (1.91 g, 6.06 mmol, 84%).  
Characterisation data were consistent with literature values: 19F, 13C{1H} NMR and IR.[7] 
1H NMR (400 MHz, CDCl3): δ 7.62 (dd, J = 7.9, 1.3 Hz, 1H), 7.54 – 7.48 (m, 2H), 7.46 – 
7.34 (m, 2H), 7.29 (app. td, J = 7.5, 1.3 Hz, 1H), 7.21 – 7.11 (m, 2H), 4.20 (s, 2H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 140.6, 139.5, 133.2, 132.4 (q, J = 1.6 Hz), 131.2, 130.9 (q, J = 
32.0 Hz), 129.0, 128.5, 127.8, 125.8 (q, J = 3.9 Hz), 125.0, 124.3 (q, J = 270 Hz), 123.4 (q, J 
= 3.8 Hz), 41.7. 19F NMR (377 MHz, CDCl3): δ -62.6 (s). νmax(neat)/cm–1: 3063, 2955, 2911, 
2876, 1440, 1330, 1163, 1122, 1072, 1025, 741.  
Trimethyl{2-[3-(trifluoromethyl)benzyl]phenyl}silane: Following General Procedure 3, 
nBuLi (2.38 M in hexanes, 2.23 mL, 5.32 mmol) was added to 1-bromo-2-[3-
(trifluoromethyl)benzyl]benzene (1.40 g, 4.43 mmol) in THF (15 mL) at –78 °C. The reaction 
was stirred at this temperature for 1 h, then Me3SiCl (0.84 mL, 6.65 mmol) was added 
dropwise, and the mixture was stirred at room temperature overnight. Purification via flash 
column chromatography (hexanes) afforded the title compound as a colourless liquid (1.05 g, 
3.40 mmol, 76%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.3, 1.5 Hz, 1H), 7.50 – 7.46 (m, 1H), 7.42 – 
7.36 (m, 2H), 7.30 (app. td, J = 7.4, 1.7 Hz, 1H), 7.28 – 7.21 (m, 2H), 6.98 (m, 1H), 4.22 (s, 
2H), 0.32 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 145.1, 142.6, 139.2, 134.9, 132.6, 
130.8 (q, J = 32.1 Hz), 130.0, 129.7, 128.9, 126.0, 125.9 (q, J = 3.8 Hz), 124.4 (q, J = 272 Hz), 
123.1 (q, J = 3.9 Hz), 41.5, 0.46. 19F NMR (377 MHz, CDCl3): δ -62.6 (s). νmax(neat)/cm–1: 
2956, 1466, 1330, 1251, 1161, 1120, 1073, 834, 739, 701. HRMS calcd. for C17H19F3Si: 







3-(2-Bromobenzyl)phenol: Boron tribromide (1.0 M in CH2Cl2; 6.10 mL,  6.10 mmol) was 
added dropwise to a stirred solution of 1-bromo-2-(3-methoxybenzyl)benzene (1.69 g, 6.10 
mmol; prepared as for 1j in CH2Cl2 (15 mL) at 0 °C. The reaction was allowed to warm to 
room temperature and was stirred overnight. H2O (10 mL) was added, dropwise at first, and 
the biphasic mixture was stirred vigorously for 15 min. The aqueous phase was separated and 
extracted with CH2Cl2 (3 × 10 mL), and the combined organic portions were dried (MgSO4), 
filtered and concentrated in vacuo. Purification via flash column chromatography (15% EtOAc 
in hexanes) afforded 3-(2-bromobenzyl)phenol as a brown oil (1.41 g, 5.36 mmol, 88%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 8.0, 1.3 Hz, 1H), 7.24 (app. td, J = 7.5, 1.4 Hz, 
1H), 7.20 – 7.13 (m, 2H), 7.09 (app. td, J = 7.8, 1.8 Hz, 1H), 6.83 – 6.75 (m, 1H), 6.73 – 6.65 
(m, 1H), 6.67 – 6.61 (m, 1H), 4.76 (br.s, 1H), 4.08 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): 
δ 155.7, 141.6, 140.2, 133.0, 131.3, 129.8, 128.1, 127.6, 125.0, 121.7, 116.0, 113.4, 41.7. 
νmax(neat)/cm–1: 3325, 3053, 1589, 1453, 1438, 1263, 1149, 1115, 1023, 952, 739. HRMS 
calcd. for C13H11BrO: 261.9988 [M]+; found (EI+): 262.0003 
3-(2-Trimethylsilylbenzyl)phenol: nBuLi (2.38 M in hexanes, 2.70 mL, 6.40 mmol) was added 
dropwise to a stirred solution of 3-(2-bromobenzyl)phenol (0.77 g, 2.91 mmol) in THF 
(10 mL) at –78 °C. The reaction was stirred at this temperature for 1.5 h, then Me3SiCl (1.29 
mL, 10.2 mmol) was added dropwise, and the mixture was stirred at room temperature 
overnight. H2O (5 mL), followed by glacial acetic acid (2 mL), was added, and the biphasic 
mixture was stirred vigorously for 1 h, then the aqueous phase was separated and extracted 
with Et2O (3 × 10 mL), and the combined organic portions were dried (MgSO4), filtered and 
concentrated in vacuo. Purification via flash column chromatography (10% EtOAc in hexanes) 
afforded the title compound as a yellow, viscous liquid (0.37 g, 1.44 mmol, 49%). 
1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 7.4, 1.4 Hz, 1H), 7.28 (app. td, J = 7.4, 1.7 Hz, 
1H), 7.22 (app. td, J = 7.4, 1.4 Hz, 1H), 7.16 (app. t, J = 7.8 Hz, 1H), 7.07 – 7.00 (m, 1H), 6.74 
– 6.63 (m, 2H), 6.55 – 6.48 (m, 1H), 4.61 (s, 1H), 4.11 (s, 2H), 0.31 (s, 9H).13C{1H} NMR 
(100 MHz, CDCl3): δ 155.7, 146.0, 143.6, 139.0, 134.7, 130.1, 129.7, 129.5, 125.7, 121.9, 
116.2, 113.1, 41.6, 0.48. νmax(neat)/cm–1: 3352, 2952, 1588, 1454, 1248, 1148, 1122, 833, 





3-[2-(Trimethylsilyl)benzyl]phenyl trifluoromethanesulfonate (1n) 
 
Triflic anhydride (0.28 mL, 1.62 mmol) was added dropwise to a stirred solution of 3-(2-
trimethylsilylbenzyl)phenol (0.19 g, 0.74 mmol) and pyridine (0.78 mL,  9.70 mmol) in 
CH2Cl2 (10 mL) at 0 °C. The reaction was stirred overnight at room temperature, then H2O (5 
mL) was added, then the aqueous phase was separated and extracted with CH2Cl2 (3 × 10 mL), 
and the combined organic portions were dried (MgSO4), filtered and concentrated in vacuo. 
Purification via flash column chromatography (10% EtOAc in hexanes) afforded the title 
compound as a colourless liquid (0.28 g, 0.72 mmol, 97%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.3, 1.4 Hz, 1H), 7.39 – 7.29 (m, 2H), 7.26 (app. 
td, J = 7.4 Hz, 1.4 Hz, 1H), 7.14 – 7.09 (m, 2H), 7.00 – 6.96 (m, 2H), 4.20 (s, 2H), 0.30 (s, 
9H). 13C{1H} NMR (100 MHz, CDCl3): δ 149.9, 144.9, 144.6, 139.2, 135.0, 130.2, 130.1, 
129.7, 129.1, 126.2, 122.0, 119.0, 118.9 (q, J = 321 Hz), 41.3, 0.43. 19F NMR (377 MHz, 
CDCl3): δ -72.9 (s). νmax(neat)/cm–1: 2957, 1613, 1581, 1421, 1250, 1206, 1139, 1115, 941, 
833, 756. HRMS calcd. for C17H19O3F3NaSSi:  411.0669 [M+Na]+; found (ESI+):  411.0647. 
2-(2-Trimethylsilylbenzyl)-1,4-dimethylbenzene (1a) 
 
2-(2-Bromobenzyl)-1,4-dimethylbenzene:[8] Indium(III) chloride (106 mg, 0.50 mmol) was 
added to a stirred solution of 2-bromobenzyl bromide (1.25 g, 5.00 mmol) and p-xylene (3.10 
mL, 25.0 mmol) in CH2Cl2 (10 mL) containing 4 Å molecular sieves (2.5 g). After 4 h, the 
reaction was filtered through a pad of Celite and concentrated in vacuo. Purification via flash 
column chromatography (hexanes) afforded 2-(2-bromobenzyl)-1,4-dimethylbenzene as a 
colourless liquid (1.07 g, 3.89 mmol, 78%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[9] 
1H NMR (400 MHz, CDCl3): δ 7.60 (dd, J = 7.9 Hz, 1.5 Hz, 1H), 7.19 (app. td, J = 7.5 Hz, 
1.3 Hz, 1H), 7.12-7.07 (m, 2H), 7.01 (dd, J = 7.7 Hz, 1.3 Hz, 1H), 6.88 (dd, J = 7.7 Hz, 1.5 





CDCl3): δ 139.8, 137.3, 135.5, 133.1, 132.6, 130.5, 130.19, 130.15, 127.6, 127.4, 127.3, 125.0, 
39.5, 21.0, 19.0.     νmax(neat)/cm–1: 2920, 1566, 1503, 1465, 1439, 1024, 803, 745. 
(2-Trimethylsilylbenzyl)-1,4-dimethylbenzene: Following General Procedure 3, nBuLi (1.6 
M in hexanes, 2.80 mL, 4.50 mmol) was added to 2-(2-bromobenzyl)-1,4-dimethylbenzene 
(1.13 g, 4.09 mmol) in THF (10 mL) at –78 °C. The reaction was stirred at this temperature 
for 1 h, then Me3SiCl (0.67 mL, 5.31 mmol) was added dropwise, and the mixture was stirred 
at room temperature overnight. Purification via flash column chromatography (hexanes) 
afforded the title compound as a colourless liquid (1.01 g, 3.76 mmol, 92%). 
1H NMR (400 MHz, CDCl3): δ 7.57-7.55 (m, 1H), 7.25 (app. td, J = 7.4 Hz, 1.9 Hz, 1H), 
7.21 (app. td, J = 7.4 Hz, 1.6 Hz, 1H), 7.10 (d, J = 7.6 Hz, 1H), 6.99 (dd, J = 7.6 Hz, 1.8 Hz, 
1H), 6.83 (dd, J = 7.1 Hz, 2.1 Hz, 1H), 6.78 (s, 1H), 4.10 (s, 2H), 2.28 (s, 3H), 2.19 (s, 3H), 
0.35 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 146.0, 138.8, 138.6, 135.4, 134.5, 133.4, 
130.8, 130.0, 129.3, 128.4, 127.0, 125.3, 39.7, 21.0, 19.2, 0.2. νmax(neat)/cm–1: 2953, 1503, 




2-(2-Bromo-4-fluorobenzyl)-1,4-dimethylbenzene:[8] Indium(III) chloride (92.9 mg, 
0.42 mmol) was added to a stirred solution of 2-bromo-4-fluorobenzyl bromide (1.11 g, 4.21 
mmol) and p-xylene (2.65 mL, 20.7 mmol) in CH2Cl2 (8 mL) containing 4 Å molecular sieves 
(2 g). After 4 h, the reaction was filtered through a pad of Celite and concentrated in vacuo. 
Purification via flash column chromatography (hexanes) afforded 2-(2-bromo-4-
fluorobenzyl)-1,4-dimethylbenzene as a colourless liquid (1.09 g, 3.71 mmol, 89%). 
1H NMR (300 MHz, CDCl3): δ 7.54 (dd, J = 8.7 Hz, 5.4 Hz, 1H), 7.11 (d, J = 7.6 Hz, 1H), 
7.03 (dd, J = 7.6 Hz, 1.4 Hz, 1H), 6.87-6.79 (m, 2H), 6.55 (dd, J = 9.8 Hz, 3.1 Hz, 1H), 3.98 
(s, 2H), 2.31 (s, 3H), 2.17 (s, 3H). 13C{1H} NMR (125 MHz, CDCl3): δ 162.1 (d, J = 246 Hz), 
142.3 (d, J = 7.6 Hz), 136.4, 135.7, 133.6, 133.5 (d, J = 7.6 Hz), 130.7, 130.4, 127.7, 118.8, 
117.1 (d, J = 22.9 Hz), 114.8 (d, J = 22.9 Hz), 39.6, 21.0, 19.0. 19F NMR (470 MHz, CDCl3): 
δ –114.9 (m). νmax(neat)/cm–1: 2921, 1603, 1579, 1463, 1265, 1147, 1028, 904. HRMS calcd. 





2-(2-Trimethylsilyl-4-fluorobenzyl)-1,4-dimethylbenzene: Following General Procedure 3, 
nBuLi (1.6 M in hexanes, 2.54 mL, 4.06 mmol) was added to 2-(2-bromo-4-fluorobenzyl)-1,4-
dimethylbenzene (1.08 g, 3.69 mmol) in THF (7 mL) at –78 °C. The reaction was stirred at 
this temperature for 1 h, then Me3SiCl (0.61 mL, 4.81 mmol) was added dropwise, and the 
mixture was stirred at room temperature overnight. Purification via flash column 
chromatography (hexanes) afforded the title compound as a colourless liquid (0.83 g, 
2.90 mmol, 79%). 
1H NMR (400 MHz, CDCl3): δ 7.51 (dd, J = 8.2, 6.8 Hz, 1H), 7.11 (d, J = 7.6 Hz, 1H), 7.01 
(d, J = 7.6 Hz, 1H), 6.89 (app. td, J = 8.5, 2.6 Hz, 1H), 6.81 (s, 1H), 6.51 (dd, J = 11.0, 2.5 Hz, 
1H), 4.08 (s, 2H), 2.30 (s, 3H), 2.17 (s, 3H), 0.36 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): 
δ 164.3 (d, J = 248 Hz), 149.4 (d, J = 6.6 Hz), 138.1, 136.4 (d, J = 7.6 Hz), 135.7, 134.1 (d, J 
= 3.6 Hz), 133.5, 131.1, 130.4, 127.5, 115.5 (d, J = 20.0 Hz), 112.3 (d, J = 19.0 Hz), 39.8, 
21.1, 19.3, 0.36. 19F NMR (470 MHz, CDCl3): δ –112.5 (ddd, J = 11.0 Hz, 8.3 Hz, 7.0 Hz). 
νmax(neat)/cm–1: 2954, 1594, 1578, 1473, 1250, 1208, 1060, 908. HRMS calcd. for C18H23FSi: 
286.1553 [M]+; found (EI+): 286.1561. 
2-(2-Trimethylsilyl-4-chlorobenzyl)-1,4-dimethylbenzene (1p) 
 
2-(2-Bromo-4-chlorobenzyl)-1,4-dimethylbenzene:[8] Indium(III) bromide (0.62 g, 1.76 
mmol) was added to a stirred solution of 2-bromo-5-chlorobenzyl bromide (5.55 g, 19.5 mmol) 
and p-xylene (10.85 mL, 88.0 mmol) in CH2Cl2 (35 mL) containing 4 Å molecular sieves (8 
g). After 6 h, the reaction was filtered through a pad of silica gel (eluent: Et2O) and 
concentrated in vacuo. Purification via flash column chromatography (hexanes) afforded 2-(2-
bromo-4-chlorobenzyl)-1,4-dimethylbenzene as a colourless liquid that solidified on standing 
(6.03 g, 19.5 mmol, quant.). 
1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 8.4 Hz, 1H), 7.15 – 6.98 (m, 3H), 6.82 (m, 2H), 
3.98 (s, 2H), 2.30 (s, 3H), 2.17 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): 142.0, 136.5, 
135.9, 133.7, 133.7, 133.7, 130.7, 130.5, 130.2, 127.9, 127.8, 122.9, 39.6, 21.2, 19.2. 
νmax(neat)/cm–1: 2996, 2905, 1583, 1500, 1451, 1426, 1387, 1091, 1024, 865, 807. HRMS 






2-(2-Trimethylsilyl-4-chlorobenzyl)-1,4-dimethylbenzene: Following General Procedure 3, 
nBuLi (2.50 M in hexanes, 6.9 mL, 17.2 mmol) was added to 2-(2-bromo-4-chlorobenzyl)-
1,4-dimethylbenzene (4.83 g, 15.6 mmol) in THF (39 mL) at –78 °C. The reaction was stirred 
at this temperature for 1 h, then Me3SiCl (3.0 mL, 23.4 mmol) was added dropwise, and the 
mixture was stirred at room temperature overnight. Purification via flash column 
chromatography (hexanes) afforded the title compound as a colourless liquid (4.16 g, 13.7 
mmol, 88%). 
1H NMR (400 MHz, CDCl3): δ 7.47 (d, J = 8.0 Hz, 1H), 7.19 (dd, J = 8.0, 2.0 Hz, 1H), 7.10 
(d, J = 7.6 Hz, 1H), 7.01 (dd, J = 7.6, 2.0 Hz, 1H), 6.80 (d, J = 2.0 Hz, 1H), 6.77 (app. s, 1H), 
4.06 (s, 2H), 2.29 (s, 3H), 2.18 (s, 3H), 0.35 (s, 9H).13C{1H} NMR (100 MHz, CDCl3): δ 
148.4, 138.0, 137.1, 136.0, 135.8, 135.7, 133.4, 131.0, 130.4, 128.5, 127.5, 125.6, 39.7, 21.2, 
19.4, 0.27. νmax(neat)/cm–1: 2953, 1575, 1548, 1460, 1249, 1108, 835, 809, 756. HRMS calcd. 
for C18H23ClSi: 302.1252 [M]+; found (EI+):  302.1257. 
Trimethyl[5-methyl-2-(4-methylbenzyl)phenyl]silane (1t) 
 
(2-Bromo-4-methylphenyl)(4-methylphenyl)methanol: Following General Procedure 1, 
nBuLi (2.38 M in hexanes, 2.10 mL, 5.00 mmol) was added dropwise to a stirred solution of 
4-bromotoluene (0.86 g, 5.00 mmol) in THF (13 mL) at –78 °C. The reaction was stirred at 
this temperature for 1 h, then 2-bromo-4-methylbenzaldehyde (1.09 g, 5.50 mmol) was added 
portionwise, and the mixture was allowed to warm to room temperature and was stirred 
overnight. Purification via flash column chromatography (10% EtOAc in hexanes) afforded 
(2-bromo-4-methylphenyl)(4-methylphenyl)methanol as a viscous, colourless liquid (1.02 
g,  3.51 mmol, 70%). 
1H NMR (400 MHz, CDCl3): δ 7.44 (d, J = 7.9 Hz, 1H), 7.36 (d, J = 0.9 Hz, 1H), 7.28 (d, J 
= 8.1 Hz, 2H), 7.17 – 7.11 (m, 3H), 6.13 (s, 1H), 2.33 (s, 3H), 2.31 (s, 3H), 2.26 (br.s, 
1H).13C{1H} NMR (100 MHz, CDCl3): δ 139.8, 139.6, 139.3, 137.5, 133.4, 129.3, 128.6, 
128.3, 127.0, 122.7, 74.7, 21.3, 20.8. νmax(neat)/cm–1: 3300, 3025, 2980, 2919, 2863, 1562, 
1512, 1486, 1446, 1378, 1308, 1175, 1044, 1025, 871, 816, 768. HRMS calcd. for C15H15OBr: 
290.0301 [M]+; found (EI+): 290.0309.  
2-Bromo-4-methyl-1-(4-methylbenzyl)benzene: Following General Procedure 2A, (2-





was reacted with TFA  (1.00 mL, 13.4 mmol) and Et3SiH (1.10 mL, 6.68 mmol). Purification 
via flash column chromatography (hexanes) afforded 2-bromo-4-methyl-1-(4-
methylbenzyl)benzene as a colourless liquid (0.82 g, 2.99 mmol, 90%). 
1H NMR (400 MHz, CDCl3): δ 7.41 (s, 1H), 7.14 – 7.00 (m, 6H), 4.05 (s, 2H), 2.33 (s, 3H), 
2.31 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 137.8, 137.5, 136.8, 135.7, 133.2, 130.7, 
129.2, 128.8, 128.3, 124.6, 40.9, 21.1, 20.6. νmax(neat)/cm–1: 3046, 3020, 2977, 2919, 2860, 
1513, 1489, 1437, 1381, 1211, 1038, 911, 861,  846, 821, 806, 763. HRMS calcd. for 
C15H15Br: 274.0352[M]+; found (EI+): 274.0349. 
Trimethyl[5-methyl-2-(4-methylbenzyl)phenyl]silane: Following General Procedure 3, 
nBuLi (2.38 M in hexanes, 1.30 mL, 3.08 mmol) was added to 2-bromo-4-methyl-1-(4-
methylbenzyl)benzene (0.71 g, 2.57 mmol) in THF (8 mL) at –78 °C. The reaction was stirred 
at this temperature for 1 h, then Me3SiCl (0.49 mL, 3.86 mmol) was added dropwise, and the 
mixture was stirred at room temperature overnight. Purification via flash column 
chromatography (hexanes) afforded the title compound as a colourless liquid (0.60 g, 2.23 
mmol, 87%).  
1H NMR (400 MHz, CDCl3): δ 7.36 (d, J = 2.0 Hz, 1H), 7.14 – 7.08 (m, 3H), 7.01 (d, J = 8.0 
Hz, 2H), 6.93 (d, J = 7.8 Hz, 1H), 4.11 (s, 2H), 2.35 (s, 3H), 2.36 (s, 3H), 0.34 (s, 9H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 143.6, 138.73, 138.66, 135.5, 135.3, 134.6, 130.2, 129.9, 129.16, 
129.15, 40.9, 21.3, 21.2, 0.54. νmax(neat)/cm–1: 3045, 3005, 2952, 2920, 2863, 1513, 1481, 
1442, 1409, 1381, 1248, 1142, 1072, 1022, 993, 886, 833, 750. HRMS calcd. for C18H24Si: 
268.1642 [M]+; found (EI+):  268.1645 
Trimethyl(2-phenoxyphenyl)silane (1v)[10] 
 
A Schlenk flask containing Pd(OAc)2 (4.50 mg, 0.02 mmol), 
tBu-XPhos (12.7 mg, 0.03 mmol) 
and potassium phosphate (0.42 g, 2.00 mmol) was evacuated and back-filled with N2 three 
times, then 2-(trimethylsilyl)phenol[11] (0.20 g, 1.20 mmol) and bromobenzene (105 μL, 1.00 
mmol) in toluene (2 mL) was added, and the flask was sealed and heated at 100 °C overnight. 
The reaction mixture was filtered through a pad of Celite (eluent: hexanes) and concentrated 
in vacuo. Purification via flash column chromatography (hexanes) afforded the title compound 





1H NMR (400 MHz, CDCl3): δ 7.50 (dd, J = 7.3, 1.6 Hz, 1H), 7.36 – 7.27 (m, 3H), 7.15 – 
7.04 (m, 2H), 7.00 – 6.92 (m, 2H), 6.80 (dd, J = 8.2, 1.0 Hz, 1H), 0.28 (s, 9H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 162.1, 157.7, 135.5, 130.8, 130.83, 129.80, 123.1, 123.0, 118.9, 117.6, 
-0.76. νmax(neat)/cm–1:  3064, 2954, 2897, 1587, 1566, 1489, 1466, 1433, 1219, 1076, 834, 
748, 720. HRMS calcd. for C15H18OSi: 242.1122 [M]+; found (EI+):  242.1115. 
[4-Chloro-2-(2-phenylethyl)phenyl]trimethylsilane (3b)  
1-
Bromo-4-chloro-2-(2-phenylethenyl)benzene: Sodium bis(trimethylsilyl)amide (2.0 M in 
hexanes, 1.25 mL, 2.50 mmol) was added dropwise to a stirred suspension of 
benzyltriphenylphosphonium bromide (1.08 g, 2.50 mmol) in THF (7 mL) at 0 °C. The 
reaction was stirred at this temperature for 1 h, then a solution of 2-bromo-5-
chlorobenzaldehyde (0.55 g, 2.50 mmol) in THF (7 mL) was added dropwise, and the mixture 
was allowed to warm to room temperature and was stirred for 3 h. The reaction was quenched 
with H2O (10 mL), then the aqueous phase was separated and extracted with Et2O (3 × 15 mL), 
and the combined organic portions were dried (MgSO4), filtered and concentrated in vacuo. 
Purification via flash column chromatography (hexanes) afforded a 6.4:1 mixture of (E)- to 
(Z)-1-bromo-4-chloro-2-(2-phenylethenyl)benzene as a colourless oil (0.67 g, 2.28 mmol, 
91%). The identity of the major (E) isomer was confirmed by 1H NMR (3JHH analysis) and the 
mixture was used without further purification. 
Data for (E)-isomer: 1H NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.5 Hz, 1H), 7.24 – 7.19 (m, 
3H), 7.17 – 7.11 (m, 3H), 7.07 (ddd, J = 8.5, 2.6, 0.6 Hz, 1H), 6.73 (d, J = 12.1 Hz, 1H), 6.59 
– 6.50 (m, 1H). HRMS calcd. for C14H10BrCl: 291.9649 [M]+; found (EI+): 291.9658.  
 
[4-Chloro-2-(2-phenylethenyl)phenyl](trimethyl)silane: nBuLi (2.38 M in hexanes, 0.83 mL, 
1.97 mmol) was added dropwise to a stirred solution of (E)/(Z)-1-bromo-4-chloro-2-(2-





at this temperature for 1 h, then Me3SiCl (0.31 mL, 2.46 mmol) was added dropwise, and the 
mixture was allowed to warm to room temperature and was stirred overnight. The reaction 
was quenched with H2O (5 mL), then the aqueous phase was separated and extracted with Et2O 
(3 × 10 mL), and the combined organic portions were dried (MgSO4), filtered and concentrated 
in vacuo. Purification via flash column chromatography (hexanes) afforded a 6.4:1 mixture of 
(E)- to (Z)- [4-chloro-2-(2-phenylethenyl)phenyl](trimethyl)silane as a colourless oil (0.41 g, 
1.43 mmol, 88%). The identity of the major (E)-isomer was confirmed by 1H NMR (3JHH) 
analysis and the mixture was used without further purification. 
Data for (E)-isomer: 1H NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.0 Hz, 1H), 7.27 – 7.18 (m, 
3H), 7.15 (d, J = 2.0 Hz, 2H), 7.12 – 7.07 (m, 2H), 6.80 (d, J = 12.2 Hz, 1H), 6.65 (d, J = 12.2 
Hz, 1H), 0.34 (s, 9H). HRMS calcd. for C17H19ClSi: 286.0939 [M]+; found (EI+): 286.0946.  
[4-Chloro-2-(2-phenylethyl)phenyl]trimethylsilane: The mixture of (E)/(Z)-4-chloro-2-(2-
phenylethenyl)phenyl](trimethyl)silane (0.20 g, 0.70 mmol) was dissolved in EtOH (5 mL) 
and nitrogen was bubbled through the solution for 10 min. Pd/C (10 wt%; 30 mg) was added 
and a balloon of H2 was fitted and H2 was bubbled through the solution. Another balloon of 
H2 was fitted and the reaction was stirred under a static H2 atmosphere for 5 h. The suspension 
was filtered through a pad of Celite (eluent: CH2Cl2) and the filtrate was concentrated in vacuo. 
Purification via flash column chromatography (hexanes) afforded the title compound as a 
colourless liquid (0.12 g, 0.41 mmol, 59%). 
1H NMR (400 MHz, CDCl3): δ 7.42 (d, J = 8.0 Hz, 1H), 7.36 – 7.31 (m, 2H), 7.27 – 7.23 (m, 
4H), 7.19 (dd, J = 8.0, 2.1 Hz, 1H), 3.05 – 2.97 (m, 2H), 2.96 – 2.88 (m, 2H), 0.34 (s, 9H). 
13C{1H} NMR (100 MHz, CDCl3): δ 149.6, 141.5, 136.6, 136.1, 135.6, 128.9, 128.7, 128.5, 
126.3, 125.6, 38.6, 38.0, 0.57. νmax(neat)/cm–1: 3062, 2954, 1576, 1549, 1496, 1470, 1454, 
1408, 1382, 1249, 1190, 1076, 1061, 1030, 891, 874, 834, 813, 752, 723. HRMS calcd. for 











Trimethyl[2-(2-phenylethyl)-4-(trifluoromethyl)phenyl]silane  (3c) 
1-
Bromo-2-(2-phenylethenyl)-4-(trifluoromethyl)benzene: Sodium bis(trimethylsilyl)amide 
(2.0 M in hexanes, 1.25 mL, 2.50 mmol) was added dropwise to a stirred suspension of 
benzyltriphenylphosphonium bromide (1.08 g, 2.50 mmol) in THF (7 mL) at 0 °C. The 
reaction was stirred at this temperature for 1 h, then a solution of 2-bromo-5-
(trifluoromethyl)benzaldehyde (0.63 g, 2.50 mmol) in THF (7 mL) was added dropwise, and 
the mixture was stirred for 4 h at room temperature. The reaction was quenched with H2O 
(15 mL), then the aqueous phase was separated and extracted with Et2O (3 × 15 mL), and the 
combined organic portions were dried (MgSO4), filtered and concentrated in vacuo. 
Purification via flash column chromatography (hexanes) afforded a 9:1 mixture of (E)- to (Z)-
1-bromo-2-(2-phenylethenyl)-4-(trifluoromethyl)benzene as a colourless oil (0.59 g, 1.80 
mmol, 72%).  The identity of the major (E)-isomer was confirmed by 1H NMR (3JHH analysis) 
and the mixture was used without further purification. 
Data for (E)-isomer: 1H NMR (400 MHz, CDCl3): δ 7.72 (d, J = 8.4 Hz, 1H), 7.41 (m, 1H), 
7.35 – 7.29 (m, 1H), 7.24 – 7.17 (m, 3H), 7.15 – 7.08 (m, 2H), 6.80 (d, J = 12.1 Hz, 1H), 6.61 
(d, J = 12.1 Hz, 1H). 19F NMR (377 MHz, CD2Cl2): δ – 63.0 (s, major), -62.7 (s, minor). 
HRMS calcd. for C15H10BrF3: 325.9913 [M]+; found (EI+): 325.9912. 
Trimethyl[2-(2-phenylethenyl)-4-(trifluoromethyl)phenyl]silane:  nBuLi (2.38 M in hexanes, 
0.58 mL, 1.39 mmol) was added dropwise to a stirred solution of (E)/(Z)-1-bromo-2-(2-
phenylethenyl)-4-(trifluoromethyl)benzene (0.41 g, 1.26 mmol) in THF (3 mL) at –78 °C. The 
reaction was stirred at this temperature for 1 h, then Me3SiCl (0.24 mL, 1.89 mmol) was added 
dropwise, and the mixture was allowed to warm to room temperature and was stirred 
overnight. The reaction was quenched with H2O (5 mL), then the aqueous phase was separated 
and extracted with Et2O (3 × 10 mL), and the combined organic portions were dried (MgSO4), 





afforded a 9:1 mixture of (E)- to (Z)-trimethyl[2-(2-phenylethenyl)-4-
(trifluoromethyl)phenyl]silane (0.27 g, 0.85 mmol, 67%). The identity of the major (E)- isomer 
was confirmed by 1H NMR (3JHH analysis) and the mixture was used without further 
purification. 
Data for (E)-isomer: 1H NMR (400 MHz, CDCl3): δ 7.71 (d, J = 7.8 Hz, 1H), 7.50 – 7.46 (m, 
1H), 7.39 (s, 1H), 7.21 – 7.15 (m, 3H), 7.10 – 7.03 (m, 2H), 6.86 (d, J = 12.2 Hz, 1H), 6.71 (d, 
J = 12.2 Hz, 1H), 0.38 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 144.8, 143.7, 136.2, 
135.2, 131.8, 131.1 (q, J = 32 Hz), 130.7, 129.3, 128.3, 127.6, 125.9 (q, J = 3.7 Hz), 122.7 (q, 
J = 3.7 Hz), -0.41. 1 × CAr not observed. 19F NMR (377 MHz, CD2Cl2): δ – 63.2 (s), – 62.9 
(s, minor). HRMS calcd. for C18H19F3Si: 320.1203 [M]+; found (EI+): 320.1196. 
Trimethyl[2-(2-phenylethyl)-4-(trifluoromethyl)phenyl]silane:  The mixture of (E)/(Z)-
trimethyl[2-(2-phenylethenyl)-4-(trifluoromethyl)phenyl]silane (0.22 g, 0.69 mmol) was 
dissolved in EtOH (5 mL) and N2 was bubbled through the solution for 10 min. Pd/C (10 wt%; 
22 mg) was added and a balloon of H2 was fitted and H2 was bubbled through the solution. 
Another balloon of H2 was fitted and the reaction was stirred under a static H2 atmosphere 
overnight. The suspension was filtered through a pad of Celite (eluent: CH2Cl2) and the filtrate 
was concentrated in vacuo. Purification via flash column chromatography (hexanes) afforded 
the title compound as a colourless liquid (0.20 g, 0.61 mmol, 88%). 
1H NMR (400 MHz, CDCl3): δ 7.61 (app. d, J = 7.7 Hz, 1H), 7.48 – 7.41 (m, 2H), 7.38 – 7.31 
(m, 2H), 7.29 – 7.22 (m, 3H), 3.17 – 3.06 (m, 2H), 3.03 – 2.88 (m, 2H), 0.38 (s, 9H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 148.4, 143.2, 141.3, 135.2, 131.4 (q, J = 32 Hz), 128.7, 128.5, 
126.4, 125.2 (q, J = 3.7 Hz), 124.4 (q, J = 270 Hz), 121.9 (q, J = 3.8 Hz), 38.6, 38.1, 0.46. 19F 
NMR (377 MHz, CDCl3): δ -62.9 (s). νmax(neat)/cm–1: 3065, 3028, 2957, 1603, 1400, 1329, 
1263, 1251, 1163, 1121, 1096, 828, 754, 726. HRMS calcd. for C18H21F3Si: 322.1359 [M]+; 
found (EI+): 322.1369.  
Trimethyl[2-(phenoxymethyl)phenyl]silane (3d) 
 
1-Bromo-2-(phenoxymethyl)benzene: A suspension of K2CO3 (0.62 g, 4.50 mmol), 2-
bromobenzyl bromide (0.75 g, 3.00 mmol) and phenol (0.31 g, 3.30 mmol) in acetone (12 mL) 
was heated at reflux for 14 h. The reaction mixture was cooled to room temperature, filtered 





Et2O); concentration of the filtrate in vacuo afforded 1-bromo-2-(phenoxymethyl)benzene as 
a colourless liquid (0.79 g, 2.99 mmol, >99%).  
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[12] 
1H NMR (400 MHz, CDCl3): δ 7.67 – 7.54 (m, 2H), 7.35 (app. td, J = 7.5, 1.3 Hz, 1H), 7.32 
(dd, J = 8.9, 7.9 Hz, 2H), 7.20 (app. td, J = 7.4, 1.8 Hz, 1H), 7.02-6.98 (m, 3H), 5.16 (s, 2H). 
13C{1H} NMR (125 MHz, CDCl3): δ 158.4, 136.4, 132.6, 129.5, 129.2, 128.9, 127.5, 122.2, 
121.2, 114.9, 69.3. HRMS calcd. for C13H11OBr: 261.9993 [M]+; found (EI+): 261.9985.  
Trimethyl[2-(phenoxymethyl)phenyl]silane: Following General Procedure 3, nBuLi (1.6 M 
in hexanes, 2.06 mL, 3.30 mmol) was added to 1-bromo-2-(phenoxymethyl)benzene (0.79 g, 
2.99 mmol) in THF (6 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 
Me3SiCl (0.49 mL, 3.90 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (10% toluene in 
hexanes) afforded the title compound as a viscous, colourless liquid (0.71 g, 2.78 mmol, 93%). 
1H NMR (500 MHz, CDCl3): δ 7.62 (app. d, J = 7.3 Hz, 1H), 7.51 (app. d, J = 7.6 Hz, 1H), 
7.42 (app. t, J = 7.5 Hz, 1H), 7.37-7.31 (m, 3H), 7.01-6.98 (m, 3H), 5.11 (s, 2H), 0.36 (s, 9H). 
13C{1H} NMR (125 MHz, CDCl3): δ 158.7, 142.0, 138.8, 134.8, 129.5, 129.4, 128.7, 127.4, 
120.9, 114.7, 70.2, 0.3. νmax(neat)/cm–1: 3058, 2953, 2896, 1598, 1586, 1495, 1235, 1171, 
1127, 1078, 1031, 1012, 833, 747, 724. HRMS calcd. for C16H20OSi: 256.1283 [M]+; found 
(EI+): 256.1281. 
Trimethyl{2-[(2-phenylethoxy)methyl]phenyl}silane (7) 
2-Bromobenzyl 2-phenylethyl ether: 2-Phenylethanol (0.60 mL, 5.50 mmol) was added slowly 
to NaH (99%; 0.14 g, 6.00 mmol) and 2-bromobenzyl bromide (1.25 g, 5.00 mmol) in THF 
(10 mL) at room temperature. The reaction was stirred overnight at room temperature, then 
quenched with HCl (10% aqueous, 0.5 mL) and diluted with Et2O (20 mL). The mixture was 
dried by addition of MgSO4, filtered and concentrated in vacuo. Purification via flash column 
chromatography (10% Et2O in hexanes) afforded 2-bromobenzyl 2-phenylethyl ether as a 
viscous, colourless liquid (1.39 g, 4.77 mmol, 95%). 
1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 8.0, 1.3 Hz, 1H), 7.42 (ddt, J = 7.7, 1.8, 0.9 Hz, 





Hz, 2H), 2.99 (t, J = 7.1 Hz, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 138.9, 137.8, 132.4, 
128.9, 128.8, 128.7, 128.3, 127.4, 126.2, 122.5, 72.1, 71.2, 36.3.  
Trimethyl{2-[(2-phenylethoxy)methyl]phenyl}silane: Following General Procedure 3, 
nBuLi (1.6 M in hexanes, 3.60 mL, 5.75 mmol) was added to 2-bromobenzyl 2-phenylethyl 
ether (1.36 g, 4.79 mmol) in THF (5 mL) at –78 °C. The reaction was stirred at this temperature 
for 1 h, then Me3SiCl (0.91 mL, 7.19 mmol) was added dropwise, and the mixture was stirred 
at room temperature overnight. Purification by filtration through a pad of silica gel (eluent: 
hexanes) afforded the title compound as a colourless liquid (0.93 g, 3.28 mmol, 66%). 
1H NMR (400 MHz, CDCl3): δ. 7.54 (dd, J = 7.3, 1.1 Hz, 1H), 7.44 – 7.36 (m, 1H), 7.35 (app. 
td, J = 7.4, 1.5 Hz, 1H), 7.33 – 7.20 (m, 6H), 4.61 (s, 2H), 3.73 (t, J = 7.3 Hz, 2H), 2.97 (t, J 
= 7.3 Hz, 2H), 0.33 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ. 143.8, 139.1, 138.4, 134.7, 
129.3, 129.1, 128.5, 128.3, 127.0, 126.4, 73.3, 71.7, 36.6, 0.42. νmax(neat)/cm–1: 3058, 3028, 
2951, 1496, 1453, 1358, 1247, 1203, 1127, 1094, 833, 744, 726. HRMS calcd. for C18H24OSi: 
284.1591 [M]+; found (EI+): 284.1601.  
Trimethyl[2-(3-phenylpropoxy)methyl]phenylsilane (9) 
1-Bromo-2-[(3-phenylpropoxy)methyl]benzene: 3-Phenyl-1-propanol (0.68 mL, 5.00 mmol) 
was added slowly to NaH (60%; 0.24 g, 6.00 mmol) in THF (10 mL) at 0 °C and was stirred 
for 30 min. 2-Bromobenzyl bromide (1.25 g, 5.00 mmol) was added portionwise and the 
reaction was allowed to warm to room temperature and stirred for 4 h. The reaction was 
quenched with H2O (10 mL) and diluted with Et2O (20 mL). The aqueous phase was separated 
and extracted with Et2O (3 × 20 mL), and the combined organic portions were dried (MgSO4), 
filtered and concentrated in vacuo. Purification via flash column chromatography (2% EtOAc 
in hexanes) afforded 1-bromo-2-[(3-phenylpropoxy)methyl]benzene as a viscous, colourless 
liquid (1.25 g, 4.10 mmol, 82%). 
1H NMR (400 MHz, CDCl3): δ 7.55 (dd, J = 8.0, 1.2 Hz, 1H), 7.51 – 7.48 (m, 1H), 7.36 – 
7.26 (m, 3H), 7.23 – 7.12 (m, 4H), 4.57 (s, 2H), 3.58 (t, J = 6.3 Hz, 2H), 2.79 – 2.72 (m, 2H), 
2.06 – 1.82 (m, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 142.1, 138.1, 132.6, 129.1, 128.9, 
128.6, 128.5, 127.5, 125.9, 122.8, 72.3, 70.2, 32.6, 31.5. νmax(neat)/cm–1: 3061, 2857, 2791, 






Trimethyl[2-(3-phenylpropoxy)methyl]phenylsilane: Following General Procedure 3, nBuLi 
(2.38 M in hexanes, 1.20 mL, 2.84 mmol) was added to 1-bromo-2-[(3-
phenylpropoxy)methyl]benzene (0.79 g, 2.59 mmol) in THF (7 mL) at –78 °C. The reaction 
was stirred at this temperature for 1 h, then Me3SiCl (0.49 mL, 3.82 mmol) was added 
dropwise, and the mixture was stirred at room temperature overnight. Purification via flash 
column chromatography (2% EtOAc in hexanes) afforded the title compound as a colourless 
liquid (0.63 g, 2.11 mmol, 82%). 
1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 7.4, 1.2 Hz, 1H), 7.50 – 7.43 (m, 1H), 7.38 (app. 
td, J = 7.5, 1.5 Hz, 1H), 7.33 – 7.26 (m, 3H), 7.23 – 7.16 (m, 3H), 4.58 (s, 2H), 3.54 (t, J = 6.4 
Hz, 2H), 2.79 – 2.68 (m, 2H), 2.04 – 1.87 (m, 2H), 0.35 (s, 9H). 13C{1H} NMR (100 MHz, 
CDCl3): δ 144.0, 142.2, 138.4, 134.7, 129.3, 128.6, 128.5, 128.4, 127.0, 125.9, 73.3, 70.0, 
32.7, 31.6, 0.47. νmax(neat)/cm–1: 3058, 2949, 2858, 1436, 1247, 1099, 833, 742, 697. HRMS 
calcd. for C19H26OSi: 298.1748 [M]+; found (EI+): 298.1759.  
(2-Benzyl-4-methoxyphenyl)trimethylsilane (iso-1j) 
  
(2-Bromo-5-methoxyphenyl)(phenyl)methanol: Following General Procedure 1, nBuLi 
(2.38 M in hexanes, 2.41 mL, 5.73 mmol) was added dropwise to a stirred solution of 
bromobenzene (0.60 mL, 5.73 mmol) in THF (15 mL) at –78 °C. The reaction was stirred at 
this temperature for 1 h, then 2-bromo-5-methoxybenzaldehyde (1.36 g, 6.30 mmol) was 
added portionwise, and the mixture was allowed to warm to room temperature and was stirred 
for 2 h. Purification via flash column chromatography (15% EtOAc in hexanes) afforded (2-
bromo-5-methoxyphenyl)(phenyl)methanol as a viscous, pale yellow liquid (1.30 g, 
4.43 mmol, 77%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR:[13]  
1H NMR (400 MHz, CDCl3): δ 7.46 – 7.38 (m, 3H), 7.37 – 7.27 (m, 3H), 7.17 (d, J = 3.1 Hz, 
1H), 6.72 (dd, J = 8.8, 3.1 Hz, 1H), 6.14 (s, 1H), 3.79 (s, 3H), 2.31 (br.s, 1H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 159.4, 143.6, 142.1, 133.6, 128.6, 128.0, 127.2, 115.2, 114.1, 113.1, 
74.9, 55.6. νmax(neat)/cm–1: 3382 (br), 3062, 3029, 3001, 2961, 2936, 2905, 2835, 1592, 1572, 





2-Benzyl-1-bromo-4-methoxybenzene: Following General Procedure 2A, (2-bromo-5-
methoxyphenyl)(phenyl)methanol (1.26 g, 4.29 mmol)  in CH2Cl2 (13 mL) was reacted with 
TFA  (1.31 mL, 17.2 mmol) and Et3SiH (1.37 mL, 8.59 mmol). Purification via flash column 
chromatography (5% EtOAc in hexanes) afforded 2-benzyl-1-bromo-4-methoxybenzene as a 
colourless liquid (0.87 g, 3.12 mmol, 72%).  
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR:[14] 
1H NMR (400 MHz, CDCl3): δ 7.46 (d, J = 8.6 Hz, 1H), 7.35 – 7.28 (m, 2H), 7.25 – 7.18 (m, 
3H), 6.73 – 6.64 (m, 2H), 4.08 (s, 2H), 3.73 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 
159.1, 141.5, 139.5, 133.5, 129.1, 128.6, 126.4, 117.1, 115.5, 113.5, 55.5, 42.0. νmax(neat)/cm–
1: 3084, 3061, 3027, 3001, 2958, 2935, 2906, 2834, 1594, 1570, 1473, 1453, 1430, 1291, 1276, 
1237, 1157, 1054, 1015, 859, 801, 721.    
(2-Benzyl-4-methoxyphenyl)trimethylsilane: Following General Procedure 3, nBuLi (2.38 
M in hexanes, 1.24 mL, 2.94 mmol) was added to 2-benzyl-1-bromo-4-methoxybenzene (0.68 
g, 2.45 mmol) in THF (7 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, 
then Me3SiCl (0.47 mL, 3.67 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (5% EtOAc in hexanes) 
afforded the title compound as a colourless liquid (0.53 g, 1.94 mmol, 79%). 
1H NMR (400 MHz, CDCl3): δ 7.48 (d, J = 8.3 Hz, 1H), 7.35 – 7.27 (m, 2H), 7.24 – 7.18 (m, 
1H), 7.15 – 7.10 (m, 2H), 6.79 (dd, J = 8.3, 2.5 Hz, 1H), 6.59 (d, J = 2.5 Hz, 1H), 4.16 (s, 2H), 
3.73 (s, 3H), 0.31 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 160.8, 148.3, 141.2, 136.1, 
130.1, 129.3, 128.5, 126.2, 116.2, 110.8, 55.0, 41.9, 0.62. νmax(neat)/cm–1: 3062, 3026, 2953, 
2898, 2835, 1592, 1561, 1453, 1292, 1248, 1225, 1159, 1121, 1077, 1033, 833, 754, 723. 
HRMS calcd. for C17H22OSi: 270.1435 [M]+; found (EI+):  270.1434 
(2-Benzyl-4-fluorophenyl)trimethylsilane (iso-1k) 
 
(2-Bromo-5-fluorophenyl)(phenyl)methanol: Following General Procedure 1, nBuLi (2.38 
M in hexanes, 2.41 mL, 5.73 mmol) was added dropwise to a stirred solution of bromobenzene 
(0.60 mL, 5.73 mmol) in THF (15 mL) at –78 °C. The reaction was stirred at this temperature 
for 1 h, then 2-bromo-5-fluorobenzaldehyde (1.28 g, 6.30 mmol) was added portionwise, and 





flash column chromatography (10% EtOAc in hexanes) afforded (2-bromo-5-
fluorophenyl)(phenyl)methanol as a viscous, pale yellow liquid (1.06 g,  4.00 mmol, 70%). 
1H NMR (400 MHz, CDCl3): δ 7.48 (dd, J = 8.7, 5.2 Hz, 1H), 7.44 – 7.27 (m, 6H), 6.89 (ddd, 
J = 8.7, 7.7, 3.1 Hz, 1H), 6.12 (d, J = 3.5 Hz, 1H), 2.37 (d, J = 3.5 Hz, 1H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 162.5 (d, J = 247 Hz), 144.9 (d, J = 6.8 Hz), 141.6, 134.2 (d, J = 7.9 
Hz), 128.8, 128.3, 127.3, 116.6 (d, J = 3.2 Hz), 116.4 (d, J = 22.9 Hz), 115.8 (d, J = 23.9 Hz), 
74.8. 19F NMR (377 MHz, CDCl3): δ –113.6 (m). νmax(neat)/cm–1: 3310, 3065, 3031, 1464, 
1408, 1143, 1105, 1014, 960, 881, 829, 809, 733. HRMS calcd. for C13H10OBrF: 279.9894 
[M]+; found (EI+): 279.9894. 
2-Benzyl-1-bromo-4-fluorobenzene: A Schlenk flask containing (2-bromo-5-
fluorophenyl)(phenyl)methanol (1.01 g, 3.81 mmol) was evacuated and back-filled with N2 
three times, then Et3SiH (1.22 mL, 15.2 mmol) was added and the mixture was stirred and 
cooled to 0 °C. Cold TFA (5 mL, 65 mmol) was added dropwise and the reaction was allowed 
to warm to room temperature and was stirred overnight. The volatiles were then evaporated 
under a stream of N2 to give the crude product which was purified via flash column 
chromatography (hexanes) to afford 2-benzyl-1-bromo-4-fluorobenzene as a colourless liquid 
(0.87 g, 3.49 mmol, 90%). 
1H NMR (400 MHz, CDCl3): δ 7.52 (dd, J = 9.6, 5.3 Hz, 1H), 7.37 – 7.28 (m, 2H), 7.28 – 
7.15 (m, 3H), 6.87 – 6.76 (m, 2H), 4.09 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 162.2 
(d, J = 247 Hz), 142.8 (d, J = 7.2 Hz), 138.8, 134.0 (d, J = 8.0 Hz), 129.2, 128.8, 126.7, 118.9 
(d, J = 3.1 Hz), 118.0 (d, J = 23 Hz), 115.2 (d, J = 23 Hz), 42.0 (d, J = 1.4 Hz).19F NMR (377 
MHz, CDCl3): δ –114.8 (m). νmax(neat)/cm–1: 3063, 3028, 2980, 2915, 1601, 1578, 1494, 
1465, 1431, 1405, 1269, 1233, 1148, 1102, 1074, 1028, 957, 872, 807, 721. HRMS calcd. for 
C13H10BrF: 263.9944 [M]+; found (EI+): 263.9936. 
(2-Benzyl-4-fluorophenyl)trimethylsilane: Following General Procedure 3, nBuLi (2.38 M 
in hexanes, 1.50 mL, 3.57 mmol) was added to 2-benzyl-1-bromo-4-fluorobenzene (0.75 g, 
3.00 mmol) in THF (9 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 
Me3SiCl (0.57 mL, 4.50 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (hexanes) afforded the 
title compound as a colourless liquid (0.63 g, 2.45 mmol, 82%). 
1H NMR (400 MHz, CDCl3): δ 7.51 (dd, J = 8.3, 6.8 Hz, 1H), 7.35 – 7.30 (m, 2H), 7.28 – 
7.21 (m, 1H), 7.12 (m, 2H), 6.91 (app. td, J = 8.4, 2.5 Hz, 1H), 6.71 (dd, J = 10.7, 2.5 Hz, 1H), 





(d, J = 6.5 Hz), 140.7, 136.4 (d, J = 7.6 Hz), 134.4 (d, J = 3.6 Hz), 129.3, 128.7, 126.4, 116.8 
(d, J = 20 Hz), 112.6 (d, J = 19 Hz), 41.6 (d, J = 1.9 Hz), 0.49. 19F NMR (377 MHz, CDCl3): 
δ –112.5 (ddd, J = 10.7, 8.7, 6.8 Hz). νmax(neat)/cm–1: 3063, 3028, 2954, 2898, 2854, 1594, 
1576, 1495, 1476, 1453, 1397, 1274, 1249, 1212, 964, 834, 814, 755, 723. HRMS calcd. for 
C16H19FSi: 258.1235 [M]+; found (EI+): 258.1237. 
(2-Benzyl-4-chlorophenyl)trimethylsilane (iso-1l) 
 
(2-Bromo-5-chlorophenyl)(phenyl)methanol: Following General Procedure 1, nBuLi (2.38 
M in hexanes, 1.45 mL, 3.45 mmol) was added dropwise to a stirred solution of bromobenzene 
(0.36 mL, 3.45 mmol) in THF (9 mL) at –78 °C. The reaction was stirred at this temperature 
for 1 h, then 2-bromo-5-chlorobenzaldehyde (0.83 g, 3.80 mmol) was added portionwise, and 
the mixture was allowed to warm to room temperature and was stirred overnight. Purification 
via flash column chromatography (10% EtOAc in hexanes) afforded (2-bromo-5-
chlorophenyl)(phenyl)methanol as a viscous, yellow liquid (0.69 g, 2.31 mmol, 67%). 
Characterisation data were consistent with literature values: 1H NMR and IR:[15]  
1H NMR (400 MHz, CDCl3): δ 7.66 (d, J = 2.6 Hz, 1H), 7.45 (d, J = 8.5 Hz, 1H), 7.42 – 7.27 
(m, 5H), 7.14 (dd, J = 8.5, 2.6 Hz, 1H), 6.12 (s, 1H), 2.32 (s, 1H). 13C{1H} NMR (100 MHz, 
CDCl3): δ 144.3, 141.6, 134.1, 134.0, 129.3, 128.8, 128.6, 128.3, 127.3, 120.5, 74.8. 
νmax(neat)/cm–1: 3335, 3086, 3063, 1452, 1391, 1374, 1038, 1014, 891, 809. 
2-Benzyl-1-bromo-4-chlorobenzene: Following General Procedure 2B, (2-bromo-5-
chlorophenyl)(phenyl)methanol (0.69 g, 2.31 mmol)  in CH2Cl2 (1.4 mL) was reacted with 
TFA  (1.40 mL, 18.5 mmol) and Et3SiH (0.74 mL, 4.62 mmol). Purification via flash column 
chromatography (hexanes) afforded 2-benzyl-1-bromo-4-chlorobenzene as a colourless liquid 
(0.50 g, 1.78 mmol, 77%). 1H NMR (400 MHz, CDCl3): δ 7.49 (d, J = 8.4 Hz, 1H), 7.37 – 
7.29 (m, 2H), 7.28 – 7.22 (m, 1H), 7.23 – 7.16 (m, 2H), 7.13 – 7.06 (m, 2H), 4.08 (s, 2H). 
13C{1H} NMR (100 MHz, CDCl3): δ 142.2, 138.6, 133.9, 133.4, 130.9, 129.0, 128.7, 128.0, 
126.6, 122.7, 41.7. νmax(neat)/cm–1: 3085, 3061, 3027, 2914, 1494, 1460, 1451, 1427, 1390, 
1182, 1096, 1073, 1025, 876, 808, 755, 714, 703. HRMS calcd. for C13H10BrCl: 279.9649 





(2-Benzyl-4-chlorophenyl)trimethylsilane: Following General Procedure 3, nBuLi (2.38 M 
in hexanes, 0.80 mL, 1.92 mmol) was added to 2-benzyl-1-bromo-4-chlorobenzene (0.45 g, 
1.60 mmol) in THF (5 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 
Me3SiCl (0.30 mL, 2.40 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. Purification via flash column chromatography (hexanes) afforded the 
title compound as a colourless liquid (0.31 g, 1.13 mmol, 71%). 
1H NMR (400 MHz, CDCl3): δ 7.45 (d, J = 8.0 Hz, 1H), 7.35 – 7.28 (m, 2H), 7.26 – 7.20 (m, 
1H), 7.19 (dd, J = 8.0, 2.0 Hz, 1H), 7.13 – 7.05 (m, 2H), 6.98 (d, J = 2.0 Hz, 1H), 4.13 (s, 2H), 
0.32 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 148.4, 140.6, 137.3, 136.0, 135.7, 129.9, 
129.3, 128.7, 126.4, 125.8, 41.5, 0.39. νmax(neat)/cm–1: 3085, 3061, 3027, 2914, 1460, 1096, 
1025, 808, 714, 703,  693. HRMS calcd. for C16H19ClSi: 274.0939 [M]+; found (EI+):  
274.0946. 
[2-Benzyl-4-(trifluoromethyl)phenyl]trimethylsilane (iso-1m)  
 
Following General Procedure 1, nBuLi (2.38 M in hexanes, 2.10 mL, 5.00 mmol) was added 
dropwise to a stirred solution of bromobenzene (0.53 mL, 5.00 mmol) in THF (13 mL) at –
78 °C. The reaction was stirred at this temperature for 1 h, then 2-bromo-5-
(trifluoromethyl)benzaldehyde (1.39 g, 5.50 mmol) was added, and the mixture was allowed 
to warm to room temperature and was stirred overnight. Flash column chromatography (5% 
EtOAc in hexanes) afforded [2-bromo-5-(trifluoromethyl)phenyl](phenyl)methanol (0.33 g) 
contaminated with ca. 30% of a number of unidentified impurities. TFA (1.3 mL, 17.0 mmol) 
was added directly to the impure [2-bromo-5-(trifluoromethyl)phenyl](phenyl)methanol (0.33 
g) at 0 °C. After 2 min, Et3SiH (0.32 mL, 2.02 mmol) was added dropwise, and the reaction 
stirred at room temperature for 1 h. The volatiles were then evaporated under a stream of N2 
to give the crude product. Flash column chromatography (hexanes) afforded 2-benzyl-1-
bromo-4-(trifluoromethyl)benzene (0.15 g) contaminated with ca. 20% of a number of 
unidentified impurities. Following General Procedure 3, nBuLi (2.38 M in hexanes, 0.21 mL, 
0.49 mmol) was added to the impure 2-benzyl-1-bromo-4-(trifluoromethyl)benzene (0.15 g) 
in THF (1.2 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then Me3SiCl 





overnight. Purification via flash column chromatography (hexanes) afforded the title 
compound as a colourless liquid (98 mg, 0.32 mmol, 6%). 
1H NMR (400 MHz, CDCl3): δ 7.66 (app. d, J = 7.8 Hz, 1H), 7.45 (app. d, J = 7.8 Hz, 1H), 
7.33 – 7.28 (m, 2H), 7.27 – 7.20 (m, 2H), 7.11 – 7.03 (m, 2H), 4.21 (s, 2H), 0.34 (s, 9H). 
13C{1H} NMR (100 MHz, CDCl3): δ 147.0, 143.0, 140.4, 135.0, 131.3 (q, J = 32.0 Hz), 129.0, 
128.6, 126.4, 126.2 (q, J = 3.7 Hz), 124.2 (q, J = 270 Hz), 122.0 (q, J = 3.7 Hz), 41.5, 0.13. 
19F NMR (377 MHz, CDCl3): δ -62.9 (s). νmax(neat)/cm–1: 3065, 3029, 2980, 2900, 1329, 
1264, 1252, 1162, 1121, 1095, 1075, 1056, 829, 755, 725. HRMS calcd. for C17H19F3Si: 
308.1203 [M]+; found (EI+):  308.1196 
3-Benzyl-4-(trimethylsilyl)phenol 
 
3-Benzyl-4-bromophenol: Boron tribromide (1.0 M in CH2Cl2; 3.90 mL, 3.90 mmol) was 
added dropwise to a stirred solution of 2-benzyl-1-bromo-4-methoxybenzene (0.99 g, 3.55 
mmol; prepared as for iso-1j), in CH2Cl2 (8 mL) at 0 °C. The reaction was allowed to warm to 
room temperature and was stirred overnight. H2O (10 mL) was added, dropwise at first, and 
the biphasic mixture was stirred vigorously for 15 min. The aqueous phase was separated and 
extracted with CH2Cl2 (3 × 10 mL), and the combined organic portions were dried (MgSO4), 
filtered and concentrated in vacuo. Purification via flash column chromatography (20% EtOAc 
in hexanes) afforded 3-benzyl-4-bromophenol as a viscous brown oil (0.80 g, 3.02 mmol, 
85%). 
1H NMR (400 MHz, CDCl3): δ 7.41 (d, J = 8.1 Hz, 1H), 7.36 – 7.29 (m, 2H), 7.27 – 7.18 (m, 
3H), 6.64 – 6.54 (m, 2H), 4.82 (s, 1H), 4.05 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 
154.9, 141.9, 139.3, 133.7, 129.2, 128.7, 126.5, 118.0, 115.5, 115.3, 41.8. νmax(neat)/cm–1:  
3331 (br), 3063, 3028, 2913, 1572, 1466, 1449, 1426, 1344, 1279, 1265, 1241, 1189, 1157, 
1121, 1072, 1025, 956, 930, 891, 876, 843, 811, 763, 725, 705. HRMS calcd. for C13H11BrO: 





3-Benzyl-4-(trimethylsilyl)phenol: To a Schlenk flask containing a solution of 3-benzyl-4-
bromophenol (0.44 g, 1.67 mmol) in THF (3.3 mL) was added N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA). The flask was sealed and heated to 65 °C for 
1 h. The reaction was cooled to 0 °C and the solvent was removed in vacuo directly from the 
Schlenk flask. Removal of an aliquot showed quantitative formation of the trimethylsilyl ether 
(as determined by 1H NMR spectroscopy). The silyl ether was re-dissolved in THF (4 mL) and 
cooled to –78 °C. nBuLi (2.17 M in hexanes, 0.85 mL, 1.84 mmol) was added dropwise to the 
solution and it was stirred at –78 °C for 1 h, then Me3SiCl (0.32 mL, 2.51 mmol) was added 
dropwise, and the mixture was stirred for 6 h at room temperature.  HCl (10% aqueous, 10 
mL) was added and the biphasic mixture was stirred vigorously for 1 h. The aqueous phase 
was separated and extracted with Et2O (3 × 15 mL), and the combined organic portions were 
dried (MgSO4), filtered and concentrated in vacuo. 1H NMR spectroscopy of the crude material 
showed a significant amount of the des-silyl product, presumably the result of 
protodesilylation during the acidic work up. Purification via flash column chromatography 
(10% EtOAc in hexanes) afforded the title compound as pale yellow liquid (52 mg, 0.20 mmol, 
12%). 
1H NMR (400 MHz, CDCl3): δ 7.41 (d, J = 8.1 Hz, 1H), 7.33 – 7.27 (m, 2H), 7.24 – 7.18 (m, 
1H), 7.16 – 7.06 (m, 2H), 6.69 (dd, J = 8.1, 2.5 Hz, 1H), 6.44 (d, J = 2.5 Hz, 1H), 4.64 (s, 1H), 
4.11 (s, 2H), 0.30 (s, 9H).13C{1H} NMR (100 MHz, CDCl3): δ 156.7, 148.8, 141.1, 136.4, 
130.2, 129.4, 128.6, 126.3, 116.9, 112.7, 41.7, 0.61. νmax(neat)/cm–1: 3320, 2952, 1595, 1572, 
1494, 1452, 1248, 1059, 968, 833, 725. HRMS calcd. for C16H20OSi: 256.1278 [M]+; found 
(EI+): 256.1282 
3-Benzyl-4-(trimethylsilyl)phenyl trifluoromethanesulfonate (iso-1n) 
 
Triflic anhydride (0.37 mL, 2.20 mmol) was added dropwise to a stirred solution of 3-benzyl-
4-(trimethylsilyl)phenol (0.28 g, 1.10 mmol) and pyridine (1.16 mL, 14.4 mmol) in CH2Cl2 
(10 mL) at 0 °C. The reaction was stirred overnight at room temperature, then H2O (10 mL) 
was added, then the aqueous phase was separated and extracted with CH2Cl2 (3 × 10 mL), and 
the combined organic portions were dried (MgSO4), filtered and concentrated in vacuo. 
Purification via flash column chromatography (5% EtOAc in hexanes) afforded the title 





1H NMR (400 MHz, CDCl3): δ 7.60 (d, J = 8.3 Hz, 1H), 7.36 – 7.30 (m, 2H), 7.28 – 7.22 (m, 
1H), 7.12 (dd, J = 8.3, 2.5 Hz, 1H), 7.11 – 7.03 (m, 2H), 6.86 (d, J = 2.5 Hz, 1H), 4.19 (s, 2H), 
0.34 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 150.9, 149.6, 140.1, 140.0, 136.5, 129.2, 
128.8, 126.7, 122.3, 118.8 (q, J = 320 Hz), 118.2, 41.5, 0.26. 19F NMR (377 MHz, CDCl3): 
δ -73.0 (s). νmax(neat)/cm–1: 3029, 2957, 1588, 1571, 1422, 1246, 1205, 1137, 1064, 954, 833, 
758, 724. HRMS calcd. for C17H19F3O3SSi: 388.0771 [M]+; found (EI+): 338.0760. 
[4-Chloro-2-(3-chlorobenzyl)phenyl](trimethyl)silane (1ae) 
 
(2-Bromo-5-chlorophenyl)(3-chlorophenyl)methanol: Following General Procedure 1, 
nBuLi (2.38 M in hexanes, 2.59 mL, 6.17 mmol) was added dropwise to a stirred solution of 
1-bromo-3-chlorobenzene (0.72 mL, 6.17 mmol) in THF (15 mL) at –78 °C. The reaction was 
stirred at this temperature for 1 h, then 2-bromo-5-chlorobenzaldehyde (1.30 g, 6.79 mmol) 
was added portionwise, and the mixture was allowed to warm to room temperature and was 
stirred overnight. Purification via flash column chromatography (10% EtOAc in hexanes) 
afforded (2-bromo-5-chlorophenyl)(3-chlorophenyl)methanol as a viscous, colourless liquid 
(1.45 g, 4.37 mmol, 71%). 
1H NMR (400 MHz, CDCl3): δ 7.58 (d, J = 2.6 Hz, 1H), 7.47 (d, J = 8.5 Hz, 1H), 7.43 – 7.36 
(m, 1H), 7.31 – 7.24 (m, 3H), 7.16 (dd, J = 8.5, 2.6 Hz, 1H), 6.10 (s, 1H), 2.43 (br.s, 1H). 
13C{1H} NMR (100 MHz, CDCl3): δ 143.8, 143.6, 134.7, 134.3, 134.1, 130.0, 129.7, 128.7, 
128.4, 127.3, 125.4, 120.4, 74.1. νmax(neat)/cm–1: 3064 (br), 2980, 1595, 1575, 1456, 1431, 
1391, 1375, 1254, 1180, 1095, 1080, 1040, 1019, 899, 880, 810, 787, 735, 708, 700. HRMS 
calcd. for C13H9OBrCl2: 329.9208 [M]+; found (EI+): 329.9208. 
1-Bromo-4-chloro-2-(3-chlorobenzyl)benzene: Following General Procedure 2B, (2-bromo-
5-chlorophenyl)(3-chlorophenyl)methanol (1.38 g, 4.16 mmol)  in CH2Cl2 (2.5 mL) was 
reacted with TFA  (2.6 mL, 33.5 mmol) and Et3SiH (1.33 mL, 8.32 mmol). Purification via 
flash column chromatography (hexanes) afforded 1-bromo-4-chloro-2-(3-
chlorobenzyl)benzene as a colourless liquid (0.75 g, 2.38 mmol, 57%). 
1H NMR (400 MHz, CDCl3): δ 7.52 – 7.48 (m, 1H), 7.28 – 7.20 (m, 2H), 7.20 – 7.14 (m, 
1H), 7.13 – 7.03 (m, 3H), 4.05 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 141.3, 140.6, 





3061, 2980, 2912, 1597, 1574, 1475, 1461, 1428, 1390, 1078, 1025, 930, 888, 809, 777, 734. 
HRMS calcd. for C13H9BrCl2: 313.9259 [M]+; found (EI+): 313.9265. 
[4-Chloro-2-(3-chlorobenzyl)phenyl](trimethyl)silane: Following General Procedure 3, 
nBuLi (2.38 M in hexanes, 0.92 mL, 2.18 mmol) was added to 1-bromo-4-chloro-2-(3-
chlorobenzyl)benzene (0.58 g, 1.82 mmol) in THF (5.5 mL) at –78 °C. The reaction was stirred 
at this temperature for 1 h, then Me3SiCl (0.35 mL, 2.73 mmol) was added dropwise, and the 
mixture was stirred at room temperature overnight. Purification via flash column 
chromatography (hexanes) afforded the title compound as a colourless liquid (0.46 g, 
1.49 mmol, 82%). 
1H NMR (400 MHz, CDCl3): δ 7.46 (d, J = 8.0 Hz, 1H), 7.30 – 7.17 (m, 3H), 7.11 – 7.04 (m, 
1H), 6.99 – 6.90 (m, 2H), 4.10 (s, 2H), 0.31 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 
147.3, 142.7, 137.2, 136.2, 135.8, 134.6, 129.9, 129.3, 127.4, 126.7, 126.1, 41.1, 0.38. 1 × CAr 
not observed. νmax(neat)/cm–1: 3062, 2954, 2898, 1596, 1574, 1548, 1474, 1428, 1250, 1184, 




nBuLi (2.38 M in hexanes, 3.91 mL, 9.33 mmol) was added dropwise to a stirred solution of 
1,2-dibromobenzene (1.00 mL, 8.48 mmol) in THF/Et2O (24 mL, 1:1) over 15 min, 
maintaining the reaction temperature below –110 °C. The reaction was stirred at this 
temperature for 30 min, then methanol-d1 (1.03 mL, 25.4 mmol) was added dropwise slowly, 
and the mixture was left in the cooling bath and allowed to warm to room temperature 
overnight. The reaction was quenched with H2O (15 mL), then the aqueous phase was 
separated and extracted with Et2O (3 × 20 mL), and the combined organic portions were dried 
(MgSO4), filtered and concentrated in vacuo. Purification by distillation afforded the title 
compound as a colourless liquid (0.46 g, 2.93 mmol, 35%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR:[16] 
1H NMR (400 MHz, CDCl3): δ 7.55 – 7.49 (m, 1H), 7.35 – 7.22 (m, 3H). 13C{1H} NMR (100 







(2-Bromophenyl)[(2-d1)phenyl]methanol: Following General Procedure 1, 
nBuLi (2.38 M in 
hexanes, 1.14 mL, 2.72 mmol) was added dropwise to a stirred solution of 2-d1-bromobenzene 
(0.43 g, 2.72 mmol) in THF (6 mL) at –78 °C. The reaction was stirred at this temperature for 
30 min, then 2-bromobenzaldehyde (0.32 mL, 2.72 mmol) was added dropwise, and the 
mixture was allowed to warm to room temperature and was stirred for 2 h. Purification via 
flash column chromatography (10% EtOAc in hexanes) afforded (2-bromophenyl)[(2-
d1)phenyl]methanol as a viscous, yellow liquid (0.50 g, 1.88 mmol, 69%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR.[17] 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.8, 1.7 Hz, 1H), 7.55 (dd, J = 8.0, 1.3 Hz, 1H), 
7.43 – 7.38 (m, 1H), 7.37 – 7.31 (m, 3H), 7.32 – 7.25 (m, 1H), 7.15 (app. td, J = 7.7, 1.7 Hz, 
1H), 6.20 (s, 1H), 2.38 (br.s, 1H). 13C{1H} NMR (100 MHz, CDCl3): δ 142.7, 142.2, 133.0, 
129.3, 128.63, 128.61, 128.5, 127.90, 127.86, 127.2, 126.9 (t, J = 24 Hz), 122.9, 74.9. 
νmax(neat)/cm–1: 3327 (br), 3061, 3019, 1567, 1468, 1438, 1333, 1302, 1228, 1183, 1159, 
1119, 1011, 949, 869, 846, 820, 775, 747. 
1-Bromo-2-[(2-d1)phenylmethyl]benzene: Following General Procedure 2A, (2-
bromophenyl)[(2-d1)phenyl]methanol (0.46 g, 1.86 mmol) in CH2Cl2 (6 mL) was reacted with 
TFA  (0.57 mL, 7.45 mmol) and Et3SiH (0.59 mL, 3.72 mmol). Purification via flash column 
chromatography (hexanes) afforded 1-bromo-2-[(2-d1)phenylmethyl]benzene as a colourless 
liquid (0.37 g, 1.47 mmol, 79%). 
1H NMR (500 MHz, CDCl3): δ 7.58 (dd, J = 8.0, 1.3 Hz, 1H), 7.35 – 7.28 (m, 2H), 7.26 – 
7.17 (m, 3H), 7.14 (dd, J = 7.7, 1.8 Hz, 1H), 7.09 (app. td, J = 7.6, 1.8 Hz, 1H), 4.13 (s, 2H).  
13C{1H} NMR (125 MHz, CDCl3): δ 140.5, 139.6, 133.0, 131.2, 129.1, 128.8 (t, J = 24.0 Hz), 
128.6, 128.5, 128.0, 127.6, 126.4, 125.1, 41.8. νmax(neat)/cm–1: 3062, 3015, 2980, 2912, 1593, 
1566, 1474, 1438, 1258, 1158, 1114, 1045, 1024, 950, 917, 868, 806, 774, 744, 714. HRMS 
calcd. for C13H10DBr: 247.0101 [M]+; found (EI+): 247.0108. 
Trimethyl{2-[(2-d1)phenylmethyl]phenyl}silane: Following General Procedure 3, 
nBuLi 
(2.38 M in hexanes, 0.73 mL, 1.74 mmol) was added to 1-bromo-2-[(2-
d1)phenylmethyl]benzene (0.36 g, 1.45 mmol) in THF (4 mL) at –78 °C. The reaction was 





and the mixture was stirred at room temperature overnight. Purification via flash column 
chromatography (hexanes) afforded the title compound as a colourless liquid (0.23 g, 
0.94 mmol, 65%). The deuterium content was observed to be >98% by 1H NMR spectroscopy. 
1H NMR (400 MHz, CDCl3): δ 7.56 (dd, J = 7.3, 1.4 Hz, 1H), 7.34 – 7.26 (m, 3H), 7.25 – 
7.17 (m, 2H), 7.14 – 7.07 (m, 1.02H), 7.02 (app. dd, J = 7.6 0.6 Hz, 1H), 4.18 (s, 2H), 0.33 (s, 
9H). 13C{1H} NMR (100 MHz, CDCl3): δ 146.4, 141.5, 139.0, 134.7, 130.0, 129.5, 129.3, 
129.0 (t, J = 24.4 Hz), 128.5, 128.4, 126.1, 125.6, 41.8, 0.49. νmax(neat)/cm–1: 3057, 2952, 




(2-Bromophenyl)[(d5)phenyl]methanol: Following General Procedure 1, 
nBuLi (2.38 M in 
hexanes, 2.60 mL, 6.17 mmol) was added dropwise to a stirred solution of d5-bromobenzene 
(0.65 mL, 6.17 mmol) in THF (13 mL) at –78 °C. The reaction was stirred at this temperature 
for 1 h, then 2-bromobenzaldehyde (0.72 mL, 6.17 mmol) was added dropwise, and the 
mixture was allowed to warm to room temperature and was stirred for 2 h. Purification via 
flash column chromatography (15% EtOAc in hexanes) afforded (2-
bromophenyl)[(d5)phenyl]methanol as a viscous, yellow liquid (0.77 g, 2.87 mmol, 47%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.8, 1.8 Hz, 1H), 7.54 (dd, J = 8.0, 1.3 Hz, 1H), 
7.35 (m, 1H), 7.15 (app. td, J = 7.7, 1.7 Hz, 1H), 6.21 (s, 1H), 2.31 (br.s, 1H).13C{1H} NMR 
(100 MHz, CDCl3): δ 142.7, 142.1, 133.0, 129.3, 128.6, 128.1 (t, J = 24 Hz), 127.9, 127.4 (t, 
J = 24 Hz), 126.7 (t, J = 24 Hz), 122.9, 74.87. νmax(neat)/cm–1: 3334, 3061, 2274, 1628, 1467, 
1437, 1131, 1051, 1010, 853, 746, 700. HRMS calcd. for C13H6D5OBr: 267.0302 [M]+; found 
(EI+): 267.0295. 
1-Bromo-2-[(2-d5)phenylmethyl]benzene: Following General Procedure 2A, (2-
bromophenyl)[(d5)phenyl]methanol (0.77 g, 2.87 mmol)  in CH2Cl2 (9 mL) was reacted with 
TFA  (0.88 mL, 11.49 mmol) and Et3SiH (0.92 mL, 5.74 mmol). Purification via flash column 
chromatography (pentane) afforded 1-bromo-2-[(2-d5)phenylmethyl]benzene as a colourless 





1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 8.0, 1.3 Hz, 1H), 7.24 (app. td, J = 7.5, 1.3 Hz, 
1H), 7.15 (dd, J = 7.7, 1.8 Hz, 1H), 7.10 (app. td, J = 7.8, 1.8 Hz, 1H), 4.14 (s, 2H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 140.5, 139.4, 133.0, 131.2, 128.7 (t, J = 24 Hz), 128.1 (t, J = 24 
Hz), 128.0, 127.6, 125.9 (t, J = 25 Hz), 125.0, 41.8. νmax(neat)/cm–1: 3057, 2911, 2273, 1567, 
1473, 1438, 1377, 1348, 1315, 1275, 1258, 1115, 1038, 1022, 944, 908, 848, 821, 774, 744. 
HRMS calcd. for C13H6D5Br: 251.0353 [M]+; found (EI+): 251.0353. 
Trimethyl{2-[(d5)phenylmethyl]phenyl}silane: Following General Procedure 3, 
nBuLi (2.38 
M in hexanes, 1.04 mL, 2.47 mmol) was added to 1-bromo-2-[(2-d5)phenylmethyl]benzene 
(0.52 g, 2.06 mmol) in THF (6 mL) at –78 °C. The reaction was stirred at this temperature for 
1 h, then Me3SiCl (0.39 mL, 3.09 mmol) was added dropwise, and the mixture was stirred at 
room temperature overnight. Purification via flash column chromatography (hexanes) 
afforded the title compound as a colourless liquid (0.47 g, 1.93 mmol, 93%). The deuterium 
content was observed to be > 98% by 1H-NMR. 
1H NMR (400 MHz, CDCl3): δ 7.58 (dd, J = 7.3, 1.5 Hz, 1H), 7.31 (app. td, J = 7.5, 1.7 Hz, 
1H), 7.23 (app. td, J = 7.3, 1.3 Hz, 1H), 7.04 (app. d, J = 7.5 Hz, 1H), 4.20 (s, 2H), 0.35 (s, 
9H). 13C{1H} NMR (100 MHz, CDCl3): δ 146.3, 141.3, 138.9, 134.6, 129.9, 129.4, 128.8 (t, 
J = 24 Hz), 127.9 (t, J = 24 Hz), 125.5 (t, J = 24 Hz), 125.5, 41.6, 0.39. νmax(neat)/cm–1: 3054, 
2953, 2274, 1435, 1248, 1071, 833, 735. HRMS calcd. for C16H15D5NaSi: 268.1540 [M+Na]+; 
found (ESI+): 268.1526. 
Trimethyl{2-[(2-d1)phenyloxy]phenyl}silane (d1-1v)[10] 
 
A Schlenk flask containing Pd(OAc)2 (4.50 mg, 0.02 mmol), 
tBu-XPhos (12.7 mg, 0.03 mmol) 
and potassium phosphate (0.42 g, 2.00 mmol) was evacuated and back-filled with N2 three 
times, then 2-(trimethylsilyl)phenol[11] (0.20 g, 1.20 mmol) and 2-d1-bromobenzene (105 μL, 
1.00 mmol; prepared as above) in toluene (2 mL) was added, and the flask was sealed and 
heated at 100 °C overnight. The reaction mixture was filtered through a pad of Celite (eluent: 
hexanes) and concentrated in vacuo. Purification via flash column chromatography (hexanes) 
afforded the title compound as a colourless liquid (0.21 g, 0.85 mmol, 85%). 
1H NMR (400 MHz, CDCl3): δ 7.51 (ddd, J = 7.4, 1.8, 0.5 Hz, 1H), 7.37 – 7.27 (m, 3H), 7.10 
(app. qd, J = 7.4, 1.1 Hz, 2H), 6.99 (dd, J = 8.6, 1.1 Hz, 1H), 6.81 (dd, J = 8.2, 0.7 Hz, 1H), 





129.7, 123.1, 123.0, 118.9, 118.6 (t, J = 25 Hz), 117.6, -0.76. νmax(neat)/cm–1: 3065, 2954, 
1590, 1566, 1464, 1433, 1246, 1124, 1076, 834, 752, 720. HRMS calcd. for C15H17DONaSi: 
266.1082 [M+Na]+; found (ESI+):  266.1083. 
Trimethyl(2-{[(2-2H)phenyloxy]methyl}phenyl)silane (d1-3d) 
 
2-Bromobenzyl-(2-d1)phenylether: A suspension of K2CO3 (0.52 g, 3.76 mmol), 2-
bromobenzyl bromide (0.62 g, 2.50 mmol) and 2-d1-phenol[18] (0.24 g, 2.50 mmol) in acetone 
(4.5 mL) was heated at reflux for 8 h. The reaction mixture was cooled to room temperature, 
filtered and concentrated in vacuo. Purification via column chromatography (hexanes) 
afforded 2-bromobenzyl-(2-d1)phenylether as a colourless liquid (0.52 g, 1.98 mmol, 79%). 
1H NMR (400 MHz, CDCl3): δ 7.64 – 7.55 (m, 2H), 7.39 – 7.30 (m, 3H), 7.20 (app. td, J = 
7.7, 1.8 Hz, 1H), 7.05 – 6.97 (m, 2H), 5.16 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 
158.5, 136.5, 132.7, 129.7, 129.6, 129.3, 129.0, 127.7, 122.4, 121.3, 115.0, 114.7 (t, J = 24 
Hz), 69.5. νmax(neat)/cm–1: 3064, 2903, 1589, 1474, 1437, 1378, 1308, 1232, 1217, 1118, 
1045, 1023, 743. HRMS calcd. for C13H10DOBr: 263.0051 [M]+; found (EI+): 263.0051. 
Trimethyl(2-{[(2-d1)phenyloxy]methyl}phenyl)silane: Following General Procedure 3, 
nBuLi (2.17 M in hexanes, 0.91 mL, 1.98 mmol) was added to 2-bromobenzyl-(2-
d1)phenylether (0.48 g, 1.80 mmol) in THF (4.5 mL) at –78 °C. The reaction was stirred at this 
temperature for 1 h, then Me3SiCl (0.34 mL, 2.70 mmol) was added dropwise, and the mixture 
was stirred at room temperature overnight. Purification via flash column chromatography 
(hexanes) afforded the title compound as a colourless liquid (0.36 g, 1.30 mmol, 72%). 
1H NMR (400 MHz, CDCl3): δ 7.62 (dd, J = 7.3, 1.3 Hz, 1H), 7.55 – 7.48 (m, 1H), 7.42 (app. 
td, J = 7.5, 1.6 Hz, 1H), 7.38 – 7.29 (m, 3H), 7.03 – 6.96 (m, 2H), 5.12 (s, 2H), 0.36 (s, 9H). 
13C{1H} NMR (100 MHz, CDCl3): δ 158.8, 142.1, 138.9, 135.0, 129.7, 129.6, 129.5, 128.9, 
127.6, 121.0, 114.9, 114.5 (t, J = 24 Hz), 70.4, 0.42. νmax(neat)/cm–1: 3059, 2952, 2896, 1589, 
1465, 1307, 1248, 1227, 1121, 1048, 1010, 833, 744, 724. HRMS calcd. for C16H19DOSi: 









Trimethyl{2-[(2-d1)phenylethynyl]phenyl}silane: A Schlenk flask containing 
(PCy3)2Pd(OAc)2 (12.4 mg, 0.02 mmol) and copper(I) iodide (2.89 mg, 0.015 mmol) was 
evacuated and back-filled N2 three times, then diisopropylamine (5.00 mL) and 2-d1-
bromobenzene (105 μL, 1.00 mmol; prepared as above) were added. The flask was heated to 
80 °C, then (2-(phenylethynyl)phenyl)trimethylsilane (0.18 g, 1.05 mmol) was added and the 
reaction was stirred at this temperature for 6 h. The reaction mixture was allowed to cool to 
room temperature and was filtered through a pad of Celite (eluent: hexanes) and concentrated 
in vacuo. Column chromatography (hexanes) afforded trimethyl{2-[(2-
d1)phenylethynyl]phenyl}silane as a colourless liquid (0.13 g, 0.53 mmol, 53%). 
1H NMR (400 MHz, CDCl3): δ 7.64 – 7.47 (m, 3H), 7.43 – 7.28 (m, 5H), 0.44 (s, 9H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 142.5, 134.1, 132.6, 131.4, 131.1 (t, J = 25.0 Hz), 128.9, 128.6, 
128.57, 128.55, 128.4, 127.6, 123.6, 92.1, 91.3, –0.8. νmax(neat)/cm–1: 3051, 3006, 2953, 
2896, 1474, 1244, 1125, 833, 756, 718. HRMS calcd. for C17H17DSi: 251.1235 [M]+; found 
(EI+): 251.1236. 
Trimethyl(2-{2-[(2-d1)phenyl]ethyl}phenyl)silane: Trimethyl{2-[(2-
d1)phenylethynyl]phenyl}silane (121 mg, 0.48 mmol) was dissolved in EtOH (3.5 mL) and N2 
was bubbled through the solution for 10 min. Pd/C (10 wt%; 10 mg) was added and a balloon 
of H2 was fitted and H2 was bubbled through the solution. Another balloon of H2 was fitted 
and the reaction was stirred under a static H2 atmosphere overnight. The suspension was 
filtered through a pad of Celite (eluent: CH2Cl2) and the filtrate was concentrated in vacuo. 
Purification via flash column chromatography (hexanes) afforded the title compound as a 
colourless liquid (62.0 mg, 0.24 mmol, 50%). 
1H NMR (400 MHz, CDCl3): δ 7.52 (dd, J = 7.4, 1.2 Hz, 1H), 7.40 – 7.20 (m, 7H), 3.09 – 
3.01 (m, 2H), 2.98 – 2.91 (m, 2H), 0.37 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 147.7, 
142.0, 138.2, 134.8, 129.4, 128.9, 128.6, 128.52, 128.48, 128.2 (t, J = 24.1 Hz), 126.2, 125.5, 
38.9, 38.2, 0.69. νmax(neat)/cm–1: 3057, 3014, 2954, 2865, 1589, 1563, 1475, 1437, 1248, 









nBuLi (2.38 M in hexanes, 0.88 mL, 
2.10 mmol) was added dropwise to a stirred solution of d5-bromobenzene (201 µL, 1.91 mmol) 
in THF (5 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 2-
bromobenzophenone (0.35 mL, 1.91 mmol) was added dropwise, and the mixture was stirred 
at room temperature overnight. The reaction was quenched with H2O (5 mL), then the aqueous 
phase was separated and extracted with Et2O (3 × 10 mL), and the combined organic portions 
were dried (MgSO4), filtered and concentrated in vacuo. The crude reaction mixture was 
transferred to a Schlenk flask which was evacuated and back-filled with N2 three times, then 
CH2Cl2 (5.5 mL) was added. The solution was cooled to 0 °C, then TFA (0.59 mL, 7.71 mmol) 
was added dropwise. After 5 min, Et3SiH (0.61 mL, 3.86 mmol) was added dropwise, and the 
reaction mixture was allowed to warm to room temperature and was stirred for 3 h. The 
volatiles were then evaporated under a stream of N2 and then dried under vacuum to give the 
product as an off-white solid. Recrystallization (methanol) afforded 1-bromo-2-
{phenyl[(d5)phenyl]methyl}benzene as a white solid (0.34 g, 1.05 mmol, 55%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 8.0, 1.4 Hz, 1H), 7.33 – 7.18 (m, 4H), 7.14 – 
7.06 (m, 3H), 6.96 (dd, J = 7.7, 1.8 Hz, 1H), 5.97 (s, 1H). 13C{1H} NMR (100 MHz, CDCl3): 
δ 143.4, 142.8, 142.6, 133.2, 131.5, 129.8, 129.3 (t, J = 24 Hz), 128.5, 128.2, 128.0 (t, J = 24 
Hz), 127.3, 126.6, 126.1 (t, J = 24 Hz), 125.7, 56.0. νmax(neat)/cm–1: 3084, 3057, 3025, 2886, 
2275, 1600, 1584, 1563, 1493, 1463, 1450, 1436, 1372, 1345, 1325, 1301, 1274, 1238, 1181, 
1159, 1113, 1077, 1047, 1024, 1011, 960, 949, 919, 878, 858, 845, 825, 806, 752, 735, 719. 






Trimethyl(2-{phenyl[(d5)phenyl]methyl}phenyl)silane: Following General Procedure 3, 
nBuLi (2.38 M in hexanes, 0.35 mL, 0.84 mmol) was added to 1-bromo-2-
{phenyl[(d5)phenyl]methyl}benzene (0.25 g, 0.76 mmol) in THF (2.5 mL) at –78 °C. The 
reaction was stirred at this temperature for 5 min, then Me3SiCl (0.14 mL, 1.14 mmol) was 
added dropwise, and the mixture was stirred at room temperature overnight. Purification via 
flash column chromatography (hexanes) afforded the title compound as a viscous, colourless 
liquid that solidified on standing (0.12 g, 0.36 mmol, 48%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.4, 1.3 Hz, 1H), 7.34 – 7.16 (m, 5H), 7.09 – 
6.93 (m, 3H), 5.91 (s, 1H), 0.26 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 148.9, 144.8, 
144.6, 139.3, 135.1, 130.7, 129.8, 129.3 (t, J = 24 Hz), 129.2, 128.3, 127.8 (t, J = 24 Hz), 
126.3, 125.8, 55.7, 0.78. 1 × CAr not observed. νmax(neat)/cm–1: 3062, 3023, 3007, 2952, 2895, 
2276, 1598, 1587, 1561, 1493, 1467, 1447, 1430, 1371, 1343, 1309, 1262, 1250, 1244, 1192, 
1120, 1067, 1033, 833, 754, 726.  HRMS calcd. for C22H19D5Si: 321.1956 [M]+; found (EI+): 
321.1948. m.p. /°C: 81-83. 
[2-(1,2-Diphenylethyl)phenyl]trimethylsilane (102) 
 
Benzylmagnesium chloride (1.40 M in THF; 4.10 mL, 5.74 mmol) was added dropwise to a 
stirred solution of 2-bromobenzophenone (0.70 mL, 3.83 mmol) in THF (21 mL) at 0° C. The 
mixture was allowed to warm to room temperature and was stirred for 3h. The reaction was 
quenched with H2O (20 mL), then the aqueous phase was separated and extracted with Et2O 
(3 × 30 mL), and the combined organic portions were dried (MgSO4), filtered and concentrated 
in vacuo. The crude reaction mixture was transferred to a Schlenk flask which was evacuated 
and back-filled with N2 three times, then CH2Cl2 (10 mL) was added. The solution was cooled 
to 0 °C, then TFA (1.20 mL, 15.3 mmol) was added dropwise. After 5 min, Et3SiH (1.22 mL, 





and was stirred for 3 h. The volatiles were then evaporated under a stream of N2 and column 
chromatography (hexanes) afforded 0.42 g of an inseparable, 14:1 mixture of 1-bromo-2-(1,2-
diphenylethenyl)benzene and 1-bromo-2-(1,2-diphenylethyl)benzene. nBuLi (2.38 M in 
hexanes, 0.48 mL, 1.15 mmol) was added dropwise to a stirred solution of this mixture (0.39 
g, 1.15 mmol) in THF (3 mL) at –78 °C. The reaction was stirred at this temperature for 1h, 
then Me3SiCl (0.22 mL, 1.73 mmol) was added dropwise, and the mixture was stirred at room 
temperature overnight. The reaction was quenched with H2O (5 mL), then the aqueous phase 
was separated and extracted with Et2O (3 × 10 mL), and the combined organic portions were 
dried (MgSO4), filtered and concentrated in vacuo. Column chromatography (2% EtOAc in 
hexanes) afforded 0.31 g of a 14:1 mixture of [2-(1,2-
diphenylethenyl)phenyl](trimethyl)silane and the title compound. The mixture was transferred 
to a round bottom flask and EtOH (5 mL) and THF (2.5 mL) were added and N2 was bubbled 
through this solution for 10 min. Pd/C (10 wt%; 16 mg) was added and a balloon of H2 was 
fitted and H2 was bubbled through the solution. Another balloon of H2 was fitted and the 
reaction was stirred rapidly under a static H2 atmosphere for 12 h. The suspension was filtered 
through a pad of Celite (eluent: CH2Cl2) and the filtrate was concentrated in vacuo. Purification 
via flash column chromatography (hexanes) afforded the title compound as a viscous, 
colourless liquid that solidified on standing (0.20 g, 0.60 mmol, 10%). 
1H NMR (400 MHz, CDCl3): δ 7.51 (app. dd, J = 7.5, 0.9 Hz, 1H), 7.46 – 7.35 (m, 2H), 7.25 
– 7.11 (m, 9H), 7.10 – 7.04 (m, 2H), 4.68 (app. t, J = 7.6 Hz, 1H), 3.45 – 3.32 (m, 2H), 0.23 
(s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 150.1, 144.3, 140.3, 138.9, 135.1, 129.4, 129.2, 
128.6, 128.5, 128.3, 128.2, 126.1, 125.8, 50.6, 43.7, 0.96. νmax(neat)/cm–1: 3083, 3023, 2953, 
2847, 1562, 1494, 1448, 1252, 1122, 1072, 833, 750, 723. HRMS calcd. for C23H26Si: 















1-Bromo-2-[(3-chlorophenyl)(phenyl)methyl]benzene: nBuLi (2.38 M in hexanes, 0.88 mL, 
2.10 mmol) was added dropwise to a stirred solution of 1-bromo-3-chlorobenzene (224 µL, 
1.91 mmol) in THF (5 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 
2-bromobenzophenone (0.35 mL, 1.91 mmol) was added dropwise, and the mixture was 
stirred at room temperature overnight. The reaction was quenched with H2O (5 mL), then the 
aqueous phase was separated and extracted with Et2O (3 × 10 mL), and the combined organic 
portions were dried (MgSO4), filtered and concentrated in vacuo. The crude reaction mixture 
was transferred to a Schlenk flask which was evacuated and back-filled with N2 three times, 
then CH2Cl2 (5.5 mL) was added. The solution was cooled to 0 °C, then TFA (0.59 mL, 7.71 
mmol) was added dropwise. After 5 min, Et3SiH (0.61 mL, 3.86 mmol) was added dropwise, 
and the reaction mixture was allowed to warm to room temperature and was stirred for 3 h. 
The volatiles were then evaporated under a stream of N2 and purification via flash column 
chromatography (hexanes) afforded 1-bromo-2-[(3-chlorophenyl)(phenyl)-methyl]benzene as 
a colourless liquid (0.35 g, 0.98 mmol, 51%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 8.0, 1.3 Hz, 1H), 7.36 – 7.29 (m, 2H), 7.28 – 
7.20 (m, 4H), 7.12 (app. td, J = 7.7, 1.7 Hz, 1H), 7.08 – 7.03 (m, 3H), 6.99 – 6.95 (m, 1H), 
6.93 (dd, J = 7.8, 1.7 Hz, 1H), 5.93 (s, 1H). 13C{1H} NMR (100 MHz, CDCl3): δ 144.9, 142.6, 
142.0, 134.5, 133.4, 131.4, 129.79, 129.72, 129.69, 128.7, 128.5, 128.0, 127.5, 126.93, 126.91, 
125.6, 55.8. νmax(neat)/cm–1: 3060, 1592, 1570, 1494, 1438, 1424, 1025, 780, 747, 699. 
HRMS calcd. for C19H14BrCl: 355.9962 [M]+; found (EI+): 355.9946. 
{2-[(3-Chlorophenyl)(phenyl)methyl]phenyl}trimethylsilane: Following General Procedure 





chlorophenyl)(phenyl)methyl]benzene (0.31 g, 0.88 mmol) in THF (2.6 mL) at –78 °C. The 
reaction was stirred at this temperature for 5 min, then Me3SiCl (0.17 mL, 1.31 mmol) was 
added dropwise, and the mixture was stirred at room temperature overnight. Purification via 
flash column chromatography (hexanes) afforded the title compound as a viscous, colourless 
liquid that solidified on standing (0.22 g, 0.63 mmol, 72%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.4, 1.4 Hz, 1H), 7.35 – 7.15 (m, 7H), 7.07 – 
6.98 (m, 3H), 6.98 (dd, J = 7.7, 1.1 Hz, 1H), 6.95 – 6.91 (m, 1H), 5.86 (s, 1H), 0.25 (s, 9H). 
13C{1H} NMR (100 MHz, CDCl3): δ 148.0, 147.0, 144.0, 139.4, 135.3, 134.3, 130.6, 129.8, 
129.7, 129.5, 129.4, 128.5, 128.1, 126.60, 126.57, 126.1, 55.5, 0.79. νmax(neat)/cm–1: 3057, 
3026, 2953, 2896, 1592, 1570, 1493, 1473, 1449, 1425, 1249, 1122, 1095, 1079, 833, 780, 




1-Bromo-2-[(4-tert-butylphenyl)(phenyl)methyl]benzene: nBuLi (2.38 M in hexanes, 
0.88 mL, 2.10 mmol) was added dropwise to a stirred solution of 1-bromo-4-tert-butylbenzene 
(0.33 mL, 1.91 mmol) in THF (5 mL) at –78 °C. The reaction was stirred at this temperature 
for 1 h, then 2-bromobenzophenone (0.35 mL, 1.91 mmol) was added dropwise, and the 
mixture was allowed to warm to room temperature and was stirred overnight. The reaction 
was quenched with H2O (5 mL), then the aqueous phase was separated and extracted with Et2O 
(3 × 10 mL), and the combined organic portions were dried (MgSO4), filtered and concentrated 
in vacuo. The crude reaction mixture was transferred to a Schlenk flask which was evacuated 
and back-filled with N2 three times, then CH2Cl2 (5.5 mL) was added. The solution was cooled 
to 0 °C, then TFA (0.59 mL, 7.71 mmol) was added dropwise. After 5 min, Et3SiH (0.61 mL, 





3 h. The volatiles were then evaporated under a stream of N2 and purification via flash column 
chromatography (twice 5% toluene in hexanes) afforded 1-bromo-2-[(4-tert-
butylphenyl)(phenyl)methyl]benzene as a colourless liquid (0.11 g, 0.29 mmol, 15%) 
alongside trace amounts of an unidentified, highly UV active impurity. The identity of the 
desired product was confirmed by NMR spectroscopy and used without further purification. 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.9, 1.4 Hz, 1H), 7.34 – 7.17 (m, 6H), 7.12 – 
7.06 (m, 3H), 7.03 – 6.96 (m, 3H), 5.93 (s, 1H), 1.31 (s, 9H). 13C{1H} NMR (100 MHz, 
CDCl3): δ 149.4, 143.6, 143.0, 139.6, 133.2, 131.5, 129.7, 129.3, 128.4, 128.1, 127.3, 126.5, 
125.7, 125.4, 55.6, 34.6, 31.5. 
2-[(4-tert-Butylphenyl)(phenyl)methyl]phenyl}(trimethyl)silane: Following General 
Procedure 3, nBuLi (2.38 M in hexanes, 0.12 mL, 0.30 mmol) was added to 1-bromo-2-[(4-
tert-butylphenyl)(phenyl)methyl]benzene (100 mg, 0.27 mmol) in THF (1 mL) at –78 °C. The 
reaction was stirred at this temperature for 5 min, then Me3SiCl (51 μL, 0.40 mmol) was added 
dropwise, and the mixture was stirred at room temperature overnight. Purification via flash 
column chromatography (hexanes) afforded the title compound as a viscous, colourless liquid 
(37 mg, 0.10 mmol, 37%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.4, 1.6 Hz, 1H), 7.35 – 7.16 (m, 7H), 7.10 – 
7.01 (m, 3H), 6.95 (d, J = 8.4 Hz, 2H), 5.85 (s, 1H), 1.3 (s, 9H), 0.24 (s, 9H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 149.3, 149.0, 144.8, 141.8, 139.3, 135.0, 130.7, 129.8, 129.3, 129.2, 
128.2, 126.2, 125.7, 125.1, 55.4, 34.5, 31.5, 0.79. νmax(neat)/cm–1: 3056, 3025, 2959, 2902, 
2868, 1513, 1493, 1465, 1449, 1429, 1410, 1363, 1307, 1262, 1249, 1122, 1019, 833, 806, 














1-Bromo-2-[(4-fluorophenyl)(phenyl)methyl]benzene: nBuLi (2.17 M in hexanes, 0.90 mL, 
1.96 mmol) was added dropwise to a stirred solution of 1-bromo-4-fluorobenzene (0.23 mL, 
2.06 mmol) in THF (5 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 
2-bromobenzophenone (0.37 mL, 2.00 mmol) was added dropwise, and the mixture was 
stirred at room temperature overnight. The reaction was quenched with H2O (10 mL), then the 
aqueous phase was separated and extracted with Et2O (3 × 15 mL), and the combined organic 
portions were dried (MgSO4), filtered and concentrated in vacuo. The crude reaction mixture 
was transferred to a Schlenk flask which was evacuated and back-filled with N2 three times, 
then CH2Cl2 (5.5 mL) was added. The solution was cooled to 0 °C, then TFA (0.61 mL, 8.00 
mmol) was added dropwise. After 5 min, Et3SiH (0.64 mL, 4.00 mmol) was added dropwise, 
and the reaction mixture was allowed to warm to room temperature and was stirred for 2 h. 
The volatiles were then evaporated under a stream of N2 and purification via flash column 
chromatography (hexanes) afforded 1-bromo-2-[(4-fluorophenyl)(phenyl)methyl]-benzene as 
a colourless liquid (0.45 g, 1.33 mmol, 67%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.9, 1.3 Hz, 1H), 7.36 – 7.19 (m, 4H), 7.11 (app. 
td, J = 7.7, 1.7 Hz, 1H), 7.08 – 6.95 (m, 6H), 6.92 (dd, J = 7.7, 1.8 Hz, 1H), 5.93 (s, 1H). 
13C{1H} NMR (100 MHz, CDCl3): δ 161.6 (d, J = 245 Hz), 143.2, 142.6, 138.4 (d, J = 3.4 
Hz), 133.3, 131.4, 131.2 (d, J = 7.9 Hz), 129.7, 128.6, 128.3, 127.4, 126.8, 125.6, 115.3 (d, J 
= 21 Hz), 55.4. 19F NMR (377 MHz, CDCl3): –116.5 (m). νmax(neat)/cm–1: 3056, 3026, 1600, 
1505, 1437, 1222, 1157, 1022, 792, 744. HRMS calcd. for C19H14BrF: 340.0257 [M]+; found 
(EI+): 340.0262. 
{2-[(4-Fluorophenyl)(phenyl)methyl]phenyl}trimethylsilane: Following General Procedure 




fluorophenyl)(phenyl)methyl]benzene (0.41 g, 1.20 mmol) in THF (3 mL) at –78 °C. The 
reaction was stirred at this temperature for 5 min, then Me3SiCl (0.23 mL, 1.79 mmol) was 
added dropwise, and the mixture was stirred at room temperature overnight. Purification via 
flash column chromatography (hexanes) afforded the title compound as a viscous, colourless 
liquid that solidified on standing (0.32 g, 0.96 mmol, 80%). 
1H NMR (400 MHz, CDCl3): δ 7.58 (dd, J = 7.4, 1.7 Hz, 1H), 7.38 – 7.17 (m, 5H), 7.07 – 
6.90 (m, 7H), 5.86 (s, 1H), 0.24 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 161.5 (d, J = 
245 Hz), 148.7, 144.7, 140.5 (d, J = 3.3 Hz), 139.3, 135.2, 131.2 (d, J = 7.9 Hz), 130.6, 129.7, 
129.3, 128.4, 126.4, 126.0, 115.1 (d, J = 21 Hz), 55.0, 0.78. 19F NMR (377 MHz, CDCl3): –
117.0 (m). νmax(neat)/cm–1: 3054, 2955, 1599, 1505, 1427, 1248, 1223, 1159, 1120, 1032, 
833, 794, 755, 739. HRMS calcd. for C22H23FSi: 334.1548 [M]+; found (EI+): 334.1547. m.p. 
/°C: 70.  
{2-[(4-Chlorophenyl)(phenyl)methyl]phenyl}trimethylsilane (1ab) 
 
1-Bromo-2-[(4-chlorophenyl)(phenyl)methyl]benzene: nBuLi (2.38 M in hexanes, 0.88 mL, 
2.10 mmol) was added dropwise to a stirred solution of 1-bromo-4-chlorobenzene (0.37 g, 
1.91 mmol) in THF (5 mL) at –78 °C. The reaction was stirred at this temperature for 1 h, then 
2-bromobenzophenone (0.35 mL, 1.91 mmol) was added dropwise, and the mixture was 
stirred at room temperature overnight. The reaction was quenched with H2O (5 mL), then the 
aqueous phase was separated and extracted with Et2O (3 × 10 mL), and the combined organic 
portions were dried (MgSO4), filtered and concentrated in vacuo. The crude reaction mixture 
was transferred to a Schlenk flask which was evacuated and back-filled with N2 three times, 
then CH2Cl2 (5.5 mL) was added. The solution was cooled to 0 °C, then TFA (0.59 mL, 7.71 
mmol) was added dropwise. After 5 min, Et3SiH (0.61 mL, 3.86 mmol) was added dropwise, 




The volatiles were then evaporated under a stream of N2 and purification via flash column 
chromatography (hexanes) afforded 1-bromo-2-[(4-chlorophenyl)(phenyl)methyl]benzene as 
a colourless liquid (0.46 g, 1.28 mmol, 67%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.9, 1.3 Hz, 1H), 7.36 – 7.19 (m, 6H), 7.11 (app. 
td, J = 7.6, 1.8 Hz, 1H), 7.07 – 6.98 (m, 4H), 6.91 (dd, J = 7.8, 1.8 Hz, 1H), 5.92 (s, 
1H).13C{1H} NMR (100 MHz, CDCl3): δ 142.9, 142.3, 141.3, 133.3, 132.5, 131.4, 131.1, 
129.7, 128.66, 128.62, 128.4, 127.5, 126.8, 125.6, 55.5. νmax(neat)/cm–1: 3059, 3025, 2980, 
2890, 1599, 1566, 1488, 1464, 1450, 1438, 1405, 1089, 1014, 799, 745, 699. HRMS calcd. 
for C19H14BrCl: 355.9962 [M]+; found (EI+): 355.9962. 
{2-[(4-Chlorophenyl)(phenyl)methyl]phenyl}(trimethyl)silane: Following General 
Procedure 3, nBuLi (2.38 M in hexanes, 0.55 mL, 1.31 mmol) was added to 1-bromo-2-[(4-
chlorophenyl)(phenyl)methyl]benzene (0.43 g, 1.19 mmol) in THF (3.5 mL) at –78 °C. The 
reaction was stirred at this temperature for 5 min, then Me3SiCl (0.23 mL, 1.79 mmol) was 
added dropwise, and the mixture was stirred at room temperature overnight. Purification via 
flash column chromatography (hexanes) afforded the title compound as a viscous, colourless 
liquid that solidified on standing (0.31 g, 0.88 mmol, 74%). 
1H NMR (400 MHz, CDCl3): δ 7.58 (dd, J = 7.4, 1.3 Hz, 1H), 7.35 – 7.17 (m, 7H), 7.04 – 
6.99 (m, 2H), 6.99 – 6.94 (m, 3H), 5.85 (s, 1H), 0.24 (s, 9H). 13C{1H} NMR (100 MHz, 
CDCl3): δ 148.4, 144.4, 143.4, 139.4, 135.2, 132.1, 131.1, 130.6, 129.7, 129.3, 128.44, 128.42, 
126.5, 126.0, 55.2, 0.79. νmax(neat)/cm–1: 3056, 3026, 2955, 2895, 1489, 1470, 1449, 1431, 
1404, 1249, 1122, 1090, 1014, 832, 798, 757, 744, 729, 700. HRMS calcd. for C22H23ClSi: 














1-Bromo-2-{phenyl[4-(trifluoromethyl)phenyl]methyl}benzene: nBuLi (2.38 M in hexanes, 
0.88 mL, 2.10 mmol) was added dropwise to a stirred solution of 4-bromobenzotrifluoride 
(0.27 mL, 1.91 mmol) in THF (5 mL) at –78 °C. The reaction was stirred at this temperature 
for 1 h, then 2-bromobenzophenone (0.35 mL, 1.91 mmol) was added dropwise, and the 
mixture was allowed to warm to room temperature and was stirred overnight. The reaction 
was quenched with H2O (5 mL), then the aqueous phase was separated and extracted with Et2O 
(3 × 10 mL), and the combined organic portions were dried (MgSO4), filtered and concentrated 
in vacuo. The crude reaction mixture was transferred to a Schlenk flask which was evacuated 
and back-filled with N2 three times, then CH2Cl2 (5.5 mL) was added. The solution was cooled 
to 0 °C, then TFA (0.59 mL, 7.71 mmol) was added dropwise. After 5 min, Et3SiH (0.61 mL, 
3.86 mmol) was added dropwise, and the reaction was allowed to warm to room temperature 
and was stirred for 3 h. The volatiles were then evaporated under a stream of N2 and 
purification via flash column chromatography (hexanes) afforded 1-bromo-2-{phenyl[4-
(trifluoromethyl)phenyl]methyl}benzene as a colourless liquid (0.41 g, 1.04 mmol, 54%). 
1H NMR (400 MHz, CD2Cl2): δ 7.62 (dd, J = 7.9, 1.4 Hz, 1H), 7.57 (d, J = 8.1 Hz, 2H), 7.36 
– 7.20 (m, 6H), 7.15 (app. td, J = 7.6, 1.7 Hz, 1H), 7.10 – 7.05 (m, 2H), 6.93 (dd, J = 7.7, 1.7 
Hz, 1H), 6.02 (s, 1H). 13C{1H} NMR (100 MHz, CD2Cl2): δ 147.5, 142.9, 142.3, 133.8, 131.8, 
130.6, 130.1, 129.12, 129.05, 128.0, 127.4, 125.9, 125.8 (q, J = 3.7 Hz), 124.9 (q, J = 270 Hz), 
56.4. 1 × CAr not observed. 19F NMR (377 MHz, CD2Cl2): δ -62.7 (s). νmax(neat)/cm–1: 3062, 
3028, 1618, 1601, 1585, 1494, 1465, 1438, 1415, 1322, 1162, 1120, 1066, 1018, 874, 837, 
806, 749, 719, 699. HRMS calcd. for C20H14BrF3: 390.0223 [M]+; found (EI+): 390.0233. 
Trimethyl(2-{phenyl[4-(trifluoromethyl)phenyl]methyl}phenyl)silane: Following General 




{phenyl[4-(trifluoromethyl)phenyl]methyl}benzene (0.38 g, 0.98 mmol) in THF (3 mL) at –
78 °C. The reaction was stirred at this temperature for 5 min, then Me3SiCl (0.19 mL, 1.47 
mmol) was added dropwise, and the mixture was stirred at room temperature overnight. 
Purification via flash column chromatography (hexanes) afforded the title compound as a 
viscous, colourless liquid (0.23 g, 0.59 mmol, 60%). 
1H NMR (400 MHz, CDCl3): δ 7.60 (dd, J = 7.4, 1.5 Hz, 1H), 7.52 (d, J = 8.0 Hz, 2H), 7.36 
– 7.19 (m, 5H), 7.16 (d, J = 8.0 Hz, 2H), 7.05 – 6.99 (m, 2H), 6.97 (dd, J = 7.7, 1.1 Hz, 1H), 
5.93 (s, 1H), 0.25 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 149.0, 147.9, 143.9, 139.5, 
135.3, 130.6, 130.1, 129.7, 129.4, 128.6 (q, J = 32 Hz), 128.5, 126.7, 126.2, 125.2 (q, J = 3.7 
Hz), 124.4 (q, J = 270 Hz), 55.6, 0.79. 19F NMR (377 MHz, CDCl3): δ -62.3 (s). 
νmax(neat)/cm–1: 3059, 3027, 2958, 2897, 1618, 1414, 1323, 1251, 1162, 1121, 1111, 1067, 




Bis(2-bromophenyl)methanol: Sodium borohydride (58 mg, 1.52 mmol) was added 
portionwise over 5 min to a solution of 2,2′-dibromobenzophenone (0.52 g, 1.52 mmol) in 
methanol (12 mL) and THF (3 mL) at 0 °C. The reaction was stirred at room temperature for 
2 h, then diluted with a saturated solution of NH4Cl (20 mL). The aqueous phase was separated 
and extracted with EtOAc (3 × 20 mL), and the combined organic portions were dried 
(MgSO4), filtered and concentrated in vacuo. Purification via flash column chromatography 
(10% EtOAc in hexanes) afforded bis(2-bromophenyl)methanol as a viscous oil that solidified 
on standing (0.49 g, 1.42 mmol, 92%).  
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR:[20] 
1H NMR (400 MHz, CDCl3): 7.58 (dd, J = 7.7, 1.0 Hz, 2H), 7.36 – 7.28 (m, 4H), 7.21 – 7.15 
(m, 2H), 6.41 (d, J = 4.0 Hz, 1H). 13C{1H} NMR (100 MHz, CDCl3): 141.0, 133.1, 129.5, 




2,2'-Dibromodiphenylmethane: Following General Procedure 2B, bis(2-
bromophenyl)methanol (0.71 g, 2.06 mmol) in CH2Cl2 (1.3 mL) was reacted with TFA (1.8 
mL, 16.5 mmol) and Et3SiH (0.65 mL, 4.12 mmol). Purification via flash column 
chromatography (hexanes) afforded 2,2'-dibromodiphenylmethane (0.54 g, 1.65 mmol, 80%) 
as a colourless liquid. 
1H NMR (400 MHz, CDCl3): δ 7.61 (dd, J = 7.9, 1.3 Hz, 2H), 7.23 (app. td, J = 7.5, 1.3 Hz, 
2H), 7.12 (app. td, J = 7.7, 1.8 Hz, 2H), 6.99 (dd, J = 7.6, 1.6 Hz, 2H), 4.21 (s, 2H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 139.0, 133.0, 130.8, 128.2, 127.7, 125.2, 42.2. νmax(neat)/cm–1: 
3056, 1566, 1466, 1438, 1045, 1022, 945, 740. HRMS calcd. for C13H10Br2: 323.9144[M]+; 
found (EI+): 323.9142. 
Bis-[2-trimethyl(phenyl)silyl]-methane: nBuLi (2.38 M in hexanes, 1.28 mL, 3.05 mmol) was 
added dropwise to a stirred solution of 2,2'-dibromodiphenylmethane (0.40 g, 1.22 mmol) in 
THF (6 mL) at –78 °C. The reaction was stirred at this temperature for 1.5 h, then Me3SiCl 
(0.46 mL, 3.66 mmol) was added dropwise, and the mixture was allowed to warm to room 
temperature and was stirred overnight. The reaction was quenched with H2O (10 mL), then the 
aqueous phase was separated and extracted with Et2O (3 × 15 mL), and the combined organic 
portions were dried (MgSO4), filtered and concentrated in vacuo. Purification via flash column 
chromatography (hexanes) afforded the title compound as a colourless liquid that solidified on 
standing (0.25 g, 0.81 mmol, 66%). 
1H NMR (400 MHz, CDCl3): δ 7.56 (dd, J = 7.1, 1.7 Hz, 2H), 7.34 – 7.14 (m, 4H), 6.85 (app. 
d, J = 8.4 Hz, 2H), 4.32 (s, 2H), 0.35 (s, 18H). 13C{1H} NMR (100 MHz, CDCl3): δ 147.0, 
139.0, 134.5, 129.8, 129.5, 125.5, 42.1, 0.43. νmax(neat)/cm–1: 3068, 2959, 2896, 1587, 1560, 
1467, 1422, 1248, 1191, 1121, 833, 755, 745, 729. HRMS calcd. for C19H28Si2: 312.1724[M]+; 










8.3 Intramolecular Direct Arylation: Scope 
8.3.1 General Procedure and Considerations 
thtAuBr3 (1-4 mol%, as specified for individual compounds) was added to a 25 mL vial 
containing the requisite aryltrimethylsilane (0.50 mmol) in CHCl3 (5 mL) and MeOH (100 
μL). Camphorsulfonic acid (151 mg, 0.65 mmol) and iodobenzene diacetate (177 mg, 0.55 
mmol) were added, and the reaction was stirred at 27 °C (reaction time as specified for 
individual compounds). After analysis of the composition by 1H NMR spectroscopy, the 
reaction mixture was concentrated in vacuo and purified by flash column chromatography 
(dry-loaded onto silica gel, eluent as specified for individual compounds).  
Notes:  
- For reproducibility, reactions were performed in an oil bath set to 27 °C due to 
variations in room temperature throughout the year.   
- The CHCl3 used was CHROMASOLVRTM Plus, for HPLC, =99.9%, containing 
amylenes as stabilizers, bought from Sigma Aldrich. Ethanol stabilized CHCl3 led to 
longer reaction times and reduced yields in certain examples (e.g. 1m to 2m, yield 
changes from 40% to 88%). The CHCl3 was passed through a plug of activated basic 
Al2O3 (Brockmann I), distilled and held over 3 Å MS. 
- Methanol was held over 3 Å MS. 
- Camphorsulfonic acid was held in a desiccator and weighed out immediately before 
use.  
- A useful indication that the reaction is complete is the change of colour from pale 
yellow to black. This occurs when all the oxidant is consumed and, presumably, 
deposition of gold nanoparticles occurs. This is most obvious in the faster reactions. 
8.3.2 Experimental Procedures and Characterisation Data 
9H-Fluorene (2b) 
 
Subjecting 1b (120 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 1 h) afforded, after flash column chromatography (hexanes), the title 




Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR:[21] 
1H NMR (400 MHz, CDCl3): δ 7.81 (app. d, J = 7.6 Hz, 2H), 7.56 (app. d, J = 7.4 Hz, 2H), 
7.44 – 7.34 (m, 2H), 7.31 (app. td, J = 7.4, 1.2 Hz, 2H), 3.92 (s, 2H). 13C{1H} NMR (100 
MHz, CDCl3): δ 143.4, 141.8, 126.85, 126.83, 125.2, 120.0, 37.1. νmax(neat)/cm–1: 3059, 
3037, 2919, 1477, 1446, 1384, 1187, 953, 732. m.p. /°C: 114 (Lit.[22] 113-114).  
3-Methoxyl-9H-fluorene (2c) 
 
thtAuBr3 (2.62 mg, 0.005 mmol, 1 mol%) was added to a 7 mL vial containing 1c (135 mg, 
0.50 mmol) in CHCl3 (5 mL) and MeOH (100 μL). PIFA (237 mg, 0.55 mmol) was added, 
and the reaction was stirred at 27 °C for 1.5 h. The reaction mixture was concentrated in vacuo 
and purification by flash column chromatography (dry-loaded onto silica gel, 2% EtOAc) 
afforded the title compound as a white solid (87 mg, 0.44 mmol, 88%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR:[22,23] 
1H NMR (600 MHz, CDCl3): δ 7.76 (d, J = 7.6 Hz, 1H), 7.54 (d, J = 7.4 Hz, 1H), 7.44 (d, J 
= 8.3 Hz, 1H), 7.38 (app. t, J = 7.5 Hz, 1H), 7.33 – 7.29 (m, 2H), 6.89 (dd, J = 8.2, 2.4 Hz, 
1H), 3.91 (s, 3H), 3.84 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 159.4, 144.4, 143.1, 
141.8, 135.5, 126.9, 126.8, 125.7, 125.2, 119.9, 113.4, 105.1, 55.7, 36.3. νmax(neat)/cm–1: 
3047, 2932, 1607, 1576, 1453, 1436, 1305, 1243, 1215, 1169, 1034, 848, 766, 734. 
3-tert-Butyl-9H-fluorene (2e) 
 
Subjecting 1e (148 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 1 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (90 mg, 0.40 mmol, 81%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[22] 
1H NMR (600 MHz, CDCl3): δ 7.85 (d, J=1.7 Hz, 1H), 7.83 (d, J=7.6 Hz, 1H), 7.54 (app. d, 
J=7.5 Hz, 1H), 7.50 (app. d, J= 7.9 Hz, 1H), 7.41 – 7.37 (m, 2H), 7.32 (app. td, J = 7.4, 1.1 
Hz, 1H), 3.88 (s, 2H), 1.43 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 150.1, 143.8, 142.1, 




1: 3042, 2967, 2955, 2863, 1613, 1469, 1452, 1397, 1359, 1312, 1254, 1202, 1105, 1034, 820, 
765, 735, 704. m.p. /°C: 56-57 (Lit.[22] 55-56). 
3-Chloro-9H-fluorene (2f) 
 
Subjecting 1f (137 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 4 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (90 mg, 0.45 mmol, 90%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR:[23] 
1H NMR (400 MHz, CDCl3): δ 7.77 – 7.72 (m, 2H), 7.55 (app. d, J = 7.4 Hz, 1H), 7.45 (d, J 
= 8.0 Hz, 1H), 7.42 – 7.37 (m, 1H), 7.34 (app. td, J = 7.4, 1.3 Hz, 1H), 7.27 (dd, J = 8.1, 1.8 
Hz, 1H), 3.86 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 143.8, 143.6, 141.5, 140.7, 132.9, 
127.5, 127.1, 126.8, 126.1, 125.3, 120.3, 36.7. 1 × CAr not observed, in agreement with 
literature. νmax(neat)/cm–1: 3050, 2926, 1597, 1473, 1441, 1386, 1069, 879, 856, 806, 766, 
733.  m.p. /°C: 89-90 (Lit.[23] 90-92). 
9H-Fluoren-3-yl 2,2-dimethylpropanoate (2g) 
 
Subjecting 1g (175 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 6 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (108 mg, 0.41 mmol, 81%). 
1H NMR (400 MHz, CDCl3): δ 7.75 (app. d, J = 7.5 Hz, 1H), 7.55 (app. d, J = 7.4 Hz, 1H), 
7.52 (d, J = 8.2 Hz, 1H), 7.47 (d, J = 2.1 Hz, 1H), 7.38 (app. td, J = 7.4, 1.1 Hz, 1H), 7.33 
(app. td, J = 7.4, 1.1 Hz , 1H), 6.99 (dd, J = 8.2, 2.2 Hz, 1H), 3.88 (s, 2H), 1.42 (s, 9H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 177.5, 150.6, 144.1, 143.2, 141.2, 140.4, 127.2, 126.9, 125.6, 
125.2, 120.3, 119.9, 113.3, 39.3, 36.6, 27.4. νmax(neat)/cm–1: 2961, 2929, 2870, 1741, 1615, 
1477, 1449, 1395, 1267, 1175, 1157, 1119, 916, 761, 728. HRMS calcd. for C18H18O2: 








Subjecting 1h (154 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 14.5 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (94 mg, 0.40 mmol, 80%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR:[23] 
1H NMR (400 MHz, CDCl3): δ 8.02 (s, 1H), 7.83 (d, J = 7.4 Hz, 1H), 7.64 (app. d, J = 7.9 
Hz, 1H), 7.62 – 7.55 (m, 2H), 7.45 – 7.40 (m, 1H), 7.37 (app. td, J = 7.4, 1.3 Hz, 1H), 3.95 (s, 
2H). 13C{1H} NMR (100 MHz, CDCl3): δ 146.9, 143.4, 142.5, 140.6, 129.5 (q, J = 32.0 Hz), 
127.8, 127.2, 125.4, 125.3, 124.8 (q, J = 270 Hz), 123.6 (q, J = 3.7 Hz), 120.4, 116.9 (q, J = 
3.9 Hz), 37.1. 19F NMR (377 MHz, CDCl3): δ -61.9 (s). νmax(neat)/cm–1: 3054, 2930, 1789, 
1611, 1404, 1321, 1265, 1233, 1160, 1098, 1056, 896, 827, 769, 736. m.p. /°C: 69-70 (MeOH) 
(Lit.[23] 65-67).  
9H-Fluoren-3-yl trifluoromethanesulfonate (2n) 
 
Subjecting 1n (194 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 5.24 mg, 
0.01 mmol, 2 mol%, 16 h) afforded, after flash column chromatography (2% EtOAc in 
hexanes), the title compound as a colourless oil (145 mg, 0.46 mmol, 92%). 
1H NMR (400 MHz, CDCl3): δ 7.78 (app. d, J = 6.7 Hz, 1H), 7.64 (d, J = 2.3 Hz, 1H), 7.60 
– 7.53 (m, 2H), 7.45 – 7.34 (m, 2H), 7.19 (dd, J = 8.2, 2.4 Hz, 1H), 3.92 (s, 2H). 13C{1H} 
NMR (100 MHz, CDCl3): δ 149.2, 144.2, 144.0, 143.2, 140.2, 128.1, 127.3, 126.4, 125.4, 
120.6, 119.3, 119.0 (q, J = 320 Hz), 113.0, 36.7. 19F NMR (377 MHz, CDCl3): δ –72.8 (s). 
νmax(neat)/cm–1: 3066, 2899, 1482, 1418, 1244, 1202, 1137, 1118, 903, 850, 811, 765, 727. 








3-Methyl-9H-fluorene / 4-Methyl-9H-fluorene (2i) 
 
thtAuBr3 (2.62 mg, 0.005 mmol, 1 mol%) was added to a 7 mL vial containing 1i (127 mg, 
0.50 mmol) in CHCl3 (5 mL) and MeOH (100 μL). PIFA (237 mg, 0.55 mmol) was added, 
and the reaction was stirred at 27 °C for 1 h. The reaction mixture was concentrated in vacuo 
and purification by flash column chromatography (dry-loaded onto silica gel, hexanes) 
afforded the title compounds as a white solid (95:5 mixture of isomers; 87 mg, 0.47 mmol, 
95%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR:42, 45  
Data for major regioisomer: 1H NMR (400 MHz, CDCl3): δ 7.77 (app. d, J = 7.6 Hz, 1H), 
7.69 (d, J = 7.7 Hz, 1H), 7.58 – 7.50 (m, 1H), 7.41 – 7.35 (m, 2H), 7.29 (app. td, J = 7.4, 1.2 
Hz, 1H), 7.23 – 7.19 (m, 1H), 3.88 (s, 2H), 2.46 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): 
δ 143.5, 143.1, 141.8, 139.1, 136.6, 127.6, 126.7, 126.2, 125.8, 125.0, 119.60, 119.56, 36.8, 
21.7. Select data for minor regioisomer: 1H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 7.8 Hz, 
1H), 3.96 (s, 2H), 2.76 (s, 3H). νmax(neat)/cm–1: 3020, 2910, 2853, 1453, 1400, 1393, 1298, 
1177, 953, 821, 760, 728. LRMS (EI+): 180 ([M]+, 90%), 165 ([M - CH3]+, 100%). 
2-Methoxy-9H-fluorene (2j) 
 
thtAuBr3 (2.62 mg, 0.005 mmol, 1 mol%) was added to a 7 mL vial containing 1j (135 mg, 
0.50 mmol) in CHCl3 (5 mL) and MeOH (100 μL). PIFA (237 mg, 0.55 mmol) was added, 
and the reaction was stirred at 27 °C for 1 h. Analysis of the composition by 1H NMR 
spectroscopy showed a mixture of 2/4-methoxy-9H-fluorene (88:12). The reaction mixture 
was concentrated in vacuo and purification by flash column chromatography (dry-loaded onto 
silica gel, 4% EtOAc) afforded the title compound as a white solid (79 mg, 0.40 mmol, 80%; 
91% conversion based on both isomers). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR:[24] 
1H NMR (400 MHz, CDCl3): 7.74 – 7.66 (m, 2H), 7.51 (app. d, J = 7.4 Hz, 1H), 7.35 (app. t, 




Hz, 1H), 3.88 (s, 5H).13C{1H} NMR (100 MHz, CDCl3): 159.4, 145.2, 142.8, 141.8, 134.9, 
126.9, 125.7, 125.0, 120.6, 119.2, 113.1, 110.7, 55.7, 37.2. νmax(neat)/cm–1: 3039, 2827, 1603, 
1488, 1420, 1309, 1266, 1139, 1038, 829, 764, 733. m.p. /°C: 109-110 (Lit.[25] 109-110). 
2-Fluoro-9H-fluorene (2k) 
 
Subjecting 1k (129 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 2 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (78 mg, 0.42 mmol, 85%).  
Characterisation data were consistent with literature values: 1H, 13C{1H} 19F NMR and IR:[26,27] 
1H NMR (600 MHz, CDCl3): δ 7.74 (app. d, J = 7.6 Hz, 1H), 7.71 (dd, J = 8.3, 5.2 Hz, 1H), 
7.55 – 7.53 (m, 1H), 7.39 (app. t, J = 7.5 Hz, 1H), 7.30 (app. td, J = 7.5, 1.2 Hz, 1H), 7.27 – 
7.24 (m, 1H), 7.09 (app. td, J = 8.7, 2.4 Hz, 1H), 3.89 (s, 2H). 13C{1H} NMR (150 MHz, 
CDCl3): δ 162.5 (d, J = 240 Hz), 145.4 (d, J = 8.6 Hz), 143.1 (d, J = 1.8 Hz), 141.0, 137.9 (d, 
J = 2.5 Hz), 127.0, 126.5, 125.1, 120.8 (d, J = 8.9 Hz), 119.7, 114.1 (d, J = 23 Hz), 112.4 (d, 
J = 23 Hz), 37.1 (d, J = 2.4 Hz). 19F NMR (377 MHz, CDCl3): –115.8 (app. td, J = 9.1, 5.1 
Hz). νmax(neat)/cm–1: 3051, 2923, 2906, 2854, 1589, 1469, 1423, 1399, 1249, 1120, 926, 821, 
761, 728. m.p. /°C: 99-100 (Lit.[28] 99-100). 
2-Chloro-9H-fluorene (2l) 
 
thtAuBr3 (10.5 mg, 0.002 mmol, 1 mol%) was added to a 50 mL round bottom flask containing 
1l (549 mg, 2.00 mmol) in CHCl3 (20 mL) and MeOH (400 μL). Camphorsulfonic acid (603 
mg, 2.60 mmol) and iodobenzene diacetate (709 mg, 2.20 mmol) were added, and the reaction 
was stirred at 27 °C for 3 h. After analysis of the composition by 1H NMR spectroscopy, the 
reaction mixture was concentrated in vacuo and purification by flash column chromatography 
(dry-loaded onto silica gel, hexanes) afforded the title compound as a white solid (362 mg, 
1.80 mmol, 90%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR:[23] 
1H NMR (400 MHz, CDCl3): δ 7.75 (d, J = 7.5 Hz, 1H), 7.69 (d, J = 8.1 Hz, 1H), 7.57 – 7.52 




140.8, 140.4, 132.5, 127.18, 127.12, 127.07, 125.5, 125.2, 120.9, 120.0, 36.9. νmax(neat)/cm–




Subjecting 1m (154 mg, 0.50 mmol) to a modified general coupling procedure (thtAuBr3: 2.62 
mg, 0.005 mmol, 1 mol%, 16 h) and CSA (232 mg, 0.20 mmol) afforded, after flash column 
chromatography (hexanes), the title compound as a pale yellow solid (103 mg, 0.44 mmol, 
88%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} and IR:[23] 
1H NMR (400 MHz, CDCl3): δ 7.85 (app. t, J = 7.3 Hz, 2H), 7.80 (s, 1H), 7.68 – 7.55 (m, 
2H), 7.46 – 7.35 (m, 2H), 3.96 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 145.2, 143.9, 
143.6, 140.4, 128.7 (q, J = 32 Hz), 128.1, 127.8, 127.2, 125.4, 124.8 (q, J = 270 Hz), 124.2 (q, 
J = 3.9 Hz), 122.1 (q, J = 3.9 Hz), 120.0, 37.1. 19F NMR (377 MHz, CDCl3): δ -61.7 (s). 
νmax(neat)/cm–1: 3051, 2858, 1619, 1427, 1325, 1284, 1159, 1099, 1061, 882, 839, 772, 738. 
9H-Fluoren-2-yl-trifluoromethanesulfonate (2n) 
 
thtAuBr3 (2.26 mg, 0.0043 mmol, 1 mol%) was added to a 7 mL vial containing 1n (166 mg, 
0.43 mmol) in CHCl3 (4.3 mL) and MeOH (86 μL). Camphorsulfonic acid (130 mg, 0.56 
mmol) and iodobenzene diacetate (152 mg, 0.47 mmol) were added, and the reaction was 
stirred at 27 °C for 15 h. The reaction mixture was concentrated in vacuo and purification by 
flash column chromatography (dry-loaded onto silica gel, 3% EtOAc in hexanes) afforded the 
title compound as a white solid (105 mg, 0.34 mmol, 78%). 
1H NMR (400 MHz, CDCl3): δ 7.84 – 7.76 (m, 2H), 7.57 (app. d, J = 7.4 Hz, 1H), 7.48 – 7.45 
(m, 1H), 7.44 – 7.38 (m, 1H), 7.36 (app. td, J = 7.4, 1.3 Hz, 1H), 7.29 (dd, J = 8.3, 2.3 Hz, 
1H), 3.95 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 148.6, 145.4, 143.5, 142.1, 140.1, 
127.7, 127.3, 125.3, 121.0, 120.4, 120.1, 119.0 (q, J = 320 Hz), 118.4, 37.2. 19F NMR (377 
MHz, CDCl3): δ -72.8 (s). νmax(neat)/cm–1: 3062, 3022, 2919, 1418, 1207, 1130, 1094, 933, 
866, 849, 833, 818, 769, 752, 735, 710. HRMS calcd. for C14H9F3O3S: 314.0219 [M]+; found 






Subjecting 1a (134 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 10 min) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (94 mg, 0.48 mmol, 95%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR. [2] 
1H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 7.6 Hz, 1H), 7.60 (d, J = 7.4 Hz, 1H), 7.41 (m, 
1H), 7.34 (app. td, J = 7.4 Hz, 1.0 Hz, 1H), 7.10 (d, J = 7.6 Hz, 1H), 7.05 (d, J = 7.6 Hz, 1H), 
3.80 (s, 2H), 2.73 (s, 3H), 2.41 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 143.6, 143.2, 
142.4, 139.4, 131.4, 130.6, 129.4, 127.5, 126.7, 126.0, 125.0, 123.2, 36.2, 20.9, 18.8. 
νmax(neat)/cm–1: 3037, 2955, 1455, 1379, 1027, 804, 732. 
7-Fluoro-1,4-dimethylfluorene (2o) 
 
Subjecting 1o (143 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 15 min) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (94 mg, 0.44 mmol, 89%). 
1H NMR (400 MHz, CDCl3): δ 7.86-7.82 (dd, J = 8.5, 5.2 Hz, 1H), 7.31 – 7.23 (m, 1H), 7.12 
– 7.06 (m, 2H), 7.03 (d, J = 7.6 Hz, 1H), 3.74 (s, 2H), 2.68 (s, 3H), 2.39 (s, 3H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 161.8 (d, J = 244 Hz), 145.9 (d, J = 8.6 Hz), 142.2 (d, J = 2.1 Hz), 139.2 
(d, J = 2.3 Hz), 138.6, 131.5, 130.0 (d, J = 0.9 Hz), 129.5, 127.3, 123.9 (d, J = 8.7 Hz), 113.7 
(d, J = 22.3 Hz), 112.3 (d, J = 22.5 Hz), 36.2 (d, J = 2.4 Hz), 20.7, 18.7. 19F NMR (377 MHz, 
CDCl3): –116.9 (app. td, J = 9.0, 5.1 Hz). νmax(neat)/cm–1: 3050, 3023, 2976, 2946, 2918, 
2888, 2863, 1592, 1466, 1384, 1222, 925, 855, 807. HRMS calcd. for C15H13F: 212.0996 [M]+; 






thtAuBr3 (15.8 mg, 0.03 mmol, 2 mol%) was added to a 50 mL round bottom flask containing 
1p (454 mg, 1.50 mmol) in CHCl3 (15 mL) and MeOH (300 μL). Camphorsulfonic acid (453 
mg, 1.95 mmol) and iodobenzene diacetate (531 mg, 1.65 mmol) were added, and the reaction 
was stirred at 27 °C for 1 h. After analysis of the composition by 1H NMR spectroscopy, the 
reaction mixture was concentrated in vacuo and purification by flash column chromatography 
(dry-loaded onto silica gel, hexanes) afforded the title compound as a white solid (311 mg, 
1.36 mmol, 91%). 
1H NMR (400 MHz, CDCl3): δ 7.82 (d, J = 8.3 Hz, 1H), 7.54 (s, 1H), 7.35 (dd, J = 8.3, 2.1 
Hz, 1H), 7.12 – 7.02 (m, 2H), 3.75 (s, 2H), 2.67 (s, 3H), 2.38 (s, 3H). 13C{1H} NMR (100 
MHz, CDCl3): δ 145.4, 142.2, 141.7, 138.5, 131.8, 131.6, 130.5, 129.6, 127.9, 127.0, 125.3, 
123.9, 36.0, 20.8, 18.7. νmax(neat)/cm–1: 3042, 2971, 2944, 2916, 2889, 1500, 1452, 1442, 
1376, 1188, 1076, 891, 852, 805,753, 735. HRMS calcd. for C15H13Cl: 228.0700 [M]+; found 
(EI+): 228.0691. m.p. /°C: 98-100 (EtOH). 
1-Fluoro-9H-fluorene (2q) 
 
Subjecting 1q (129 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 16 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (80 mg, 0.44 mmol, 87%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR:[30] 
1H NMR (600 MHz, CDCl3): δ 7.79 (app. d, J = 7.3 Hz, 1H), 7.58 (app. d, J = 8.1 Hz, 2H), 
7.40 (app. t, J = 7.4 Hz, 1H), 7.38 – 7.34 (m, 2H), 7.01 (app. t, J = 8.7 Hz, 1H), 3.94 (s, 2H). 
13C{1H} NMR (150 MHz, CDCl3): δ 159.9 (d, J = 250 Hz), 145.2 (d, J = 6.6 Hz), 143.0, 141.1 
(d, J = 2.5 Hz), 129.0 (d, J = 7.1 Hz), 128.7 (d, J = 18.0 Hz), 127.5, 127.1, 125.4, 120.4, 115.9 
(d, J = 3.1 Hz), 113.5 (d, J = 21 Hz), 33.6. 19F NMR (377 MHz, CDCl3): –118.3 (dd, J = 9.2, 
5.1 Hz). νmax(neat)/cm–1: 3052, 3035, 1622, 1579, 1490, 1453, 1277, 1235, 1206, 1071, 907, 










Subjecting 1r (136 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 5 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (88 mg, 0.44 mmol, 89%). 
1H NMR (400 MHz, CDCl3): δ 7.68 (dd, J = 8.3, 5.2 Hz, 1H), 7.55 (s, 1H), 7.41 (d, J = 7.6 
Hz, 1H), 7.25 – 7.21 (m, 1H), 7.13 – 7.03 (m, 2H), 3.84 (s, 2H), 2.46 (s, 3H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 162.4 (d, J = 240 Hz), 145.8 (d, J = 8.6 Hz), 141.1, 140.2 (d, J = 2.0 
Hz), 137.9 (d, J = 2.4 Hz), 136.7, 127.5, 124.8, 120.6 (d, J = 9.0 Hz), 120.3, 114.0 (d, J = 23 
Hz), 112.4 (d, J = 23 Hz), 36.8 (d, J = 2.5 Hz), 21.7. νmax(neat)/cm–1: 3008, 2919, 2858, 2733, 
2711, 1613, 1585, 1480, 1432, 1381, 1250, 1213, 1123, 1091, 925, 854, 831, 806, 736, 715. 
19F NMR (377 MHz, CDCl3): –116.1 (app. td, J = 9.0, 5.1 Hz). HRMS calcd. for C14H11F: 
198.0839 [M]+; found (EI+): 198.0841. m.p. /°C: 79-80 (MeOH). 
11H-Benzo[a]fluorene (2s) 
 
thtAuBr3 (2.62 mg, 0.005 mmol, 1 mol%) was added to a 7 mL vial containing 1s (145 mg, 
0.50 mmol) in CHCl3 (5 mL) and MeOH (100 μL). PIFA (237 mg, 0.55 mmol) was added, 
and the reaction was stirred at 27 °C for 1 h. The reaction mixture was concentrated in vacuo 
and purification by flash column chromatography (dry-loaded onto silica gel, hexanes) 
afforded the title compound as a white solid (90 mg, 0.40 mmol, 80%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[22]  
1H NMR (400 MHz, CDCl3): δ 8.03 (d, J = 8.2 Hz, 1H), 7.96 – 7.82 (m, 4H), 7.64 (app. d, J 
= 7.4 Hz, 1H), 7.59 – 7.51 (m, 1H), 7.51 – 7.43 (m, 1H), 7.42 (app. t, J = 7.4 Hz, 1H), 7.33 
(app. td, J = 7.4, 1.2 Hz, 1H), 4.20 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): δ 143.4, 142.8, 
139.9, 139.1, 133.0, 130.9, 129.1, 127.9, 126.9, 126.6, 126.5, 125.4, 125.0, 124.2, 119.8, 
118.9, 35.8. νmax(neat)/cm–1: 3051, 1467, 1407, 1393, 1370, 1327, 1260, 1167, 1015, 943, 








Subjecting 1t (134 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 1 h) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (74 mg, 0.38 mmol, 76%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR:[31] 
1H NMR (400 MHz, CDCl3): δ 7.62 (br. s, 2H), 7.44 (d, J = 7.6 Hz, 2H), 7.14 (app. d, J = 8.2 
Hz, 2H), 3.84 (s, 2H), 2.49 (s, 6H). 13C{1H} NMR (100 MHz, CDCl3): δ 142.0, 140.9, 136.3, 
127.6, 124.8, 120.5, 36.3, 21.7. νmax(neat)/cm–1: 3006, 2915, 2857, 1613, 1496, 1454, 1399, 
1307, 1281, 1194, 1147, 1035, 884, 801, 752. m.p. /°C: 129-130 °C (Lit.[32] 130-131 °C).  
2,9-Dimethyl-9H-fluorene/ 4,9-dimethyl-9H-fluorene (2u) 
 
thtAuBr3 (5.24 mg, 0.05 mmol, 2 mol%) was added to a 7 mL vial containing 1u (134 mg, 
0.50 mmol) in CHCl3 (5 mL) and MeOH (100 μL). PIFA (237 mg, 0.55 mmol) was added, 
and the reaction was stirred at 27 °C for 1 h. The reaction mixture was concentrated in vacuo 
and purification by flash column chromatography (dry-loaded onto silica gel, hexanes) 
afforded the title compound as a yellow oil (97:3 mixture of isomers, 77 mg, 0.40 mmol, 79%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[33,34] 
Major: 1H NMR (400 MHz, CDCl3): δ 7.74 (app. d, J = 7.5 Hz, 1H), 7.67 (d, J = 7.7 Hz, 1H), 
7.54 – 7.49 (m, 1H), 7.39 – 7.36 (m, 1H), 7.35 (s, 1H), 7.31 (app. td, J = 7.4, 1.2 Hz, 1H), 7.23 
– 7.19 (m, 1H), 3.93 (q, J = 7.5 Hz, 1H), 2.47 (s, 3H), 1.54 (d, J = 7.5 Hz, 3H). 13C{1H} NMR 
(100 MHz, CDCl3): 149.4, 149.0, 140.8, 138.0, 136.9, 127.9, 127.0, 126.6, 124.9, 124.1, 
119.72, 119.65, 42.4, 21.8, 18.4. Select minor peaks: 1H NMR (400 MHz, CDCl3): 7.92 (d, J 
= 7.7 Hz, 1H), 2.75 (s, 3H), 1.54 (d, J = 7.5 Hz, 3H). νmax(neat)/cm–1: 2924, 1454, 1089, 821, 








To a 2 mL screw-cap borosilicate vial containing 1ae (15.5 mg, 0.05 mmol) was added CDCl3 
(436 μL), CD3OD (10 μL) and thtAuBr3 (0.001 mmol, 64 μL of a 0.0155 M stock solution in 
CDCl3). CSA (0.065 mmol, 15.1 mg) followed immediately by IBDA (0.055 mmol, 17.7 mg) 
were added. The vial was sealed and shaken vigorously until all the contents had dissolved. 
The solution was stirred for 48 h and then filtered through a plug of silica gel. The product 
was isolated by preparative TLC as a white solid (eluent: hexanes).  
Characterisation data were consistent with literature values: 1H NMR.[35] 
1H NMR (400 MHz, CDCl3): 7.65 (d, J = 8.2 Hz, 2H), 7.51 (br. s, 2H), 7.35 (dd, J = 8.2, 1.9 
Hz, 2H), 3.87 (s, 2H). 13C{1H} NMR (100 MHz, CDCl3): 144.7, 139.4, 132.9, 127.5, 125.6, 
120.9, 36.8. LRMS (EI+): 234 ([M]+, 100%). 
Dibenzo[b,d]furan (2v) 
 
Subjecting 1v (121 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 30 min) afforded, after flash column chromatography (hexanes), the title 
compound as a white solid (79 mg, 0.44 mmol, 87%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR and IR.[36] 
1H NMR (400 MHz, CDCl3): δ 7.98 (app. d, J = 7.7 Hz, 2H), 7.60 (app. d, J = 8.2 Hz, 2H), 
7.48 (app. t, J = 7.7 Hz, 2H), 7.37 (app. t, J = 7.5 Hz, 2H). 13C{1H} NMR (100 MHz, CDCl3): 
δ 156.3, 127.2, 124.4, 122.8, 120.8, 111.8. νmax(neat)/cm–1: 3046, 1595, 1469, 1443, 1193, 











Subjecting 1w (201 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 45 min) afforded, after flash column chromatography (20% EtOAc in 
hexanes), the title compound as a white solid (153 mg, 0.47 mmol, 94%). 
1H NMR (400 MHz, CDCl3): δ 8.05 (d, J = 1.7 Hz, 1H), 7.97 – 7.93 (m, 1H), 7.85 (dd, J = 
5.5, 3.0 Hz, 2H), 7.69 (dd, J = 5.5, 3.0 Hz, 2H), 7.58 (dd, J = 8.5, 1.8 Hz, 1H), 7.55 – 7.48 (m, 
2H), 7.48 – 7.39 (m, 1H), 7.33 (app. td, J = 7.5, 1.0 Hz, 1H), 5.00 (s, 2H). 13C{1H} NMR (100 
MHz, CDCl3): δ 168.2, 156.7, 155.9, 134.1, 132.3, 131.2, 128.3, 127.4, 124.7, 124.1, 123.5, 
122.9, 121.4, 121.0, 111.9, 111.8, 41.8. νmax(neat)/cm–1: 3042, 3027, 2962, 1770, 1702, 1481, 
1393, 1327, 1198, 1106, 952, 797, 745, 720. HRMS calcd. for C21H13NO3: 327.0890 [M]+; 
found (EI+): 327.0880. m.p. /°C: 154-156 (EtOH). 
9,10-dihydrophenanthrene (4a) 
 
Subjecting 3a (127 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 2.62 mg, 
0.005 mmol, 1 mol%, 1 h) afforded, after flash column chromatography (hexanes), the title 
compound as a colourless oil (75 mg, 0.36 mmol, 72%). 
Characterisation data were consistent with literature values: 1H, 13C{H} NMR and IR.[37] 
1H NMR (400 MHz, CDCl3): 7.78 (app. d, J = 7.7 Hz, 2H), 7.37 – 7.17 (m, 6H), 2.90 (s, 4H). 
13C{1H} NMR (100 MHz, CDCl3): 137.5, 134.6, 128.3, 127.5, 127.1, 123.8, 29.2. 
νmax(neat)/cm–1: 3064, 3015, 2932, 2890, 2833, 1484, 1453, 1442, 771, 741, 724. 
2-chloro-9,10-dihydrophenanthrene (4b) 
 
Subjecting 3b (144 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 5.25 mg, 
0.01 mmol, 2 mol%, 1 h) afforded, after flash column chromatography (hexanes), the title 




1H NMR (400 MHz, CDCl3): 7.71 (app. d, J = 7.5 Hz, 1H), 7.67 (d, J = 8.3 Hz, 1H), 7.36 – 
7.21 (m, 5H), 3.04 – 2.65 (m, 4H). 13C{1H} NMR (100 MHz, CDCl3): 139.3, 137.2, 133.7, 
133.2, 133.0, 128.4, 128.2, 127.8, 127.24, 127.15, 125.2, 123.7, 29.1, 28.9. νmax(neat)/cm–1: 
3063, 3027, 2936, 2892, 2834, 1597, 1476, 1451, 1408, 1188, 1105, 1088, 1005, 875, 846, 
820, 762, 723. HRMS calcd. for C14H11Cl: 214.0544 [M]+; found (EI+): 214.0535 
2-(Trifluoromethyl)-9,10-dihydrophenanthrene (4c) 
 
thtAuBr3 (4.04 mg, 0.0078 mmol, 2 mol%) was added to a 7 mL vial containing 3c (124 mg, 
0.39 mmol) in CHCl3 (3.9 mL) and MeOH (77 μL). Camphorsulfonic acid (116 mg, 0.50 
mmol) and iodobenzene diacetate (135 mg, 0.42 mmol) were added, and the reaction was 
stirred at 27 °C for 15 h. The reaction mixture was concentrated in vacuo and purification by 
flash column chromatography (dry-loaded onto silica gel, hexanes) afforded the title 
compound as a yellow oil (79 mg, 0.32 mmol, 82%). 
1H NMR (400 MHz, CDCl3): δ 7.84 (d, J = 8.1 Hz, 1H), 7.78 (dd, J = 7.4, 1.4 Hz, 1H), 7.55 
(app. d, J = 8.2 Hz, 1H), 7.50 (s, 1H), 7.38 – 7.26 (m, 3H), 2.99 – 2.86 (m, 4H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 138.1, 138.0, 137.8, 133.4, 129.2 (q, J = 32 Hz), 128.6, 128.5, 127.4, 
125.1 (q, J = 3.8 Hz), 124.5 (q, J = 270 Hz), 124.3, 124.1, 124.0 (q, J = 4.0 Hz), 29.1, 28.8. 
19F NMR (377 MHz, CDCl3): δ -62.4 (s). νmax(neat)/cm–1: 2942, 2897, 2839, 1620, 1421, 
1334, 1318, 1259, 1158, 1113, 1100, 1075, 895, 861, 833, 771, 734, 711. HRMS calcd. for 
C15H11F3: 248.0807 [M]+; found (EI+): 248.0810 
6H-Benzo[c]chromene (4d) 
 
thtAuBr3 (5.25 mg, 0.01 mmol, 2 mol%) was added to a 20 mL round bottom flask containing 
3c (128 mg, 0.50 mmol) in CHCl3 (10 mL) and MeOH (200 μL). Camphorsulfonic acid (151 
mg, 0.65 mmol) and iodobenzene diacetate (177 mg, 0.55 mmol) were added, and the reaction 
was stirred at 27 °C for 2 h. The reaction mixture was concentrated in vacuo and purification 
by flash column chromatography (dry-loaded onto silica gel, 5% toluene in hexanes) afforded 
the title compound as a colourless oil (78 mg, 0.43 mmol, 86%). 




1H NMR (400 MHz, CDCl3): δ 7.75 (dd, J = 7.8, 1.6 Hz, 1H), 7.71 (app. d, J = 7.7 Hz, 1H), 
7.42 – 7.36 (m, 1H), 7.30 (dd, J = 7.5, 1.2 Hz, 1H), 7.28 – 7.23 (m, 1H), 7.18 – 7.14 (m, 1H), 
7.07 (app. td, J = 7.6, 1.2 Hz, 1H), 7.01 (dd, J = 8.1, 1.2 Hz, 1H), 5.14 (s, 2H). 13C{1H} NMR 
(100 MHz, CDCl3): δ 154.9, 131.6, 130.3, 129.6, 128.6, 127.8, 124.8, 123.4, 123.1, 122.3, 
122.1, 117.5, 68.6. νmax(neat)/cm–1: 3069, 3035, 2964, 2839, 1605, 1592, 1485, 1438, 1242, 
1195, 1015, 937, 810, 750, 722. LRMS (EI+): 182.0 ([M]+, 100%). 
2-tert-Butyl-6H-benzo[c]chromene (4e)[12] 
 
3e (156 mg, 0.50 mmol) was added to a 20 mL round bottom flask containing thtAuBr3 (5.24 
mg, 0.01 mmol, 2 mol%) in CHCl3 (10 mL) and MeOH (200 μL). Camphorsulfonic acid (151 
mg, 0.65 mmol) and iodobenzene diacetate (177 mg, 0.55 mmol) were added, and the reaction 
was stirred at 27 °C for 1 h. The reaction mixture was concentrated in vacuo and purification 
by flash column chromatography (dry-loaded onto silica gel, 10% toluene in hexanes) afforded 
the title compound as a colourless oil (71 mg, 0.30 mmol, 60%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[12] 
1H NMR (400 MHz, CDCl3): δ 7.77 (d, J = 2.4 Hz, 1H), 7.75 (app. d, J = 7.7 Hz, 1H), 7.42 
– 7.36 (m, 1H), 7.31 – 7.26 (m, 2H), 7.20 – 7.12 (m, 1H), 6.95 (d, J = 8.5 Hz, 1H), 5.11 (s, 
2H), 1.39 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 152.7, 144.9, 131.8, 130.7, 128.5, 
127.6, 126.7, 124.8, 122.3, 122.0, 120.0, 116.2, 68.7, 34.6, 31.7. νmax(neat)/cm–1: 3035, 2960, 
2866, 2838, 1496, 1447, 1362, 1246, 1214, 1198, 1016, 821, 767, 728. LRMS (EI+): 238 
([M]+, 40%), 223 ([M - Me]+, 100%). 
3-Methyl-6H-benzo[c]chromene; 1-Methyl-6H-benzo[c]chromene (4f) 
 
thtAuBr3 (5.25 mg, 0.01 mmol, 2 mol%) was added to a 20 mL round bottom flask containing 
3f (135 mg, 0.50 mmol) in CHCl3 (10 mL) and MeOH (200 μL). Camphorsulfonic acid (151 
mg, 0.65 mmol) and iodobenzene diacetate (177 mg, 0.55 mmol) were added, and the reaction 




by flash column chromatography (dry-loaded onto silica gel, 10% toluene in hexanes) afforded 
the title compounds as a colourless oil (89:11 mixture of isomers, 78 mg, 0.43 mmol, 86%). 
Characterisation data were consistent with literature values: 1H, 13C{1H} NMR, and IR:[39] 
Major Isomer: 1H NMR (400 MHz, CDCl3): δ 7.67 (app. d, J = 7.7 Hz, 1H), 7.62 (d, J = 7.9 
Hz, 1H), 7.41 – 7.32 (m, 1H), 7.29 – 7.22 (m, 1H), 7.17 – 7.11 (m, 1H), 6.92 – 6.84 (m, 1H), 
6.82 (s, 1H), 5.11 (s, 2H), 2.35 (s, 3H). Select minor peaks: δ 7.77 (app. d, J = 7.9 Hz, 1H), 
6.97 – 6.90 (m, 1H), 4.95 (s, 2H), 2.70 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 154.8, 
140.0, 131.2, 130.4, 128.5, 127.3, 124.7, 123.23, 123.19, 121.8, 120.3, 117.9, 68.7, 21.5. 
Select minor peaks: δ 127.9, 127.0, 126.4, 125.8, 125.0, 115.2, 69.2, 22.9. νmax(neat)/cm–1: 
3030, 2962, 2841, 1618, 1484, 1448, 1206, 1150, 1030, 763, 741, 726, 701. 
6,7-Dihydro-5H-dibenzo<a,c>cycloheptene (6a) 
 
Subjecting 5a (134 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 5.24 mg, 
0.01 mmol, 2 mol%, 15 h) afforded, after flash column chromatography (hexanes), the title 
compound as a colourless oil (82 mg, 0.43 mmol, 85%). 
Characterisation data were consistent with literature values: 1H NMR.[40] 
1H NMR (500 MHz, CDCl3): δ 7.43 (dd, J = 7.5, 1.6 Hz, 2H), 7.38 (app. td, J = 7.3, 1.5 Hz, 
2H), 7.33 (app. td, J = 7.3, 1.6 Hz, 2H), 7.28 (dd, J = 7.4, 1.5 Hz, 2H), 2.55 (t, J = 7.1 Hz, 4H), 
2.24 (p, J = 7.1 Hz, 2H). 13C{1H} NMR (125 MHz, CDCl3): δ 141.2, 139.7, 128.5, 128.4, 
127.6, 126.8, 33.6, 31.5. νmax(neat)/cm–1: 3062, 3014, 2928, 2854, 1481, 1451, 1441, 1307, 
1195, 1099, 1006, 939, 746. LRMS (EI+): 194.1 ([M]+, 100%). 
6-(Methylsulfonyl)-6,7-dihydro-5H-dibenzo[c,e]azepine (6b) 
 
Subjecting 5b (174 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 5.24 mg, 
0.005 mmol, 2 mol%, 16 h) afforded, after flash column chromatography (20% EtOAc in 
hexanes), the title compound as an off-white solid (100 mg, 0.36 mmol, 73%). 
1H NMR (400 MHz, CDCl3): δ 7.56 – 7.49 (m, 4H), 7.47 – 7.41 (m, 4H), 4.18 (s, 4H), 2.81 




37.2.  νmax(neat)/cm–1: 3016, 2921, 1481, 1459, 1449, 1322, 1304, 1152, 1134, 1117, 1025, 
947, 754, 712. HRMS calcd. for C15H15NO2S: 273.0818 [M]+; found (EI+): 273.0821. m.p. 
/°C: 149-150 (MeOH). 
5,7-Dihydrodibenzo[c,e]oxepine (6c) 
 
Subjecting 5c (135 mg, 0.50 mmol) to a modified general coupling procedure (thtAuBr3: 5.24 
mg, 0.01 mmol, 2 mol%, 14 h) and CSA (232 mg, 0.20 mmol) afforded, after flash column 
chromatography (5% EtOAc in hexanes), the title compound as a colourless oil that solidified 
on standing (74 mg, 0.38 mmol, 76%). 
Characterisation data were consistent with literature values: 1H and 13C{1H} NMR.[41]  
1H NMR (400 MHz, CDCl3): δ 7.59 – 7.55 (m, 2H), 7.54 – 7.49 (m, 2H), 7.47 – 7.40 (m, 
4H), 4.37 (s, 4H). 13C{1H} NMR (100 MHz, CDCl3): δ 141.3, 135.3, 129.8, 129.1, 128.4, 
127.6, 67.7. νmax(neat)/cm–1: 3064, 3017, 2852, 1450, 1196, 1073, 1043, 994, 901, 886, 748. 
3-Fluoro-8-methyl-5,7-dihydrodibenzo[c,e]oxepine (6d) 
 
Subjecting 5d (151 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 5.24 mg, 
0.01 mmol, 2 mol%, 14.5 h) afforded, after flash column chromatography (5% EtOAc in 
hexanes), the title compound as a white solid (94 mg, 0.41 mmol, 82%). 
1H NMR (400 MHz, CDCl3): δ 7.52 (dd, J = 8.4, 5.5 Hz, 1H), 7.40 – 7.25 (m, 3H), 7.22 – 
7.11 (m, 2H), 4.39 (s, 2H), 4.29 (s, 2H), 2.52 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3): δ 
162.6 (d, J = 250 Hz), 141.1, 137.9 (d, J = 3.2 Hz), 137.0, 136.9, 133.2, 130.3, 129.2 (d, J = 
8.1 Hz), 128.5, 125.6, 116.4 (d, J = 21 Hz), 115.8 (d, J = 21 Hz), 67.4 (d, J = 1.7 Hz), 62.8, 
19.8. 19F NMR (377 MHz, CDCl3): δ –114.3 (td, J = 8.6, 5.4 Hz). νmax(neat)/cm–1: 2996, 
2857, 1593, 1493, 1461, 1229, 1064, 874, 839, 791, 773, 723. HRMS calcd. for C15H13FO: 








Subjecting 7 (142 mg, 0.50 mmol) to the general coupling procedure (thtAuBr3: 10.48 mg, 
0.020 mmol, 4 mol%, 14 h) afforded, after flash column chromatography (3% EtOAc in 
hexanes), the title compound as a white solid (79 mg, 0.38 mmol, 75%).  
1H NMR (400 MHz, CDCl3): δ 7.53 – 7.20 (m, 8H), 4.66 (d, J = 12.5 Hz, 1H), 4.21 (ddd, J 
= 11.7, 5.9, 1.7 Hz, 1H), 3.87 (d, J = 12.5 Hz, 1H), 3.61 (app. t, J = 10.9 Hz, 1H), 2.80 (dd, J 
= 14.5, 5.9 Hz, 1H), 2.54 (ddd, J = 14.5, 10.3, 1.7 Hz, 1H). 13C{1H} NMR (125 MHz, CDCl3): 
δ 140.7, 140.5, 140.2, 137.7, 130.8, 129.8, 129.61, 129.59, 128.4, 128.31, 128.29, 126.5, 71.1, 
70.5, 37.3. νmax(neat)/cm–1: 3051, 3019, 2956, 2931, 2911, 2858, 1481, 1438, 1238, 1105, 
1083, 1030, 929, 754. HRMS calcd. for C15H14O: 210.1033 [M]+; found (EI+): 210.1032. m.p. 
/°C: 99-100 (MeOH). 
 













Table 8.1:  Crystal data and structure refinement for 8. 
Formula  C15H14O  
Dcalc./ g cm-3  1.280  
/mm-1  0.609  
Formula Weight  210.26  
Colour  colourless  
Shape  block  
Max Size/mm  0.39  
Mid Size/mm  0.31  
Min Size/mm  0.07  
T/K  120.0  
Crystal System  orthorhombic  
Space Group  Pbca  
a/Å  7.69025(7)  
b/Å  13.54657(17)  
c/Å  20.9417(2)  
/°  90  
/°  90  
/°  90  
V/Å3  2181.63(4)  
Z  8  
Z'  1  
min/°  4.222  
max/°  76.161  
Measured Refl.  17154  
Independent Refl.  2265  
Reflections Used  2132  
Rint  0.0678  
Parameters  202  
Restraints  0  
Largest Peak  0.331  
Deepest Hole  -0.232  
GooF  1.054  
wR2 (all data)  0.1390  
wR2  0.1370  
R1 (all data)  0.0515  





thtAuBr3 (10.5 mg, 0.02 mmol, 4 mol%) was added to a 7.5 mL vial containing 9 (149 mg, 
0.50 mmol) in CHCl3 (5 mL) and MeOH (100 μL). Camphorsulfonic acid (232 mg, 1.00 
mmol) and iodobenzene diacetate (177 mg, 0.55 mmol) were added, and the reaction was 




flash column chromatography (dry-loaded onto silica gel, 5% EtOAc in hexanes) afforded the 
title compound as a white solid (58 mg, 0.26 mmol, 52%). 
1H NMR (400 MHz, CDCl3): δ  7.41 – 7.29 (m, 4H), 7.28 – 7.18 (m, 3H), 7.11 (dd, J = 7.5, 
1.5 Hz, 1H), 4.52 (d, J = 12.5 Hz, 1H), 4.13 (d, J = 12.5 Hz, 1H), 3.78 (ddd, J = 11.4, 5.9, 4.1 
Hz, 1H), 3.38 (ddd, J = 11.5, 7.9, 3.8 Hz, 1H), 2.61 (dt, J = 13.5, 4.0 Hz, 1H), 2.34 (ddd, J = 
13.5, 11.9, 4.5 Hz, 1H), 1.89 – 1.67 (m, 2H). 13C{1H} NMR (100 MHz, CDCl3): 142.8, 141.7, 
141.5, 137.9, 130.2, 130.1, 128.6, 128.4, 128.1, 127.9, 127.5, 125.5, 75.2, 71.4, 32.2, 30.5. 
νmax(neat)/cm–1: 3054, 2938, 2858, 1475, 1438, 1367, 1197, 1091, 977, 778, 750.  HRMS 
calcd. for C16H16O: 224.1198[M]+; found (EI+): 224.1192. m.p. /°C: 99-100 (MeOH). 
 
Figure 8.2. The molecular structure of 10 (one of two independent molecules in the unit cell), 

















Table 8.2:  Crystal data and structure refinement for 10. 
Formula  C16H16O  
Dcalc./ g cm-3  1.252  
/mm-1  0.589  
Formula Weight  224.29  
Colour  colourless  
Shape  plate  
Max Size/mm  0.21  
Mid Size/mm  0.12  
Min Size/mm  0.07  
T/K  120.0  
Crystal System  monoclinic  
Flack Parameter  -0.02(16)  
Hooft Parameter  0.01(6)  
Space Group  Cc  
a/Å  13.92506(15)  
b/Å  7.62053(8)  
c/Å  22.4351(2)  
/°  90  
/°  90.4854(9)  
/°  90  
V/Å3  2380.65(4)  
Z  8  
Z'  2  
min/°  3.941  
max/°  76.555  
Measured Refl.  55336  
Independent Refl.  4857  
Reflections Used  4802  
Rint  0.0683  
Parameters  307  
Restraints  2  
Largest Peak  0.197  
Deepest Hole  -0.140  
GooF  1.042  
wR2 (all data)  0.0932  
wR2  0.0930  
R1 (all data)  0.0360  
R1  0.0356  
 






To a solution of 86 (5.57 g, 23.9 mmol), TMSCl (3.33 mL, 26.2 mmol) and Et3N (3.66 mL, 
26.2 mmol) was added NaI (3.93 g, 26.2 mmol) in CH3CN (25 mL) over 10 min at room 
temperature. After stirring for 2 h the reaction mixture was diluted with cold hexane (20 mL). 
The hexane layer was removed via syringe into a separating funnel under an inert atmosphere 
(repeated 3 ×). The organic layer was washed rapidly with H2O (1 × 30 mL), dried (MgSO4) 
and concentrated in vacuo to afford 87 as a pale yellow oil (5.40 g, 17.6 mmol, 74%).[42] 
Repetition of this procedure gave yields in the range 74 – 85%. The identity of 87 was 
confirmed by 1H NMR and used without further purification. 1H NMR (400 MHz, CDCl3): δ 
7.48 (d, J = 8.5 Hz, 1H), 7.38 (d, J = 2.6 Hz, 1H), 7.12 (dd, J = 8.5, 2.6 Hz, 1H), 4.61 (d, J = 
1.7 Hz, 1H), 4.55 (d, J = 1.7 Hz, 1H), 0.24 (s, 9H). nBuLi (2.17 M in hexanes, 8.1 mL, 17.6 
mmol) was added dropwise to a solution of 87 (5.40 g, 17.6 mmol) in THF (50 mL) at -78 °C. 
The reaction was stirred at this temperature for 1 h, then 88 (3.82 g, 14.6 mmol) was added 
portionwise over 5 min. The reaction was allowed to warm to room temperature and was 
stirred for 16 h. The reaction was quenched with water (50 mL). The aqueous phase was 
separated and extracted with Et2O (3 × 50 mL), and the combined organic portions were dried 
(MgSO4), filtered and concentrated in vacuo. Purification via flash column chromatography 
(10 - 15% EtOAc in hexanes) afforded the title compound as a white solid (2.03 g, 4.98 mmol, 
34%). 
1H NMR (400 MHz, CDCl3): δ 7.78 (d, J = 2.0 Hz, 1H), 7.65 (d, J = 8.0 Hz, 1H), 7.47 (dd, J 
= 8.0, 2.0 Hz, 1H), 6.46 (s, 2H), 3.85 (s, 6H), 3.82 (s, 3H), 3.26 (t, J = 7.5 Hz, 2H), 3.01 (t, J 
= 7.5 Hz, 2H), 0.27 (s, 9H). 13C {1H} NMR (100 MHz, CDCl3): δ 200.6, 153.4, 144.3, 140.4, 
137.5, 136.8, 136.6, 135.3, 131.4, 129.0, 105.6, 61.0, 56.3, 41.5, 30.8, 0.41. νmax(neat)/cm-1: 
3005, 2940, 2836, 1685, 1590, 1455, 1352, 1133, 1073, 983, 833, 821, 746. HRMS calcd. for 
C21H27O4ClSi: 406.1362 [M]+; found (EI+): 406.1353. m.p. /°C: 95-96 
3-(3,4,5-Trimethoxyphenyl)-1-[2-(trimethylsilyl)phenyl]propan-1-one, 5f 
 
To a solution of 2′-bromoacetophenone 91 (10.4 g, 7.0 mL, 52 mmol), TMSCl (7.9 mL, 62 
mmol) and Et3N (8.6 mL, 62 mmol) was added NaI (9.3 g, 62 mmol) in CH3CN (60 mL) over 
15 min at room temperature. After stirring for 1 h the reaction mixture was diluted with cold 




inert atmosphere (repeated 3 ×). The organic layer was washed rapidly with H2O (1 × 50 mL), 
dried (MgSO4) and concentrated in vacuo to afford 93 as a colourless oil (11.6 g, 43 mmol, 
82%). Characterisation data were consistent with literature values: 1H NMR and 13C{1H} 
NMR.[42,43] 1H NMR (400 MHz, CDCl3): δ 7.56 (dd, J = 8.0, 1.2 Hz, 1H), 7.40 (dd, J = 7.5, 
1.8 Hz, 1H), 7.26 (app. td, J = 7.5, 1.2 Hz, 1H), 7.14 (app. td, J = 8.0, 1.8 Hz, 1H), 4.61 (d, J 
= 1.4 Hz, 1H), 4.53 (d, J = 1.4 Hz, 1H), 0.23 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3): δ 
156.1, 140.3, 133.4, 130.7, 129.5, 127.1, 121.7, 96.2, 0.25. nBuLi (2.27 M in hexanes, 19 mL, 
43 mmol) was added dropwise to a solution 93 (11.6 g, 43 mmol) in THF (110 mL) at -78 °C. 
The reaction was stirred at this temperature for 1 h, then 88 (8.05 g, 30.8 mmol) was added 
portionwise over 5 min. The reaction was allowed to warm to room temperature and was 
stirred for 5 h. The reaction was quenched with water (70 mL). The aqueous phase was 
separated and extracted with Et2O (3 × 50 mL), and the combined organic portions were dried 
(MgSO4), filtered and concentrated in vacuo. Purification via flash column chromatography 
(20% EtOAc in hexanes) afforded the title compound as a white solid (4.59 g, 12.32 mmol, 
40%). 
Note: 5f and 88 have very close Rf values, with the product having a slightly lower value. For 
TLC visualisation a freshly prepared vanillin stain was used to distinguish between the two, 
as the product appears bright blue, whereas the starting material stains black. 
 1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 7.5, 0.7 Hz, 1H), 7.75 (dd, J = 7.5, 1.0 Hz, 1H), 
7.51 (app. td, J = 7.5, 1.3 Hz, 1H), 7.44 (app.td, J = 7.5, 1.4 Hz, 1H), 6.47 (s, 2H), 3.84 (s, 
6H), 3.82 (s, 3H), 3.30 (t, J = 7.6 Hz, 2H), 3.02 (t, J = 7.6 Hz, 2H), 0.29 (s, 9H). 13C {1H} 
NMR (100 MHz, CDCl3): δ 201.7, 153.4, 142.7, 142.2, 137.2, 136.5, 136.2, 131.7, 128.9, 
105.6, 61.0, 56.2, 41.4, 31.0, 0.51. 1 × CAr not observed. νmax(neat)/cm–1: 2938, 2838, 1680, 
1587, 1459, 1282, 1129, 1007, 835, 748. HRMS calcd. for C21H28O4Si: 372.1751 [M]+; found 
(EI+):  372.1738. m.p. /°C: 61-62 
1-[5-Chloro-2-(trimethylsilyl)phenyl]-3-(3,4,5-trimethoxyphenyl)propan-1-ol, 5l 
 
NaBH4 (56 mg, 1.47 mmol) was added portionwise to a solution of 5e (199 mg, 0.49 mmol) 
in methanol and THF (9:1, 10 mL) at 0 °C. The reaction was stirred at this temperature for 10 
min then allowed to warm to room temperature and stirred for 4 h. The reaction was quenched 




The combined organic portions were dried (MgSO4), filtered, concentrated in vacuo.  
Purification via flash column chromatography (20% EtOAc in hexanes) afforded the title 
compound as a white solid (190 mg, 0.46 mmol, 94%). Repetition of this reaction on a 5 mmol 
scale afforded 5l in a 74% yield.  
1H NMR (400 MHz, CDCl3): δ 7.56 (d, J = 2.1 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 7.22 (dd, J 
= 8.0, 2.1 Hz, 1H), 6.45 (s, 2H), 4.86 (dd, J = 9.9, 3.1 Hz, 1H), 3.84 (s, 6H), 3.82 (s, 3H), 2.88 
(ddd, J = 13.6, 8.9, 4.8 Hz, 1H), 2.73 (app. dt, J = 13.6, 8.2 Hz, 1H), 2.21 – 2.07 (m, 1H), 1.94 
– 1.73 (m, 2H), 0.21 (s, 9H). 13C {1H} NMR (100 MHz, CDCl3): δ 153.4, 152.5, 137.4, 136.5, 
136.3, 136.0, 135.7, 127.4, 126.2, 105.8, 72.0, 61.0, 56.2, 40.7, 33.0, 0.51. νmax(neat)/cm-1: 
3501, 2940, 2824, 1593, 1422, 1244, 1123, 1060, 1006, 961, 839, 803, 720. HRMS calcd. for 
C21H29O4ClSi: 408.1518 [M]+; found (EI+): 408.1512. m.p. /°C: 137-139 
3-(3,4,5-Trimethoxyphenyl)-1-[2-(trimethylsilyl)phenyl]propan-1-ol, 5g 
 
NaBH4 (0.17 g, 4.45 mmol) was added portionwise to a solution of 5f (0.83 g, 2.22 mmol) in 
methanol (30 mL) at 0 °C. The reaction was stirred at this temperature for 10 min then allowed 
to warm to room temperature and stirred for 5 h. The reaction was quenched with a saturated 
aqueous solution of NH4Cl (30 mL) and then extracted with Et2O (3 × 50 mL). The combined 
organic portions were dried (MgSO4), filtered and concentrated in vacuo.  Purification via 
flash column chromatography (20% EtOAc in hexanes) afforded the title compound as a white 
solid (0.73 g, 1.96 mmol, 88%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (app. d, J = 7.8, 1H), 7.46 (dd, J = 7.5, 1.3 Hz, 1H), 7.40 
(app. td, J = 7.5, 1.3 Hz, 1H), 7.25 (app. td, J = 7.5, 1.0 Hz, 1H), 6.45 (s, 2H), 4.88 (dd, J = 
9.8, 3.2 Hz, 1H), 3.83 (s, 6H), 3.81 (s, 3H), 2.87 (ddd, J = 13.7, 9.1, 4.7 Hz, 1H), 2.72 (app. 
dt, J = 13.7, 8.3 Hz, 1H), 2.22 – 2.12 (m, 1H), 1.88 (dddd, J = 14.0, 9.1, 8.0, 3.2 Hz, 1H), 1.74 
(s, 1H), 0.23 (s, 9H). 13C {1H} NMR (100 MHz, CDCl3): δ 153.3, 150.5, 137.7, 137.6, 136.4, 
134.6, 130.0, 127.3, 125.8, 105.7, 72.4, 61.0, 56.2, 40.6, 33.1, 0.62. νmax(neat)/cm–1: 3506, 
2932, 2834, 1590, 1508, 1419, 1239, 1127, 1059, 998, 826, 760, 730. HRMS calcd. for 









MOMBr (132 μL, 1.63 mmol) was added to a solution of 5l (167 mg, 0.41 mmol), DIPEA (1.2 
mL, 6.89 mmol) and DMAP (12.2 mg, 0.10 mmol) in CH2Cl2 (4.7 mL) at 0 °C. The reaction 
was heated to reflux (70 °C) and was stirred overnight. The reaction was allowed to cool to 
room temperature then a saturated aqueous solution of NaHCO3 (10 mL) was added slowly 
and the mixture was left to stir for 30 min. The aqueous phase was separated and extracted 
with CH2Cl2 (3 × 15 mL), and the combined organic portions were dried (MgSO4), filtered 
and concentrated in vacuo. Purification via flash column chromatography (20% EtOAc in 
hexanes) afforded the title compound as a white solid (159 mg, 0.35 mmol, 85%). 
1H NMR (400 MHz, CDCl3): δ 7.51 (d, J = 2.2 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 7.20 (dd, J 
= 8.0, 2.2 Hz, 1H), 6.44 (s, 2H), 4.86 (dd, J = 10.4, 2.3 Hz, 1H), 4.52 (app. q, J = 6.8 Hz, 2H), 
3.84 (s, 6H), 3.81 (s, 3H), 3.45 (s, 3H), 3.02 – 2.89 (m, 1H), 2.73 (ddd, J = 13.5, 9.5, 6.7 Hz, 
1H), 2.09 – 1.94 (m, 1H), 1.77 (dddd, J = 14.2, 9.5, 6.7, 2.3 Hz, 1H), 0.26 (s, 9H). 13C {1H} 
NMR (100 MHz, CDCl3): δ 153.4, 151.1, 137.7, 136.4, 136.1, 135.9, 135.8, 127.2, 126.4, 
105.7, 94.4, 76.0, 61.0, 56.2, 55.9, 41.7, 33.4, 0.34. νmax(neat)/cm-1: 2924, 2839, 1589, 1420, 
1241, 1130, 1079, 1016, 935, 836, 720. HRMS calcd. for C23H33O5ClSi: 452.1780 [M]+; found 
(EI+): 452.1806. m.p. /°C: 72-73 
{2-[1-(Methoxymethoxy)-3-(3,4,5-trimethoxyphenyl)propyl]phenyl}(trimethyl)silane, 5k  
 
MOMBr (314 μL, 3.84 mmol) was added dropwise to a solution of 5g (0.48 g, 1.28 mmol), 
DIPEA (1.9 ml, 10.91 mmol) and DMAP (39 mg, 0.32 mmol) in CH2Cl2 (6 mL). The reaction 
was heated to reflux (70 °C) and was stirred for 8 h. The reaction was allowed to cool to room 
temperature then a saturated aqueous solution of NaHCO3 (10 mL) was added slowly and the 
mixture was left to stir for 30 min. The aqueous phase was separated and extracted with CH2Cl2 




in vacuo. Purification via flash column chromatography (20% EtOAc in hexanes) afforded the 
title compound as a viscous oil that solidified on standing (0.36 g, 0.86 mmol, 67%).  
1H NMR (400 MHz, CDCl3): δ 7.53 (dd, J = 7.8, 1.2 Hz, 1H), 7.46 (dd, J = 7.5, 1.2 Hz, 1H), 
7.38 (app. td, J = 7.5, 1.2 Hz, 1H), 7.24 (app.td, J = 7.5, 1.2 Hz, 1H), 6.45 (s, 2H), 4.90 (dd, J 
= 10.4, 2.3 Hz, 1H), 4.54 – 4.51 (m, 2H), 3.84 (s, 6H), 3.81 (s, 3H), 3.46 (s, 3H), 2.96 (ddd, J 
= 13.6, 10.1, 4.9 Hz, 1H), 2.75 (ddd, J = 13.6, 9.7, 6.7 Hz, 1H), 2.12 – 2.00 (m, 1H), 1.81 
(dddd, J = 14.2, 10.1, 6.7, 2.3 Hz, 1H), 0.27 (s, 9H). 13C {1H} NMR (100 MHz, CDCl3): δ 
153.3, 148.8, 137.9, 137.7, 136.3, 134.4, 129.7, 127.0, 126.2, 105.7, 94.2, 76.5, 61.0, 56.2, 
55.9, 41.7, 33.6, 0.47. νmax(neat)/cm–1: 2996, 2955, 2820, 1598, 1508, 1456, 1417, 1240, 1124, 
1091, 1014, 837, 767, 731. HRMS calcd. for C23H34O5Si: 418.2170 [M]+; found (EI+): 
418.2165. m.p. /°C: 73-74. 
2-[1-Methoxy-3-(3,4,5-trimethoxyphenyl)propyl]phenyltrimethylsilane, 5h 
 
To a solution of 5g (0.53 g, 1.41 mmol) and Proton-sponge® (0.91 g, 4.23 mmol) in CH2Cl2 
(8 ml) was added trimethyloxonium tetrafluoroborate (0.63 g, 4.23 mmol) portionwise. The 
suspension was stirred rapidly at room temperature for 16 h. Water (10 ml) was added slowly 
and the aqueous phase was separated and extracted with CH2Cl2 (3 × 15 mL), and the 
combined organic portions were dried (MgSO4), filtered and concentrated in vacuo. 
Purification via flash column chromatography (20% EtOAc in hexanes) afforded the title 
compound as a white solid (458 mg, 1.18 mmol, 84%). 
1H NMR (400 MHz, CDCl3): δ 7.55 – 7.44 (m, 2H), 7.40 (app. td, J = 7.5, 1.5 Hz, 1H), 7.25 
(app. td, J = 7.5, 1.3 Hz, 1H), 6.44 (s, 2H), 4.40 (dd, J = 10.2, 2.6 Hz, 1H), 3.84 (s, 6H), 3.82 
(s, 3H), 3.22 (s, 3H), 2.92 – 2.85 (m, 1H), 2.82 – 2.73 (m, 1H), 2.04 – 1.94 (m, 1H), 1.85 – 
1.70 (m, 1H), 0.24 (s, 9H). 13C {1H} NMR (100 MHz, CDCl3): δ 153.3, 148.8, 137.8, 137.7, 
136.4, 134.4, 129.8, 126.9, 125.8, 105.8, 81.0, 61.0, 56.4, 56.2, 41.4, 33.2, 0.87. νmax(neat)/cm-
1: 3059, 2932, 1587, 1494, 1460, 1417, 1335, 1249, 1235, 1120, 1101, 1004, 928, 828, 759, 









thtAuBr3 (13.12 mg, 0.025 mmol, 5 mol%) was added to a 20 mL vial containing 5k (209 mg, 
0.50 mmol) in CHCl3 (5 mL) and MeOH (100 μL). PIFA (258 mg, 0.60 mmol) was added, 
and the reaction was stirred at 27 °C for 2.5 h. The reaction mixture was concentrated in vacuo 
and purification by flash column chromatography (dry-loaded onto silica-gel, 5 – 15% EtOAc 
in hexanes) afforded, in order of elution, 6ah (20 mg, 0.047 mmol, 9%, 14:1 mixture of 
atropisomers,[44] see section 8.5.7) and the title compound as a viscous liquid (129 mg, 0.38 
mmol, 75%, 16.5:1 mixture of atropisomers).  
Characterisation data were consistent with literature values: 1H NMR, 13C {1H} NMR and 
IR.[45]   
Data for 6k: 1H NMR (400 MHz, CDCl3) (Major atropisomer): δ 7.63 – 7.55 (m, 1H), 7.48 – 
7.43 (m, 1H), 7.39 – 7.30 (m, 2H), 6.58 (s, 1H), 4.67 (d, J = 6.6 Hz, 1H), 4.57 (d, J = 6.6 Hz, 
1H), 4.50 (dd, J = 10.8, 7.2 Hz, 1H), 3.92 (s, 3H), 3.91 (s, 3H), 3.61 (s, 3H), 3.35 (s, 3H), 2.62 
– 2.37 (m, 2H), 2.35 – 2.22 (m, 1H), 1.97 (dddd, J = 12.0, 10.8, 7.4, 1.3 Hz, 1H). Minor 
atropisomer (select peaks): 6.59 (s, 1H), 4.26 (d, J = 6.6 Hz, 1H), 4.12 (d, J = 6.6 Hz, 1H), 
3.90 (s, 3H), 3.89 (s, 3H), 3.57 (s, 3H), 3.20 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3) (Major 
atropisomer): δ 152.7, 150.9, 141.0, 139.4, 135.5, 133.7, 129.8, 127.1, 126.4, 124.6, 123.1, 
107.6, 95.3, 74.4, 61.1, 60.9, 56.0, 55.5, 40.0, 30.4. Minor atropisomer (Select peaks): 152.1, 
150.7, 140.8, 136.0, 132.0, 129.8, 127.6, 126.6, 107.4, 93.0, 61.0, 60.6, 55.8, 55.1, 40.4. 
LRMS (EI+): 344.2 ([M+], 100%). νmax(neat)/cm–1: 2934, 1598, 1482, 1236, 1032, 917, 764, 
748. 
Data for 6ah: 1H NMR (400 MHz, CDCl3) (Major atropisomer): δ 7.66 – 7.54 (m, 1H), 7.48 
– 7.31 (m, 3H), 4.69 (d, J = 6.7 Hz, 1H), 4.58 (d, J = 6.7 Hz, 1H), 4.41 (dd, J = 10.7, 7.3 Hz, 
1H), 3.97 (s, 3H), 3.96 (s, 3H), 3.56 (s, 3H), 3.36 (s, 3H), 3.19 – 3.09 (m, 1H), 2.52 (dddd, J 
= 13.4, 12.3, 7.4, 6.0 Hz, 1H), 2.10 (app. td, J = 13.4, 7.0 Hz, 1H), 1.89 (dddd, J = 12.3, 10.7, 
7.0, 1.5 Hz, 1H). (Minor atropisomer, selected peaks): δ 4.26 (d, J = 6.6 Hz, 1H), 4.12 (d, J = 
6.6 Hz, 1H), 3.52 (s, 3H), 3.19 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3) (Major 
atropisomer): δ 150.6, 150.3, 146.2, 139.6, 134.8, 133.2, 129.9, 129.2, 128.0, 126.6, 123.3, 








To a 7 mL screw-cap borosilicate vial containing 5h (38.9 mg, 0.10 mmol) was added CDCl3 
(500 μL), CD3OD (20 μL) and thtAuBr3 (0.005 mmol, 500 μL of a 0.01 M stock solution in 
CDCl3). Dichloromethane (9.3 mg, 7 µL, 0.11 mmol) was also added as an internal standard 
for 1H NMR. PIFA was added to the vial, which was then sealed and shaken vigorously until 
all the contents had dissolved. After 1.5 h an NMR yield of 85% was determined by 
comparison to literature 1H NMR values.[46] Isolation of the product by preparative TLC (20% 
EtOAc in hexanes) confirmed the identity of 6h (13:1 mixture of atropisomers). 
1H NMR (400 MHz, CDCl3) (Major atropisomer): δ 7.56 – 7.51 (m, 1H), 7.47 (dd, J = 7.3, 
1.4 Hz, 1H), 7.42 – 7.31 (m, 2H), 6.59 (s, 1H), 4.04 (dd, J = 10.8, 7.1 Hz, 1H), 3.92 (s, 3H), 
3.91 (s, 3H), 3.64 (s, 3H), 3.33 (s, 3H), 2.61 – 2.46 (m, 1H), 2.46 – 2.36 (m, 1H), 2.34 – 2.19 
(m, 1H), 1.98 – 1.82 (m, 1H). (Minor atropisomer, selected peaks): δ 6.57 (s, 1H), 3.88 (s, 3H), 
3.63 (s, 3H), 2.90 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3) (Major atropisomer): δ 152.8, 
150.9, 141.2, 139.2, 135.8, 134.1, 130.0, 127.3, 126.5, 124.8, 123.0, 107.7, 79.6, 61.3, 61.0, 




thtAuBr3 (28.96 mg, 0.055 mmol, 5 mol%) was added to a 20 mL RBF containing 5m (500 
mg, 1.10 mmol) in CHCl3 (11 mL) and MeOH (216 μL). PIFA (568 mg, 1.32 mmol) was 
added in a single portion, and the reaction was stirred at room temperature for 5 h. The reaction 
mixture was filtered through a plug of silica gel and concentrated in vacuo. Purification by 
flash column chromatography (dry-loaded onto silica-gel, 20% EtOAc in hexanes) gave, in 




compound as a viscous pale yellow liquid (233 mg, 0.62 mmol, 56%, 23:1 mixture of 
atropisomers).  
1H NMR (400 MHz, CDCl3) (Major atropisomer): δ 7.58 (dd, J = 2.2, 0.7 Hz, 1H), 7.39 (d, J 
= 8.2 Hz, 1H), 7.34 – 7.26 (m, 1H), 6.57 (s, 1H), 4.67 (d, J = 6.7 Hz, 1H), 4.55 (d, J = 6.7 Hz, 
1H), 4.44 (dd, J = 10.7, 7.2 Hz, 1H), 3.91 (s, 6H), 3.61 (s,3H), 3.34 (s, 3H), 2.60 – 2.38 (m, 
2H), 2.34 – 2.20 (m, 1H), 2.03 – 1.89 (m, 1H). (Minor atropisomer, tentatively assigned, 
selected peaks): δ 7.50 (d, J = 8.2 Hz, 1H), 4.28 (d, J = 6.6 Hz, 1H), 3.86 (s, 3H), 3.60 (s, 3H), 
3.22 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3) (Major atropisomer): δ 153.1, 150.9, 141.7, 
141.2, 135.5, 133.2, 132.2, 131.4, 126.7, 123.7, 123.7, 107.8, 95.5, 74.2, 61.2, 61.1, 56.2, 55.7, 
39.9, 30.3. HRMS calcd. for C20H23O5Cl: 378.1229 [M]+; found (EI+): 378.1220. 
νmax(neat)/cm–1: 2936, 1596, 1455, 1398, 1236, 1146, 1034, 997, 918, 833, 819, 730.  
9,10,11-Trimethoxy-5-methoxymethoxy-6,7-dihydro-5H-dibenzo[a,c]cycloheptene-3-
carboxylic acid methyl ester 85 
 
Caution: Carbon monoxide is a highly toxic gas and must be used within a well-ventilated 
fume hood and an alarm fitted for leak detection.  
According to literature procedure,[47]  potassium carbonate (54 mg, 0.39 mmol) and molecular 
sieves (4Å, 50 mg, powdered) were added to a Schlenk tube containing a stir bar. The tube 
was sealed with a septum, evacuated, and the contents were heated using a blow torch for 2 
min. The tube was cooled to room temperature under vacuum and then refilled with nitrogen. 
The septum was briefly removed, and palladium acetate (2.37 mg, 0.011 mmol) and 
dcpp•2HBF4 (12.7 mg, 0.021 mmol) were added to the tube, followed by 6m (100 mg, 0.26 
mmol) and the contents were evacuated and backfilled with nitrogen once more. DMSO (0.9 
mL) was then added via syringe. A double-lined balloon of CO was fitted and bubbled through 
the solution, a second balloon was then fitted and the reaction mixture was lowered into an oil 
bath at 120 °C and stirred rapidly for 16 h. The balloon was removed and purged with nitrogen 
and the tube was removed from the oil bath and allowed to cooled to room temperature. The 
reaction mixture was filtered through a pad of Celite and washed with ethyl acetate. The 
solvent was removed in vacuo, then dissolved in CH2Cl2 and dry loaded onto Celite. 




compound as a viscous pale yellow oil (73 mg, 0.18 mmol, 70%, 15:1 mixture of 
atropisomers). 
Characterisation data were consistent with literature values for major and minor 
atropisomers.[45]  
1H NMR (400 MHz, CDCl3) (Major atropisomer): 8.28 (d, J = 1.8 Hz, 1H), 8.00 (dd, J = 8.0, 
1.8 Hz, 1H), 7.53 (d, J = 8.0 Hz, 1H). 6.58 (s, 1H), 4.70 (d, J = 6.7 Hz, 1H), 4.56 (d, J = 6.7 
Hz, 1H), 4.50 (dd, J = 10.7, 7.2 Hz, 1H), 3.94 (s, 3H), 3.91 (s, 6H), 3.61 (s, 3H), 3.35 (s, 3H), 
2.65 – 2.46 (m, 1H), 2.48 – 2.37 (m, 1H), 2.30 – 2.15 (m, 1H), 2.06 – 1.92 (m, 1H). (Minor 
atropisomer, selected peaks): 7.92 (d, J = 1.9 Hz, 1H), 7.61 (d, J = 8.0 Hz, 1H), 4.83 (d, J = 
6.0 Hz, 1H), 3.57 (s, 3H), 3.19 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3) (Major 
atropisomer): 167.4, 153.4, 151.1, 141.2, 140.0, 138.9, 135.6, 130.2, 128.9, 127.8, 124.8, 
123.8, 107.9, 95.6, 74.3, 61.2, 61.1, 56.2, 55.7, 52.2, 39.9, 30.4. HRMS calcd. for C22H26O7: 
402.1673[M]+; found (EI+): 402.1671. νmax(neat)/cm–1: 2938, 1717, 1595, 1484, 1400, 1229, 
1146, 1100, 1035, 917, 734. 
8.5 Domino Arylation 
8.5.1 General Procedure for Domino C–H Arylation 
A 50 mL, round-bottomed flask equipped with a stirrer bar was charged with arylsilane 1 (1.00 
mmol), arylsilane 12 (1.00 mmol), thtAuBr3 (15.8 mg, 0.03 mmol), MeOH (200 μL), and 
CHCl3 (20 mL). PhI(OAc)2 (741 mg, 2.30 mmol) and CSA (581 mg, 2.30 mmol) were added 
simultaneously in a single portion, and the flask was sealed with a glass stopper and stirred at 
rt (unless otherwise indicated) for the time specified. Following analysis of the crude product 
mixture by 19F NMR, the reaction was concentrated in vacuo and then purified as specified.  
2-Chloro-7-(4-fluorophenyl)-9H-fluorene, 133a 
 
Following the General Procedure for Domino C–H Arylation, 2l (275 mg, 1.00 mmol) and 
12a (168 mg, 1.00 mmol) were reacted for 15 h. Purification via flash column chromatography 
(SiO2, 99:1 40–60 °C petrol/EtOAc) gave an 80:20 mixture of 133a:134 (186 mg). To effect 




EtOAc (ca. 1 mL) was added dropwise until complete dissolution. The solution was allowed 
to cool to rt over 1 h, during which time colourless crystals formed. The crystals were collected 
by Buchner filtration and washed with cold EtOH, then dried in vacuo to give 133a as a white 
crystalline solid (88 mg, 30%).  
Data for 133a: 1H NMR (400 MHz, CDCl3): δ 7.79 (d, J = 7.9 Hz, 1H), 7.73–7.68 (m, 2H), 
7.63–7.51 (m, 4H), 7.37 (dd, J = 8.1, 2.1 Hz, 1H), 7.19–7.11 (m, 2H), 3.93 (s, 2H). 13C {1H} 
NMR (100 MHz, CDCl3): 162.6 (d, J = 246 Hz), 145.2, 143.9, 140.03, 140.01, 139.4, 137.6 
(d, J = 3.4 Hz), 132.7, 128.8 (d, J = 8.0 Hz), 127.4, 126.2, 125.5, 123.9, 121.0, 120.4, 115.8 
(d, J = 21.4 Hz), 37.0. 19F NMR (376 MHz, CDCl3): –115.8 (tt, J = 8.6, 5.3 Hz). 
νmax(neat)/cm–1: 3066, 2928, 1599, 1514, 1457, 1400, 1239, 1224, 1159, 1102, 1071, 830, 
811, 753. HRMS calcd. for C19H12ClF: 294.0606 [M]+; found (EI+): 294.0620. m.p. /°C:  173 
– 175 (EtOH/EtOAc). 
Data for 134 (Select Data; tentatively assigned): 1H NMR (400 MHz, CDCl3): δ 7.25 – 7.18 
(m, 2H), 7.18 – 7.09 (m, 2H), 7.07 (dd, J = 8.4, 2.0 Hz, 1H), 6.85 (d, J = 8.4 Hz, 1H), 3.99 (s, 
2H). 19F NMR (376 MHz, CDCl3): –114.4 (tt, J = 8.7, 5.4 Hz), –115.4 (tt, J = 8.6, 5.3 Hz) 
7-Fluoro-1,4-dimethyl-2-phenyl-9H-fluorene, 135-F-H 
 
 Following General Procedure 1, 1o (286 mg, 1.00 mmol) and 12c (150 mg, 1.00 
mmol) were reacted for 15 h. Purification via flash column chromatography (SiO2, 90:10 40–
60 °C petrol/toluene) gave a 94:6 mixture of 135-F-H:136-F-H as a white solid (185 mg, 
64%). 
Data for 135-F-H: 1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 8.5, 5.1 Hz, 1H), 7.50 – 7.42 
(m, 2H), 7.41 – 7.34 (m, 3H), 7.34 – 7.25 (m, 1H), 7.15 – 7.08 (m, 2H), 3.83 (s, 2H), 2.71 (s, 
3H), 2.32 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 161.9 (d, J = 245 Hz), 146.1 (d, J = 
8.5 Hz), 143.2 (d, J = 2.0 Hz), 142.0, 140.2, 139.1 (d, J = 2.4 Hz), 137.9, 131.5, 129.7, 129.6, 
129.0, 128.2, 126.8, 123.8 (d, J = 8.6 Hz), 113.8 (d, J = 22.4 Hz), 112.3 (d, J = 22.6 Hz), 36.9 
(d, J = 2.4 Hz), 20.6, 16.6. 19F NMR (376 MHz, CDCl3): δ -116.78 (m). νmax(neat)/cm–1: 
2914, 2862, 1592, 1464, 1439, 1227, 1127, 1106, 1013, 938, 852, 771, 703. HRMS calcd. for 




Selected data for 136-F-H: 1H NMR (400 MHz, CDCl3): δ 7.94 (dd, J = 8.6, 5.1 Hz, 1H), 
2.58 (s, 3H), 2.42 (s, 3H).  
2-(4-Bromophenyl)-7-fluoro-1,4-dimethyl-9H-fluorene, 135-F-Br 
 
 Following General Procedure 1, 1o (286 mg, 1.00 mmol) and 12d (229 mg, 1.00 
mmol) were reacted for 15 h. Purification via flash column chromatography (SiO2, 90:10 40–
60 °C petrol/toluene) gave a 94:6 mixture of 135-F-Br:136-F-br as a white solid (260 mg, 
71%). 
1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 8.5, 5.1 Hz, 1H), 7.60 – 7.51 (m, 2H), 7.34 – 
7.21 (m, 3H), 7.11 (app. td, J = 8.9, 2.6 Hz, 1H), 7.05 (s, 1H), 3.83 (s, 2H), 2.70 (s, 3H), 2.29 
(s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 162.0 (d, J = 245 Hz), 146.1 (d, J = 8.6 Hz), 
143.3 (d, J = 2.1 Hz), 140.9, 139.0 (d, J = 2.4 Hz), 138.9, 138.2, 131.33, 131.31, 131.2, 129.9, 
128.8, 123.9 (d, J = 8.7 Hz), 121.0, 113.9 (d, J = 22.5 Hz), 112.3 (d, J = 22.6 Hz), 36.9 (d, J = 
2.4 Hz), 20.6, 16.6. 19F NMR (377 MHz, CDCl3): δ -116.49 (m). νmax(neat)/cm–1: 2949, 2915, 
2886, 2861, 1587, 1462, 1384, 1230, 1132, 1107, 1070, 1005, 938, 895, 857, 830, 818, 756, 
723.  HRMS calcd. for C21H16BrF: 366.0414 [M]+; found (EI+): 366.0434. 
Selected data for 136-F-Br: 1H NMR (400 MHz, CDCl3): δ 7.92 (dd, J = 8.6, 5.1 Hz, 1H), 
2.55 (s, 3H), 2.41 (s, 3H). 19F NMR (377 MHz, CDCl3): δ -116.5 (m). 
7-Fluoro-1,4-dimethyl-2-[4-(trifluoromethyl)phenyl]-9H-fluorene, 135-F-CF3 
 
 Following General Procedure 1, 1o (286 mg, 1.00 mmol) and 12b (218 mg, 1.00 
mmol) were reacted for 3 h. Purification via flash column chromatography (SiO2, 99:1 40–60 




1H NMR (400 MHz, CDCl3): δ. 7.87 (dd, J = 8.6, 5.1 Hz, 1H), 7.70 (d, J = 8.0 Hz, 2H), 7.49 
(d, J = 8.0 Hz, 2H), 7.34 – 7.26 (m, 1H), 7.12 (app. td, J = 8.9, 2.6 Hz, 1H), 7.07 (s, 1H), 3.85 
(s, 2H), 2.71 (s, 3H), 2.30 (s, 3H).  13C {1H} NMR (100 MHz, CDCl3): δ 162.1 (d, J = 245 
Hz), 146.12 (d, J = 8.7 Hz), 145.7, 143.4 (d, J = 2.0 Hz), 138.9 (d, J = 2.4 Hz), 138.7, 138.6, 
131.2, 130.00, 129.97, 129.07 (q, J = 32.5 Hz), 128.9, 125.2 (q, J = 3.8 Hz), 124.5 (q, J = 272 
Hz), 124.0 (d, J = 8.7 Hz), 113.9 (d, J = 22.5 Hz), 112.4 (d, J = 22.5 Hz), 36.9 (d, J = 2.4 Hz), 
20.7, 16.6. 19F NMR (377 MHz, CDCl3): δ – 62.34 (s, 3F), -116.30 (app. td, J = 8.9, 5.1 Hz). 
νmax(neat)/cm–1: 2895, 1614, 1466, 1320, 1065, 1013, 841, 819, 759. HRMS calcd. for 
C22H16F4: 356.1183 [M]+; found (EI+): 366.1167. m.p. /°C: 189-190 (EtOH). 
2-(4-Fluorophenyl)-1,4-dimethyl-9H-fluorene, 12-H-F and 2,7-bis(4-fluorophenyl)-1,4-
dimethyl-9H-fluorene, 22 
 
Following General Procedure 1, 1a (268 mg, 1.00 mmol) and 12a (168 mg, 1.00 mmol) were 
reacted for 1 h. Purification via flash column chromatography (SiO2, 99:1 40–60 °C 
petrol/EtOAc) gave, in order of elution, a 96:4 mixture of 135-H-F:136-H-F as a white solid 
(133 mg, 46%) and 152 as an off-white solid (73 mg, 17%).  
Data for 135-H-F: 1H NMR (400 MHz, CDCl3): δ 7.96 (app. d, J = 7.8 Hz, 1H), 7.61 (app. 
d, J = 7.3 Hz, 1H), 7.42 (app. t, J = 7.5 Hz, 1H), 7.38 – 7.30 (m, 3H), 7.18 – 7.10 (m, 2H), 
7.08 (s, 1H), 3.86 (s, 2H), 2.74 (s, 3H), 2.31 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 
162.0 (d, J = 245 Hz), 143.9, 143.5, 143.0, 139.3, 138.8, 138.0 (d, J = 3.5 Hz), 131.3, 131.1 
(d, J = 7.9 Hz), 130.3, 128.9, 126.8, 126.1, 125.0, 123.1, 115.0 (d, J = 21 Hz), 36.9, 20.8, 16.6. 
19F NMR (376 MHz, CDCl3): δ -116.33 (tt, J = 8.8, 5.5 Hz). νmax(neat)/cm–1: 3067, 3042, 
2948, 2865, 1601, 1509, 1455, 1384, 1219, 1156, 1094, 1010, 838, 807, 774, 741, 707. HRMS 
calcd. for C21H17F: 288.1309 [M]+; found (EI+): 288.1307 m.p. /°C: 138-140 (EtOH).  
Selected data for 136-H-F: 1H NMR (400 MHz, CDCl3): δ 8.02 (d, J = 7.7 Hz, 1H), 2.60 (s, 




Data for 152: 1H NMR (400 MHz, CDCl3): δ 7.99 (d, J = 8.1 Hz, 1H), 7.79 (s, 1H), 7.70 – 
7.56 (m, 3H), 7.40 – 7.32 (m, 2H), 7.22 – 7.10 (m, 4H), 7.09 (s, 1H), 3.90 (s, 2H), 2.75 (s, 
3H), 2.32 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ162.4 (d, J = 246.4 Hz), 161.9 (d, J 
= 245.6 Hz), 144.6, 143.7, 142.2, 139.4, 138.5, 138.1, 137.9 (d, J = 3.3 Hz), 137.6 (d, J = 3.2 
Hz), 131.4, 131.1 (d, J = 7.8 Hz), 130.4, 129.0, 128.8 (d, J = 8.0 Hz), 125.8, 123.6, 123.3, 
115.8 (d, J = 21.4 Hz), 115.1 (d, J = 21.2 Hz), 36.9, 20.7, 16.7. 19F NMR (376 MHz, CDCl3): 
δ -115.98 (tt, J = 8.6, 5.3 Hz, 1F), -116.25 (tt, J = 8.8, 5.4 Hz, 1F). νmax(neat)/cm–1: 2920, 
1604, 1511, 1461, 1399, 1386, 1238, 1156, 1097, 1010, 890, 871, 838, 818, 732. HRMS calcd. 
for C27H20F2: 382.1528 [M]+; found (EI+): 382.1508. m.p. /°C: 233-236 (EtOAc/EtOH 1:1). 
7-Fluoro-2-(4-fluorophenyl)-1,4-dimethyl-9H-fluorene, 135-F-F 
 
Following General Procedure 1, 1o (286 mg, 1.00 mmol) and 12a (168 mg, 1.00 mmol) were 
reacted for 14 h. Purification via flash column chromatography (SiO2, 99:1 40–60 °C 
petrol/EtOAc) gave a 95:5 mixture of 135-F-F:136-F-F as a white solid (205 mg, 67%). 
Data for 135-F-F: 1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 8.5, 5.1 Hz, 1H), 7.41 – 7.28 
(m, 3H), 7.20 – 7.09 (m, 3H), 7.07 (s, 1H), 3.83 (s, 2H), 2.70 (s, 3H), 2.29 (s, 3H). 13C {1H} 
NMR (100 MHz, CDCl3): δ 162.1 (d, J = 245 Hz), 161.9 (d, J = 245 Hz), 146.1 (d, J = 8.4 
Hz), 143.2 (d, J = 2.0 Hz), 139.1, 139.02 (d, J = 2.4 Hz), 138.0, 137.9 (d, J = 3.4 Hz), 131.4, 
131.12 (d, J = 7.9 Hz), 129.8, 129.0, 123.87 (d, J = 8.7 Hz), 115.06 (d, J = 21.2 Hz), 113.83 
(d, J = 22.3 Hz), 112.32 (d, J = 22.6 Hz), 36.9 (d, J = 2.4 Hz), 20.6, 16.6. 19F NMR (376 MHz, 
CDCl3): δ -116.22 (tt, J = 8.7, 5.4 Hz), -116.62 (app. td, J = 9.0, 5.2 Hz, 1F). νmax(neat)/cm–
1: 2955, 2920, 2887, 2863, 1604, 1592, 1509, 1479, 1458, 1389, 1274, 1218, 1158, 1130, 1107, 
1090, 1013, 936, 881, 841, 815, 776, 728, 708. HRMS calcd. for C21H16F2: 306.1215 [M]+; 
found (EI+): 306.1219. m.p. /°C: 163-165 (3% EtOAc in EtOH) 
Selected data for 136-F-F: 1H NMR (400 MHz, CDCl3): δ 7.92 (dd, J = 8.6, 5.2 Hz, 1H), 2.56 








Following General Procedure 1, 1p (303 mg, 1.00 mmol) and 12a (168 mg, 1.00 mmol) were 
reacted for 15 h. Purification via flash column chromatography (SiO2, 100:0→90:10 40–60 °C 
petrol/toluene) gave a 93:7 mixture of 135-Cl-F:136-Cl-F as an off-white solid (162 mg, 
50%).  
Data for 135-Cl-F: 1H NMR (400 MHz, CDCl3): δ 7.83 (d, J = 8.3 Hz, 1H), 7.57 – 7.54 (m, 
1H), 7.37 (dd, J = 8.3, 2.0 Hz, 1H), 7.35 – 7.28 (m, 2H), 7.16 – 7.10 (m, 2H), 7.07 (s, 1H), 
3.81 (s, 2H), 2.69 (s, 3H), 2.28 (s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 162.0 (d, J = 
245 Hz), 145.6, 143.3, 141.5, 139.7, 137.85, 137.80 (d, J = 3.2 Hz), 132.0, 131.5, 131.1 (d, J 
= 7.9 Hz), 130.3, 129.1, 127.1, 125.3, 123.8, 115.1 (d, J = 21.3 Hz), 36.7, 20.6, 16.6. 19F NMR 
(376 MHz, CDCl3): δ -116.10 (tt, J = 8.8, 5.4 Hz). νmax(neat)/cm–1: 2948, 2918, 2864, 1600, 
1510, 1452, 1384, 1223, 1071, 839, 816. HRMS calcd. for C21H16ClF: 322.0919 [M]+; found 
(EI+): 322.0925. 
Selected data for 136-Cl-F: 1H NMR (400 MHz, CDCl3): δ 7.89 (d, J = 8.4 Hz, 1H), 2.55 (s, 
3H), 2.41 (s, 3H).  19F NMR (376 MHz, CDCl3): δ -116.19 (tt, J = 8.8, 5.4 Hz) 
2-(4-Fluorophenyl)-1,4-dimethyl-7-(trifluoromethyl)-9H-fluorene, 12-CF3-F 
 
A 7 mL, screw-capped scintillation vial equipped with a stirrer bar was charged with 2ah (26.2 
mg, 0.10 mmol), 12a (16.8 mg, 0.10 mmol), thtAuBr3 (300 μL of a 0.01 M stock solution in 
CDCl3, 0.003 mmol), CD3OD (20 μL), and CDCl3 (1.7 mL). Dibromomethane (18 mg, 7 µL, 
0.10 mmol) and 1-bromo-2-fluorobenzene (18 mg, 11 µL, 0.10 mmol) were also added as 
internal standards for 1H and 19F NMR respectively. CSA (34.9 mg, 0.15 mmol) and PhI(OAc)2 




until the contents were homogeneous. The mixture was stirred at 50 °C overnight. A combined 
70% NMR yield was obtained (88:12 mixture of 135-CF3-F:136-CF3-F) after analysis of the 
reaction mixture by 19F NMR spectroscopy. The mixture was isolated by preparatory TLC 
(eluent: 99:1 40–60 °C petrol/EtOAc) to give a white solid. 
Data for 135-CF3-F: 1H NMR (400 MHz, CDCl3): δ 8.01 (d, J = 8.1 Hz, 1H), 7.83 (s, 1H), 
7.71 – 7.63 (m, 1H) 7.37 – 7.28 (m, 2H), 7.17 – 7.08 (m, 3H), 3.89 (s, 2H), 2.74 (s, 3H), 2.31 
(s, 3H). 13C {1H} NMR (100 MHz, CDCl3): δ 162.1 (d, J = 245 Hz), 146.3, 144.2 (d, J = 8.0 
Hz), 140.5, 137.7 (d, J = 3.3 Hz), 137.5, 131.7, 131.13, 131.10 (d, J = 7.9 Hz), 131.05, 129.3, 
127.9 (q, J = 32.0 Hz), 124.2 (q, J = 3.8 Hz), 123.5, 123.0, 121.8 (q, J = 4.0 Hz), 115.2 (d, J = 
21.2 Hz), 36.9, 20.8, 16.7. 1 × CAr not observed (CF3). 19F NMR (377 MHz, CDCl3): δ –
61.74 (s, 3F), –115.62 (tt, J = 8.7, 5.4 Hz, 1F). HRMS calcd. for C22H16F4: 356.1183 [M]+; 
found (EI+): 356.1179 
8.6 Kinetic data: Procedure and Analysis 
8.6.1 Standard Kinetics Protocol 
 
Representative experiment: To a 7 mL screw-cap borosilicate vial containing 1b (24.0 mg, 
0.10 mmol) was added CDCl3 (900 μL), CD3OD (20 μL) and thtAuBr3 (0.001 mmol, 100 μL 
of a 0.01 M stock solution in CDCl3). The solution was transferred into a NMR tube and loaded 
into a Bruker Avance III 400 MHz NMR spectrometer with a probe temperature of 27 °C. 
After tuning to 1H, locking to CDCl3 and performing a quick shimming experiment (topshim 
1Dfast, Bruker software), the sample was ejected and poured back into the vial. CSA (0.13 
mmol, 30.2 mg) followed immediately by IBDA (0.11 mmol, 35.4 mg) were added to the vial, 
which was then sealed and shaken vigorously until all the contents had dissolved. The solution 
was transferred by a 1 mL syringe back into the NMR tube and loaded into the NMR 
spectrometer. The kinetics experiment was initiated after locking to CDCl3. The time between 
addition of IBDA/CSA and the first kinetics time-point was measured by stopwatch and was 
typically 90 – 120 sec. 
General Considerations: CDCl3 was filtered through a pad of basic Al2O3 (Brockmann I) and 
distilled prior to use and held under a nitrogen atmosphere, over 3 Å MS. CD3OD was 
transferred from a new bottle into a J Young’s tap sealed tube and held under N2, over 3 Å 




and were stored in sealed vials at 0 °C thereafter. The necessary volume of a stock solution 
was measured with a gas-tight μL-syringe once the solution had warmed to ambient 
temperature. IBDA and CSA were weighed to the nearest 0.05 mg. Measured rates varied 
depending on how wet the CSA was. For reproducibility, the CSA was stored under an inert 
atmosphere and used within 10 minutes of weighing. Kinetics experiments were implemented 
using standard Bruker software. Typical experiment: 4 scans per spectrum (20 s), total delay 
between spectra varied from 10 – 600 s depending on experiment. NMR data were processed 
using standard Mestrenova software, version 6, 8 or 9. 
8.6.2 Kinetic Data 
Figures 8.3 – 8.8 show reaction profiles (A) and rate/concentration plots (B) for the cyclisation 
of 1b. Reactions are performed as per the standard kinetics procedure. In each figure, variation 
of one variable is made from the ‘standard’ conditions of [thtAuBr3] = 0.001 M, [1b] = 0.10 
M, [IBDA] = 0.11 M, [CSA] = 0.13 M, [CD3OD] = 0.49 M, 27 °C. 
 
 






































Figure 8.4. Rate-dependence on [1b] 
 
 
Figure 8.5. Rate-dependence on [CD3OD] 










































































































Figure 8.7. Rate-dependence on [CSA] 
There is a negligible rate dependence on [CSA] in the concentration range that these reactions 
are performed, however a slight increase in rate is observed at very high concentrations. 
 
 
Figure 8.8. Rate-dependence [IBDA] (at [CSA] = 0.13 M, such that [CSA] > [IBDA]) 
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Figure 8.10. Simulated vs experimental data for cyclisation of 1b. Simulation A: k1 = 0.59 s-
1, k2 = 0.014 s-1, Keq = 100 and Keq2 = 15. Simulation B (Where both MeOH and (MeOH)2 can 
bind to gold): k1 = 0.59 s-1, k2 = 0.025 s-1, Keq = 45 and Keq2 = 20. The values reported are for 
purely illustrative purposes only and no rate or equilibrium constant should be used in isolation 
In support of the derived catalytic rate law, the experimental rate for different concentrations 
of MeOD can be predicted using the derived catalytic rate law and excel solver by changing 
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give a good fit to the experimental data. Due to the insolubility of the oxidant and acid in the 
absence of MeOH, k1 was estimated by performing the reaction with TFE (50:1 CDCl3:TFE, 
0.27 M). Good fits can still be obtained in the range 0.4 ≤ k1 ≤ 1.5 s-1. 
8.6.4 Kinetic Isotope Effects 
Independent Rate Kinetic Isotope Effects: 
The standard kinetics procedure was followed with d0 and d5 -(2-benzylphenyl)trimethylsilane 
in two independent experiments. The experiments were performed on the same day, with the 
same stock solution of catalyst, solvents and batch of reagents. 
 
 
Figure 8.11. Combined plots of rate of cyclisation of d0 and d5 -(2-
benzylphenyl)trimethylsilane 
Intramolecular Competition Kinetic Isotope Effects: 
The reactions were performed by analogy to the standard kinetics procedure: To a 7 mL screw-
cap borosilicate vial containing the requisite deuterated substrate was added CDCl3 (900 μL), 
CD3OD (20 μL) and thtAuBr3 (0.001 mmol, 100 μL of a 0.01 M stock solution in CDCl3). 
CSA (0.13 mmol, 30.2 mg) followed immediately by IBDA (0.11 mmol, 35.4 mg) were added 
to the vial, which was then sealed and shaken vigorously until all the contents had dissolved. 
Once the reaction had gone to completion (determined by 1H NMR spectroscopy) the reaction 
was filtered through a plug of silica gel (eluent: hexane) and concentrated in vacuo. The 
























of isotopologues was determined by 1H NMR spectroscopy (CDCl3 or CD2Cl2). Assignments 
were made by comparison to authentic, non-deuterated samples or literature values. 
Table 8.3: KIEs calculated from the ratio of isotopologues isolated 





































8.6.5 Hammett LFER Analysis 
The standard kinetics procedure was followed using the appropriate aryltrimethylsilane. For 
reactions that displayed pseudo zero-order profiles, rates were measured over the entire 
reaction; for reactions with non-pseudo zero-order profiles, both initial and maximum rate 












Figure 8.12. Combined concentration/time plot for rate analysis of substituted arenes (Top: 













































Figure 8.13. Arene Hammett Plot with minimum and maximum rates given for σ ≥ 0.43. 























































Figure 8.14. Combined concentration/time plot for rate analysis of substituted silanes and 
associated Hammett plot. In the absence of 2-bromothiophene unusual kinetic profiles were 




Figure 8.15. Combined concentration/time plot for rate analysis of disubstituted substrates 
 




































8.6.6 Competition Experiments 
Intermolecular interception of cyclisation by 2-bromothiophene 
 
To a 7 mL screw-cap borosilicate vial containing trimethyl{2-[3-
(trifluoromethyl)benzyl]phenyl}silane 1m (0.05 mmol) and 2-bromothiophene (0.25 mmol) 
was added CDCl3 (436 μL), CD3OD (10 μL) and thtAuBr3 (0.001 mmol, 64 μL of a 0.0155 M 
stock solution in CDCl3). CSA (0.065 mmol, 15.1 mg) followed immediately by IBDA (0.055 
mmol, 17.7 mg) were added. The vial was sealed and shaken vigorously until all the contents 
had dissolved. The solution was transferred by a 1 mL syringe into a NMR tube and loaded 
into a Bruker Avance III 400 MHz NMR spectrometer with a probe temperature of 27 °C, 
already tuned to 1H. The kinetics experiment was initiated after locking to CDCl3 and 
performing a quick shimming experiment (topshim 1Dfast, Bruker software). After the 
reaction had gone to completion, as determined by 1H NMR, the solution was filtered through 
a plug of silica gel and concentrated in vacuo. Preparative TLC (eluent: hexanes) afforded 99 
as a thin film:  1H NMR (400 MHz, CDCl3): δ 7.44 (d, J = 7.8 Hz, 1H), 7.40 – 7.28 (m, 5H), 
7.22 – 7.15 (m, 2H), 6.97 (d, J = 3.7 Hz, 1H), 6.61 (d, J = 3.7 Hz, 1H), 4.14 (s, 2H). 13C{1H} 
NMR (125 MHz, CDCl3): 144.0, 142.0, 138.4, 133.8, 132.2, 131.5, 130.84 (q, J = 32.0 Hz), 
130.81, 130.1, 129.01, 128.95, 127.2, 127.0, 125.6 (q, J = 3.9 Hz), 123.1 (q, J = 3.9 Hz), 
124.28 (app. d, J = 270 Hz), 112.1, 39.3. 19F NMR (377 MHz, CDCl3): δ – 62.6 (s). HRMS 
calcd. for C18H12BrF3S: 395.9790 [M]+; found (EI+): 395.9771. 
 
To a 2 mL screw-cap borosilicate vial containing 99 (0.05 mmol) and 2-bromothiophene (0.25 
mmol) was added CDCl3 (436 μL), CD3OD (10 μL) and thtAuBr3 (0.001 mmol, 64 μL of a 
0.0155 M stock solution in CDCl3). CSA (0.065 mmol, 15.1 mg) followed immediately by 
IBDA (0.055 mmol, 17.7 mg) were added. The vial was sealed and shaken vigorously until all 




and loaded into a Bruker Avance III 400 MHz NMR spectrometer with a probe temperature 
of 27 °C, already tuned to 1H. The kinetics experiment was initiated after locking to CDCl3 
and performing a quick shimming experiment (topshim 1Dfast, Bruker software). After the 
reaction had gone to completion, as determined by 1H NMR, the solution was filtered through 
a plug of silica gel and concentrated in vacuo.  Preparative TLC (eluent: hexanes) afforded 
99 as a thin film. 1H NMR (400 MHz, CDCl3): δ 7.36 – 7.30 (m, 1H), 7.25 – 7.16 (m, 3H), 
7.06 (d, J = 3.7 Hz, 1H), 7.02 – 6.97 (m, 1H), 6.90 – 6.82 (m, 3H), 4.12 (s, 2H). 13C{1H} NMR 
(100 MHz, CDCl3): 161.8 (dd, J = 250 Hz, 8.4 Hz), 144.1, 137.7,133.3, 131.2, 130.1, 128.9, 
128.6, 128.3 (t, J = 10.2 Hz), 127.4, 126.4, 116.2 (t, J = 20.0 Hz), 112.0, 111.3 (dd, J = 20.0, 
6.0 Hz), 26.0 (t, J = 3.0 Hz). 19F NMR (377 MHz, CDCl3): δ – 114.3 (m). HRMS calcd. for 
C17H11BrF2S: 363.9727 [M]+; found (EI+): 363.9736. 
Intramolecular competition reactions 
 
thtAuBr3 (2 mol%, 0.001 mmol, 64 μL of a 0.0155 M stock solution in CDCl3) was added to 
a 2 mL vial containing 102 (16.5 mg, 0.05 mmol) in CDCl3 (0.5 mL) and MeOH (10 μL). CSA 
(15.1 mg, 0.065 mmol) and iodobenzene diacetate (17.7 mg, 0.055 mmol) were added, and the 
reaction was stirred at room temperature for 30 min. After analysis of the composition by 1H 
NMR, the reaction mixture was filtered through a plug of silica gel to remove the CSA and 
unreacted oxidant, concentrated in vacuo and placed under high vacuum until no iodobenzene 
remained. The product ratios were determined by 1H NMR and assigned based on literature 
values.[48,49] 
 
thtAuBr3 (1 mol%, 0.0005 mmol, 32 μL of a 0.0155 M stock solution in CDCl3) was added to 
a 2 mL vial containing the requisite aryltrimethylsilane (0.05 mmol) in CDCl3 (0.5 mL) and 




mmol) were added, and the reaction was stirred at room temperature for 1 h. After analysis of 
the composition by 1H NMR, the reaction mixture was filtered through a plug of silica gel to 
remove the CSA and unreacted oxidant, concentrated in vacuo and held under high vacuum 
until no iodobenzene remained. The product ratios were determined by either 1H or 19F NMR 
spectroscopy in CDCl3 or CD2Cl2. Assignments were made by comparison to literature values 
or tentatively assigned in situ and product rations are shown in Table 8.4 
Table 8.4: Intramolecular competition of arenes 
Entry R X:X′ k(X/H) 
1 m-tBu 0.4:1[50] 2.46 
2 m-F >25:1[51] 0.04 
3 p-Cl 2.7:1[52] 0.37 




Silane homocoupling  
 
The standard kinetics procedure was followed with 1af (31.3 mg, 0.10 mmol) using 1 mol% 
thtAuBr3.  
 
Figure 8.16. Combined concentration/time plots for the cyclisation of 1a and 1af to 2b   
8.6.7 Allocolchinoid Cyclisation Kinetics and Procedure 


















Representative experiment: To a 7 mL screw-cap borosilicate vial containing 5h (38.9 mg, 
0.10 mmol) was added CDCl3 (800 μL), CD3OD (20 μL) and thtAuBr3 (0.002 mmol, 200 μL 
of a 0.01 M stock solution in CDCl3). Dichloromethane (9.3 mg, 7 µL, 0.11 mmol) was also 
added as an internal standard for 1H NMR. The solution was transferred into a NMR tube and 
loaded into a Bruker Avance III 400 MHz NMR spectrometer with a probe temperature of 27 
°C. After tuning to 1H, locking to CDCl3, and shimming, the sample was ejected and poured 
back into the vial. PIFA (51.6 mg, 0.12 mmol) was added to the vial, which was then sealed 
and shaken vigorously until all the contents had dissolved. The solution was transferred by a 
1 mL syringe back into the NMR tube and loaded into the NMR spectrometer. The kinetics 
experiment was initiated after locking to CDCl3. The time between addition of PIFA and the 
first kinetics time-point was measured by stopwatch and was typically 90 – 120 sec. 
Identification of Diaryliodonium Salt 
 
To a 7 mL screw-cap borosilicate vial containing 5k (38.9 mg, 0.10 mmol) was added CDCl3 
(1 mL) and CD3OD (20 μL). PIFA (51.6 mg, 0.12 mmol) was added to the vial, which was 
then sealed and shaken vigorously until all the contents had dissolved. In situ analysis of the 
resultant side product by 1H NMR led to the assignment of structure 109c (signals observed 
shown in bold, tentatively assigned). 1H NMR (400 MHz, CDCl3): δ 7.89 – 7.83 (m, 2H), 
6.73 (s, 1H), 3.97 (s, 3H), 3.88 (s, 3H), 3.20 (s, 3H), 0.27 (s, 9H). Dilution of the reaction 
mixture in methanol to ca. 100 µM followed by direct injection into a microTOF focus II ESI 
mass spectrometer showed the molecular ion of the diaryliodonium salt (Figure 8.17). LRMS 
calcd. for C28H36IO4Si+: 591.14 [M]+; found (ESI): 591.14 ([M+], 100%). Identical procedures 
were performed on 5k, 5m and 89 and the molecular ion was observed for each diaryliodonium 





Figure 8.17: Measured (Top) and predicted (bottom) mass spectra of 109c. 
Kinetic Procedure for Pre-formation of Inhibitor 
 
 
Figure 8.18: Kinetics of Cyclisation of 5k under: A) standard conditions; B) with premixing 
of substrate and oxidant before initiating reaction. 
To a 7 mL screw-cap borosilicate vial containing 5k (20.93 mg, 0.05 mmol) was added CDCl3 
(500 μL) and CD3OD (10 μL). Dichloromethane (9.3 mg, 7 µL, 0.11 mmol) was also added 
as an internal standard for 1H NMR. The solution was transferred into a NMR tube and loaded 
into a Bruker Avance III 400 MHz NMR spectrometer with a probe temperature of 27 °C. 



















into the vial. PIFA (25.8 mg, 0.06 mmol) was added to the vial, which was then sealed and 
shaken vigorously until all the contents had dissolved. The solution was transferred by a 1 mL 
syringe back into the NMR tube and loaded into the NMR spectrometer. The kinetics 
experiment was initiated after locking to CDCl3. After ca. 3700 s (during which time ca. 0.04 
M of 109a had formed) the NMR tube was ejected and poured into a new vial containing 3 
(20.93 mg, 0.05 mmol), CDCl3 (300 μL), CD3OD (10 μL) and thtAuBr3 (0.002 mmol, 200 μL 
of a 0.01 M stock solution in CDCl3), followed immediately by addition of PIFA as a solid 
(25.8 mg, 0.06 mmol). The solution was transferred by a 1 mL syringe back into the NMR 
tube to continue monitoring the reaction. Note: At the point of initiation, reactions A and B 
only differ by the presence of ca. 2% of 109a and the resulting consumption of PIFA and 5k 
(2% each). 
Simulation of Inhibition Kinetics 
 
Kinetic simulations were performed using DynoChem 2011 software. The models were built 
using the processes shown in Scheme 8.2 and Figure 8.19. In order to obtain to obtain good 
fits, steps for pre-catalyst activation and bromination were added to the model (ka and kb ). 
[Note: The mechanism of the pre-catalyst activation is not known and it is included here simply 
to account for loss of starting material to brominated product, see below for discussion of 
bromination products]. The model was optimised using a Levenberg-Marquardt fitting 
algorithm and Rosenbrock solver integration method. The simulation was allowed to solve 
against the concentration vs time plots for the cyclisation of 5h to 6h at both 1 and 2 mol% of 
catalyst. The rate constants obtained are shown in Table 8.5. The absolute values of k1 and k2 
were both set at ≥ 1000 dm3 mol-1 s-1 (as a turnover-limiting k3 was assumed) and are not 








   a   PreCat > Cat + 2Br 
   b 5h + Br > 5ag   
   1 5h + Cat > INT   
   2 109c + Cat > 110c   
   3 INT > 6h + Cat1   
   4 Cat1 + Oxidant > Cat   
   5 5h + Oxidant > 109c 
Scheme 8.2. Elementary steps for reaction in DynoChem format. 
 
 








Table 8.5. Rate constants from DynoChem simulation for which a good fit can be obtained. 
k1:k2 ≈1:5 for a good fit. Arbitrary examples are fixed, fitted values are iteratively optimised. 
Rate constant Value  Standard Error 
ka 0.5 s-1 Arbitrary - 
kb  0.15 dm3 mol-1 s-1 Fitted 0.06 
k1  1000 dm3 mol-1 s-1 Arbitrary  - 
k2  4974 dm3 mol-1 s-1 Fitted 284 
k3 0.0142 s-1  Fitted 0.0004 
k4 1000 dm3 mol-1 s-1 Arbitrary - 




















Bromination Products from Catalyst Activation 
 
Scheme 8.3 Possible bromination products from catalyst activation. 
In general, 2 equivalents (relative to the catalyst) of brominated products are observed after 
catalyst activation. Depending on the relative reactivity of the two aryl rings in the starting 
material, bromination can occur ipso to the silane group and/or on the arene (Scheme 8.3). A 
significant amount of cyclised brominated material 6ah was isolated from the cyclisation of 
5k to 6k, suggesting that a large proportion of the bromination occurs on the trimethoxy arene 
of 5k, to give 5ah, which can subsequently cyclise to 6ah (Scheme 8.4).  
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